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Abstract 
 
Diabetes is a chronic disease that influences almost all aspects of life of an 
individual, especially Quality of Life (QoL). This PhD thesis is the outcome of a 
research that aimed to assess the QoL of people with diabetes in Greece. The study 
is important because the area of diabetes-related QoL is generally understudied and 
is the first to have investigated this within the Greek population.  
This work involved the creation of the Greek version of the Audit of Diabetes 
Dependent Quality of Life (ADDQoL-Gr) through translating, culturally adapting 
and validating the instrument as a QoL measure. The version was accepted by the 
author and the MAPI institute as the Greek version of the ADDQoL. 
 The QoL for people with diabetes in Greece was investigated using the ADDQoL-
Gr. An assessment of their health status using the SF-36, as well as the relationship 
of QoL and health status with medical and socioeconomic factors was also 
investigated. 1027 diabetes patients participated in this cross-sectional analytical 
study from 8 different sites from central and northern Greece. 
This thesis contributes to knowledge because i) identifies some characteristics of 
QoL predictors; ii) explores and prioritises QoL determinants; iii) reveals the 
complexity of the relationship between medical-socioeconomic factors and QoL; 
and iv) offers an instrument for measuring diabetes-related QoL for Greek speaking 
populations.The main conclusion drawn from this research was that diabetes 
seriously affects QoL, with complications (microvascular disease followed by foot 
amputation)  having the most adverse effect.  
The results of this thesis are important at both theoretical and practical level 
because: i) they add knowledge to the diabetes-related QoL international literature 
ii) may have important applications for the diabetes-care system; iii) they offer a 
validated instrument in Greek for future investigations.  
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Chapter 1: Overview 
1.1 Introduction 
Diabetes Mellitus (hereafter referred to as diabetes or DM) is a chronic and 
progressive metabolic disorder. Diabetes is of great importance to all health systems 
and it has been characterised as a global epidemic. The global prevalence of diabetes 
for those over 25 years of age, according to the World Health Organisation is 10%, 
while in the Eastern Mediterranean the prevalence is 11%. The costs of Diabetes 
account for up to 15% of national health care budgets (WHO, 2011).  
Despite its importance and magnitude, the problem of diabetes has been treated by 
health systems mainly as a clinical problem (Glasgow et al. 1999). This one-
dimension biomedical approach has resulted in neglect of other outcomes. Thus, the 
impact of diabetes on Quality of Life (QoL), behavioural, functional or economic 
outcomes has not received appropriate care (ibid).   
Quality of life has become an endpoint in the evaluation of public policy (Brown et. 
al., 2004) and one of the major goals of medical care. As Patrick and Erickson (1988) 
argued:   
“Enhancing quality of life is as important as other goals of health and medical care, 
such as preventing disease, effecting a cure, alleviating symptoms of pain, averting 
complications, providing humane care, and prolonging life”.   
 
QoL and HRQoL belong to the concepts that W. Bagehot (1887) describes as “we 
know what it is when you do not ask us, but we cannot very quickly explain or define it”. 
Their definitions, and the various ways proposed for their measurement, are issues 
that have not been clarified.  Definition of a concept is a major problem, especially 
for a concept such as Quality of Life, which is a vague and amorphous construct, and 
there is always the danger that has been described by the Greek Nobel laureate G. 
Seferis (1962) as a case where “the definition displaces irreversibly the 
definiendum”.  
 
The wide acceptance of QoL as an idea, combined with its amorphous nature and the 
lack of a universally accepted definition, has resulted in confusion about the meaning 
20 
 
of the term.  The various definitions proposed for each concept are explored in the 
relevant sections of this thesis. The concept of quality of life is analysed in terms of 
its origins, and the models of it proposed by writers of various disciplines.  This 
thesis tries to clarify the term, review the existing definitions, and find the most 
suitable and operational definition for this project.    
Also, terms such as “health”, “well-being”, “happiness”, “health related quality of 
life”, and “health status”, as well as the overlap between them, are examined. Finally, 
a decision had to be made on which definition of QoL and HRQoL would be the 
most suitable for assessing the HRQoL of the Greek diabetes population.  
Improvement in the QoL of people with diabetes, together with its prevention and 
cure is part of the general goals of the St. Vincent Declaration for people with 
diabetes published in 1989. However, although progress has been made, significant 
gaps still exist in the implementation of the St. Vincent targets twenty years later 
(Felton and Hall, 2009). The task of improving QoL presupposes an identification of 
the possible determinants of diabetes related QoL and the impact that they might 
have on the lives of patients with diabetes. To this end the role of medical 
characteristics (e.g. diabetes type, glycaemic control, treatment regimen, duration of 
the disease, complications, and the quality of care that a patient receives) is 
examined, along with sociodemographic variables like gender, age, education level, 
marital status, and income level.  
Despite the fact that there is a growing interest in the associations between QoL and 
medical, demographic, and psychosocial variables (Rubin and Peyrot, 1999), there 
are areas that have not received a lot of attention from researchers at the international 
level. Research that has taken place during the last 20 years, has underestimated the 
impact of diabetes on QoL (Norris et al., 2011).  Also, the impact of diabetes on low-
income populations has been an under-studied subject area (Camacho et al. 2002).  
An area that has also not received particular attention is the constraints on access to 
services in health care systems providing “universal coverage”. Such constraints are: 
obligatory co-payments, restrictions on specialty referrals, and proximity to health 
care facilities (Gold, 1998). Co-payments are a major issue in diabetes care in 
21 
 
Greece. The differences in the services and/or reimbursements provided by the Greek 
NHS and the various organisations of social security create the environment for such 
expenditure.  As a result,   there is a rapidly growing private and quasi-private 
diabetes-care sector.  
Health care influences the disease process and therefore health outcomes in general 
can be affected by different methods of delivering care. Diabetes, as a chronic 
disease, is no exception to this rule (Bowling, 1995a; Fleming et al. 2001).  However, 
the very structure of the diabetes care system and the geographical distribution of its 
services in Greece may restrict access. This, either on its own or combined with the 
financial burden that diabetes causes, could be proved to be associated with QoL. 
Despite the fact that care delivery is receiving increased attention, in Greece the 
association between this factor and QoL, as a health outcome, has never been 
investigated.  
This study aims to examine the Quality of Life of people with diabetes in Greece and 
to what extent their self-assessed QoL is associated with demographic and 
socioeconomic factors. 
My main motives for the initiating and conducting this research were:   
a) The alarming and ever increasing prevalence of the disease, that reaches epidemic 
proportions worldwide, combined with:   
b) The importance of QoL as a concept, which is “the ultimate goal of all health 
interventions (Rubin and Peyrot, 1999); 
c) The fact that most of the studies on the impact of diabetes on QoL use health status 
measures; 
d) The fact that the determining socioeconomic factors of the diabetes-related QoL 
have been understudied;   
e) The fact that QoL, health status, and glycaemic control are almost used by Greek 
physicians as synonyms;  
f) That no similar study has ever been attempted in Greece, possibly due to lack of a 
reliable QoL instrument. 
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Chapter 2: Diabetes  
 
2.1 Diabetes: a definition    
Diabetes is a global health problem. It is one of the world’s most important causes 
of expenditure, mortality, disability and lost economic growth (IDF, 2006). 
Diabetes according to the World Health Organisation (WHO) is 
“A metabolic disorder of multiple aetiology characterized by chronic 
hyperglycaemia with disturbances of carbohydrate, fat and protein metabolism 
resulting from defects in insulin secretion, insulin action or both. The effects of 
diabetes mellitus include long term damage, dysfunction and failure of various 
organs” (WHO, 1999).                                                                              
 
2.2 Aetiology and Classification of diabetes 
A number of specific causes of diabetes have been identified, but its aetiology and 
pathogenesis are not clearly understood (Bennett and Knowler, 2004). However, 
there are two major categories of pathogenesis. The first is caused by an absolute 
deficiency of insulin secretion, while the second has its causes in factors such as 
insulin resistance at the liver and muscles, and/or an inadequate insulin secretion 
response.  
The first widely accepted classification of diabetes was published by the World 
Health Organisation in 1980. According to this diabetes was divided into two major 
classes: The Insulin Dependent Diabetes Mellitus (IDDM) or Type 1, and Non-
Insulin Dependent Diabetes Mellitus (NIDDM) or Type 2.  This classification was 
revised in 1985 when the terms Type 1 and Type 2 were omitted and remained only 
the terms IDDM and NIDDM (WHO, 1985). 
The 1985 classification had the disadvantage of using a mixture of criteria, some 
related to the degree of insulin deficiency and others to pathogenesis. In a very 
influential report published by Kuzuya and Matsuda, a new classification was 
proposed, where the aetiology and the degree of deficiency and/or insulin action 
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should be considered separately and be both incorporated in the classification 
(Kuzuya and Matsuda, 1997). Subsequently, the World Health Organisation 
followed the Kuzuya - Matsuda proposals and revised the 1985 classification. It now 
classifies diabetes according to both clinical stages and aetiologic type (WHO, 
1999). According to this classification the terms IDDM and NIDDM should be 
abandoned and the terms Type 1 and Type 2 reintroduced. Thus, since 2003 when 
some minor modifications that took place concerning mainly the diagnosis aspect, 
diabetes has been sub-divided into four clinical categories:  
 Type 1 diabetes  
 Type 2 diabetes  
 Other specific types of diabetes  
 Gestational diabetes  
Types 1 and 2 are the basic forms of diabetes, while, the gestational and other specific 
types are more rare types (WHO 1999, ADA 2009aa). Symptoms of diabetes include 
thirst, polyuria, blurring of vision, weight loss and in severe cases drowsiness and 
coma. In almost all cases there are high levels of glycosuria.  Many of them have no 
symptoms and are only diagnosed after many years of onset. As a consequence, 40-
50% of all people with Type 2 diabetes are not aware that they have this life-
threatening condition. 
People who develop diabetes pass through several clinical stages. The stages are of 
variable duration, according to the degree of hyperglycaemia.  
 The first stage is “impaired glucose regulation”, is a hyperglycaemic disorder 
that represents a transient stage between normoglycaemia and the 
development of type 2 diabetes but it is not diabetes; 
 The second stage,  “impaired fasting glycaemia”, which is used to classify 
individuals with glucose values above the normal range, but below those 
diagnostic for diabetes  
 The third stage is  “non-insulin requiring” diabetes;  
 The fourth stage is “insulin required for control” diabetes and;   
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 The fifth stage is “insulin required for survival” diabetes. Failure to manage 
this stage can result in ketosis and/or ketoacidosis, both life threatening 
conditions (WHO, 1999; Bennett and Knowler, 2004). 
 
2.2.1 Type 1 diabetes 
The cause of type 1 diabetes is an absolute destruction of the β-cells, usually leading 
to absolute insulin deficiency. It is also called “Insulin Requiring for Survival” 
diabetes. Patients with this type of diabetes produce very little or no insulin, and 
require daily injections of insulin to survive. Type 1 diabetes accounts for only 5-
10% of the total diabetes cases. The β-cell destruction is due to either an autoimmune 
pathologic process and is called Type 1 Autoimmune, or idiopathic reasons, the so-
called Type 1 Idiopathic diabetes. Autoimmune destruction of β-cells has multiple 
genetic predispositions, identified by human leukocyte antigen (HLA), as well as 
being related to some unidentified but presumed environmental factors. The majority 
of Type 1 patients have Type 1 autoimmune diabetes.  
Idiopathic type 1 diabetes has no known aetiologies, lacks immunological evidence 
for β-cell destruction, and it is not associated with HLA.  It is a strongly inherited 
type of diabetes and it is more common among non-white people of African or Asian 
origin. Only a minority of type 1 patients belong to this form of diabetes.  
Type 1 diabetes, if not treated can lead to ketoacidosis, which is the most severe 
acute complication, together with hypoglycaemia (the other extreme of the 
glycaemic spectrum), coma and death (WHO, 1999). 
 
2.2.2 Type 2 diabetes 
Type 2 diabetes is the most common type of diabetes. Type 2 accounts for 90-95% 
of the total diabetes population. It is characterised by a combination of resistance to 
insulin action and it ranges from insulin resistance with an inadequate compensatory 
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insulin secretory response, to insulin resistance with insulin secretory defect.  The 
insulin secretion disorder is not due to β-cell destruction, but its aetiology is unclear. 
People with disorders in insulin action cannot use insulin effectively. Risk factors 
for this type of diabetes are considered to be age, obesity, and lack of physical 
activity. 
There are two sub-divisions of type 2 diabetes. The “Not Insulin Requiring” diabetes, 
managed by lifestyle measures alone and sometimes oral drugs, and the “Insulin 
requiring for control” diabetes, where insulin is required for control, rather than 
survival (WHO, 1999; ADA, 2009b; Harmel and Mathur, 2004). 
Unlike Type 1, Type 2 diabetes is a condition where the pancreas produces some 
insulin, so hyperglycaemia may exist on a chronic asymptomatic basis, and in most 
cases cannot be easily noticed until some complication occurs. Thus, although Type 
2 diabetes does not usually provoke acute episodes, such as ketoacidosis, it may 
create severe chronic complications with a consequent impact on the individual’s 
health status and use of health services.      
 
2.2.3 Other specific types of diabetes 
There are several types of diabetes can be classified under this heading that (ADA 
2009a).  
 Those forms associated with genetic defects of the β-cells function. They are 
also referred as “maturity onset diabetes of the young” (MODY) and are 
characterised by impaired insulin secretion with minimal or no defects in 
insulin action;    
 Genetic defects in insulin action. An unusual cause of diabetes that results 
from mutations of the insulin preceptors;  
 Diseases of the exocrine pancreas, caused by any process that diffusely 
injures the pancreas; 
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 Endocrinopathies, where hormones such as cortisol, growth or epinephrine 
antagonise insulin action; 
 Drug or chemical-induced diabetes, caused by drugs that impair insulin 
secretion;  
 Infections, caused by various viruses; 
 Uncommon forms of immune-mediated diabetes and ; 
 Other genetic syndromes sometimes associated with diabetes.  
 
2.2.4 Gestational diabetes (GDM) 
Gestational diabetes is defined as glucose intolerance with onset or first recognition 
during pregnancy. This definition applies regardless to the treatment regimen or 
whether the condition continuous after pregnancy. GDM, as with all other types of 
diabetes, is characterised by insufficient β-cell function and its causes belong to the 
same spectrum of the other types of diabetes i.e. autoimmune disease, insulin 
resistance, genetic causes etc. (Buchanan et al. 2007; ADA, 2009b). 
There is recent evidence that GDM prevalence has increased by between10-100% 
during the last 20 years among several ethnicity groups (Ferrara, 2007: S141). 
Increasing maternal age, obesity, lack of physical activity and changing lifestyles in 
the developing countries are the main causes for this increase (Ibid).  
 
2.3 Prevalence of diabetes 
2.3.1 Prevalence of diabetes globally 
Diabetes and especially Type 2 diabetes is the most common endocrine disorder 
worldwide. Its prevalence is reaching epidemic proportions in many parts of the 
world. The International Diabetes Federation estimated that in 2007 the prevalence 
of Type 2 diabetes among adults of 20-79 years of age was 8.3% and the comparative 
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prevalence was 8.5% (IDF, 2013). The prevalence varies between countries, as well 
as within different strata or ethnicities of the same country. Thus, prevalence rates 
reported start from 1% in rural Malaysia up to 50% among the Pima Indians of 
Arizona- USA. The prevalence of total glucose intolerance (diabetes and IGT 
combined) for European and USA white populations ranges within 11-20%, while 
the percentage for Afro-Americans is 30% (King and Rewers, 1991).  
The prevalence in the USA for the years 2005-2006, for people aged 20 years was 
12.9%, of which around 40% was undiagnosed (Cowie et al. 2009). Between 33% 
(Franse et al. 2001) and 50 % (Rathmann et al. 2003) of the total diabetes population 
the condition may never be diagnosed. 
In the European Union in 2008, diabetes prevalence was estimated at 8.6% of the 
population aged between 20 and 79 years. Its prevalence in 2005 was 7.6%, 
suggesting an absolute increase of 1% within 3 years.  The 2008 prevalence rate 
equates to over 31 million people are now living with diabetes in the EU. Many of 
the people newly affected by diabetes are from vulnerable groups of society, 
including children and immigrants (IDF, 2008).  
 
2.3.2 Prevalence of diabetes in Greece 
In Greece the estimated number of diabetes-patients is around 800,000. The 
prevalence of diabetes in the urban population is 7.6% in men and 5.9% in women. 
Total prevalence in rural populations is estimated at 7.4% with 7.1% for men and 
7.6% for women, while 2.5% of the total population had diabetes but are unaware of 
their condition (Melidonis et al. 2006).  Other studies suggest the prevalence of 
diagnosed diabetes is 8.7% to 9.5%, but the data collection methods of these studies 
were unsatisfactory (Gikas et al. 2004, 2008).  A remarkable feature of the diabetes 
population in Greece is that a significant proportion (24% of men and 30% of 
women) of these patients was undiagnosed (Panagiotakos et al. 2005). 
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2.4 Complications of Diabetes 
2.4.1 Introduction 
Diabetes complications are divided into two main categories: micro vascular, which 
include   neuropathy, retinopathy and nephropathy (renal damage) and macro 
vascular diseases including coronary artery disease, peripheral vascular disease, 
hypertension and stroke.  
2.4.2 Diabetic Neuropathy 
Diabetes may cause major damage to the nervous system. Diabetic neuropathy is the 
most common complication. According to the World Health Organisation up to 50% 
of people with diabetes are affected to some degree (WHO, 2009). Major risk factors 
for this condition are the level and duration of elevated blood glucose. Neuropathy 
can lead to a variety of other complications such as sensory loss and damage to the 
limbs. It is also a major cause of impotence.  
2.4.3 Foot disease 
Diabetic foot disease is due to changes in blood vessels and nerves and often leads 
to ulceration and sepsis resulting in lower- limb amputation. Diabetes is the most 
common cause of non-traumatic amputation of the lower limb. Recent studies 
estimate that the amputation risk is eight times higher in diabetes compared with 
non-diabetes individuals. (Johannesson et al. 2009).  Major amputations are 
considered to have a large impact on physical and psychosocial health status (Peters 
et al. 2001). They are also considered to be one of the most costly complications of 
diabetes (Williams et al., 2002) and the single most important complication as far as 
direct economic cost is concerned (Matricali et al. 2007). 
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 2.4.4 Retinopathy 
Diabetic retinopathy is a major cause of blindness and visual disability. In the UK it 
is the leading cause of blindness in people of working age (NHS 2007). Research 
findings suggest that, after 20 years from onset, retinopathy developes in almost all 
patients with type 1 and 77% of those with type 2 diabetes. 12% of type 1 diabetes 
patients with more than 30 years from onset are blind (WHO, 2006; Klein and Klein, 
1995).   Diabetes is also among the leading causes of kidney failure, but its frequency 
varies between populations and is also related to the severity and duration of the 
disease.  
2.4.5 Cardiovascular Diseases 
Cardiovascular diseases represent the leading cause of morbidity and mortality in the 
diabetes population globally. The risk of coronary heart disease for patients with type 
2 diabetes is two to four times higher compared with non-diabetic individuals 
(Haffner, 2000). The International Diabetes Federation estimates that cardiovascular 
diseases are responsible for 50 to 80% of deaths in people with diabetes globally 
(IDF, 2007). Mortality of people with diabetes aged 30-59 years is up to five times 
higher compared to non-diabetic people (Saydah et al. 2002; Roper et al. 2002).  In 
the USA mortality of people with diabetes due to cardiovascular causes lies between 
75% and 80% of total mortality. (ADA, 1993). Risk factors for heart disease in 
people with diabetes, are similar to those of the general population, and include high 
blood pressure, high serum cholesterol, obesity and smoking. At any level of these 
risk factors diabetes patients have four to five times the risk of cardiovascular disease 
compared with individuals without diabetes (ibid). 
2.4.6 Diabetic Nephropathy 
High blood glucose and high blood pressure may cause damages to micro blood 
vessels of the kidneys. The ADA estimates that nephropathy will occur to 20-40% 
of diabetes patients and that it is the leading single cause of end-stage renal disease 
(ADA, 2009a).  
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2.5 Diabetes care 
There are two levels of care for diabetes; prevention and treatment of diabetes. 
2.5.1 Diabetes and prevention 
Diabetes prevention includes the prevention of the development of diabetes, early 
detection, prevention, and treatment of diabetes and its complications. Primary 
prevention identifies and protects individuals at risk from developing diabetes. It 
consists of lifestyle changes, such as changes in nutrition, food labelling, loss of 
weight, increased physical activity and participation in health education programs.  
Secondary level of prevention includes early diagnosis and control of diabetes in 
order to delay the progress of the disease. Early diagnosis includes screening 
programmes to detect asymptomatic individuals. Tertiary prevention refers to 
prevention or the early detection of complications in order to reduce the impact of 
the disease and the need for treatment. To this end diabetes patients should have an 
effective control of blood-glucose level and blood pressure as well as receive care 
on a regular basis from a number of health professionals with various specialties. A 
specialised physician should be the coordinator of a team that ideally consists of a 
diabetes nurse, dietician, pharmacist, physicians’ assistants and mental health 
professionals specialised in diabetes.  
Effective tertiary prevention has been proved by several studies to have a substantial 
effect on reducing the development of complications. Two major studies undertaken 
in the U.K., the Diabetes Control and Complication Trial (DCCT) and the UK 
Prospective Diabetes Study (UKPDS) have proved that intensive control of blood-
glucose level and blood pressure led to substantial reduction of complications. Thus, 
the risk for the development of retinopathy was reduced by up to 76%; for 
neuropathy the risk reduction was up to 60%; for nephropathy the risk was reduced 
by up to 50%; for microvascular diseases 25%;  and the overall reduction of mortality 
due to long term complications was  33% ( (DCCT, 1993; UKPDS, 1998a; UKPDS, 
1998b). 
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2.5.2 Treatment of diabetes 
Despite the fact that a cure for diabetes is not possible for the moment, there are 
many forms of highly effective treatment.   Before any treatment begins a thorough 
evaluation should be performed, in order to determine the type of diabetes, to detect 
the existence of any complications and to review any treatments that the patient 
received. This evaluation is necessary to ensure the optimal management of the 
patient.  It should also be noted that patients’ active participation is considered 
necessary for the management of this chronic disease. 
Treatment of diabetes is associated with good diabetes control which in turn means 
keeping the blood-glucose level as close as possible to the normal level. Intensive 
blood-glucose monitoring is the basis for any effective treatment of either type of 
diabetes. Diabetes control may be achieved by a controlled diet, physical exercise, 
and/or medication. Dietary control is needed to reduce the intake of sugar, and 
physical exercise to help the body to use blood sugar efficiently. 
Medication comes under two main categories: oral hypoglycaemic drugs and insulin. 
For type 1 diabetes patients insulin is necessary for survival. People with type 2 
diabetes may require either oral drugs and in some cases insulin.  There are four main 
types of insulin depending mainly on the onset and the duration of action: the rapid-
acting insulin, the short-acting, intermediate-acting, and long-acting insulin. 
 
2.5.3 Access to care 
Access to health care contributes to improvements in health and the relief of illness 
(Gulliford et al. 2003). It is also one of the concepts that constitute the notion of 
equity in health care (McGuire et al. 1992). As such it is one of the four components, 
together with effectiveness, acceptability and efficiency, that a definition of quality 
of health care should include (Higginson 1994).  Access has two dimensions; 
geographical distance between the patient and the provider, and the waiting time 
needed for the provision of services.  
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Aday and Andersen (1981) define access in terms of the “dimensions which describe 
the potential and actual entry of a given population group to the health care delivery 
system”. From this ‘access to care’ would include the ‘potential access’, which 
concerns the availability of services and the ‘realised access’ that is the use of those 
services by patients. Realised access includes objective and subjective indicators of 
the process of seeking care (Aday et al.2004), and may be constrained or influenced 
by various factors such as structural, financial, and personal barriers. Proximity to 
providers, health-insurance coverage, gatekeeping, required co-payments, income, 
education and culture are some of the factors that fall into those three broad 
categories of barriers (Gold, 1998).   
It is estimated that in the USA up to 40% in some cases of adults having diabetes 
were undiagnosed (Cowie et al. 2009). According to Zhang et al. (2008) this is 
mainly a matter of restricted access to diabetes care. Lack of adequate insurance 
coverage is the main cause of this limited access and the effect of what call they call 
‘the missed patient with diabetes’ is an unseen but clinically important burden of 
diabetes, with significant metabolic derangements and long term impact on health 
care use. 
The problem of access has another dimension that has received a lot of attention 
lately. This is the question of ‘open access to diabetes care against the pre-scheduled 
appointments (Murray and Berwick, 2003). Open access is possible when the 
providers’ capacity matches patients’ demand for appointments. Proponents of open 
access argue that this strategy eliminates unwanted delays for appointments, 
increases clinical productivity, and increases patient satisfaction.  However, the case 
of diabetes as a chronic disease seems to be different. Recent research in diabetes 
settings concludes that what matters most for the quality of care is not open access, 
which in some cases might worsen outcomes (Subramanian et al. 2009), but 
continuity of care, which is associated with improvements in diabetes control (Sperl-
Hillen et al. 2008).   
Last, it should be mentioned that as far as diabetes is concerned access to diabetes-
education is of great importance to the health and well-being of diabetes patients. 
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Nevertheless, this is an undervalued function of health systems. Peyrot et al.(2009) 
state that there are several important barriers that reduce access to diabetes self-
management education and as a result only one third to one half of persons with 
diabetes in the US receive this critically important service. These barriers include 
lack of insurance coverage, residence in rural areas, and lack of social networks.  
 
2.5.4 Diabetes-care organisations  
Diabetes, as a chronic disease, presents a set of challenges to patients including 
dealing with symptoms, emotional impact, disability, complex medication regimens, 
lifestyle adjustments, and the use of quality medical services. However, health care 
systems are historically oriented to respond rapidly and efficiently to acute disease 
or injury and not to chronic illnesses like diabetes, which requires a wide delivery 
system with coordinated actions and productive interaction with the patients, and 
modern technology (Wagner et al. 2001b).  
Quality of care is one of the major goals in the St. Vincent Declaration.  The relative 
weight of medical care for improving health in general is a controversial issue and 
the answer rather depends on both the nature of the disease and the level of 
development of the health care system. However, in a chronic disease like diabetes, 
it is accepted that medical organisations influence the process of care, which in turn 
influences health outcomes (Fleming et al. 2001). The ways that these organisations 
influence outcomes varies ranging from the identification of persons with 
undiagnosed diabetes, to the provision of effective treatment, and patient education.  
The question about the level and organisation of services that should deliver diabetes 
care is an old one with no conclusive answers (Wagner et. al., 1996; Renders et al. 
2001). There is a generally accepted view that diabetes control is more effective 
when executed by a consultant than a General Practitioner (GP). However, good 
results have been obtained in settings where GPs collaborate with diabetes-nurses 
and dieticians in developing a strategy for treatment, education, diet, physical 
activity and any necessary interventions. Germany, Sweden, and the Netherlands 
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have been used as examples of this model of care (Van Loon et al. 2000). The 
participation of specialist diabetes nurses in diabetes care is also a field of 
controversy, although a review of literature has shown that there is no strong 
evidence of benefit of care provided by these specialists (Loveman et al., 2009).     
The initial optimism created by the St. Vincent Declaration about swift changes in 
quality of diabetes care was not justified. The implementation of programs necessary 
to bring about improvements in care was too slow and in some European countries 
twenty years later has not even begun (Hall and Felton, 2009).   
 
2.6 Diabetes care in Greece 
Diabetes care is provided by both state and private institutions. However, diabetes 
is not included in the priorities of the Ministry of Health and is treated as all other 
chronic diseases. There is not any kind of a national diabetes program addressing 
this major public health problem. As a result there is not any screening program 
for the general population and a significant proportion of people with diabetes 
population is undiagnosed (Panagiotakos et al. 2005). There are not any data 
concerning the diagnosis of diabetes, but diabetologists argue that routine blood 
tests is the main diagnostic method for both types of diabetes, while diabetic 
ketoacidosis is sometimes the way type 1 diabetes is diagnosed (Fig. 2).  The tests 
usually take place at the NHS, social security and private sector primary care 
establishments (Fig. 1). However, the high cost of diabetes treatment forces the 
majority of patients to turn to social security and the NHS hospital clinics.    
There are 131 state hospitals, but almost half of them do not provide any diabetes-
care. There are only 17 diabetes centres in Greece twelve in Athens, three in 
Salonica, one in Patras, and one in Heraclion- Crete. Another 50-55 hospitals have a 
diabetes clinic, but most of them not on a permanent basis, depending on the 
availability of medical staff. The majority of them when they operate accept patients 
only one or two days a week.  
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Diabetology in Greece is a medical sub-specialty that can be obtained by attending 
one year education-training usually at a university hospital. To enter these courses a 
medical doctor should be either an endocrinologist, or internist, or a paediatrician. 
Medical doctors from other specialists are not allowed to participate in the courses. 
During the last years there is an increased pressure from various sources for general 
practitioners to be allowed to attend diabetes training courses. The total number of 
diabetologists in Greece is below the needed level. 
Nurses are used to support daily procedures in outpatient diabetes clinics and provide 
elementary education to patients, mainly on injecting and blood testing techniques.  
These nurses have received “on the job training” by diabetologists at diabetes clinics, 
because diabetes nursing is not recognised by health authorities as a specialisation, 
there is not any education for it, nor they receive any kind of compensation or fringe 
benefit.   
Dieticians are employed by all major hospitals in Greece with a general education 
on diabetes diet, but we did not find any dietician specialised in diabetes. Moreover, 
dieticians in hospitals are responsible for diets of acute care patients and do not have 
any cooperation with outpatient diabetes clinics. Psychologists specialised in 
diabetes are very rarely used by hospitals or other diabetes care institutions. During 
the course of this research only one diabetes centre (Polycliniki of Athens) was found 
with a psychologist among its staff.  
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Fig 1: The Greek health system 
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Fig 2: The structure of Diabetes Care 
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Chapter 3: Quality of Life. 
 
 
3.1 Introduction 
Quality of Life (QoL) is an increasingly important concept. It is a multi-level, 
complex, and rather amorphous concept. Its importance was highlighted in the 
Stiglitz and Sen Report to the President of the French Republic (Stiglitz et al. 2009), 
where the two Nobel laureates and their associates suggested that  
 “Quality of life is a broader concept than economic production and living 
standards. It includes the full range of factors that influences what we value in living, 
reaching beyond its material standards”.    
They suggest that indicators that go beyond being measures of income, wealth and 
consumption, and incorporate the non-monetary aspects of life, have an important 
role to play. These non-monetary aspects of life are defined by them as “Quality of 
Life”. To emphasise the importance of QoL, they recommend its use alongside with 
economic indices such as Dross Domestic Product (GDP) or income per capita.  
 
Interest in Quality of Life emanates from the idea that patients want to live, not just 
to survive (McDowell, 2006). Quality of Life is a concept distinct from health, 
although in many ways is related to it (Wilson and Cleary, 1995).  The concept of 
QoL incorporates all aspects of an individual’s existence (Torrance, 1987). These 
aspects might be health, education, housing, income, culture freedom, and 
perceptions of immediate environment (Bowling, 1995a:3; Guyatt et. al. 1993).  
 
The health part of QoL, the so called Health-Related Quality of life (HRQoL) might 
be seen as the highest level of health outcomes, which start with biological and 
physiological factors and continue with symptoms, functional states,  general health 
perceptions ending up to quality of life (Wilson and Cleary, 1995). Moreover, there 
is an increasing acceptance in the scientific community that QoL should be assessed 
when evaluating the outcome of a medical intervention (Bowling, 1996). The 
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growing interest in QoL measurement is best given by Gill and Feinstein (1994) who 
commented that:  
“Since the 1970’s, the measurement of quality of life has grown from a small cottage 
industry to a large academic enterprise”. 
 
QoL in general can incorporate a wide range of perceptions, experiences or states in 
many different domains. It can contain notions or domains of a psychological, 
cultural, interpersonal, spiritual, financial, political, temporal or philosophical nature 
(Calman, 1987). 
 
3.2 The evolution of the concept  
Although the term Quality of Life first appears in literature in the 20th century early 
approaches to notions similar to QoL appear in the work of Ancient Greek 
philosophers, especially Aristotle (Aristotle 384-322 BC; Patrick and Erickson, 
1993; Fayers and Machin 2007). In his Nicomachean Ethics Aristotle used the word 
“ευδαιμονία” (eudaimonia), which is equivalent to “well-being” (despite the fact that 
by most writers, following Rackham’s translation (1868-1944), the term is rendered 
as “happiness”). The two concepts have been used interchangeably, although they 
are distinct since well-being is a broader concept than happiness (Deci and Ryan, 
2008), as it contains more dimensions such as life satisfaction, morale, self-esteem 
and sense of coherence (Bowling 2005c). Aristotle’s perception of eudaimonia is 
considered to be the foundation of what later was called perfectionism (Sandoe, 
1999). 
 
It was not until the late 18th early 19th Century that the concept appeared again in the 
work of the English philosopher Jeremy Bentham (1748 – 1832). The founder of 
utilitarianism used the term “well-being”, which he defined as “the excess of pleasure 
over pain” and made qualitative and quantitative proposals for its measurement 
(Bentham, 1834). Along the lines of Aristotle he considers well-being as a concept 
that man should pursue in life and not as God’s gift. Bentham himself explains that 
this is the reason why his analysis is included in his book called Deontology. (Deon 
means that which is proper and logia means knowledge) [Bentham, 1834]. Bentham 
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considered well-being a more suitable term than happiness because he thought that 
happiness:  
“...represents pleasure in too elevated a shape; it seems associated with the idea of 
enjoyment in its superlative degree” (ibid).   
                                                                                              
The opposite of well-being is ill-being. He also proposed that these measurements 
should be based on the subjective evaluations and concerns of those directly involved 
(Bentham, 1834). Bentham’s views on well-being are in some respect narrower than 
Aristotle’s, as he restricts the notion to the boundaries between pain and pleasure 
(Nussbaum, 2004). This perception might be influenced by the not so accurate 
Epicurean definition of happiness, which equates happiness with the combination of 
two states: that of tranquillity (ataraxia) and the absence of bodily pain (Bergsma et 
al. 2008). Another very important issue in Bentham’s work is the concept of “need”. 
Without the basic “needs” well-being becomes ill-being (Collard, 2006). Bentham’s 
theory of QoL, as seeking the enjoyment of pleasure and the avoidance of pain, has 
been classified in literature as hedonism (Sandoe, 1999). 
These early philosophical approaches have in later years influenced some traditional 
social sciences approaches to quality of life. Although conceptually different from 
QoL, notions such as “happiness”, “good life”, “social well-being”, “life 
satisfaction”, or “morale” have been used as the basis of these QoL models (Bowling, 
2005e). The first attempts to assess ‘level-of-living’ of families in the USA can be 
traced back to 1918. The attempts continued throughout the next two decades with 
sociologists such as McKain and Cottam trying to develop the idea of a “social 
report” and “level-of-living measures”. In 1942 Cottam and Mangus described the 
components of ‘standard of living’ as level of living, social participation, and social 
adjustment, concepts that come close to QoL (Sirgy et al. 2006).  
 
Research on QoL started in the 1960s. The report of the President’s Commission on 
National Goals in 1960, and President Johnson in 1964, declared that goals can only 
be measured in terms of the quality of lives that people lead.  In 1967 J.K. Galbraith 
stated that “What counts is not the quantity of our goods but the quality of life”. 
Bauer’s work on social indicators in 1966 and NASA’s reports on the nature and 
magnitude of secondary effects of the space programs gave impetus to QoL as a 
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separate field of research. The work of Bauer (1967) on ‘social indicators’ was the 
foundation of the social indicator movement which using statistical time series 
analyses tried to measure, evaluate, and forecast well-being and  other conditions of 
society.   
 
However, the turn of interest towards subjective indicators energized the domain of 
social indicators and measures of quality of life were introduced into sociological 
research in the 1970s and 1980s. In 1976, Campbell recognised the importance of 
personal responses to QoL issues, pointing out the limitations of statistical indicators 
and suggesting that economic - social indicators differ substantially from personal 
indicators of QoL (Campbell, 1976). With his associates they developed a lengthy 
questionnaire for measuring satisfaction with various domains of life (Campbell et 
al. 1976).  The same year Liu developed a QoL index using objective indicators. 
QoL was defined as subjective satisfaction and, in terms of utility, as a political 
economy concept.  The term QoL in sociological research appears around the end of 
the 1960s, and as late as 1979 in Sociological Abstracts (Schuessler and Fisher, 
1985). 
   
In 1976 a publication by Gerson attempted to conceptualise QoL using health-related 
quality of life as an example (Gerson, 1976). He argued that in a condition of chronic 
illness or morbidity several factors, such as money (ability to meet patient’s financial 
needs), time (time needed for disease management), sentiment (losses and gains in 
respect, affection, self-esteem), and skill (self-administration of the disease) 
contribute to the quality of life of the patient. This approach, he argued: ‘is capable 
of framing and answering questions about quality of life in any social situation’ 
(ibid). Since then QoL has become a main theme in sociological research and it is 
the issue where: ‘the concerns of sociology and medicine converge’ (Levine, 1987). 
 
3.3 Models of QoL 
The term Quality of Life is an elusive and to a great extent vague concept, lacking 
conceptual clarity. It is a multi-level and amorphous concept for which there is no 
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consensus definition (Brown et. al., 2004; Bowling, 1995a; Bowling et al. 2003).It 
has been said that “quality of life is easy to understand, but hard to define” 
(Voruganti, 2008). 
 
There is no consensus on a definition or measurement of quality of life. The 
establishment of an accepted theoretical framework for the concept would help its 
consistency and coherence as a health outcome. It would also help as a tool for 
monitoring and analysing quality of life in changing social structures (Noll, 2002).  
A model of QoL should give a representation or description of the concept, try to 
identify its constituents and predictors as well as give concrete answers to the 
problem of measurement. However, the nature of QoL per se makes this task 
essential because 
 “QoL is a multi-level and amorphous concept which reflects both macro societal 
and socio-demographic influences and also micro concerns, such as individuals’ 
experiences, circumstances, health, social well-being, values, perceptions, and 
psychology” (Bowling et al. 2003). 
 
Nevertheless, there is not any consistent quality of life model. A number of theories 
have been proposed using different attributes of QoL in order to explain this complex 
phenomenon. Any attempt to taxonomise these theories and models proposed might 
be considered, according to Cummin’s phrase (1996), as “an attempt to order chaos”.  
 
Bowling created a comprehensive list of models, by grouping together various 
theories that have been proposed and dividing them into nine main categories (Brown 
et al. 2004; Bowling, 2005e). ). These categories, which will be discussed in some 
detail, are: 
 objective indicators; 
 subjective indicators; 
 satisfaction of human needs; 
 psychological models; 
 health and functioning models; 
 social health, social networks, support and activities; 
 social cohesion and social capital; 
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 environmental models; 
 idiographic approaches. 
 
3.3.1 Objective indicators  
The objective indicators usually include areas such as health, income, standard of 
living, housing, education etc. These factors have been proposed by researchers as 
constituents of quality of life and they are focused on measuring “hard” facts 
(Veenhoven, 2002). Objective indicators have the advantage of collecting data 
relatively easy.  
 
Objective indicators might be of a demographic, economic, or epidemiological 
nature. Socioeconomic status and health (as indicated by morbidity or mortality and 
not by subjective health status) are two indicators used as objective predictors of 
QoL There are correlations between them and one indicator determines the level of 
another, affecting the quality of life. In most cases these mechanisms have not been 
explained but the association is well established. However there is strong evidence 
that the two are consistently associated, although the mechanisms, causality and the 
complexity of this association have not been determined (Adler et al. 1994).   
 
Gender also has an influence on QoL both in a direct and indirect way: direct, due to 
the injustice women face in society that affects their QoL (Annas, 1993); indirect 
through health related quality of life, where women almost in all cases experience 
higher morbidity, more extensive use of health care (Kandrack et al. 1991, less 
treatment satisfaction, and greater likelihood of developing depression due to the 
presence of a clinical disorder (Rubin and Peyrot, 1999; 1998; Unden et al. 2008).  
Age is another factor that plays an important role in determining the level of QoL for 
old people in general (Bowling, 2005e) or people having a health problem like 
diabetes (Brown et al. 2004). 
 
Social indicators are a variant of objective indicators. A social indicator was meant 
to be a direct measure of welfare and it was a statistic of direct normative interest, 
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which facilitated judgements about a major aspect of society (Schneider, 1976). They 
have been used to detect changes over time, to monitor the social system, to evaluate 
interventions, and to forecast the future (Sirgy et al. 2006).  Objective indicators 
could represent social, economic and environmental conditions as represented in the 
System of National Accounts, developed in the 1960s. This was based on the view 
that social monitoring should be expanded beyond traditional economic indicators 
and seeing output in terms of individual living conditions. The “institutionalisation” 
of social indicators (public recognition, political influence and participation in 
decision making) did not succeed and they eventually were abandoned (Hagerty et 
al. 2002).  
 
However, the sole use of objective indicators might result to misleading conclusions. 
Objective indicators have not been very successful in predicting quality of life 
because they are focused only on external factors and conditions that researchers 
thought constitute QoL. Although there were statistical relationships between 
demographic and socioeconomic factors and QoL, these relationships were proved 
to be weak (Day and Jankey, 1996).  It now widely accepted that QoL is more than 
the objective conditions in which people live and that QoL is of a highly subjective 
nature i.e. it is what the respondent perceives it is. 
 
3.3.2 Subjective indicators 
Subjective or experiential indicators are those which involve some sort of evaluation 
by a person concerning some aspect or condition of his/her life (Brown et al. 2004). 
There are concepts such as well-being, happiness, or quality of life that cannot be 
fully understood without asking people how they experience and perceive the 
condition. It has been established that quality of life is mainly a subjective perception 
of life and that the features affecting it relies on value judgements rather than 
objective observations. Thus, the evaluations performed by people of concepts 
concerning their lives as their experience them are institutionalised or formalised by 
subjective indicators (ibid).     
45 
 
Criticism of subjective indicators has mainly focused on their comparability, validity 
and reliability. The first concerns the limited capability of subjective indicators to 
compare the conditions of different persons, cultures, or changing standards over 
time (Veenhoven, 2002). Validity questions arise because there is a possibility for a 
respondent to understand questions differently from what the investigator has in 
mind, while doubts about reliability arise due to lack of precision of the responses, 
as well as various distortions such as social desirability bias or other cultural biases 
(ibid). However, Veenhoven argued that objective indicators can only provide part 
of the information required, and focus on details rather than on the whole (ibid). 
 
3.3.2.1 Objective versus subjective indicators 
Measurements based on objective indicators could be seen mostly as mechanical 
methods, involving no human judgement and based mainly on laboratory tests. 
Objective indicators are what Campbell et al. (1976) called ‘harder’ than most 
subjective measurements, and are therefore more reliable. When human 
measurements are involved for an objective indicator, these are performed by 
external observers and are based on explicit criteria (Veenhoven, 2002). In this case, 
it is important to note that the distinction between objective and subjective indicators 
is not only a distinction between observers. A measurement is not subjective because 
it is performed by the patient or objective because it is performed by a third person 
e.g. a health professional. It is the measurement perspective that matters and not the 
person performing the measurement. As Mor and Guadagnoli (1988) argued: 
“Objectivity is not bestowed upon a measure merely because another person makes 
it”. Subjective measurements on the other hand are results of personal value-
judgements, made by the people concerned, which are used as health outcomes 
(McDowell, 2006).    
 
Proponents of objective indicators argue that these indicators are necessary because 
they give truer and clearer answers to the questions asked, whilst subjective 
indicators lack adequate clarity and quantitative strength. This reasoning might be 
true when the measurement concerns issues what Feinstein has called “paraclinical 
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data” such as a laboratory test, a pathology report, an expert’s opinion based on 
clinical indicators, etc. However, although objective indicators can be assessed 
independently of the patient’s evaluation, Hollandsworth (1988) proposed that 
objective criteria may relate more to the ‘quantity’ of life than its ‘quality’. 
 
In health, subjective appraisals not only lack clarity, but they might be objectively 
wrong. According to Veenhoven (2002), this is the “doctor knows best” argument. 
However, there are conditions where doctors do not succeed in identifying the 
aspects of disease that are important to the individual patient. Also, it is sometimes 
difficult for patients to explain or describe to a doctor the feeling and the experience 
of a condition such as pain for example.  As Virginia Woolf (2008) wrote in 1926:  
“English, which can express the thoughts of Hamlet and the tragedy of Lear, has no 
words for the shiver and the headache... The merest schoolgirl, when she falls in 
love, has Shakespeare or Keats to speak her mind for her; but let a sufferer try to 
describe a pain in his head to a doctor and language at once runs dry”.     
 
Furthermore, an objective indicator could be sufficient in assessing performance (for 
example the “ability” to perform a task), but there are assessments that need to 
measure concepts like the “capacity” to perform a task. Capacity cannot be measured 
by objective indicators or a third person, a health professional for example, as it 
requires value judgements by the respondent. Thus it is a subjective estimate and the 
only person who can assess it is the patient.        
 
As far as QoL is concerned, the relationship between the two categories of indicators 
is a complicated issue because the mechanisms that determine the level of quality of 
life have not been explained adequately enough. Veenhoven (2002) argued that there 
are cases where correlations between objective conditions and subjective appraisals 
are modest or weak.  
 
However, in some cases these correlations do not exist at all. The relationship 
between quality of life and disease is neither linear nor simple and indicators of the 
two concepts appear sometimes to have a reciprocal relationship. Thus, patients with 
an objectively poor quality of life report levels of wellness that exceed even those of 
the general population (Evans, 1991; Carr and Higginson, 2001). This phenomenon 
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has been called the “paradox of well-being” (Brown et. al. 2004) or the “disability 
paradox” (Carr and Higginson, 2001). The paradox consists in the presence of 
subjective well–being despite objective difficulties that should predict unhappiness 
(Mroczek and Kolarz, 1998). This discrepancy could partially be explained by the 
expectations model of QoL. The experiences of a person who lives with a condition 
or disease change their expectations, and their quality of life as a whole (Carr et. 
al.2001). The phenomenon is not new. In late 19th century Leon Tolstoy first noticed 
that: 
There are no conditions of life to which a man cannot get accustomed, especially if 
he sees them accepted by everyone (Tolstoy, 1877 [2004]). 
 
This change is also true when health conditions change, as most patients can adapt 
to the adverse life circumstances that occur after the appearance of a disease (Evans, 
1991). The phenomenon is called “response shift” and poses certain problems to QoL 
measurement (Donaldson, 2005; Oort, 2005b). ‘Response shift’ involves 
recalibration of internal standards, reprioritisation of values, as well as 
reconceptualisation of quality of life ((Sprangers and Schwartz, 1999; Oort 2005a; 
Schwartz et al. 2007; Swartz, 2010). Although response shift has received a lot of 
attention, there is no adequate explanation of the phenomenon. Probably the 
explanation lies in other disciplines, such as philosophy, where suffering was 
considered by Nietzsche as a constituent of life: “To live means to suffer, to survive 
is to find some meaning in the suffering”.  
 
Although suffering is not desirable Nietzsche believes that:  
  
“when misfortune strikes us, we can overcome it either by removing its cause or else 
by changing the effect it has on our feelings, that is, by reinterprenting the misfortune 
as a good, whose benefit may only later become clear”(Nietzsche, 1886). 
 
Lawton (1991) proposed that objective and subjective indicators of QoL should be 
used in parallel. Both of them are important for quality of life with objective 
measures providing “an anchoring point from which individual perceptions may 
deviate”. According to him (1999) the two types represent a continuum and a clear 
separation between objective and subjective indicators in QoL research is not always 
possible. For example, when the source of information is an individual, indicators 
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considered as objective, (e.g. income or education), could encompass subjective 
biases.  
 
Stiglitz et al. (2009) in their report support the combined use of objective and 
subjective indicators arguing that:  
“There is a consensus that quality of life depends on people’s health and education, 
their everyday activities (which include the right to a decent job and housing), their 
participation in the political process, the social and natural environment in which 
they live, and the factors shaping their personal and economic security. Measuring 
all these features requires both objective and subjective data”.  
 
The current trend among investigators is to use both types of indicators. However, 
the choice of some particular objective indicators requires knowledge of people’s 
values and how these indicators influence them (Diener and Suh, 1997). Also, the 
interrelationships between the two types of indicators should be taken into 
consideration because not only they affect the assessment of QoL but they can also 
influence the choice of the measuring indicator per se.  
 
Finally, it should be noted that even the combined use of the two types of indicators 
does not provide a conclusive answer to QoL assessment. QoL should be considered 
as “a multidimensional collection of objective and subjective areas of life, the parts 
of which can affect each other as well as the sum” (Bowling and Gabriel, 2004). 
Nevertheless, both types of indicators are not sufficient in explaining this “sum”, 
despite the fact that they affect it. In a survey published by Bowling and Windsor 
(2001) searching for subjective and objective predictors of quality of life, the 
objective indicators (12 socio-demographic + a health status indicator) accounted for 
only 5% of the variation of the total ratings. When subjective indicators were 
included in the model (six variables) the variance explained was only 16% of the 
total. While subjective indicators explained more variance than the objective ones 
(11%) the total was still very low, highlighting the complexity of the quality of life 
concept and leaving the question of measuring it unanswered.  Therefore, the 
discussion about the relative importance of the two types of indicators or the 
relationship between them is only part of the problem of QoL assessment and 
provides no answers to the problem of QoL measurement.      
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3.3.3 Satisfaction of human needs  
The concept of need, first introduced by Bentham [1834], reappears in contemporary 
quality of life literature. The needs approach relates QoL to the ability and capacity 
of patients to satisfy certain human needs. This approach is based on Maslow’s 
hierarchy of basic human needs, which claims that there is a general pattern of needs 
that people try to satisfy in the same sequence.  This pattern consists of five 
categories or levels of needs arranged in a structure in which the appearance of one 
need usually rests on the prior satisfaction of another. He called this hierarchy “pre-
potency”.  These needs are: The “physiological” needs, safety needs, love needs, 
esteem needs, and the need for self-actualisation (Maslow, 1943). Needs, according 
to Veenhoven (1991), are neither arbitrary demands nor can they be arbitrarily 
adjusted. To the contrary, they are given requirements for functioning, inherent to 
the human organism.     
  
Human needs have been used as theoretical basis for the development of quality of 
life measures especially for people with mental health problems (Hunt and 
McKenna, 1992; Bigelow et al. 1991).  Fayers and Machin (2007) argued that the 
level of quality of life depends upon the degree of fulfilment of basic needs that 
include aspects such as employment, food, sleep, mobility, identity, self-esteem, 
affection, love, security, shelter, and pain avoidance. However, this view could be 
considered as a general one because basic needs differ among people or societies. In 
the developed countries especially, satisfaction of basic needs is far from considered 
as being a feature of quality of life.  
 
3.3.4 Psychological models 
This general heading covers various concepts that have been used as QoL proxy 
variables. These concepts are conceptually distinct from quality of life, despite the 
fact that they overlap and are sometimes used interchangeably (Bowling 2005e). 
These are: 
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 The concept of subjective well-being includes aspects such as moods and 
emotions (affect) as well as overall life satisfaction. Well-being according to 
Diener has three characteristics. It is subjective, it includes positive factors 
and not just negative as most of the measures of mental health, and it is 
usually measured by global assessments of all aspects of a person’s life 
(Diener, 1984; Diener et al. 1999); 
 Life satisfaction, which is the result of an assessment of one’s overall life 
compared with an appropriate standard ( Diener et al. 1985, cited by Brown 
et al. 2004); 
 Happiness, which according to Veenhoven (1989) is: “the degree to which 
an individual judges the overall quality of his life as a whole favourably”. 
Health has been considered as the main predictor of well-being (Hayes and 
Ross, 1986), satisfaction with life as a whole, satisfaction with quality of life, 
and general happiness (Michalos et al., 2000). However, the relationship 
between health and happiness is not unidirectional at least at the prevention 
level.   Happiness protects physical health and according to Veenhoven 
(2008) although it “does not cure illness it does protect against becoming 
ill”;  
 Morale, which is a mental state that encompasses concepts like confidence, 
cheerfulness, enthusiasm, willingness to perform a task or respond to a 
problem. Also discipline and loyalty to a cause are sometimes included in 
this multi-defined and thus undefined concept; 
 Self-esteem and self-concept. Self-esteem according to Maslow (1943) is a 
basic human need. It could be described as one’s self-image and refers to how 
much value people place on themselves (Baumeister et al. 2003). Self-esteem 
has a strong relation to happiness, although the causation has not being 
established, as well as overall physical health (ibid). Self-concept could be 
seen as the whole of self-related beliefs that emerge from different aspects or 
domains of life and it may be described as evolving within a context of 
associations and configurations with objects, persons, and other concepts 
(Ziller, 1974); 
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 Social comparisons and expectations theory. According to this model QoL is 
the discrepancy between desired and attained goals (Calman, 1984;   Bergner, 
1989). By narrowing the gap between expectations and reality QoL is 
improving. Michalos (1985) argued that there are seven types of 
discrepancies and classified them as not-attained goals, keeping the attained 
goals (i.e. with the present situation as constant. The seven types of gaps exist 
between: a) What one has and what wants b) What one has and relevant 
others have c) What one has and the best ever had in the past d) What one 
has and what one deserves e) What one has and what one is expected to have 
at a certain point of time in the past f) What one has and what one needs g) 
What one has and expects to have in the future; 
 Optimism and pessimism. Optimism and its opposite pessimism are 
personality constructs that may have important implications for the manner 
in which people deal with the stresses of life (Scheier et al. 1989). Optimists 
differ from pessimists in the manner in which they cope with serious disease 
or specific health threats (Scheier et al. 1994);  
 Self efficacy, self-mastery, autonomy and control.  The first two concepts 
refer to one’s competency or capability in succeeding an intended goal. As 
optimism, they are also personality constructs. (Brown et al. 2004).  
Autonomy and control encompass the notions of independence (freedom 
from control), and autonomy (the freedom for self-determination). 
Autonomy is a basic human need and it is a distinct notion from 
independence.  The differences between the two concepts and their relation 
to diabetes will be discussed in Chapter 9 of this thesis, where semantic 
equivalence is discussed;   
 
3.3.5 Health and functioning models 
Health status is in theory and through empirical evidence related to Quality of life 
by its subset, Health Related Quality of Life (HRQoL). The concept of HRQoL has 
also been related to functional status, either physical or social. However, the two 
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concepts are different in nature. Also, their association as well as the direction of this 
association are still controversial. The lack of agreement among writers on these 
issues is reflected in the multiplicity of measures proposed for the assessment of the 
concepts. The various types of measures are discussed further in this chapter. 
 
3.3.6 Social health, social networks, support and activities 
There is strong evidence emerging that the above concepts affect QoL each one in 
its own way and capacity. Social health has been defined as: “the social support 
system that might intervene and modify the effect of the environment and stress on 
both mental and physical health” (Bowling 2005e).   The notion of social networks 
refers to: “the social relationships that surround a person, their characteristics and 
individuals’ perceptions and valuations of them” (ibid). There is no agreement on a 
precise definition of social support, but in general terms is the aid, (emotional, 
instrumental, or financial) network members might get from each other.  There is 
evidence however, relating social support with physical and mental health (Cohen, 
1988). The way that concepts such as social networks and support are connected to 
QoL is still a matter of research and the type of their association (direct or indirect) 
remains controversial.   
 
3.3.7 Social cohesion and social capital 
The concept of social cohesion is based on the principle that individuals are 
influenced both by external societal forces as well as internal personal factors. There 
is no agreement on a definition of the concept, but in general terms it could be 
described as all that which brings people together. It refers to ideas like community 
participation, reciprocity, social relationships and social bonds.  Chan et al. (2006) 
defined social cohesion as:  
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“A state of affairs concerning both the vertical and the horizontal interactions among 
members of society as characterised by a set of attitudes and norms that includes 
trust, a sense of belonging and the willingness to participate and help, as well as 
their behavioural manifestations”.  
Although the definition of the concept is still controversial there is a general 
consensus on the features that a cohesive community should have. The 
characteristics of a cohesive community, according to the British Government, is one 
where there is a common vision and a sense of belonging; the diversity of people is 
appreciated and positively valued; people from different backgrounds have similar 
life opportunities; and strong and positive relationships are developed between 
people from different backgrounds in the workplace, schools and neighbourhoods 
(Home Office, 2002).  Social cohesion is an important feature of every society and 
should be considered as a ‘social value’ depending on culture and other 
socioeconomic factors (Chan et al. 2006). Social cohesion, in relation to social 
capital, is a more holistic concept affecting society in general and not individuals. In 
this sense it is possible for a society to maintain a high level of social capital but have 
no social cohesion (e.g. segregated societies). 
Social capital is a different to social cohesion concept. According to Putnam (1993) 
it refers to: “features of social organisation, such as networks, norms, and trust that 
facilitate coordination and cooperation for mutual benefit”. Social capital should be 
considered as a subset of the concept of social cohesion and refers to the 
opportunities offered to individuals by communities and social networks to: “act 
together more effectively to pursue shared objectives” (Putnam, 1995). The 
definition of social capital is a highly controversial issue (Szreter and Woolcock 
2004a; Putnam, 2004), but most definitions are in some respect overlapping (De 
Silva et al. 2005; Szreter and Woolcock, 2004b).  
There is also some conceptual disagreement between social capital and support. 
Walkup (2003) suggested that social capital is connected with the supportive 
relationships among individuals. This is related rather to social support than social 
capital, which is an attribute of a society or a group (McKenzie, 2003). Social capital 
should be considered as a “public good” (Putnam, 1993), because unlike 
conventional capital it is not the private property of the people who benefit from it. 
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Putnam’s view however, does not mean that social capital is something material 
because it is a term describing a variety of social processes (McKenzie, 2003). 
Finally, it has been suggested that social capital is related to self-rated health, 
physical, and mental health, although the mechanisms of this linking have not been 
adequately explained (Kawachi et al. 1999; DoH, 2001; Kawachi and Berkman, 
2001; Hawe and Shiell, 2000). 
 
3.3.8 Environmental models 
Environment, according to the WHOQOL, constitutes one of the six broad domains 
of quality of life. It is so important that the other five domains (physical and 
psychological domains, independence, social relationships and beliefs) although 
independent from each other are also seen in relation to: “salient features of the 
environment” (WHOQOL, 1995). Environmental factors affect both the 
pathogenesis as well as the treatment of a disease. Objective environmental factors 
such as water and air quality, pollution of any kind, nutrition, lack of physical 
mobility, are some of the factors considered responsible for the onset of a disease. 
Lawton (1983) argued that some environmental features are directly relevant to QoL. 
He differentiates between “Objective environment” which is everything that “lies 
outside the individual and is capable of being counted.... by observers other than the 
subjects” and the “environment as perceived by a person (which) ... is a domain of 
perceived quality of life”.     
There are only a few studies trying to identify environmental factors influencing QoL 
of diabetes patients. However, family environment, dependence on spouses, 
neighbourhood characteristics or problems, as well as new technologies concerning 
treatment regimens are determinants for complications, competence and diabetes 
management, which are directly related to QoL (Gary et al. 2008; Maddigan et al. 
2006; Trief et al. 1998). 
55 
 
 
3.3.9 Idiographic approaches.  
These approaches are based on the fact that each person is an individual, living in a 
particular environment to which general rules or universal principles cannot be 
applied. This perspective is called phenomenological and its central issue is that QoL 
cannot be assessed by group analyses as the concept is focused on perceptions of the 
individual or on what Ziller (1974) calls the views of the ‘experiencer’.  
 
The individualised approach to QoL therefore begins with the perspective that “QoL 
is what the individual says it is” (Joyce, 1994). When lay people’s views are not 
been taken into consideration for the construction of a questionnaire, the items reflect 
the “culture” of the developers and not that of the respondents (Fox-Rushby and 
Parker, 1995; Bowling, 2005e). Also, a measure should be sensitive to differing 
values people place on various aspects of their lives, as well as to different priorities 
they set relatively to these values (Bowling, 2005b). 
 
By approaching QoL through pre-defined constituents, for example according to the 
WHO definition, there is the possibility that domains important to people to be 
excluded from the analysis. An individual should be allowed to identify the concepts 
of quality of life that are important to him/her, indicate their relative importance and 
then be asked to evaluate QoL according to these concepts (McGee et al. 1991).  
 
Mc Dowell (2006) argued that translation and cultural adaptation of an instrument 
into another language is in essence an idiographic approach. This view seems self-
contradictory as the word “idiographic” describes the study of the individual (Greek: 
idio) and does not allow a macro approach to a concept, unless a language or a nation, 
compared with another, might be considered as an individual entity and treated as 
such.  
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3.3.10 Conclusion 
The taxonomy of quality of life models highlights the complexity of the concept. 
Each model approaches quality of life from a different perspective, based on what 
their proponents consider underpins quality of life. This is the only characteristic that 
these models have in common. At the same time it could be considered as their 
common weakness. All of them have been based on expert opinion rather than on 
lay people‘s judgements about their quality of life (Walker and Lowenstein, 2009). 
Therefore: 
“Investigation of lay views is essential if the current body of knowledge on the 
constituents of this complex concept is to be developed, if measurement scales are to 
have any relevance to people and their everyday lives, and if public policies which 
affect life quality thereby influenced” (Bowling et al. 2003). 
 
3.4 Towards a definition of QoL  
There is a plethora of definitions with conceptual differences among them 
concerning the real meaning of the term and the topics it covers.  Thus, there is no 
widely accepted definition, but in general terms quality of life should be conceived 
as a grade of “goodness” (Bowling, 2005c).  
 
The lack of a consensus definition has its origins, as mentioned above, in the 
disagreement among scientists about the theoretical framework of the concept. The 
lack of agreement and the differences in definitions of quality of life have created 
doubts even for the value of the concept per se.  Rapley (2003), asked the question: 
“should we hang up quality of life as a hopeless term?”, responding that the concept 
can be useful only if we consider it as a ‘sensitising concept’ for approaching issues 
like service provision, or the question of how ill people live, rather than as a 
‘formalised, psychometric, conceptual framework’ (ibid).   
The variety of definitions has been demonstrated by Farquhar. In 1995 she proposed 
a taxonomy classifying the various definitions of QoL into four categories: 
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 Global definitions: All encompassing, usually incorporating notions such as 
satisfaction and happiness. They are too general (indicating little about the 
components of QoL) and too non-specific to be used on their own; 
 Component definitions: They break down QoL into components or 
dimensions. They operationalize the concept of QoL better than global 
definitions and can identify certain characteristics essential to any evaluation; 
 Focused definitions: They refer only to a small number of QoL dimensions 
(e.g. health/functional ability); 
 Combination definitions: They are global definitions combined with 
components of QoL (Farquhar 1995).  
However, despite the disagreement on definition, there is some degree of consensus 
about three characteristics of QoL (WHOQOL 1995): 
 Quality of life is subjective; 
 It is of a multidimensional nature and; 
 It includes both positive and negative dimensions. 
Almost all investigators agree on the first feature of QoL. This belief is rather based 
on the acceptance that health as a construct exists as some perceptual property of 
patients, i.e. health is a percept (Hyland 1993).  
 
As far as the second characteristic is concerned, the vast majority of investigators, 
with some exceptions, such as, Beckie and Hayduk (1997), agree on the multi-
dimensionality feature of QoL. Beckie and Hayduk (1997) investigating the 
dimensionality, globality and domain specificity of QoL, considered QoL: “as a 
global personal assessment”, and concluded that QoL was: “a unidimensional 
concept despite the multiplicity, diversity, and complexity of its causes”.   
 
The World Health Organization QoL Group (WHO, 1995) argued that quality of life 
is of a multi-dimensional nature and includes at least three dimensions on which 
there is a high degree of a consensual agreement: 
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 Physical   i.e. individuals’ perception of their physical state; 
 Psychological   i.e. individuals’ perception of their cognitive and affective 
state; 
 Social   i.e. individuals’ perception of the interpersonal relationships and 
social roles in their life.  
It also adds a fourth dimension, the spiritual, which it defines as the individual’s 
perception of meaning in life (WHO, 1995). 
Taking into consideration the characteristics and dimensions mentioned above, the 
World Health Organization defined quality of life as:  
“... individuals’ perception of their position in life in the context of the culture and 
value systems in which they live and in relation to their goals expectations, standards 
and concerns. It is a broad-ranging concept incorporating in a complex way 
individuals’ physical health, psychological state, level of independence , social 
relationships, personal beliefs, and their relationships to salient features of the 
environment” (WHOQOL Group, 1995). 
                                                                                                             
Others have deduced definitions by referring to the factors influencing quality of life. 
Thus, the majority of definitions are based on attempts to break-down the QoL 
construct into constituent domains. However, neither the variety nor the number of 
domains that should be included in a definition has been agreed. Such an attempt has 
been characterised by Cummins (1996) as: “an attempt to order chaos”.   
 
Bergner (1989) argued that certain dimensions should be taken into consideration 
when one is trying to define quality of life. These dimensions are:  physical activity, 
social and leisure activity, work, symptoms, loss of income, cognition, emotional 
adaptation, self-esteem, anxiety, stress, sexual activity, interpersonal relationships, 
impotence, incontinence, and overall satisfaction with life.  
 
The above problems have led to a situation where investigators do not provide a 
definition of QoL in their reports, or even justify their selection of quality of life 
measures (Haas, 1999). Others adopt implicit, narrow or discipline-bound 
perspective of quality of life (Bowling and Gabriel 2007). Evaluating 75 articles Gill 
and Feinstein (1994) discovered that only 11 (15%) conceptually defined QoL, 35 
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(47%) identified the targeted domains, and only 27 (36%) explained their selection 
of the chosen QoL measure.  
 
McDowell (2006) supported that investigators leave the term of QoL undefined 
when they want to have the freedom to select whichever indicator they wish. Others 
limit their definitions to components of QoL which they see as the whole concept 
(Farquhar, 1995). Along the same line Bradley (1996) argued that the meanings 
which are given by investigators to QoL differ from one another and in many cases 
it is one that fits their own work. Thus:  
“…the term (QoL) is used without definition though a remarkably wide range of 
meanings is implied by the choice of instruments used to measure quality of life. Just 
as psychologists often resort to defining intelligence as ‘that which intelligence tests 
measure’, so too quality of life may be defined as ‘that which quality of life 
instruments measure”.  
 
However, this post hoc approach in defining QoL is a fallacy “brush under the 
carpet” approach and not a definition based on theory or practical experience. There 
is a need to find the exact constituents of the concept that is a definition on which 
the study should be based. As Sen (1993) stated:  
“If an underlying idea has an essential ambiguity, a precise formulation of that idea 
must try to capture that ambiguity rather than hide or eliminate it”.  
 
3.5 Theoretical – Operational Definitions 
The disparities between theory and real life subjective judgements go back to 
Aristotle ([384-322] 1975)) who first correctly identified the differences between the 
judgements of “wise-men” and of “lay people” (Joyce 1994). Along the same logic 
Nietzsche declared in Zarathustra that “there is more wisdom in your body than in 
the deepest philosophy” (Nietzsche, 1887).  
 
Discussing the role of theory and conceptual models within population health 
research Carpiano and Daley (2006) state that: “Theory is a necessity” (their italics). 
They define “theory” as the:  
“Logically related propositions that aim to explain and predict a fairly general set 
of phenomena” (ibid).  
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However, the controversy over theoretical and operational definition models does 
not aim to repudiate the value of theory in conceptualising or explaining phenomena. 
Popay (2006) distinguished academic theories used in research and the ones 
developed in ordinary life by lay people. The former theories are: “multifactorial 
involving the addition of more and more variables into putative models”.  In contrast 
to these: 
“...the theories we all develop as lay people as we seek to make sense of our 
experience of health and illness  are interpretations and elaborations of the meaning 
of causal factors in the context of everyday life” (ibid.). 
She further argued that lay theories represent a challenge to the objectivity of expert 
theories as well as to the authority of professionals to determine the way in which 
problems are defined. Thus, she concluded, lay theories represent a scientific as well 
as a political challenge to the institutional power of expert theories (ibid).  
 
In practice, as far as research for quality of life of an individual or a population is 
concerned Bowling (2005e) argued that although the division of QoL into predefined 
individual components helps measurement, it may not tap people’s subjective 
perceptions of QoL. Evaluations of QoL should evolve from the person whose life 
quality is assessed and in Merleau-Ponty’s (1962) terms is the ‘perceivable 
perceiver’.  What should matter most therefore, are the people’s beliefs about their 
own quality of life or as Joyce (1994) stated that “quality of life is what the patient 
says it is”. Nevertheless, the problem of disparity between theory and experience, 
according to Joyce, still besets the study of QoL.  
 
Having accepted that quality of life is a subjective individualistic perception of a 
patient’s values about life, the fact that there are common values among people 
within a society concerning what constitutes a good life or quality of life should be 
ignored. A definition based on the values that people assign to the notion of quality 
of life, as these emerge from various research would be most representative, 
operational, and reliable. Bowling (2005c) proposed that:  
“most people define their quality of life in terms of having a positive psychological 
outlook and emotional well-being, having good physical and mental health and the 
physical ability to do the things they want to do, having good relationships with 
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friends and family, participating in social activities and recreation, living in a safe 
neighbourhood with good facilities and services, having enough money and being 
independent”.  
 
This definition embraces to a great extent the important factors influencing quality 
of life and seems to be operationally and functionally suitable to be used as a guide 
for the final choice of measure for this research. However, by accepting this 
definition the problem could not be considered as solved, because this research has 
to compare quality of life between groups of patients with different socioeconomic 
background and residence. This represents an additional difficulty and raises 
questions on whether the QoL of a farmer for example differs from that of a city 
dweller or that of a housewife and a businessman with similar illness (Schipper, 
1983). It seems that there is not a simple answer to this question. Priorities and 
notions that concern quality of life differ among groups of society. Bowling 
presented evidence that young people seem to prioritize finance and employment 
whilst older people prioritize the ability to get out (Bowling et. al., 2003). 
Differences do not exist only among young and old people. Although adults within 
a community share a basic core of values, irrespective of their age, social, cultural 
and demographic strata, they tend to prioritize these values differently. Thus, QoL 
measures should be sensitive in detecting these differences (Bowling, 2005e). 
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Chapter 4: Health and Health Related         
Quality of Life 
 
4.1 Health 
Health has been defined by the World Health Organization (WHO, 1952) as:  
“A state of complete physical, mental, and social well-being and not merely the 
absence of disease or infirmity”. 
 
This definition has the advantage of focusing on the positive aspect of health and not 
the negative one by its absence during disease or illness. Positive health could be 
considered as:  
“the ability to cope with stressful situations, the maintenance of a strong social-
support system, integration in the community, high morale and life satisfaction, 
psychological well-being and even levels of fitness as well as physical health” 
(Bowling, 2005c).                                           
 
The concept of positive health is important because it has been used by many writers 
in trying to define concepts such as quality of life or even in their attempt to link the 
broad concept of health to QoL.  
                                                                     
Nevertheless, the WHO definition has some disadvantages. It is a definition of a 
utopian nature (Bowling, 2005c: 4) and at the same time its concepts suffer from a 
lack of clarity. Criticism has been concentrated mainly on three issues:  
 The definition identifies three dimensions of health namely physical, mental and 
social. It does not include physiologic health i.e. the status and functioning of specific 
organ systems. This fourth dimension was introduced later by Brook et al. (1979).    
 The WHO definition does not delineate which state of well-being is healthier than 
others (Patrick and Erickson, 1993). 
 Also, it is not clear whether the term social well-being refers to socioeconomic 
environment in general or to social integration and social interaction (ibid). 
Despite its utopian nature and the above disadvantages the WHO definition 
encompasses meanings that are used in other health related concepts and provides a 
basis for defining health status, quality of life, morbidity, or well-being. Thus, a 
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plethora of health related measures have been created which are not based on 
demographic or epidemiological indicators only, but contain the concepts of 
physical, mental, and social well-being introduced as health domains by this 
definition (Bowling, 2005e).    
 
4.2 Health Related Quality of Life 
Health Related Quality of Life (HRQoL) has its origins in the concept of positive 
health, and is not defined simply as the absence of disease, but it has a positive 
dimension. Physical, mental, social well-being, functioning, ability to cope, 
adjustment and efficiency of mind and body are some of the conditions embodied in 
positive health and constitute parts of the concept health-related quality of life 
(Bowling, 1995a).  
 
By having defined QoL as a grade of “goodness”, HRQoL should be seen as the 
“goodness” of the aspects that might be affected by health. Thus, HRQoL is a distinct 
concept and it represents only one dimension of the wider QoL (Bowling, 2005c).  
Also, the scope of HRQoL is of a more limited nature and it is usually used to assess 
health determinants and evaluate interventions. 
 
There are no clear boundaries between QoL and HRQoL. This is because the other 
parameters mentioned above can affect a persons’ HRQoL. At the same time, the 
opposite is equally true. When a person is ill or diseased almost all domains of life 
are affected and may become health related (Guyatt et. al. 1993). This holistic 
approach to the nature of quality of life (Haas, 1999) has resulted to a situation for 
which the terms “Quality of Life” and “Health Related Quality of Life” are often 
used interchangeably in medical literature, despite the fact that they are distinct  from 
one another.  
 
Patrick and Erickson (1993), argued that:  
“Health related quality of life is the value assigned by individuals, groups, or society 
to the duration of life as modified by the impairments, functional states, perceptions, 
and social opportunities that are influenced by disease, injury, treatment, or policy”. 
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This appears to be a sound definition of HRQOL because it encompasses five 
different aspects: One quantitative (duration) and four qualitative (impairments, 
functional states, perceptions, and opportunities). Therefore, according to this 
definition, HRQOL combines quantity and quality of life into a single value. 
   
Finally, Polonsky (2000) introduced a distinction between HRQoL and disease-
specific QoL. Focusing on diabetes-specific QoL and accepting the three dimensions 
of the WHOQOL definition, he argued that disease-specific QoL is a subset of 
overall HRQoL. Disease-specific HRQoL then refers to patient’s sense of how the 
disease is compromising his well-being in physical, psychological and social 
functioning. He distinguished between two categories of distress caused by the 
disease: Intrinsic impairments (the perceived direct burden caused by the disease or 
some aspect of it); and attributional impairments (the perception of the disease as 
being responsible for distress in the three areas of functioning). He continued arguing 
that although other parameters of HRQoL, such as self-efficacy, coping style, 
treatment satisfaction, are very important variables and sometimes contributors to 
disease-specific QoL, they are not elements of the construct and cannot be 
considered synonymous to it.   Thus, instruments should refer solely to patient’s 
perception of how the disease affects the well-being in the three areas of physical, 
psychological and social functioning.  
 
                                                             
4.2.1 Health-Related Quality of Life – Health Status 
Very often terms such as HRQoL health status, functional status, well-being and 
health related quality of life are used by writers with different and sometimes 
interchangeable meanings (Patrick and Bergner, 1990; Gill and Feinstein, 1994; 
Smith et al 1999; Speight, 2002). The extent of this phenomenon has led Gill to 
question whether QoL has in practice “lost its distinctive or unique meaning” (Gill, 
1995). This is probably because a chronic disease does not affect quality of life only. 
When a patient is ill almost all aspects of life can be considered as health related 
65 
 
(Guyatt et. al., 1993). Thus, the answer to the question “what is or isn’t part of 
health” (Patrick and Erickson, 1993) is still to a great extent inconclusive.  
 
Bergner compared the use of these terms by reviewing papers abstracted from Index 
Medicus. She concluded that QoL, as used in clinical research, is a vague term 
without conceptual clarity. On the health status and QoL controversy she argued that:  
“One of the striking differences between the notion of quality of life and that of health 
status is level of conceptualization. Quality of life as it is used in clinical research is 
a vague term without conceptual clarity. It is what investigators mean it to be” 
(Bergner, 1989). 
 
Moreover, as if the lack of conceptual clarity was not enough, there is also a problem 
regarding the direction of causality. Bergner argued that QoL was considered by 
people as a risk factor or cause of disease and at the same time as an outcome of 
medical care.  
On the other hand health status:  
“...is clearly concerned with health and not with other aspects of life, many of which 
influence its quality” (ibid). 
 
The lack of clear distinction between the concepts of subjective health status and 
health-related quality of life could be attributed to the fact that both concepts are 
patient-based assessments. However, subjective health status is simply a self-
reflecting assessment of health, while HRQoL refers to the impact of a perceived 
health state on an individual’s potential to live a subjectively fulfilling life (Bullinger 
et al. 1993).  
 
Other writers believe that there is real no distinction between general health status 
measures and measures of HRQoL and if there is any it is that QoL is broader and 
extends to other topics (Mc Dowell, 2006). This view could be partly justified by 
taking into consideration the fact that the term health status is currently used as a 
multifaceted concept and overlaps with the broader concept of health-related quality 
of life. Nevertheless, health status is and should be considered as only one domain 
of HRQoL (Bowling, 2001), or as Lawton (1991) notes:  
“Self-rated health is an operationalization of the health domain of perceived quality 
of life”.    
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Health status therefore and HRQoL, although related, are two different concepts and 
should be treated as such. Moreover, Bradley (2001) argued that the two notions not 
only differ in essence but sometimes act in an antagonistic way, as efforts to achieve 
a high level of health status may cause damage to QoL, especially when management 
of diabetes is concerned. Intensive treatment of diabetes with insulin for example, 
may lead to a higher health status but not necessarily to a better QoL.  Bradley’s 
argument might be reinforced by Glasgow et al. (1999), who state that there is a 
distinction between ‘disease-oriented medicine’ and ‘patient-oriented medicine’.  
The first one aims at making the disease better. In the case of diabetes this is possible 
through a successful glycaemic control. The second kind of medicine achieves its 
aims if the patient is better, enjoying a higher quality of life.  HRQoL measures are 
directed to ‘patient-oriented medicine’ and their role is of great importance to this 
kind of care. 
                                                                                            
There is a wide consensus about the dimensions that the term health status covers. 
The five dimensions of health status are: Genetic foundation, biological, 
physiological, anatomical condition (disease state, disability or handicap state), 
functional condition (social role performance, physical performance, cognitive 
performance), mental condition (mood or feeling state, affective state), and health 
potential (longevity, functioning, disease & disability, disadvantage). 
 
On the contrary, although QoL extends to other wider topics there is no consensus 
over the dimensions that should be included in the concept. Thus, tackling the 
definition problem of QoL becomes a complicated issue that needs a lot more 
attention. Despite the controversy, throughout this work a clear distinction will be 
made between the concepts of “Health Status” and “Quality of Life”. This distinction 
is very important for this project and the two concepts are to be measured separately 
by two different instruments. 
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4.3 The Measurement of HRQoL   
“Everything that can be counted does not necessarily count, everything that counts cannot necessarily 
be counted”        (Albert Einstein 1879-1955) 
 
4.3.1 Introduction  
Measurement is the most important aspect in assessing a condition or an outcome. 
As Stiglitz and his associates (2009) stated:  
“What we measure affects what we do; and if our measurements are flawed, 
decisions may be distorted”.  
 
Measures of health, disease, and Health Related Quality of Life belong to the broad 
category of “subjective health assessment” or “patient-reported outcomes”. The need 
to measure these concepts occurred when evidence showed that objective test results, 
clinical measures and socio-demographic data suitable for a diagnosis were not 
enough to explain how a patient experiences illness or disease (Albrecht, 1994).  
 
The measurement of medical outcomes methodologically is mainly based on the 
positivist approach. The core assumption of the positive approach is that social 
science is identical in logic with natural science and that its concepts can be 
explained in terms of cause and effect relationships, and measured with methods 
similar to the natural sciences. However, this approach has been criticised, especially 
during the last 40 years, as misleading because unlike natural science social theories 
are not about independent objects, but they are constituted by self-understanding that 
is the meanings that participants attach to them (Taylor, 1985). Also, positivism does 
not pay attention to the underlying mechanisms that determine these concepts.  
Another approach to health and disease measurements is the so-called 
phenomenologist approach, which is based on the idea that medical outcomes depend 
on individuals’ perceptions and not on predetermined measurement scales, which 
cannot capture the subjectivity of the individual.  A third way to tackle the 
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measurement problem is of a more idiographic nature, trying to tap the values and 
measure the aspects that are unique to individual’s life (Bowling, 1999). 
 
4.3.2 The value of measuring HRQoL 
The measurement of HRQoL has been defined as “the level of health status filtered 
by individual health perceptions” (Testa, 2000). This measurement definition tries 
to define HRQoL by combining the level of health status, (as expressed in terms of 
function, symptoms, emotion etc.) with the patients’ perceptions of worry distress, 
well-being, satisfaction, expectations etc. This bidimensionality, according to Testa, 
gives an understanding of the forces that shape patient behaviour and their ability to 
adhere to diabetes treatment regimens.    
 
There is a variety of opinion concerning the importance and use of HRQoL 
measurement and an analogous number of reasons has been proposed. Health-related 
quality of life is important for measuring the impact of chronic disease (Patrick and 
Erickson, 1993; Guyatt et. al. 1993).  Bowling (2001) extends this view arguing that: 
“HRQoL as an outcome measure broadens outcome towards considering the impact 
of the condition and its treatment on the person’s emotional, physical and social 
functioning and lifestyle”.  
 
McDowell (2006) argued that quality of life measurement in health research provides 
a formal means for the patient’s judgement to influence treatment. Guyatt and his 
associates give a comprehensive reasoning about the use of QoL measurements by 
arguing that these measurements can have three purposes. The first is discriminative 
that is to distinguish among individuals or groups, the second is predictive that is to 
classify individuals into a set of predefined categories, and third is evaluative i.e. to 
measure the magnitude of longitudinal change of an individual or group (Guyatt et. 
al., 1993; Kirshner and Guyatt, 1985).   
 
Higginson and Carr (2001) proposed that the measuring quality of life in clinical 
practice may have five different uses: a) identifying and prioritising problems; b) 
facilitating patients to communicate their problem; c) screening for any hidden 
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problems; d) facilitating shared clinical decision making; and e) monitoring changes 
or responses to treatment.  Nevertheless, despite the value, significance and the 
variety of its uses, there is no widely accepted theory or instrument for the 
measurement of quality of life (Brown et. al., 2004). 
 
4.3.3 What is important in measuring HRQoL 
There are three implicit assumptions in measuring quality of life: The first one is that 
we know what is to be measured, the second one is to understand why particular 
variables are measured, and the third is that the estimate is a valid indicator of overall 
quality of life (Lancet, 1995). 
 
As far as the first assumption is concerned, that is the knowledge of what is to be 
measured, it is accepted that there is no consensus definition of quality of life. The 
lack of a gold standard instrument for measuring quality of life is attributed by 
Farquhar (1995) to this lack of definition. However, even by accepting that the 
domains described by the WHOQOL definition (physical, psychological, and social 
functioning) are necessary for measuring QoL, they are not sufficient to tackle the 
problem of subjectivity and lay perceptions of QoL (Bowling, 2005b).   
 
This has implications concerning the second assumption that is why particular 
variables are measured. Quality of life as a concept extends over a wide range of 
topics and disciplines, therefore the mechanisms that determine people’s perceptions 
and the choice of variables for measuring the concept will never be explained 
adequately enough. Instruments and the variables used to measure QoL are based on 
expert opinions rather than those of lay people and empirical evidence. This is 
against the widely accepted view that: “the problems and priorities which are 
important are those of the individual and not of the observer” (Calman 1984). The 
lack of empirical evidence results in the construction of measures that include items 
with little importance or relevance to people in everyday life (Brown et. al. 2004).   
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It is the importance of items that plays the significant role in relation to the third 
Lancet (1995) assumption, which is that the estimate is a valid indicator of overall 
quality of life. Importance in this case should be seen under two distinct perspectives: 
One of values and one of priorities. The first is based on the view that quality of life 
is a concept that invokes the notion of value (Patrick and Erickson, 1993). Values 
may differ among different societies. However, within a society people in general 
share a basic core of values. Various groups of any society (cultural, social, 
demographic etc.) have different priorities concerning these values. Importance in 
this case relates to emphasis or priority people place on these values (Bowling, 
2005b). Thus, importance refers to the personal values as well as the priorities of the 
respondent. 
 
Care should be taken in assuring that the measure is a valid and reliable indicator of 
what it purports to measure. However, the validity of an indicator depends largely 
on importance of items rather than multiplicity or variation. Measures that are not 
focused on domains or items that are important to the individual patient could not be 
valid or reliable. As Gill (1995) argued quality of life will be measured not just with 
statistical elegance, but only when investigators acknowledge the importance of 
patients’ values and preferences. 
 
Furthermore, there are some other factors referring to questionnaires and the mode 
of administration that should be taken into consideration in QoL measurements. 
Standardised instruments that use the same questioning and weighting for all 
respondents could create biasing influences and distort the results. In a study 
published by Bowling, different results were obtained depending on the method of 
questioning and coding. There were differences between the responses obtained 
when respondents chose a pre-coded show-card and the ones obtained from open 
coding of verbatim responses (Bowling, 1995b). In a later study Bowling suggested 
that results could also be influenced by the question order as well as response-choice 
available on a self-reported instrument (Bowling and Windsor, 2008). Last, the 
method of questionnaire administration can also influence responses and thus the 
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results of a survey, making comparisons of data produced by different types of 
administration difficult to compare (Bowling, 2001). 
 
Attention should be paid in distinguishing measurements between individual and 
group assessments. In group comparisons usually the emphasis lies in testing 
hypotheses, but in measuring individuals the emphasis is about estimating values. 
Thus, a higher degree of precision, reliability, and validity of the measurement is 
necessary (Donaldson, 2008). This is the reason why writers propose different 
acceptable levels of psychometric properties for groups and individuals (Nunnally 
and Bernstein, 1994; Streiner and Norman, 2008).  
 
4.3.4 Types of Measures 
There are many attempts to classify HRQoL measures and various criteria have been 
used. Thus, measures are classified according to:  
 The types of scores they produce; 
 The range of populations and concepts covered; 
 The weighting system used in scoring items (Patrick and Erickson, 1993). 
The first type of classification produces measures such as: single indicators which 
produce a single score obtained from a single item, single indices that produce a 
single score but summarise multiple concepts, profiles producing multiple scores on 
the same or related domains, and batteries that produce multiple scores of 
independent domains (Fayers and Machin, 2007).        
 
The second type of classification covers generic and specific measures which are 
divided into disease, domain and population specific measures. Generic measures 
are used across various types and severity of diseases, different treatments or 
interventions, and different demographic or cultural subgroups.  Disease-specific 
measures are used to assess or detect minimally important changes of specific 
diseases. Domain-specific measures are developed to assess a condition or symptom. 
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Population-specific measures are designed to address population sub-groups usually 
characterised by age, ethnicity, or medical condition (ibid). 
 
When the weighting system is used as a classification criterion two types of measure 
emerge: The utility weighting measures, with weighted preferences from patients, 
providers, or community. Measures are also classified according to the type of 
statistical weighting with items weighted equally or from frequency of responses.  
  
Other taxonomies propose that measures can broadly be classified under seven 
categories: generic, disease specific, dimension-specific, site or region-specific, 
summary items, individualised, and utility measures (Fitzpatrick et al., 1998; Garrat 
et. al. 2002a). The vast majority of them fall within the first two categories namely 
the generic and disease-specific ones.  
 
Two final points should be made. First, having described the classification criteria, 
it should be noted that because the criteria used are more than one and are different 
in essence, groups are not mutually exclusive and instruments do not necessarily 
belong to one group only. Another interesting point concerning the nature of quality 
of life measures has been raised by Bowling, who notes that although QoL is usually 
defined in positive terms it is mostly measured and presented in negative terms. Thus, 
most types of measures are expressed in terms of what has been lost rather than what 
exists in someone’s life (Brown et al. 2004). 
 
4.3.4.1 Generic measures 
Generic measures are designed to summarize a wide spectrum of health status or 
quality of life (Patrick and Erickson, 1993).  They can be used across different types 
and severities of disease, medical treatments, health interventions, and different 
demographic and cultural subgroups. Additionally, generic measures are useful for 
assessing the burden of populations suffering from chronic medical or mental 
conditions compared with healthy populations. Also, they have been proved useful 
in comparing health outcomes across different health care delivering systems. Thus, 
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by allowing the comparisons of different populations help decision making, resource 
allocation, and make policy implementation possible (Patrick and Deyo, 1989; 
McHorney et al. 1994, Anderson et. al. 1997). 
 
They include three types of measures: single indicators, health profiles, and indices 
(McDowell, 2006). Single indicators express an aggregate of separate scores with a 
single number. Health profiles present separately the various aspects of health, while 
health indices combine these aspects into an overall score (ibid). 
 
In literature generic measures are often defined as QoL measures but they should be 
called health status measures, because their main focus is on physical symptoms 
(Fayers and Machin, 2007). The underlying assumption of this approach is that low 
levels of health status indicate poor quality of life. However, this is not always the 
case, since there are cases where efforts to achieve high levels of health status may 
damage quality of life. The management of diabetes is one of these cases where a 
health status measure used for assessing the level of quality of life can lead to 
misleading conclusions (Bradley, 2001).  
 
Generic measures could in some cases elicit information relevant to quality of life of 
a specific condition or disease, but in order to accomplish this they would have to be 
of enormous length (Bowling, 2001). In such a case many of the items contained 
have little or no relevance to a specific group of patients. If the length is reduced the 
number of items covering a certain domain has to be reduced, resulting in reduced 
ability to capture changes in individual patients or differences among them (Streiner 
and Norman, 2008).   
 
Since they address a wide range of issues generic measures may lack items relevant 
to the disease, thus failing to focus on certain aspects of the disease or treatment that 
might be of particular concern to patients (Snoek, 2000). As a result these 
instruments may lack sensitivity, specificity and utility within a disease entity 
(Anderson et. al., 1997). An example of this is the SF-36 and diabetes. The 
measurement of quality of life of people with diabetes and the impact that the disease 
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has on it is a very complicated issue. This is because various factors enter into 
diabetes life and its management. People with diabetes need a high degree medical 
care, life-time medication, health literacy and extensive self-management. 
Furthermore, diabetes is a condition that creates a wide range of complications. The 
problem in assessing diabetes-related QoL with generic-health status measures is that 
individuals do not react the same to medication, self-management, impairment, or 
perceive disease in various ways, and therefore their QoL is affected differently. 
Generic measures cover domains like pain, mobility and physical function, areas of 
little importance to people with diabetes, but ignore restrictions on diet, which is 
something very important for patients and which is considered to have the most 
negative impact of diabetes on QoL (Bradley –Speight, 2002). Moreover, generic 
measures are not sensitive to detect small, clinically important changes of specific 
conditions (Guyatt et al. 1986). To detect these changes generic measures should be 
implemented by disease-specific measures. 
 
4.3.4.2 Disease-specific measures 
Disease-specific health-related QOL instruments are designed for application to 
individuals, conditions or diseases, domains, or populations (Patrick and Deyo, 
1989). The rational for these instruments is that they are measures narrowly focused 
giving more detailed information about the disease or condition of interest (Bowling, 
2001). There are particular issues in all conditions or diseases which contribute to a 
much greater extent to QoL than other issues (Orley et. al. 1998).  Pain for example 
is a major concern for people with orthopaedic problems, but not for insulin 
dependent people with diabetes to whom the fear of hypoglycaemia is the dominant 
concern (Bradley, 1994). Also, a diabetes-specific QoL measure should be focused 
on dietary restrictions, which for people with diabetes is a major issue compared with 
patients with other diseases (Bowling, 1996). 
Disease- specific measures are often developed aiming at detecting minimally 
important changes in certain conditions or diseases in clinical trials or longitudinal 
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studies (Guyatt et al. 1986). This is because disease specific measures are more 
sensitive (responsive) to changes that occur over time (Patrick and Deyo, 1989). 
However, the advantage of disease-specific measures that focus on the impact of a 
disease or an intervention might also be considered as a disadvantage. Every 
intervention has “primary” as well as “secondary” endpoints or side-effects. From 
the clinical - provider point of view, measurement is mostly focused on the main 
effects of the intervention, while the patient is concerned with health as a whole and 
not a particular aspect of it. For the patient there is no distinction between main and 
side effects, there are only general endpoints and effects, which should be measured 
for establishing preferences and deciding policies (Dowie, 2002).      
Moreover, disease-specific instruments cannot provide information for comparisons 
between diseases, as they are focused on particular diseases. Therefore, disease 
specific measures are not very suitable for examining the effectiveness of alternative 
or competing policies and health care programs. As a result, the final choice about 
the type of measure to be chosen depends entirely on the structure of the decision 
different types of measures should be used for different decisions (Dowie, 2002).  
 
 
4.3.4.3 Global questions v multi-item measures 
-“When I use a word” Humpty Dumpty said in a rather scornful tone, “it means   just what I choose to 
mean – neither more nor less. 
-“The question is”, said Alice, “whether you can make words mean so many different thinks” 
-“The question is” said Humpty Dumpty, “which is to be master – that’s all”  
                                                                             Lewis Carrol: Through the looking-glass 
 
Another issue concerning the types of measures is the value of the global questions. 
That is whether the answer to only one question can give a realistic picture of the 
existing situation. The controversy over the value of global questions for the 
assessment of QoL starts with the onset of the concept in literature in the 1970s 
(Schneider, 1976).  
 
There are writers who believe that:  
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“The simplest and most overtly sensible approach to measure quality of life is to use 
global rating scales. These ratings... can allow expression for the disparate values 
and preferences of individual patients” (Gill, 1995).   
 
Global items are necessary because:  
“Quality of life may encompass not only health-related factors, but also many non-
medical phenomena, such as work, religion and relationships.”  
Gill extended his argument, and together with Feinstein, argued that:  
“To ensure that separate effects of health-related factors and nonmedical 
phenomena are suitably determined and distinguished, investigators should ask 
patients to give two global ratings, one for overall quality of life and another one for 
health-related quality of life” (Gill and Feinstein, 1994). 
 
However, there is a considerable disagreement among investigators about the value 
and use of global questions in quality of life assessment.  According to Fayers and 
Manchin (2007): 
“Global questions are often regarded as too vague and non-specific to be used on 
their own”.  
 
Moreover, the problem of QoL definition and perception in assessing quality of life 
enters the global and single-item discussion. The meaning of QoL is not just an 
academic controversy that torments the scientific community only but a practical 
problem when the term is used in questionnaires concerning patients’ perception of 
QoL. As Hyland (1998) argued:   
“If a global scale of quality of life is used, i.e. when patients are asked directly to 
evaluate their quality of life on a single scale, the meaning of the term quality of life 
will be interpreted differently by different respondents”. 
 
Joyce (1994) takes the argument even further arguing that single item questions have 
untestable reliability.  
 
Reports of various investigators cannot provide concrete answers on the issue. There 
are studies that support the possibility of substitution of a multi-item scale with a 
global single-item question (Jenkinson et. al. 1995; Hurny et. al. 1996) and others 
that argue that this substitution, although desirable, is not feasible (Barofsky et. al. 
2004). 
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In conclusion, QoL is a construct and as such cannot be measured directly. 
Psychometric theory suggests that in these cases a series of questions tapping various 
aspects of the same concept have to be asked. Although global questions can be 
simple, reliable, and valid they cannot be detailed enough to provide information on 
various dimensions of QoL.   
 
Multi-item questionnaires on the other hand provide more information on QoL 
dimensions, are more stable, precise, and reliable,  more consistent in terms of 
results, and they are less prone to distortion from various biases, avoiding random 
errors (Bowling, 2005d). Thus, there is a trade-off between simplicity and precision 
and these are the criteria for choosing between them. The needs and the purpose of 
the study should guide the investigators for their final choice (ibid). However, this 
final choice should not necessarily be of a disjunctive nature. This is because:  
“Single item measures can be used alongside multi-dimensional measures, and are 
useful as broad summary ratings of diverse aspects of respondents’ health, QoL, and 
HRQoL...” (Bowling, 2005d). 
 
Nevertheless, most diabetes-specific questionnaires seem to underestimate the value 
of global questions. 
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Chapter 5: Diabetes and Quality of Life 
 
5.1 Introduction 
There has been a growing interest in the last few years in determining the factors that 
affect quality of life of people with diabetes. Rubin and Peyrot (1999) argue that:  
“The literature concerning associations between quality of life and disease specific, 
demographic and psychosocial variables in people with diabetes is larger than that 
for differences in quality of life between people with diabetes and the general 
population, or between diabetes and other chronic conditions”.  
 
When assessing the impact of diabetes on quality of life, the factors that could be 
considered predictors are a controversial issue. Investigators report different, and in 
many cases conflicting, findings for various predictors of QoL and their role in 
determining QoL. This could be attributed mainly to three factors. First, it is the 
complexity of the concept and the definitional problems, discussed in the previous 
chapter, that create some confusion regarding the nature of QoL. The second factor 
refers to the different instruments used for the assessments. These instruments tap 
different dimensions of QoL as well as present their results in various ways, making 
comparisons unreliable (Wandell, 2005). A third factor that influences health 
outcomes and thus quality of life of chronically ill is the health care system. Different 
systems produce different health outcomes, thus making conclusions about certain 
predictors unreliable (Ware et al.1996).  
 
5.2 Variables associated with QoL in diabetes 
Diabetes has a serious impact on quality of life. Diabetes, as a chronic disease affects 
almost all aspects and domains of life. However, diabetes as a disease is not 
experienced in the same way across different population around the world, different 
ages, sexes, or among people with different socioeconomic status or education level.  
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Rubin and Peyrot (1999) in a very influential narrative review described three types 
of determinants associated with quality of life in people with diabetes: Medical 
predictors, attitudinal predictors and demographic predictors. Medical predictors 
include the type and duration of diabetes, the treatment regimen, glycaemic control, 
and presence of complications. Attitudinal predictors include self-efficacy, locus of 
control, and social support. Demographic predictors of diabetes are gender, 
socioeconomic status, education level, ethnicity, age and marital status. 
 
The word ‘predictor’ is used by Rubin and Peyrot (1999) to describe all the variables 
that are hypothesised to affect quality of life. The word not only describes an 
association between two variables but it also implies the direction of causality 
between the variable and the QoL The fact that the causality among all those 
variables is complex and sometimes reciprocal does not permit the use of the word 
‘predictor’ in its absolute sense, as nothing can be considered a priori as predictor or 
outcome.  
 
The role of access to health-care, either in the form of geographical proximity or in 
relation to socioeconomic status, a subject that has not received particular attention 
by researchers, is a central question for this study. Thus, the role of the health-care 
system as a variable of diabetes-specific quality of life is going to be examined 
together with the other determinants. Attitudinal variables like self-efficacy or social 
support are also of great importance for diabetes, and probably the subject of a future 
investigation, but they are beyond the scope of this study.  
 
5.2.1 Type of Diabetes 
Bradley and Speight (2002) using the 13 item ADDQoL pointed out that patients 
with either type of diabetes almost always experience a negative impact in QoL. 
However, there are differences among patients with different type of diabetes with 
type 2 diabetes patients reporting better QoL than those with type 1 (Jacobson et al. 
1994; Glasgow et al.1997; Polonsky et al.1995). These differences are mitigated for 
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type 2 diabetes patients on insulin regimen, who reported greater impact of diabetes 
on quality of life than the ones on oral medication-dietary regimens. Thus, these 
differences might be attributed to different treatment regimens and not to the type of 
diabetes per se. 
 
5.2.2 Diabetes Control 
There is a widely accepted view that diabetes control is associated with quality of 
life in various ways.  This is because control is the end-result of different aspects and 
activities. Food intake, oral medication or insulin dose, psychological factors, 
exercise and physical activity are some of the factors influencing diabetes control. 
Thus, the continuous attempt of finding a balance among these factors usually affects 
quality of life in many different ways (Eiser and Tooke, 1993; Chyun et al. 2006).   
 
Glucose and blood pressure control result to reduction of complications, and thus to 
better QoL. The findings of the initial UKPDS as well as 10 years follow-up studies 
confirm the association of diabetes-control and complications (UKPDS, 1998a; 
UKPDS, 1999; Holman et al 2008a; Holman et al. 2008b).  Patients with good 
control report better QoL than those with poor control (Shen et al. 1999). Rubin and 
Peyrot (1999) stated that long term glycaemic control, as long as it is not associated 
with burden or hypoglycaemia, results to better quality of life. Moreover, they note 
that this is more obvious when diabetes-specific measures which capture patient 
perceptions of symptoms are used for QoL assessment.  
 
5.2.3 Treatment regimen 
Insulin-dependent patients report a greater impact of diabetes on their lives. Using 
the ADDQoL Bradley et al. (1999) found that in 12 out of 13 items of the measure 
the impact of diabetes was greater for insulin-dependent patients. Similar results, 
with patients on insulin reporting the lowest quality of life, have been reported by 
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various other writers (Meadows et al. 2000; Jacobson et al. 1994; Glasgow et al. 
1997). Rubin and Peyrot (1999) argued that research findings support the view that 
treatment intensification from diet only, to oral medication to insulin is associated 
with decrements in QoL.  
  
Differences have also been reported among insulin treated diabetes patients, 
depending on the type of insulin they receive. Kotsanos et al. (1997), using the 
Diabetes Quality of Life Clinical Trial Questionnaire, found that patients receiving 
the first acting insulin analogue (insulin lispro) appear to have higher quality of life, 
treatment satisfaction,  and treatment flexibility than those using regular human 
insulin. Similar results have been reported by Howorka et al. (2000) as well as by 
Bott et al. (2003) who used insulin aspart as analogue. 
 
The type of insulin intake might also be a QoL variable. Pump users are reported to 
score significantly higher than patients injecting insulin, in domains such as ‘worries 
about the future’, ‘leisure time flexibility’, and ‘diet restrictions’. Also, patients with 
a flexible adaptation of insulin dosage (i.e. insulin intake according to food 
consumption), achieved better scores in ‘social relations’, ‘leisure time flexibility’, 
‘worries’, and ‘diet restrictions’ (Bott et al. 1998). 
 
However, not all researchers agree with the above views. Polonsky et al. (1995), 
contrary to their initial hypothesis, found no significant difference between insulin 
and oral medication treated type 2 diabetes patients. Similar findings were also 
reported by the UKPDS Group in 1999 (op.cit.) who argued that intensive policies 
of insulin therapy had no greater impact on QoL than other treatments of diabetes 
(UKPDS Group, 1999).    
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5.2.4 Complications 
It has been established by various investigators that diabetes complications is the 
most important determinant of QoL (Rubin and Peyrot, 1999; Jacobson et.al.1994; 
Trief et al. 1998; Anderson et al. 1997; Glasgow et al. 1997; Polonsky et al. 1995).  
Diabetes complications are divided into two main categories: microvascular and 
macrovascular. Retinopathy, nephropathy, and neuropathy are considered to be the 
most common microvascular complications. Macrovascular ones include coronary 
heart disease, cerebrovascular disease and stroke. Diabetes-patients with macro 
vascular and micro vascular diseases, especially nephropathy, report lower quality 
of life compared with patients without any of these complications (Lloyd et. al. 
1992). In 1999, the UK Prospective Diabetes Study Group (UKPDS, 1999) 
announced that the results of two cross-sectional studies show that patients with 
macrovascular complications reported significantly worse health, problems with 
mobility, and reduced vigour. Patients with microvascular complications reported 
more tension and total mood disturbance.  Wandell (2005) argued that macro 
vascular diseases, especially coronary heart disease, and non-vascular diseases, are 
the strongest predictors of QoL in diabetes. He also found that microvascular 
diseases had only weak associations with QoL. Foot ulcers have a major negative 
effect on all aspects of quality of life, particularly on the physical domain because of 
reduced mobility (Brod, 1998; Goodridge et al. 2005; Ribu et al. 2008). 
 
5.2.5 Duration 
Research findings show that the relationship between diabetes duration and quality 
of life is inconsistent. Some investigators argue that duration of either type of 
diabetes has no influence on quality of life (Jacobson et al. 1994; Parkerson et 
al.1993). However, other writers argue that development of diabetes early in life may 
have a negative effect on personal development in the domains of autonomy, 
independence, self-perception, and social integration (Gafvels et al.1993; Aalto et 
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al. 1997). At the same time an early onset of the disease facilitates long term 
psychological adjustment and management of diabetes. On the other hand, according 
to Bott et al. (1998), short duration is positively related to physical components of 
QoL with young patients reporting fewer physical complaints and greater leisure 
time flexibility. Similar findings were also reported by Lloyd and Orchard (1999). 
 
It is interesting to note that duration should not be seen only as a variable in its own 
capacity as it might also affect the importance of other variables. Jonsson et al. 
(2001) argued that for young patients the main variables of self-rated health in the 
onset of the disease were social class, marital status, and employment. Eight years 
after the diagnosis the importance of variables changed with gender being the most 
powerful one, followed by age and socioeconomic factors.    
Last, duration is indirectly related to QoL through the complications attributed to 
diabetes. These complications occur at an increasing rate during the course of the 
disease, thus influencing QoL (Klein et al. 1998). 
 
5.2.6 Socio-economic Status  
Socio-economic status (SES) is consistently related to health outcomes, although the 
mechanisms concerning this relationship are not adequately explained. People with 
diabetes are unlikely to be immune from this general pattern of SES and illness. 
Various studies prove a powerful association between SES, morbidity and mortality 
(Robinson et al. 1998; Chatuverdi et al. 1998; Roper et al. 2001). SES is also 
connected with high rate of complications and low use of medical care (Bachman et 
al. 2003).  SES can influence diabetes in many different ways. It can influence the 
access to care as well as the quality of care (Muhlhauser et al. 1998; McCall et al. 
2004; Hippisley-Cox et al. 2004). It can also influence diabetes-related knowledge, 
social support, communication with providers, ability to receive recommended 
medication and treatment, and dietary and treatment regimens (Brown et al. 2004). 
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Low SES is an identifiable risk factor for poor quality of life. However, although the 
association of health and SES pertains mainly to low levels of SES, it is not a 
characteristic of poverty and deprivation. There is evidence of a graded association 
with health at all levels of SES and not only at the lower levels of it (Adler et al. 
1994). Glasgow et al. (1997) reported significant and large differences in the quality 
of life between diabetes patients of different income levels. Similar findings have 
been reported by various other writers (Bott et al. 1998; Camacho et al. 2002; 
Lindsay et al. 2011). 
 
5.2.7 Gender 
Gender in diabetes-related QoL has not received sufficient attention by researchers. 
Many articles do not include in their findings gender composition and more than half 
of those that include it fail to examine the differences between sexes (Rubin and 
Peyrot, 1998). Nevertheless, the majority of the studies that examined the gender 
issue found that they were statistically significant differences on quality of life 
between men and women.  
 
Men report higher quality of life in general compared with women (Eiser et al. 1992; 
Glasgow et al. 1997; Lloyd and Orchard, 1999; Unden et al. 2008). However, most 
writers differentiate between men and women according to certain domains of 
quality of life. Jacobson et al. (1994) found significant differences between sexes on 
two domains only, with men reporting less impact of diabetes and fewer diabetes-
related worries.   Rubin and Peyrot (1998) argued that men enjoy higher quality of 
life than women, especially regarding dietary issues and overall treatment 
satisfaction. They also achieve better glycaemic control, fewer complications, and 
they are more confident in managing their diabetes. Women on the other hand show 
higher rates of anxiety and depression, which in turn have a negative impact on 
glycaemic control and complications (Gafvels et al. 1993).  Hammond and Aoki 
(1992) reported that women complained about more symptoms, less diabetes-related 
morale and lower well-being. Boyer and Earp (1997) using the D-39 measure found 
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that women scored higher than men on the energy-mobility, control and anxiety- 
worry scales, while men proved to have more troubles on sexual functioning than 
women. Shen et al.(1999) using the Diabetes QoL Clinical Trial Questionnaire 
(DQLCTQ: Chapter 6 and Appendix A) reported that male patients perceived better 
quality of life than females in 30 out of 34 domains.      
 
There are doubts on whether the differences between men and women on self 
assessed QoL are real or artificial because men in general are willing to pronounce 
themselves successful and less willing to admit problems.  On the other hand, it is 
more acceptable for women in western societies to be more sensitive to physiological 
changes and express their emotions overtly (Nathanson 1975; Bradley, 1980; Marcus 
and Seeman, 1981). However, observed differences in the number of complications 
and glycaemic control suggest that some differences rather exist on the real level.  
 
5.2.8 Age 
The association between age and QoL of people with diabetes is not very clear. It is 
certain though that QoL of elderly individuals differs from that of younger adults. It 
is natural older people to report problems especially regarding general health but 
when certain domains are assessed results are more complicated. Trief et al. (2003) 
compared HRQoL of insulin-treated diabetes patients aged 65 years or older with 
that of young patients aged between 30 and 64 years. The comparison was performed 
with the SF-36 and three diabetes-specific measures. The SF-36 results showed that 
patients from the older group reported more physical problems but scored better in 
social functioning. Lindsay et al. (2011) using the PAID questionnaire (Problem 
Areas in Diabetes: Chapter 6 and Appendix A) reported a significant deterioration 
of QoL scores as age increased.    
 
However, other diabetes-specific measures showed that elderly patients are coping 
better and reported less distress and greater satisfaction with aspects related to 
diabetes. Similar findings were reported by Brown et al. (2004). The findings of 
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Glasgow et al. (1997) found that young patients reported better QoL in physical as 
well as social functioning. 
 
Jacobson et al. (1994) found age to have only a limited influence on overall diabetes-
specific quality of life, while Hammond and Aoki (1992) reported that age was 
positively correlated with diabetes-related morale and well-being subscales of the 
Diabetes Impact Measurement Scale (DIMS: Chapter 6 and Appendix A). On the 
other hand according to Bott et al. (1998) young patients report better quality of life 
in the domains of physical complaints and leisure time flexibility. 
 
Trying to assess the relation of age with diabetes-specific quality of life, the level 
and quality of ‘realised’ health care should be considered as a confounding variable. 
Weiner et al. (1995), assessing the quality of care at primary care settings, found that 
elderly people do not appear to receive optimal care, with those living in rural areas 
receiving even less care than those living in urban locations (ibid). Therefore, 
reduced care combined with the natural debilitation that ageing causes might be 
major influences in certain domains of quality of life.  
 
5.2.9 Education 
Educational status is an important factor for health as well as QoL. In a nationwide 
study in Sweden it was shown that low-educated people with diabetes had a 40% 
excess in all-cause mortality compared with high-educated patients (Nilsson et al. 
1998).   According to Glasgow et al. (1997) people with diabetes who had college 
education had higher QoL compared with people with high school education or less.  
 
Education is also related to diabetes complications. According to Peyrot and Rubin 
(1997) college graduates with diabetes experience less than half the risk of 
psychological disturbance or depression compared with those who did not graduate 
from high school.  
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However, Jacobson et al. (1994) using a diabetes-specific and a generic measure, the 
Diabetes Quality of Life (DQOL: Chapter 6 and Appendix A) and the SF-36 
respectively argued that education level did not influence quality of life.  
 
5.2.10 Marital Status 
Research indicates that there is a strong relationship between marital status and 
quality of life. Jacobson et al. (1994) reported that divorced or separated diabetes 
patients experience worse quality of life than those who were single or married. 
Married patients run a lower risk for diabetes-related depression (Peyrot and Rubin 
1997) and they report higher treatment satisfaction (Bott et al. 1998). Boyer and Earp 
(1997) argued that single people feel a greater impact on energy-mobility and 
anxiety-worry scales, but less impact on sexual functioning than married ones. 
 
Marital status is not the only factor that affects quality of life in diabetes. Trief et al. 
(2001; 2002) argued that even quality of marriage is associated with quality of life. 
Better marital satisfaction is related to less impact of diabetes, less diabetes-related 
distress, and better diabetes-specific as well as general quality of life.  
 
5.2.11 Quality of care 
There are writers who believe that improving health is not an end in itself but a means 
or part of the attempt to improve quality of life. Ware (1987) argued that:  
“The goal of the health care system is to maximise the health component of quality 
of life, namely health status”.  
 
However, the types of health care organisation, the level of care, equity and the type 
of access to care are controversial issues that do not have unequivocal answers. 
Moreover, the evaluation of health care as a whole is almost an impossible task. 
Klein et al. (1961) argued that:  
“...it seems quite likely that there will never be a single comprehensive criterion by 
which to measure quality of patient care” (cited by Donabedian, 2005). 
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Some writers believe that health care is a predictor of HRQoL.  Ashing-Giwa (2005) 
argues that:  
 
“Traditional HRQoL framework follows a predominantly individual centred 
paradigm excluding contextual domains (e.g. health care system, cultural and socio-
ecological factors)”.  
 
According to his model of HRQoL systemic factors, such as access to care, quality 
of care, and the quality of physician-patient relationship, affect overall HRQoL. 
Leufstedt (2002), the president of the Swedish Diabetes Association, epitomised the 
relationship between the diabetes patient and health care arguing that the patient is 
not part of health care team but rather health care is part of the care of the person 
with diabetes. 
Although the actual level of quality of care cannot be easily assessed, empirical 
evidence shows that there is an association between quality of life and quality of 
care. Collins et al. (2009) using multivariate analysis, the ADDQoL as quality of life 
measure, and allowing for age, sex, complications and other confounders, found that 
there are differences in QoL among people receiving care at different levels. Patients 
receiving structured GP care are almost twice as likely to have higher quality of life, 
relatively to others receiving traditional hospital care or hospital/GP shared care.  
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Chapter 6: Aims and Objectives 
 
6.1 Aims of the study 
Internationally, QoL and diabetes appears not have received the attention 
commensurate with the size of the problem. However, in Greece, the field is virtually 
untouched and there is not a diabetes-specific measure for assessing the QoL of 
Greek patients.  
The principal aim of this study was:  
 To examine the QoL of people with diabetes in Greece and to investigate to 
what extent self-assessed QoL is associated with demographic, 
socioeconomic, and medical factors. 
Subsidiary aims included: 
 The rating of the impact of diabetes on various domains of life using the Audit 
of Diabetes Dependent Quality of Life measure, translated and culturally 
adopted for this study; 
 The assessment of health status of people with diabetes in Greece using the 
SF-36v2 Health Survey.  
 
6.2 Objectives 
The following research objectives were identified: 
 to examine the relationship between various medical factors and the QoL of 
people with diabetes in Greece; 
 to investigate whether there is any association between the area of residence 
and QoL of people with diabetes in Greece; 
 to explore the relationship between socioeconomic status and QoL of people 
with diabetes in Greece; 
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 to examine the relationship of demographic, socioeconomic, and medical 
factors and health status; 
 to investigate any associations between health status components and QoL 
domains; 
 to examine the structure of the existing diabetes-care system in Greece as 
well as its relation, if any, to diabetes-related QoL; 
 to use the knowledge that will be gained by making recommendations about 
the restructuring of the diabetes-care system in Greece. 
 
To achieve these aims and objectives, the following steps were required:  
 Selection of the most suitable HRQOL (diabetes-specific) measure through 
a systematic search of the literature (Chapter 8);  
 Translation and cultural adaptation of the selected HRQoL measure into 
Greek (Chapter 9); 
 The construction of a questionnaire for collecting the socioeconomic and 
medical variables of the respondents (Chapter 10); 
 A cross sectional survey using the diabetes-specific QoL measure and SF-36 
(Chapter 10);  
 Testing of the translated measure for reliability and validity in Greece 
(Chapter 11);   
 Rating of diabetes impact on various domains of life using the diabetes-
specific QoL  measure (Chapter 12); 
 Comparison of the HRQOL with generic SF-36 (Chapter 14). 
 
In Part II: Selection of a diabetes-specific QoL instrument for the Greek population 
(Chapters 7 and 8) of this thesis, the properties of QoL instruments to be considered 
during the development of an instrument are discussed. An understanding of these 
properties was considered necessary for the review and the selection of the most 
suitable HRQOL (diabetes-specific) measure for the Greek population.  11 diabetes-
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specific QoL instruments were identified from a search strategy involving five 
databases and the retrieval of an initial 2020 articles. 
  
 In Part III: Producing the ADDQoL-Gr (Chapter 9), translation into Greek and 
cultural adaptation to the Greek population of the selected HRQOL diabetes-specific 
measure was performed. This follows the defined process as described by the 
Agreement for the translation and use of the ADDQoL 19 rev 1.3.06 signed by the 
owner of the instrument Prof. Clare Bradley, Mrs J. Ross of the Royal Holloway- 
University of London, Prof. Ann Bowling of the UCL and me. 
In Part IV: Survey of the Greek Population (Chapters 10 and 11), the cross sectional 
survey of the Greek population using the HRQOL, SF-36 (for which a translated 
version for the Greek population exists), a demographic-socioeconomic-medical 
questionnaire including construction and tests on the validity of the ADDQoL-Gr are 
described. The latter involved testing the translated instrument for its psychometric 
properties. This is necessary because “the psychometric properties cannot be 
assumed to travel well” (Bradley, 1996). The results are compared with the results 
of the original instrument as well as the results of its translations into other languages 
(Bradley et al. 1999; Kamarul et al.2007; Da-Costa et al. 2006). 
In Part V: Diabetes and Quality of Life in Greece (Chapters 12 and13) the findings 
of the main QoL study are reported, results are discussed and the impact of diabetes 
on QoL is examined. It is in this part that analysis and synthesis takes place in the 
sense that the findings are compared and contrasted against each other, among the 
various sub-groups of the respondents, as well as against the findings of the 
international literature. Chapter 12 deals with the impact of diabetes on the lives of 
Greek patients, using the ADDQoL-Gr. This impact is assessed both as a whole (total 
weighted and unweighted) and according to the 19 different domains of the 
instrument. Various statistical techniques are used and the results of this work are 
discussed and compared with the international literature. Chapter 13 assesses the 
QoL sub-groups clustered according to demographic, socioeconomic or diabetes-
related characteristics of the respondents. In this sense predictors of diabetes-related 
quality of life are identified and their contribution to QoL is assessed.  
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In Part VI: Diabetes and Health Status the impact of diabetes on health status is 
investigated and the association of medical and socioeconomic variables with health 
components of the SF-36. 
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PART II: Selection of a diabetes- specific QoL 
instrument  
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Chapter 7: Properties of Quality of Life 
Instruments 
 
7.1 Introduction 
The merits as well as the shortcomings of disease-specific quality of life measures 
in general have already been discussed.  However, before the selection and 
application of an instrument is decided certain problems have to be met.    
The selection of an instrument is complicated, and potentially as a consequence of 
this has lacked a systematic approach. According to Polonsky (2000) many writers 
choose one of the following rules when selecting a QoL instrument: a) Use whatever 
others seem to use more often; b) assume that HRQoL correlates with psychological 
status and use any instrument that tackles some aspect of the patient’s psychology 
(e.g. depression) and; c) use any questionnaire that includes “quality of life” and 
“diabetes” in its title.  
In order to explain the selection of the appropriate instrument for this research, to 
avoid any theoretical misconceptions as well as the scientific loopholes described by 
Polonsky (ibid), it is necessary to understand and clarify the concepts involved in the 
process. Moreover, the new instrument that has to be produced for the measurement 
of the Greek population with diabetes has to undergo procedures that will prove it as 
a valid a reliable instrument.   
This chapter is an introduction to the theory related to instruments’ development, an 
attempt to define some concepts that suffer from some degree of ambiguity, and      
provide elements of the background which is necessary for the achievement of the 
two goals described in the previous paragraph.  
                                                                                                                                                                                                                                                        
The first problem in the attempt to develop or evaluate the instruments is the lack of 
a unanimously accepted definition of Health Related Quality of Life (HRQoL). Such 
a definition would provide the basis against to which the conceptual underpinnings 
of the instruments would be compared and its psychometric properties would be 
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assessed. Thus, the inclusion criteria, the review as well as the final choice of a 
measure was a value judgement, dependent to a great extent on the accepted 
definition of HRQoL. 
Another difficulty with QoL instruments lies in the field of property measurement. 
The attributes of the instruments concerned HRQoL are not physical attributes, but 
psychological ones. Psychological attributes cannot be directly observable, 
physically measured, or operationally defined. (Cronbach and Meehl, 1955). These 
attributes are “hypothetical constructs”.  
“A construct can be thought of as a ‘mini theory’ to explain the relationships among 
various behaviours or attitudes” (Streiner and Norman, 2008). 
 
As such, they cannot be measured directly, but by using various indicators that can 
explain a great part of the construct and never the full spectrum of it. In this sense no 
construct measurement can be fully complete.  These not directly observable 
constructs lack evidence independent of their measures. As a result no “gold 
standard” can be created for such measurements. However, despite the fact that they 
are “hypothetical” these constructs have an ontological status on their own; that is, 
they exist independently of their measurements (Hyland, 1993).  
The lack of a “gold standard” that might be used for the instruments’ evaluation 
creates in turn various difficulties concerning: 
 The attributes that should be used as criteria for the evaluation; 
 Methodology for the assessment of a particular property; 
 Terminology. In some cases it is impossible to clarify the exact meaning, content and 
definition of these criteria. Quite often terms like “discriminant” and 
“discriminative” validity, “sensitivity to change” and “responsiveness” or even 
“acceptability”, “burden”, and “feasibility” are used interchangeably; 
 Index interpretation. That is a compilation of rules aiming to explain the results of a 
test. This is another confusing topic. As Guyatt et al. (1998) pointed out:  
“Several questionnaires on quality of life related to health are available, but 
interpreting their results may be difficult”.  
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7.2 Conceptual - Measurement Model 
The conceptual model is the starting point for the development of an instrument. It 
is:  
“A rational for and description of the concepts and the populations that a measure 
is intended to assess and the relationship between those concepts” (SACMOT, 
2002). 
 
The conceptual model contains theory about the concept to be measured, literature 
review, any new research carried out for or during the development of the new 
measure and/or any existing scales that have been used and on which the 
development of the instrument was based. It also contains information about the 
conceptual and empirical bases for its item generation. 
 
7.2.1 Item generation  
It is probably the most important part of an instruments’ development. As Streiner 
and Norman stated:  
This is far from being a trivial task, since no amount of statistical manipulation after 
the fact can compensate for poorly chosen questions; those that are badly worded, 
ambiguous, irrelevant, or-even worse- not present (Streiner and Norman, 2008). 
 
There are a number of factors influencing the selection of items in an instruments’ 
construction. First, it is theory that should play an important role in this process. This 
term encompasses formal and refutable models of how things relate to one another, 
as well as vaguely formed hunches of how people behave (ibid). Research helps the 
developers of a questionnaire to create items that have been shown empirically to be 
the characteristics of the target group (ibid). Also, it is the developer’s personal 
judgement that has a significant role in items selection and the structure of the 
instrument. Sometimes this personal judgement can be the sole basis for the 
construction of the whole instrument. This is something that even the developers 
cannot deny. Ware himself, the main developer of the SF-36, in the preface of the 
manual, accepted that it was he who decided on the eight dimensions of the SF-36 
out of dozens under study in the MOS (Ware et al., 1993). 
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The patient, expert and clinician’s involvement in conjunction with the place and the 
period that the instrument was developed gives an idea about the culture of the 
instrument, as “HRQL instruments are not “culture free” but “culture full” (Fox-
Rushby and Parker, 1995). This in an important argument for the necessity of patient 
participation in instruments’ development; without it the culture of the researchers is 
reflected in the items as they are:  
“the most influential group of people in the development of generic instruments to 
date” (ibid). 
 
Another characteristic of instruments analysed in this section is the “measurement 
model”. A measurement model according to the SACMOT (2002):  
“Operationalizes the conceptual model and is reflected in an instrument\s scale and 
subscale structure and the procedures followed to create scale and subscale scores”. 
 
Item scaling is an important feature of an instrument. This is the range of options 
available for patients in answering each question (Kirshner and Guyatt, 1985). This 
characteristic is not simply a way of facilitating or improving the acceptability of a 
measure by the respondents. It is important when correlations with a criterion 
measure are examined, it facilitates the uniform interpretation of results and its 
grading determines to a great extent the ability of the instrument to register changes 
(ibid). 
 
The items generated have to undergo tests such as Factor Analysis or Principal 
Component Analysis in order to obtain information about dimensionality and 
distinctiveness of multiple scales.    
 
7.2.2 Factor Analysis 
Factor analysis (FA) consists of a number of statistical techniques aiming to simplify 
complex sets of data. The aim of this simplification is to explore the structure of 
these data and therefore their meaning (Howitt and Cramer, 2005). FA takes a large 
set of variables and tries to reduce them by finding those which correlate most with 
each other, producing a smaller set of variables called factors. It is based on the idea 
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that an array of variables can be described in terms of a reduced number of 
underlying factors (Streiner-Norman, 2008). “Factor” is a dimension or “underlying 
construct” or simply “construct”, which is a condensed statement of the relationships 
(correlations) between a set of variables. A factor is a construct operationally defined 
by its “factor loadings”. Factor loadings are the correlations (r) of a variable with a 
factor (Kline, 1994). 
 
FA is used to define the dimensionality of an instrument. The dimensionality of an 
instrument is important because it is an essential component of construct validity 
(Slocum-Gori and Zumbo, 2011). In this respect it is used to assess construct validity. 
In order to understand the use of FA a distinction should be made between 
Exploratory and Confirmatory Factor Analysis. 
 
7.2.2.1 Exploratory Factor Analysis 
According to Streiner and Norman (2008) Exploratory Factor Analysis: 
“Is a hypothesis generating technique, used when we do not know beforehand what 
relationships exist among the variables”. 
 
Exploratory FA aims to explore a set of data, by identifying the main constructs or 
dimensions. It shows how the variables cluster together to represent underlying 
constructs, even if these have not been formally defined. It also shows the importance 
that the variables have in the field. In the Exploratory Factor Analysis there are no a 
priori hypotheses based on theory or previous research about the composition of the 
subscales and this form of analysis is used to discover the latent variables of the scale 
(Floyd and Widaman, 1995).  
7.2.2.2 Confirmatory Factor Analysis 
As mentioned above Factor Analysis in its exploratory role is a hypothesis generating 
technique. However, FA is also used to confirm and evaluate the hypothesised scales 
of the conceptual model. In this respect Confirmatory Factor Analysis is used as a 
hypothesis testing approach (Streiner-Norman, 2008: 413). The factor structure 
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which appears in the exploratory factor analysis, has to be proved real and capable 
of supporting the proposed conceptual structure. To this end, initially the factors 
loadings of the variables have to be hypothesised. CFA is then used to fit these 
loadings in the target matrix (high, low or zero loading) as closely as possible (Kline, 
1994).  
 
7.2.2.3 Factor Rotation 
Factor rotation is a technique for improving interpretation of the results by presenting 
the pattern of loadings. Factor loadings are the correlations of the variables with a 
factor. This is necessary in order to facilitate the discrimination between factors. 
Items should have a high loading on one factor only and a zero or insignificant 
loading on any other factors. If a factor loads on any other factor (cross loading), it 
means that the item may refer to something other than intended by the developer and 
in most cases it is removed.  
By rotating the factors a maximum loading on one factor is obtained, minimising the 
loadings on other factors, and the pattern of the factor loading is facilitated. There 
are two types of rotation: Orthogonal and Oblique. 
Orthogonal rotation is used when there is a sound theoretical assumption that the 
factors are independent (not correlated) and wanted to be kept so. By rotating the 
factors orthogonally their overlapping is minimised, enhancing the interpretability 
of the instrument (Bowling, 2005a).  
Oblique rotation is used when the underlying factors are supposed to be related and 
can be allowed to correlate with the rotation. The results of the oblique rotation, due 
to factor correlation, are not very easy to interpret and should be used only in cases 
where there is a sound theoretical foundation that the factors are related. 
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7.3 Reliability 
Reliability is one of the most basic psychometric properties of an instrument. It is 
the measure of consistency and reproducibility of an instrument. A reliable 
instrument must be internally consistent and produce stable and repeatable results. 
Reliability refers to homogeneity and the degree to which an instrument is free from 
random error (Bowling, 2005a).   
Any measurement score includes two components: the real score and some degree 
of error. This error could be a random error (noise) and/or a systematic error (bias). 
Reliability refers to the degree to which a measurement represents the real score only, 
which is free from random error (Biases are examined in validation tests). Thus, 
reliability assures that any changes observed are due to actual variations in health 
levels as a result of an intervention and not due to problems of the instrument. 
Reliability is not a fixed property of an instrument. In other words it is not a property 
that exists in a manicheistic sense that is either it fully exists or it does not exist at 
all. It is rather a property that any measure will have a certain degree of it, when 
applied to certain populations, under certain conditions. According to Streiner and 
Norman (2008):  
“It is an interaction among the instrument, the specific group of people taking the 
test, and the situation”.    
      
There are four types of reliability:  
 internal consistency,  
 test-retest reliability,  
 inter-rater reliability and  
 Parallel (alternative) forms reliability (SACMOT 2002). 
All the above different types of reliability and their estimation methods are not 
necessarily mutually exclusive, nor do they necessarily lead to the same results. The 
various types of reliability are estimates of different characteristics that cannot be 
seen as equal (Streiner and Norman, 2008). It is almost certain that each method will 
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result in a different value for reliability. Usually test-retest and inter-rater reliability 
estimates will be lower in value than internal consistency. This is because, contrary 
to the methods calculating internal consistency, they involve measurement at 
different times or by different raters. Nevertheless, Streiner and Norman’s warning 
should be remembered that internal consistency, the most commonly used type of 
reliability, is not in itself reliable and should be treated with care, because it ignores 
potentially important sources of variation that may occur over time (ibid.).  
Furthermore, no type of reliability can cover all the possible sources of variance, as 
each one of them identifies and quantifies only one source of error variance (ibid). 
However, each form of reliability should be examined on its own and any attempt to 
produce an average index by combining different types of reliability does not make 
any sense. Thus, more than one type should be used in the same evaluation project. 
Also, it should be remembered that reliability is not a built-in property of an 
instrument and should be examined often within a range of clinical and 
organisational contexts (Sheldon, 1993). The general idea, applying to all types of 
reliability, is that the question of reliability is in its essence a question of correlation 
of the items. At this point internal consistency, which is considered as the most 
important type of reliability, will be discussed. 
 
7.3.1 Internal consistency  
In general, internal consistency is the extent to which tests or procedures assess the 
same characteristic, skill or quality. This is the case when items comprising a scale 
or a dimension relate only to this particular construct. By relating to this construct it 
means that all of the items constituting the measure are measuring the same thing. 
Items that measure the same thing correlate with the other items in the measure 
(Howitt-Cramer, 2005). Four methods are used for internal consistency assessment 
to estimate: the split-half reliability; alpha reliability (Cronbach’s α); item-item 
correlation; and item-total correlation. Cronbach’s α and item-total correlation were 
used for the reliability assessment of the Greek instrument. 
102 
 
7.3.1.1 Alpha reliability (Cronbach’s α) 
Alpha reliability is an improvement of split-half reliability. It estimates the average 
of all possible correlations between the items of the scale. It is mathematically 
equivalent to calculating all the possible split-half reliabilities, by calculating all the 
possible combinations of items and estimating the average.  Alpha reliability is also 
called Cronbach’s α and it is the most common form of internal consistency. 
“The α is basically the ratio of the sum of the covariances among the components of 
the linear combination (items), which estimates true variance, to the sum of all 
elements in the variance-covariance matrix of measures, which equals the observed 
variance” (Nunnally-Bernstein, 1994). 
 
The general rule is that the higher the Cronbach’s α, the higher the internal 
consistency. There are no universally accepted minimum-maximum levels of alpha. 
First, there are differences depending on the type of assessment one wants to make 
i.e. individual or group comparisons. For group comparisons, these levels are 
considered to be 0.70 -0.90 (Fitzpatrick et al.  1998), although Streiner and Norman 
(2008) clearly state that internal consistency should exceed 0.80.  
 
7.3.1.2 Item-total correlation  
After the item-item correlation is estimated, the total score of the items is used as 
another variable. Each item is then correlated with this new variable (the total score), 
giving the level of correlation between each item and the total. The item-total 
correlation measures the homogeneity of the scale. According to a “rule of thumb”, 
each item’s correlation with the remainder of the scale should be ≥ 0.20 (Streiner – 
Norman, 2008; Fitzpatrick et al., 1998). 
7.4 Validity  
After the examination of the importance of reliability as a psychometric property of 
an instrument, one should examine the other most important property, that of 
validity. This is necessary, because an instrument might be reliable but not valid. Of 
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course, an instrument cannot be valid without being reliable. Thus, reliability is a 
necessary but not sufficient condition for validity. 
As it has already been said, reliability is the degree to which an instrument measures 
a specific concept. Validity on the other hand refers to the degree to which an 
instrument measures the specific concept that it purports to measure. Validity, like 
reliability, is not a manicheistic property (all-or-none) of a measure but it is a matter 
of degree. Thus, the keyword in validity is the word “degree” (Nunnally and 
Bernstein, 1994).     
There are four types of validity: predictive validity, concurrent validity, content 
validity and construct validity. The first two can be combined and considered 
together as criterion-oriented validity (Cronbach – Meehl, 1955). The final division 
into three types of validity are established in literature as the “trinitarian” view of 
validity or the three Cs: Content, Criterion and Construct validity (Streiner-Norman, 
2008). 
 
7.4.1 Content Validity  
Content Validity refers to the extent to which the content of an instrument appears 
logically to examine and comprehensively include the full scope of the characteristic 
or domain it is intended to measure (Bowling, 2005a). Content validity depends to a 
great extend on established previous theory and research. It is obtained from an 
examination of the items of a questionnaire to judge whether it taps the range of 
topics it claims to measure and it is assessed by judgements made by a panel of 
experts, usually the instrument developers (Hyland, 1992: 44). Patient’s involvement 
in this development process should be considered as a prerequisite, as it helps the 
experts to formulate the content of the instrument, but in some cases developers do 
not follow this widely accepted view. 
The fact that content validity depends on experts’ judgements makes it unique 
compared with the other two basic types of validity i.e. the criterion and construct 
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validity. In contrast with the other two, content validity, as a qualitative judgement, 
is independent from test scores, or comparisons with other measures results, or 
changes after some kind of intervention. 
Also, it should be mentioned that these instruments intend to measure quality of life, 
which is not a highly developed theoretical construct. Thus, developer’s claims about 
the content validity of an instrument should not be taken in any way as an oracle 
(Bowling, 1995b).     
 
7.4.2 Face validity 
Face validity is concerned with how a measure or procedure appears i.e. how well 
designed the instrument looks or how reliable seems to be in gaining the information 
needed. Face validity is a superficial and the most value-judgement based type of 
validity.  It is not in any way a technical type of validity. Moreover, it is not based 
on any theory or supported by any research, as the content validity, but on the 
developers’ view about the test’s appearance, design and capability to gain the 
information it purports to obtain.  Despite the fact that face validity is a superficial 
form of validity it is widely accepted in literature as a form of validity.  
Face validity should not be confused with content validity. It should rather be 
considered as the informal evaluation of apparent validity by the test users (Hyland, 
1993). A practical way to distinguish the two is by thinking that content validity is 
concerned with the items of an instrument before the instrument is constructed. Face 
validity is concerned with the items after the construction of the instrument 
(Nunnally and Bernstein, 1994; Fayers and Machin, 2007).  
It is in this sense, that Nunnally and Bernstein (ibid.)argued that face validity could 
be considered as “one limited aspect of content validity”, dealing with the final 
inspection of an instrument in order to ensure that the initial plans have been 
transformed into a new completed instrument. Nevertheless, Nunnally and Bernstein 
accept that by adjusting the face of an instrument to the terminology or jargon of the 
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target group could play an important indirect role in the construction and use of 
predictor instruments. However, even if one accepts the Nunnally-Bernstein view 
that face validity is part of content validity,   these two types differ in essence and 
should not be confused. 
The controversy about face validity goes even further, to the extent that serious 
doubts have been expressed as to whether face validity is validity. Downing and 
Haladyna (2004) argue that:  
“...superficial qualities ... may represent an essential characteristic of the 
assessment but it is not validity... The appearance of validity is not validity; 
appearance is not scientific evidence, derived from hypothesis and theory, supported 
or unsupported... by empirical data and formed into logical arguments.” 
 
On the other hand face validity is considered by other writers to be very important 
and lack of this property might cancel the instrument per se. Gill and Feinstein (1994) 
raising the question of:  
“...whether the academic psychometric principles, although perhaps elegant 
statistically, are satisfactory for the clinical goal of indicating what clinicians and 
patients perceive as quality of life”,  
concluded that:  
“Many published measurements of quality of life seem clinically inappropriate 
because they have poor face validity”. 
Care should be taken therefore in treating face validity as a separate psychometric 
property, but it should not be considered as something negligible when assessing an 
instrument. 
 
7.4.3 Criterion Validity  
Criterion validity is the correlation of a scale with some other measure used as 
criterion. It is used to demonstrate the accuracy of a measure by comparing it with 
another one which has been used and accepted to be valid. This other measure   
ideally acts as a “gold standard” (Streiner-Norman, 2008). 
 
Criterion validity is determined by the degree of association between the instrument 
under examination and the criterion. This means that the criterion in a validation 
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process has to be accepted as “given”. This in turn means that this criterion has to be 
appropriate. At this point two problems arise: First, what is ‘appropriate’ and second, 
the so-called “criterion problem”, the problem of deciding what exactly should be 
measured. There are no simple answers to these problems. 
It should also be noted that these problems represent a semantic differential between 
criterion and construct validity, analysed below. Construct validity is not tied to a 
criterion and the criterion is not “given”. A construct validation allows the evaluation 
of both the nominal predictor and the nominal criterion at the same time. This is the 
reason, according to Nunnally and Bernstein (1994), why criterion validity is direct, 
simple but limited in scientific generalisation and in real sense limited in its 
applicability. 
Criterion validity can be examined under two different forms. The “concurrent” 
validity and “predictive” validity, depending on the existence of the criterion at the 
moment of the test or it will occur at some time in the future.  
Concurrent validity is the corroboration that an instrument is measuring what it 
purports to measure against a criterion measure. The two measures should be 
administered at the same time (Bowling, 2005c). Predictive validity is the ability of 
a measure to predict future differences in key variables in the expected direction. The 
criterion in this case is unavailable until sometime in the future (ibid). 
Predictive validity can also take the form of discriminative validity. This type of 
validity should not be confused with discriminant validity, which is a type of 
construct validity. Discriminative validity refers to whether a scale is able to 
differentiate between two groups with different traits (Streiner and Norman, 2008). 
It is based on the hypothesis that certain groups of patients are supposed to score 
differently than other groups (Fayers and Hand, 2002). An instrument is valid, when 
the scores of different groups, on the scales measured, are different.  It is assessed 
by comparing group mean scores, using the same instrument. The scores should 
appear significant differences, or prove the hypothesized ones. In this sense known 
groups comparisons is a combination of a validity test and a form of sensitivity 
assessment (Fayers and Machin, 2007).  
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The notion of discriminative validity can be found under various terms. Streiner and 
Norman (2008) refer to it as “extreme groups” validity. In Lamping’s evaluation 
studies the term “known groups” appears for the same notion (Lamping et al., 2002; 
Smith et al., 2005; Cano et al., 2006). The term “criterion groups validity” is also 
found in literature as synonymous (Todd and Bradley, 1994).  
 
7.4.4 Construct validity 
Construct validity is the extent to which an instrument tests the hypothesis or theory 
it is measuring (Bowling, 2005a). It has already been mentioned that QoL 
instruments measure “hypothetical constructs”. As such these attributes are not 
operationally defined and they cannot be directly observable and quantified 
(Cronbach and Meehl, 1955). However, these constructs despite the fact that they 
are “hypothetical” have an ontological status on their own that is they exist 
independently of their measurements (Hyland, 1993).  
As mentioned in the introduction a construct is a ‘mini theory’. To explain what a 
theory is and how it works one could borrow some of Milton Friedman’s thoughts 
from the methodology of economics:  
“A theory is a body of substantive hypotheses and has to be judged by its predictive 
power for the class of phenomena which it is intended to ‘explain’. Only factual 
evidence can show whether it is ‘right’ or ‘wrong’ ... the only relevant test of the 
«validity» of a hypothesis is comparison of its prediction with experience” 
(Friedman, 1953).  
    
When an instrument is designed, the first step is to specify the theoretical concept 
that is the construct that it intends to measure. Construct validity assumes the 
existence of a construct. According to Cronbach and Meehl (1955), this construct is: 
“... some postulated attribute of people assumed to be reflected in test performance. 
In test validation the attribute about which we make statements in interpreting a test 
is a construct”. 
  
The designers have to form some hypotheses about the constructs the instrument 
purports to measure, as well as its theoretical relationships with other similar 
constructs or variables. Hyland (1993) made an interesting distinction between QoL 
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and these constructs. He argued that quality of life is not a single construct but rather 
several causally connected ones. He further argued that definitions of health or QoL 
are not the same as constructs. Thus, these definitions provide a useful basis for 
establishing content validity, but provide little information about the construct as 
such.   
Therefore, construct validation of an instrument is the process that seeks agreement 
between these theoretical concepts, the postulated attributes, and the empirical 
evidence that occurred from its administration. In this sense construct validity 
estimates the extent to which an instrument is measuring qualities that it is intended 
to measure. 
This is succeeded by comparing the scores of the instrument with the scores of other 
instruments or variables. Construct validation is a three phase procedure. In the first 
phase, certain hypotheses about the relationship of the instrument with other scales 
have to be determined. In the second phase, the empirical relationships between the 
measures must be assessed. Lastly, the empirical evidence (the experience according 
to Friedman) must be interpreted in terms of how it clarifies the construct validity of 
the instrument that is tested.  
Certain problems arise during this procedure. First of all, a new measure is created 
to measure certain constructs in a different manner and not to replicate another 
instrument. Therefore, the two instruments should not be perfectly correlated. The 
extent to which the measures should correlate is another problem, as instrument 
developers do not explain why certain correlation scores that occur from the tests are 
satisfactory and show adequate construct validity (McDowell, 2006).  Not explaining 
the correlation scores is only part of the problem. In most cases writers do not give 
any theoretical reasoning why they expect the certain type of association. It could be 
argued by a new comer to the field, that sometimes some hypotheses are made just 
to justify the results.  
Construct validity is different from content and criterion validity. But their 
differences are only methodological. Construct and criterion validity differ in how 
directly they address properties of the instrument. However, despite the direct or 
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indirect approach to the issue, validity still addresses two properties: first the ability 
of the instrument to measure what it purports to measure and second its suitability 
for the pre-defined purpose (Williams and Naylor, 1992).   
Conceptually construct validity is the same with all other types of validity. Streiner-
Norman (op.cit.), argue that conceptually all three types of validity are the same. 
They extend their argument even further, quoting Guion’s argument that construct 
validity is the basic meaning of validity and any other type is basically some form of 
construct validity.  In this sense McDowell (2006) considers criterion validity simply 
as a “subcategory” of construct validity.  
Methodologically, construct validity differs from the other types of validity in 
various ways. First, other types of validity, such as content and criterion, can be 
assessed with only one study. Construct validity is an on-going process, of learning 
more about the instrument, making new predictions and test them.  
Second, with construct validity we test both theory and the instrument at the same 
time. If either or both are wrong the instrument is useless. In such a case, it is obvious 
that more than one test is needed to identify the source of the problem. 
Finally, both theory and the scale could be right, but the experiment is wrong. Again 
it is impossible to spot the cause of the problem in one single test (Streiner and 
Norman, 2008). 
Construct validity can be divided into two categories: “Convergent” and 
“Discriminant” validity. 
Convergent validity is the extent to which measures theoretically purport to measure 
the same topic correlate (Bowling, 2005b). If the scores of these measures do not 
correlate there should be a problem either with the new measure or the theory or even 
its autonomic sensitivity. Again the measures should not be highly correlated 
because this indicates that the measures are almost identical (Streiner and Norman, 
2008).  Correlations between measures that theoretically measure the same attribute 
should range between 0.40 – 0.80. Correlations lower than 0.40 indicate either an 
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unacceptable low reliability of one measure or that the measures are measuring 
different phenomena (ibid). 
Discriminant or divergent validity on the other hand indicates that the scale should 
not correlate with dissimilar or unrelated variables (Bowling, 2001; Streiner and 
Norman 2008). If such a correlation exists either the theory or the scale itself might 
be wrong. Of course, a novel instrument should have de jure discriminant validity in 
the sense that it measures something different from existing methods (Nunnally and 
Bernstein, 1994).    
Finally, taking into consideration that a measure taps various dimensions of quality 
of life, one could consider that convergent and discriminant validity represent the 
two extremes in a continuum of associations between the dimensions of QoL (Fayers 
and Machin, 2007). 
 
7.4.5 A summary for validity 
Having discussed the various types of validity at least three points should be 
mentioned:      
First, the validity of an instrument concerns the use to which the instrument purports 
to measure and not the instrument itself. Measures are often valid for one use but not 
for another (Nunnally and Bernstein, 1994). This is true even in cases where a 
disease-specific instrument is used for different groups of the same disease such as 
type 1 and type 2 diabetes patients. As Bradley (1996) argued “the psychometric 
properties cannot be assumed to travel well”.  A typical example of this, concerning 
this review, is the use of the DQOL, which was designed for assessing QoL of people 
with type 1diabetes. Its use with type 2 diabetes patients proved that its psychometric 
properties were less satisfactory. 
Second, even if validity is seen as a property of an instrument’s it is not an ‘all-or-
none’ property, but a matter of degree (Nunnally- Bernstein, 1994). 
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Third, validity is not a ‘once and for all’ attained property of an instrument. Due to 
the very nature of the (hypothetical) constructs the validation process should consist 
of learning more about the construct, taking into consideration any new theories, 
making new predictions or hypotheses and testing them all together (Streiner-
Norman, 2008). In other words, the on-going validation process is something like 
accumulating validity in a construct.    
 
7.5 Responsiveness – Sensitivity to Change 
When one first approaches the concept of responsiveness one cannot avoid its 
association with one of Einstein’s anecdotes. During the period of the turmoil about 
the relativity theory, in the course of an examination, by mistake or on purpose, he 
handed out the previous year’s examination paper. His aids informed him that “these 
were last year’s questions”. “Yes”, answered the Professor, “but this years’ answers 
are different”. Likewise, responsiveness tries to detect different (new) answers to the 
same problem.     
By reviewing the literature, about QoL instruments, one can easily reach the 
conclusion that responsiveness is an underestimated property by the vast majority of 
measures developers. Responsiveness is the ability of an instrument to detect 
changes. Changes always occur in different parameters during the course of time. In 
this respect responsiveness might be the most important property when the use of an 
evaluative instrument is needed. An evaluative instrument, according to the Guyatt 
et al. (1992) methodological framework for assessing health indices, is an instrument 
designed to detect longitudinal differences within people over time.    
Responsiveness is probably the most ambiguous psychometric property. It embodies 
most of the problems mentioned in previous pages. First of all there is no 
unanimously accepted definition of responsiveness. Twenty-five different 
definitions have been found in literature grouped under 3 categories: The first group 
defines responsiveness as the ability to detect change in general; the second defines 
it as the ability to detect clinically important change; the third group defines 
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responsiveness as the ability to detect real changes in the concept being measured 
(Terwee et al.  2003). 
Many writers use the terms responsiveness and sensitivity to change interchangeably. 
Others argue that the two are different and there should be a clear distinction between 
them. Sensitivity to change is the property defined by the first group that is to detect 
changes in general, while responsiveness deals with clinically important changes 
(Liang, 2000). In this respect, Liang argues, sensitivity to change is a necessary but 
insufficient condition for responsiveness. 
The very existence of responsiveness as a distinguishable property is controversial. 
Some writers believe that there is a conceptual distinction between validity and 
responsiveness. Thus, they should be treated as two distinct properties when 
assessing an instrument (Guyatt et al., 1989). 
Other writers consider the distinction between responsiveness and validity as 
artificial. They argue that this is result of the false view that dichotomises the 
instruments as valid and not valid, failing to recognise that instruments are valid to 
varying degrees (Hays and Hadorn, 1992). Liang (op.cit) argues that responsiveness 
is equivalent to longitudinal construct validity i.e. the ability of an instrument to 
measure a clinically meaningful change. Terwee et al. (2003) agree with Liang’s 
view and think of responsiveness as an indication of a measure’s construct validity 
or a facet of it, i.e. longitudinal validity. Last, Streiner and Norman (2008) agree with 
the view that conceptually responsiveness is an aspect of validation, but it is most 
akin to criterion validity, i.e. whether the change detected by the test under validation 
correlates with the change as measured by another measure. 
A study published in 2005 by Lindeboom et al.  provided some empirical evidence 
supporting the above theoretical views. They concluded that responsiveness is not a 
separate psychometric property of health scales and that the internal consistency 
coefficient reflects an instrument’s sensitivity to change over time. However, this 
view was contradicted by another study, claiming that internal consistency reliability 
is a poor predictor of responsiveness (Puhan et al.  2005). 
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Due to the conceptual interrelation that exists between responsiveness and validity, 
in this review, responsiveness will be reported separately whenever it is formally 
assessed, but under the heading of validity.  
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Chapter 8: Selection of Diabetes-specific 
Quality of Life Instrument for the 
Greek Population 
 
8.1 Introduction 
This chapter describes how diabetes-specific QoL measures were identified and 
reviewed. The review is focused at the identification of diabetes-related QoL 
measures and the selection of the most appropriate for this research instrument. 
Eleven diabetes-specific quality of life measures were identified and critically 
reviewed to find the most suitable to be used for this study. This task contained 
various difficulties, which mainly originated from the nature of the instruments used 
to measure a concept such as quality of life. The chapter also describes the method 
and the search strategy used to locate and retrieve references from electronic 
resources, as well as other sources used for data extraction, and reports the inclusion 
criteria.  
The method and the format used for the review was influenced mainly by the 
instructions given by the Scientific Advisory Committee of the Medical Outcomes 
Trust (SACMOT, 2002) and other previous reviews (Garrat et al., 2002b; Fitzpatrick 
et al., 2006). A very brief account for each instruments’ properties is given in this 
chapter referring to the background, conceptual-measurement model, reliability, 
validity and responsiveness, burden and acceptability, and any alternative forms or 
translations.   Also, a brief critical summary of each instrument is given, including 
comments about strengths and weaknesses and a conclusion about the use of each 
particular measure. Four tables are included concerning the description, details about 
the conceptual and measurement models of the instruments, the tests that have taken 
place for each one of them, as well as their psychometric properties. At the end of 
the chapter a detailed account of the criteria for the selection of an instrument is 
given, as well as documentation justifying the final selection. However, a 
comprehensive and expanded version of the critique of individual measures is given 
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in Appendix A with details of the statistical methods used for the instruments’ 
assessment, as well as the universally accepted levels, if any, against which a 
property should be compared. As there are no gold-standards for this, references to 
authorities in the relevant field have been made. The terms “heuristic” and “rule of 
the thumb” could not be avoided. However, one should bear in mind that “heuristic 
is a way of thinking about a topic which is convenient even if not absolutely true” 
(Darlington, 2006).    
 
8.2 Search strategy 
8.2.1 Aim 
The aim of the search strategy was to identify diabetes-related quality of life 
instruments. A prerequisite for this search was to locate references concerning:   
 Concepts such as QoL, health status, HRQoL;  
 The measurement of QoL and HRQoL;  
 The development and assessment of diabetes-specific instruments.  
 
The first problem faced at this stage was to define quality of life, in order to avoid 
retrieving articles concerning other aspects of diabetes. Finding an acceptable and 
operationally suitable definition for this study was a complicated and multi 
parametric issue.  
 
A good background had to be obtained before the work started. The theoretical 
background was obtained by reviewing the relevant literature. Bowling’s four books 
(1995a; 2001; 2005a; 2005c; 2005e) have been used as the basis and the starting 
point of this work. Many topics on the instrument development process, including 
the psychometric validation, have been clarified by referring initially to the first 
edition of Streiner and Norman’s book on Health Measurement Scales (1989) and 
later to the more complete 2008 edition. Nunnally and Bernstein’s book (1994) was 
also of great help in clarifying areas of psychometric theory. 
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Reviews were also used to identify instruments. For example, the review of Garratt 
et al. (2000), of diabetes patient-reported health instruments reported studies up to 
1999. Thus, some instruments and especially their subsequent validation studies 
were out of its reach.  
 
Some useful but very brief synoptic reviews appeared more recently. Garratt et al. 
(2002) published a short version of the 2000 review for 9 instruments and Watkins 
and Connell reviewed 12 instruments in 2004. The more up-to-date work of the 
Patient-reported Health Instruments Group (Fitzpatrick et al. 2006) also served as a 
guide for this work. This review drew substantially to the Garratt et al. work and 
examined six diabetes-specific instruments. 
 
 
The structure of my review might cause some misunderstanding. After a long period 
of trial and error the final result is a synthesis of proposals found in the literature, 
mixed with a degree of improvisation that I thought would be helpful for this 
particular work. The subheadings of this review should be considered only as a 
methodological convenience and by no means as a classification and assessment of 
independent properties. The underlying concept of the analysis is that there are no 
clear cut boundaries within the properties of an instrument. Thus, an attempt has 
been made in the comments section, to tackle the problem in a holistic manner, 
treating the properties as a continuum, and aiming to decide in the end about the 
validity of the instrument as a whole.  
 
8.2.2 The electronic search 
The electronic search followed these steps:  
 First, it was necessary to decide the type of articles to be searched;    
 Second, the inclusion criteria should be decided. This task would help before 
the beginning of the electronic search to identify key words, and after the 
search in accepting or rejecting articles and their corresponding instruments; 
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 Third, the design of the search strategy;  
 Fourth, to find the most relevant databases and choose among them.  
8.2.2.1 Inclusion criteria 
In order to search the literature a series of inclusion criteria had to be decided for the 
selection of articles on diabetes and quality of life. To this end the following criteria 
have been used: 
 The article should refer to a patient-reported or patient-assessed diabetes 
measure; 
 The article should refer to a measure that is developed or translated into the 
English language. A thorough investigation of the Greek literature proved 
that there is no diabetes-specific quality of life instrument either developed 
in or translated into Greek;  
 The measure should be characterised by its developers as assessing diabetes-
related quality of life. To overcome the difficulties regarding the existing 
conceptual differences described elsewhere, instruments that used the term 
health status have been included;  
 Articles that described measures addressing topics wider than QoL, but 
containing and assessing areas or dimensions of QoL were included; 
 The measures should have been assessed at least once for its psychometric 
properties with adult patients, with published results concerning 
methodology and measurement issues; 
 The measures should be referring to adults.  
The following electronic bibliographic databases were searched using the Wolters 
Kluwer – Health Ovid SP software provided by the UCL Library Services: 
 AMED. The Allied and Complementary Medicine Database, Health Care 
Information Service, the British Library; 
 EMBASE. The Excerpta Medica Database, Elsevier; 
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 HaPI. Health and Psychosocial Instruments Database, Behavioural 
Measurement Database Services; 
 MEDLINE. The United States National Library of Medicine. Electronic 
counterpart of index Medicus; 
 PsycINFO. The American Psychological Association. 
The search started by collecting keywords from books and articles in a step-by-step 
procedure. The search terms in the beginning were the word “diabet*” combined 
with the Boolean operator “and” with keywords indicating either quality of life or 
measure or questionnaire. The results showed hundreds of thousands of relevant 
articles.  Truncation was performed by using a second “and” with words indicating 
the development or assessment of instruments. This included many articles 
concerning instruments dealing with topics other than QoL in diabetes (adherence, 
education etc.).  
The first electronic search was performed in December 2007 and it continued under 
different strategies throughout 2008. The strategy that evolved was not considered 
as final and the search process was updated during the study.  
The search strategy was as follows:  
(Diabet* and (Index or indices or instrument* or measure* or questionnaire* or 
profile* or scale* or score* or status or survey or appraisal or HRQOL or HRQL 
or QOL or quality of life or quality-of-life) and (develop* or assess* or evaluat* or 
stud* or review or investigat* or appraisal or valid* or reliability or psychometric* 
or propert* or responsive*)).m_titl. 
 
The search in the five databases retrieved 2020 articles. Then, two limits were 
introduced: Articles should be in English and published between 1976 and 2009. The 
starting year was chosen because it was the year that the term “Quality of Life” was 
first introduced in “Index Medicus”.  
Having examined the results of the electronic search as well as the relevant literature 
a list of instruments was created. A new search was performed including the names 
of the instruments. The final search strategy was: 
 (((Diabet* and (Index or indices or instrument* or measure* or questionnaire* or 
profile* or scale* or score* or status or survey or appraisal or HRQOL or HRQL 
or QOL or quality of life or quality-of-life) and (develop* or assess* or evaluat* or 
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stud* or review or investigat* or appraisal or valid* or reliability or psychometric* 
or propert* or responsive* or status or HRQOL or HRQL or QOL or quality of life 
or quality-of-life)) or ADS or Appraisal of Diabetes Scale or ADDQOL or Audit of 
Diabetes Dependent Quality of Life or DCP or Diabetes Care Profile or DHP or 
Diabetes Health Profile or DHS or Diabetes Health Status or DQOL or Diabetes 
Quality of Life or DSQOLS or Diabetes Specific Quality of Life Scale or D-39 or 
Diabetes-39 or DDS or Diabetes Distress Scale or DIMS or Diabetes Impact 
Measurement Scales or PAID or Problem Areas in Diabetes or DQLCTQ or 
DQLCTQ-R or Diabetes Quality of Life Clinical Trial Questionnaire or LQD or 
Quality of Life with Diabetes Questionnaire) and (develop* or assess* or evaluat* 
or stud* or review or valid* or reliability or psychometric* or propert* or 
responsive*)).m_titl. 
 
8.2.3 Other Sources:  
The reference lists of the books and articles which emerged from the electronic 
search were checked and revealed publications that had not been identified by the 
electronic search. Also, a manual search of four journals was performed in July 2009. 
These journals are:   
 Quality of Life Research;  
 Diabetes Care;  
 Health and Quality of Life Outcomes;  
 Applied Research in Quality of Life. 
Last, already published reviews were used for additional references. The work of 
Fitzpatrick et al. (1998) and Lohr et al. of the SACMOT (2002) and Fitzpatrick et 
al. (2006) were of great help not only for deciding on the review criteria, but also on 
the structure of the review as well. However, the final inclusion-exclusion decision 
was to a great extent a matter of personal value judgement. 
 
8.2.4 Results 
Out of the 2020 records initially located 1088 records remained when the duplicates 
and the non-English language papers were removed. 995 records were screened and 
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after examining their titles and/or abstracts another 815 were removed. The full texts 
of the remaining 180 were retrieved and assessed for eligibility and 124 of them were 
excluded as not meeting the inclusion criteria either because QoL did not represent 
a significant component in their structure, or because they did not have sufficient 
information about the development and evaluation of the instrument. The remaining 
56 studies were included in qualitative as well as the quantitative synthesis of the 
review. Out of these 56 studies 11 instruments were identified and reviewed.  
These instruments are:  
 Appraisal of Diabetes Scale (ADS) 
 Audit of Diabetes Dependent Quality of Life (ADDQoL) 
 Diabetes Care Profile (DCP) 
 Diabetes Health Profile (DHP) 
 Diabetes Impact Measurement Scale (DIMS) 
 Diabetes Quality of Life (DQoL) 
 Diabetes QoL Clinical Trial Questionnaire (DQOLCTQ) 
 Diabetes-Specific Quality-of-Life Scale (DSQoLS) 
 Diabetes – 39 (D-39) 
 Problems Areas In Diabetes (PAID) 
 Diabetes Distress Scale (DDS) 
 
 The flowchart of the search is presented in Figure 3. 
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Figure 3: Flowchart of search strategy (Moher et al. 2009) 
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8.3 Instrument Review 
8.3.1 Introduction  
The structure of this review was based mainly on the criteria developed by the 
Scientific Advisory Committee of the Medical Outcomes Trust (SACMOT, 2002). 
A subheading concerning the background of the instrument was added in the 
beginning, as well as some critical comments in the end. Thus, the structure of the 
review concerning each instrument contains the following subheadings: 
 Background;  
 Conceptual and Measurement model;  
 Reliability; 
 Validity and Responsiveness;  
 Acceptability; 
 Alternative forms; 
 Cultural and Language Adaptations; 
 Comments. 
 
 
Four tables are included in the review. Table 1 summarises the description of the 
instrument providing information about the type of diabetes that the instrument 
assesses, the name of the developer and country of origin, the original language, time 
of administration, its main aim, the content as well as any existing translations. Table 
2 contains information about the conceptual and measurement models of the 
instruments. A brief account of the underlying concepts is given, the item generation 
and item reduction process, the response format, and the scoring method. Table 3 
summarises the tests that the instruments have undergone and table 4 gives details 
about the results of the tests concerning their psychometric properties in the form of 
reliability, validity and responsiveness.       
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Table 1: Description of instruments 
Instrument Diabetes 
type 
Developer Country/ 
Year 
Original 
Language 
Time 
needed 
Aim Content 
 
Translations 
Appraisal of Diabetes 
Scale 
1 & 2 Carey M.P 
et al 
USA English 
(USA) 
≤ 5 min  To assess 
patients’ appraisal 
of diabetes 
Single index, 7 items 
distress, control (2), 
uncertainty, prediction 
about the future, coping 
and effect on life goals 
None  
Audit of Diabetes 
Dependent Quality of 
Life 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 & 2 
 
C.Bradley UK English 
(UK) 
10 min To measure how 
the individual 
perceive and rate 
the impact of DM 
on all applicable 
aspects of life, 
together with the 
perceived 
importance of 
each domain 
 
 
 
 
 
 
 
 
 
 
 
 
 
Single Index Diabetes 
impact:  
19 domain-specific:  
leisure activities, working 
life, travelling, holidays, 
physical activity, family 
life, friendships-social life, 
personal relationships, 
sexual life, physical 
appearance, self 
confidence, motivation, 
people’s reaction, future 
worries, financial situation, 
living conditions, 
dependence on others, 
freedom to eat, freedom to 
drink. 
+ 
2 overview items: 
present QoL, diabetes & 
QoL. 
 
 
French (for France, 
Canada), 
German, Italian, 
Polish, Spanish (for 
Spain, Mexico, 
USA),English (for 
USA, Australia, 
Canada, India, 
Singapore),Hindi 
(+for UK), 
Portuguese for Brazil, 
Chinese, Cantonese 
for Hong Kong, 
Hungarian, Malay, 
Punjabi (+for UK), 
Slovak, Greek. 
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Table 1: Continued 
Instrument Diabetes 
Type 
Developer Country/ 
Year 
Original 
Language 
Time 
needed 
Aim Content 
 
Translations 
Diabetes Care Profile 
 
1 &2 
 
J. Fitzgeral USA English 
(USA) 
30-40 
min 
To measure the 
social & 
psychological 
factors in 
patient’s 
adjustment to DM 
and its treatment 
234 items in total.16 sub- 
scales measuring: Control 
problems, social –personal 
factors, positive, negative 
attitude, self-care ability, 
care importance, self-care 
and diet adherence, 
medical monitoring and 
exercise barriers, 
understanding mgt 
practice, long -term care 
benefits, support attitudes, 
support and needs.  
 
Chinese 
Diabetes Health 
Profile 
1  
 
 
2 
Meadows K 
 
 
Meadows K 
UK/1996 
 
 
UK/2000 
English 
(UK) 
- To identify 
psychosocial 
dysfunctioning of 
adult IDDM  
 
Total 32 items. 3 subscales: 
psycho logical distress 
(14), barriers to activity 
(13), disinhibited eating (5) 
14 in total. Danish, 
Dutch, English (Au, 
SA), Flemish, French, 
German (+CH), 
Hebrew, Italian, 
Polish, Russian, 
Spanish, Urdu  
Diabetes Impact 
Measurement Scales 
 
 
 
1&2 S Hammond USA/1992 English 
(USA) 
15-20 To measure lo- 
ngitudinal cha- 
nge in patients to 
quantitate 
treatment bene 
fits in cl. Trials 
 
44 items; 4 domains 
Symptoms: 17 
Well-being: 11 
Morale: 11 
Social role: 5     
Chinese (Mandarin) 
French, Italian 
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Table 1: continued 
Instrument Diabetes 
Type 
Developer Country/ 
Year 
Original 
Language 
Time 
needed 
Aim Content 
 
Translations 
Diabetes QoL 
Clinical Trial 
Questionnaire 
 
1&2 W. Shen 
J. Kotsanos 
USA 
(mainly) 
English 
(USA) 
+ 
German 
French 
(before 
validation) 
 The development 
of a reliable instr. 
For use in 
multinational 
clinical trials for 
both types of 
diabetes 
Rev: 57 items, 8 domains. 
Physical function, 
energy/fatigue, health 
distress, mental health, 
satisfaction, treatment 
satisfaction, treatment 
flexibility and frequency of 
symptoms 
 
German , French 
Diabetes-Specific 
Quality-Of Life Scale 
 
1 U. Bott Germany German 10-20 To measure QoL 
of patients with 
T1 diabetes and 
assess preference- 
weighted treat 
ment satisfaction 
39 items 6 scales: Social 
relations 11, leisure time 
flexibility 6, physical 
complaints 8, worries about 
future 5, diet restr. 5, daily 
hassles 4  
English 
Diabetes-39 
 
1&2 G. Boyer 
JA Earp 
USA 
1997 
English 
(USA) 
NR To assess the QoL 
of people with 
diabetes 
39 items–5domains 
Energy-mobility 15 control 
12, anxiety-worry4, social-
peer burden 5, sexual 
functioning 3. 
Spanish for Mexico 
Problem Areas In 
Diabetes 
 
 
 
 
 
 
 
 
1&2 W Polonsky  USA 
1995 
English 
(USA) 
3-5 min 
 
To assess diabetes 
related emotional 
distress 
Single index 20- items in  
areas: distress, anger, guilt 
worry, fear, depressed 
mood 
Chinese, Chinese, 
Danish, Dutch, 
Finnish, German, 
Japanese, Portuguese 
(+for Brazil), 
Spanish, Chinese, 
Swedish 
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Table 1: continued 
 
Diabetes Distress 
Scale 
 
1&2 
 
W Polonsky 
 
USA 
2005 
 
English 
(USA) 
 
NR 
 
To assess diabetes 
related emotional 
distress 
 
17 items-4 domains: 
Emotion 
al burden 5, regimen 
distress 
5, physician distress 4, 
inter- 
personal distress 3 
 
 
- 
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Table 2:  Conceptual & measurement models 
Instrument Underlying construct  Item generation Item Reduction 
Factor generation 
Response 
format 
Scoring method 
Appraisal of 
Diabetes Scale 
Lazarus & Folkman’s 
theory of stress 
management. (stress: when 
pressure exceeds ones’ 
ability to cope. 
Management: Factor & 
methods’ identification for 
controlling the pressure) 
 
Items adopted from  
Hammen – Mayol’s 
Attribution Questionnaire, 
and  research on appraisal 
processes. 
No patient involvement 
PCA: 1 factor explaining 39% 
of total variance 
5-point scale Summated items produce a 
single index 
Audit of Diabetes 
Dependent Quality 
of Life 
Joyce’s theory of patients’ 
views & perception and the 
generation of domains of 
importance by them, as 
first applied in SEIQoL 
 
 
SEIQoL’s philosophy used 
for framework + design. Lite 
rature review,  Health experts 
+ existing instruments , in-
depth interviews with12 
patients 
FA . 18 items loading on 1 
factor >0.50 
impact: 5-
point scale 
from -3 to +1 
importance: 
from 0 to 3 
Summated (items + 
importance) produce a single 
index 
Diabetes Care 
Profile 
 
Theory of adherence to 
various dimensions of 
diabetes regimens  
 
DEP, HBM (perceived 
severity of disease, perceived 
susceptibility to 
complications, benefits and 
barriers to adherence).       No 
patient involvement 
FA and CFA  5-point scale Score/scale =  Mean score of 
total items 
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Table 2: continued 
Instrument Underlying construct  Item generation Item Reduction 
Factor generation 
Response 
format 
Scoring method 
Diabetes Health 
Profile 
 
NR 
Literature review, in-depth 
interviews with patients, 
existing instruments, 
discussions with experts 
95 items in 5 constructs 
2 consecutive tests on patients 
& PAF analyses. 
1st: 43 items remain, 3 factors 
2nd: 32 items remain, 3factors 
explaining 33% of total 
variance.   3rd test (2000): 3 fa 
ctors expl. 40.3-45.6% of var.  
4 point Likert 
scale  
0: No impact 
3: high impact 
Summated scores for each 
subscale, producing scores 0-
100 according to SF-36 
formula 
 
Diabetes Impact  
Measurement 
Scales 
NR 
Literature review, health 
status instruments SF-36, SIP 
AIMS, discussions with 
experts. 
No patient involvement 
PCA : 1 factor explaining 32% 
of total variance 
0- 4 Likert 
0: Low QoL 
4: High QoL 
subscale & total scores 
computed by adding indivi 
dual item scores 
 
Diabetes Quality  
Of  
Life 
DCCT theory of intensive 
therapy of diabetes and 
glycaemic control  
Literature review, mental 
health - diabetes clinicians, 
nurses, and patients. 
Other instruments NR 
NR 5point Likert 
1: Low QoL 
5: High QoL 
 
Summated scores to 0-100 
scale 
Diabetes QoL 
Clinical Trial 
Questionnaire 
NR Literature review, 30 patients 
Items drawn from SF-36,  
SF-20, the DQOL measure,  
The HFS, and 31items newly 
developed by experts 
 
 
3 consecutive stages  
1st : 293 items 
2nd : 142 items 
3rd: 57 items 
5point Likert 
 
Domains scores converted to 
 0 -- 100  
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Table 2: continued 
Instrument Underlying construct  Item generation Item Reduction 
Factor generation 
Response 
format 
Scoring method 
Diabetes Specific 
QOL Scale 
NR 2 existing instruments in 
Germany, discussions with 
patients, health experts 
PCA for 44 items resulted in 
39-items, 6 factors. Factors 
confirmed by CFA 
6-point Likert  
1: Low QoL 
6: High QoL 
summated scores 
Diabetes-39 NR Literature review, interviews 
with diabetes clinicians, 
educators, and patients 
3 consecutive stages  
1st : 93 items 
2nd :42 items 
3rd: 39 items 
VAS 
1-7  
7:high impact 
 
5-point Likert. 0= no problem-
4 serious problem 
Conversion to 0-100= Item 
scores sum X 1.25 
Problem Areas In 
Diabetes 
NR Literature review, discussions 
diabetes experts, interviews 
with patients 
PCA: 1 factor explaining 
52.4% of total variance 
5 point Likert 
1: High QoL 
4: Low QoL 
Score converted to 100. Item 
score sum  X 1.25 
Diabetes Distress 
Scale 
NR Revision of PAID, QSD-R, 
ATT-39 by diabetes  experts 
and patients 
EFA: 1 factor. Loading not 
reported.  
6 point Likert 
1: High QoL 
6: Low QoL 
NR 
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Table 3: Field tests: Study & Respondent characteristics 
Instrument 
& 
Studies 
Test Site 
 
Mode of 
Admini 
stration  
Diabetes 
Type 
Sample 
Size 
Gender 
   (M) 
Mean Age 
  (M – F) 
Treatment 
Regimen 
Tablets & 
Diet 
Duration 
(years) 
Appraisal of Diabetes Scale 
Carey et al (1991) 
 
Veterans medical 
centre 
interviews and 
postal  
 200 100% 58.4 34% 15 
Audit of Diabetes 
Dependent Quality of Life 
a : Bradley et al (1999) 
b : Costa et al    (2006) 
c : Kamarun Imran et al (2007) 
d : Wee et al (2006) 
 
 
a1. Bromley        
a2. Cambridge      
b. Portugal        
c. Malaysia        
d. Singapore      
e. Greece 
 1&2 
1&2 
1 &2  
2  
1&2 
  
a1 : 102 
a2 : 52 
b : 100 
c : 288 
d : 173 
 
 
53.9% 
53.8% 
46% 
61.1% 
55.3% 
61.60 
52.38 
61.3 
52.7-51.1 
52.0 
67.5% 
37.2% 
73% 
73% 
64.8% 
7.27 
12.71 
12 
8.7 – 7.6 
10.1 
Diabetes Care Profile 
a : Fitzgerald, Davis et al ; (1996)  
b: Fitzgerald, Grupp et al; (2000) 
c. Anderson et al (1997) 
 
 
All in Michigan 
a1. Community  
a2: Med. centre  
b: Various clinics 
c:Research centre 
a1: interviews 
a2: postal      
b: interviews 
c: interviews 
1&2 
1&2 
2 
2 
a1: 440 
a2:  352 
b:  672 
c: 255 
45% 
40% 
44.8% 
45% 
61 
54 
63.1 
63.4 
55% 
33% 
48% 
64% 
10 
14 
12.45 
8.6 
Diabetes Health Profile 
a: Meadows et al (1996) 
 
b: Godijn et al (1996) 
c: Whitty et al (1997) 
d: Meadows et al (2000) 
UK 1outpatient clinic   
UK 54 outpatient clin 
UK 7 outpatient clin 
NL 1 outpatient clinic 
UK 6 diabetes clinic 
UK 1 diabetes centre 
DK 1 diabetes centre 
postal 
postal 
postal  
 
 
postal 
postal 
1 
1 
1 
1 
2 
2 
2 
a1: 239 
a2 : 2239 
a3 : 233 
b  : 99 
c  : 48 
dUK : 426 
dDK : 460 
NR 
a2 : 51% 
a3 : 52% 
48.5% 
42.0% 
   57.0% 
   53.9% 
 
40.85 
39.80 
51.46 
61.20 
NR 
61.63 
63.66 
0 
0 
0 
100% 
100% 
58.9% 
80.7% 
13.7 
13.1 
NA 
8.5 
NA 
NR 
NR 
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Table 3: continued 
Instrument 
& 
studies 
Test Site 
 
Mode of 
Admini 
stration  
Diabetes 
Type 
Sample 
Size 
Gender 
   (M) 
Mean Age 
  (M – F) 
Treatment 
Regimen 
Tablets & 
Diet 
Duration 
(years) 
Diabetes Impact 
Measurement Scales 
a: Hammond – Aoki (1992) 
b: Li et al (2006) 
a : California  
b : Taiwan - China 
interviews 
interviews 
1&2 
2 
a: 130 
b : 219 
42% 
35% 
45 
63.5 
22% 
NR 
11 
8 
Diabetes Quality Of Life 
 
 
a:USA 21 diab centres 
b:Boston diab centre 
interviews 
interviews 
 1 
T1:48.25%,T2:53.75 
190 
240 
60% 
47% 
28 
T1:44T2:60 
0 
47% 
8 
T1:18.8,T2:12 
Diabetes Quality of Life 
Clinical Trial  
Questionnaire 
J. Kotsanos 
 
Various clinical trials 
in the USA, France, 
Germany & Canada. 
interviews 
during various 
randomised 
clinical trials 
1&2 942 56.6% T1: 33.8 
T2: 58.2 
 12.6 
Diabetes-Specific Quality-
Of Life Scale 
 
Germany: Northrhine 
Primary care units 
interviews 1 657 58% 36 0 18 
Diabetes-39 
 
a:Cary:diab. Centre 
b: Iowa: gen. practice  
c:Carolina outpatient 
    hospital clinic 
postal 
postal 
postal 
T1:67.5%,T2:27% 
T1: 19%, T2:81% 
T1: 9.5%, T2:90% 
 
516 
165 
262 
45.5% 
45% 
36% 
52.4 
61.7 
55.3 
27% 
44% 
35% 
14.2 
11.5 
10.1 
Problem Areas In Diabetes a:Joslin diab. Centre 
b:Joslin diab. Centre 
c: Dutch diab. Associ 
interviews 
interviews 
Postal 
T1:82.4% 
T2:17.6% 
T1:52.7% T2:47.3 
T1:50.2% 
T2:47.6% 
 
451 
256 
1472 
0 
40.7% 
51% 
36.4 
52.3 
51 
0 
14% 
13.5% 
15.9 
15.1 
16 
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Table 3: continued 
Instrument 
& 
studies 
Test Site 
 
Mode of 
Admini 
stration  
Diabetes 
Type 
Sample 
Size 
Gender 
   (M) 
Mean Age 
  (M – F) 
Treatment 
Regimen 
Tablets & 
Diet 
Duration 
(years) 
Diabetes Distress Scale San Diego USA 
Boston 
Honolulu interviews T2: 83.3 683 52.3% 56.4 49.6% 12.8 
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Table 4: Field tests: Psychometric Properties of Diabetes-specific QoL Instruments                                                                                                                         
Instrument/Study Reliability   Validity   
                                 Cronbach’s a Item total Test-retest Scale  
Analysis 
Convergent/ 
Discriminant 
Other 
variables 
Known groups 
differences 
Responsiveness 
Appraisal of Diabetes 
Scale 
Carey et al 1991 
0.73 0.281-0.589 1h-1w: 
.89 -  .85 
A single factor 
accounted for 39% 
of variance 
PSI r:0 .39 -0 .58 
DDHS r: 0.59 
DHBQ-R r:0.31- 0.42 
PSS r: 0 .49 
DRAQ-R r: 0.17 
    
HbA1c r:0.18 NR NR 
Audit of Diabetes 
Dependent Quality of 
Life 
a : Bradley et al 1999 
b : Costa et al    2006 
c : Kamarun Imran et al 2007 
d : Wee et al 2006 
e : Bradley & Speight 2002 
 
 
 
 
a:  0.84 
b:  0.89 
c:  0.94 
d:  0.94 
e:  0.92 
 
a: 0.37-0.67 
c: 0.51-0.78 
- 
- 
 
c: 0-1w:0.81 
 
All items loaded 
On one factor: 
a: >0 .40 
b: >0 .43 
c: >0 .52 
d::>0 .40;explained 
49.2% of variance  
e: > .51 
 
Overview items of 
ADDQoL:  
QoL without D: 0.47 
Present QoL: 0.31 
 
Other instruments: 
              NR 
Hypoglycaemia: 
r: 0.32 
Complications: 
r: 0.21 
Greater impact of D 
for people: 
IDDM 
complications 
hypoglycaemia 
 
NR 
Diabetes Care Profile 
 a: Fitzgerald et al 1996 
 a1: Community 
 a2: Medical Centre 
b: Fitzgerald et al 2000 
c: Cunningham et al 2005  
c1: White- non Hispanic 
c2: Hispanic 
 
a1: 0.60 - 0 .95 
a2: 0.66 - 0 .94 
b: 
c1: 0.63 - 0.95 
c2: 0.54 -0.97 
NR NR NR a: SPS r: -0.34- 0.32 
a: CESD r: -0.53-0.48 
a:HSS r: -0.27-0.32 
 
c1: BDI:-0.50- 0.45 
c2: BDI:-0.53- 0.44  
c1:: DFBC: 0.30-0.24 
c2: DFBC: -0.33-0.36 
a:GHb: -0.33-0.21 
b: 
c: GHb: -0.26-0.19 
a&b: Insulin users 
report greater 
impact on social/ 
personal lives. 
b: Caucasians using 
insulin- the most  
nega tive to diabetes 
 
NR 
Diabetes Health Profile 
a: Meadows et al (1996) 
b : Godijn et al (1996) 
c : Whitty et al (1997) 
d : Meadows et al (2000 
 
 
a2: 0.77 - 0.86 
a3 :00.80 - 0.85 
d : 0.70 - 0.88 
 
a: 0.47-0.75 
d: >0.40 
(except item 
6)  
NR 3 factors accounting 
for 33% of variance 
a:HADS r=0.28-0.62 
SF-36 r=0.17-0.68 
b:SF-36 r=0.07-0.65 
NR Women score higher 
v men. Young 
patients worse 
scores 
c: 2 scales assessed 6 weeks 
from baseline: SRM: 
Psychological distress 0.23 
barriers to activity 0.02 
(insignificant changes-
scales no responsive) 
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Table 4: continued  
Instrument/Study Reliability   Validity   
                                 Cronbach’s a Item total Test-retest Scale  
Analysis 
Convergent/ 
Discriminant 
Other 
variables 
Known groups 
differences 
Responsiveness 
 
Diabetes Impact 
Measurement Scales 
a: Hammond, Aoki (1992) 
b : Li et al (2006) 
 
 
 
a: .60- .85 -.94 
b: .61- .86 
 
NR 
 
a: 1m: 0.61-0.78 
(not traditional) 
 
b: 1-2     
w:0.55-0.92 
 
One factor account. 
for 32% of variance 
  
 
a: DC(Pat):0.22-0 .55 
   DC(Clin):0.24-0.35 
   GW(Pat):0.27- 0.47 
   GW(Cl):0.29-0.45 
 
HbA1c:: negative 
correlation ( .04 - 
.01) 
Age: pos cor/ed 
with well-being 
Sex: neg  cor/ted 
with symptoms  
 
 
Women reporting 
more  
Symptoms 
 
NR 
Diabetes Quality Of Life 
a:Jacobson et al (1988) 
b:Parkerson et al (1993) 
c:Jacobson et al (1994) 
a: 0.67-0.92 
b: 0.52-088 
c: 0.47-0.87 
NR a: 0.78-0.92 NR SCL:0.40-0.60(total) 
ABS:0.25-0.57(total) 
PAIS:0.06-0.63 
c:SF-36:-0.003 – 0.59 
 
 
NR Males: less impact,  
worries. 
Complications: 
greater impact. 
Insulin: greater 
impact, less worries. 
Married: less 
worries, better 
mental health. Age: 
mixed effects 
 
NR 
Diabetes Quality of Life 
Clinical Trial 
Questionnaire 
 
0.53 - 08.89 
DQLCTQ-R: 
0.77-0.91 
NR n=50 
ICC>0.70 
except 2 
domains(worry 
& stigma) 
NR NR NR T1 patients, males, 
with tight metabolic 
control, high-self 
perceived control = 
better QoL 
 
Check of GHb 6 months-
baseline. Health distress, 
mental health, satisfaction, 
and treat. satisfaction. 
Responsive to change 
Diabetes-Specific 
Quality-Of Life Scale 
 
 
 
0.70 – 0.88 NR NR 6 factors explaining 
50.1% of variance 
Positive Well-being 
Scale (r: 0.35-0.53) 
HbA1c:: negative 
correlations (0 - 
.24) 
 
age: r=-0.01 -0.23 
duration r=0.02-0.22 
social status: r=0.24-
0.04 
 
 
 
NR 
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Table 4: continued 
Instrument/Study Reliability   Validity   
                                 Cronbach’s a Item total Test-retest Scale  
Analysis 
Convergent/ 
Discriminant 
Other 
variables 
Known groups 
differences 
Responsiveness 
 
Diabetes-39 
a :Iowa 
b : Carolina 
 
 
 
a: 0.82-0.93 
b:0.81-0.93 
patients >75 
years or <high 
school α:0.70 
 
 
0.45-0.84 
 
 
NR 
 
 
5 factors explaining 
90.4% of varianve 
 
 
SF-36: 
a: 0.15-0.71 
b:0.20-0.68 
Overall QoL: 
a: 0.22-044 
b:0.22-0.35 
Diabetes severity: 
a:0.24-0.56 
b:0.27-0.56 
 
 
NR 
 
 
comorbidity 
patients: and >75 
years high on 
energy-mobility. 
Young pat: High on 
control, worry, 
social burden. Men: 
higher on sexual 
functioning.  
T1 higher than T2 
for worry, control. 
    
 
 
NR 
Problem Areas In 
Diabetes 
a: Polonsky 1995 
b: Welch 1997 
c: Snoec 2000 Dutch USA 
d:Welch 2003 
 
 
 
 
a: 0.95 
b: 0.95 
c: 0.93-0.95 
a: 0.32-0.84 
mean: 0.68 
 
c:0.83 (66 days) b:Single factor 
accounting for 
52.4% of variance 
STAI:0.61, GSI: 0.63 
HFS-W 0.57, 
BULIT-R 0.61, SCI: 
0.09-0.49 
a:HbA1c:.30 
b: HbA1c:.15-.34 
c: s-r HbA1c:.11 
Type 1 higher 
distress than T2. 
Patients with 
hypoglycaemic, 
DKA episodes or 
mental health 
problems: higher 
distress 
d: Data from 7 studies: 
Effect sizes ranging from 
0.32 to 0.64. Half of results 
being moderate (>0.50). 
Low to moderate 
responsiveness 
Diabetes Distress Scale 0.93 NR NR 28-item v 17-item 
correlation r=0.99 
17-tem mean 
subscale cor. r=0.82 
CESD r = 0.56 Age r = -0.29 
Cholest r = 0.20 
HbA1c = 0.01 
meal planning 
r = 0.30 
NR NR 
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8.3.2 Brief Appraisal of Instruments 
8.3.2.1 “Appraisal of Diabetes Scale” (ADS) 
Background: Developed in the USA by M. Carey. First published in 1991. 
Conceptual-Measurement model 
Item generation: Previous questionnaires, research on appraisal, no patient 
involvement. 
Items: 7 items: distress, control (2), uncertainty, prediction about the future, coping 
and effect on life goals. 
Response format: 5-point scale. 
Scoring method: Summated items producing a single index 
Reliability: Cronbach’s α: acceptable but at the lowest level (0.73). Item-total: well 
above minimum (0.28-0.59). Test-retest: reliable over repeated administrations. 
Validity and Responsiveness:  
Validity: Convergent validity: tested against 5 other instruments with hypothesised 
correlations confirmed. 
Responsiveness: Not assessed. 
Burden &Acceptability 
Completion time: < 5 min. 
Acceptability: 78.5% for the 1-week retest. 
Alternative forms: None. 
Cultural and Language Adaptations: None. 
Comments: 
Strengths: 
 Easy to administer; 
 Moderate to good reliability. 
Weaknesses: 
 No patient involvement; 
 Tested on males only – no evidence on psychometrics for women; 
 Content validity not tested; 
 Convergent validity hypotheses confirmed, but expected magnitude of 
correlation was not reported; 
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 Construct validity was not assessed. 
Conclusion: 
Deficiencies in the development process (no patient involvement), as well as in 
testing (male sample only) make the instrument unreliable. 
 
8.3.2.2 “Audit of Diabetes Dependent Quality of Life” (ADDQoL) 
Background: Developed in the UK by C. Bradley, first published in 1999. 
Conceptual and Measurement model:  
Item generation: based on Joyce’s theory concerning patient’s views, SEIQOL, 
previous research, health professionals and patients with diabetes.  
Items: 19. Each item followed by importance rating. (leisure activities, working life, 
travelling, holidays, physical activity, family life, friendships-social life, personal 
relationships, sexual life, physical appearance, self-confidence, motivation, people’s 
reaction, future worries, financial situation, living conditions, dependence on others, 
freedom to eat, freedom to drink)   + 2 global questions (Life without diabetes, overall 
QoL). 
Response format: Items: 5-points scale. Importance rating: 4-point scale.  
Reliability: Measured by Cronbach’s α, and item-total correlation: very good. 
Validity and Responsiveness: 
Validity: assessed only against the two global items. Low correlations (0.21 and 
0.32) show that the measure provides good additional information.   
Responsiveness: Not assessed.  
Burden & Acceptability: Low acceptance rates in the initial two tests (47.7% and 
71.8%). 
Alternative forms: The ADDQoL-Teens for young people with Type 1 diabetes. 
Cultural and Language Adaptations: 23 adaptations (the most translated 
measure). 
Comments: 
Strengths: 
 Patient and health professional’s participation give evidence for content 
validity; 
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 The only diabetes-specific measure with importance rating; 
 The only diabetes-specific measure with ‘non-applicable’ option; 
 It allows positive responses, allowing for possible positive impact of the 
disease; 
 It contains two global questions;  
 It is the most translated measure, capable of international comparisons. 
Weaknesses: 
 Poor validity assessment (only against its global items); 
 Small sample sizes in tests and one not representative (convenient); 
 Low to moderate acceptability reported. 
 
Conclusion:  Its strengths outweigh its weaknesses. Also, the subsequent 
equivalence studies rectify to some extent these weaknesses.  The best instrument 
reviewed for this project. 
 
8.3.2.3 “Diabetes Care Profile” (DCF)  
Background: Developed in the USA by J. Fitzerald. First published in 1996 
Conceptual-Measurement model 
Aim: To measure social and psychological factors in patient’s adjustment to 
diabetes and its treatment. 
Item generation: Previous questionnaires, no patient involvement. 
Items: 234 - 16 subscales. 
Response format: 5-point scale. 
Scoring method: Score/scale or mean score of total items.  
Reliability: Cronbach’s α: acceptable but at the lowest level for all but two 
subscales. 
Validity and Responsiveness:  
Validity: Tested for construct and concurrent validity against 5 different measures 
with good results.   
Responsiveness: Not assessed. 
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Burden &Acceptability 
Completion time: Authors report 30-40΄, which is unrealistic for 234 items.  
Acceptability: Very low: 28.5% and 43.2%. 
Alternative forms: Each subscale can be used as a short-form. 
Cultural and Language Adaptations: None. 
Comments: 
Strengths: 
 Evidence for good validity. 
Weaknesses: 
 No patient involvement during development; 
 The length of the measure (234 items); 
 Validity tested for only 4 out of 16 subscales; 
 It does not cover the concept of QoL, according to the accepted definition; 
 Low acceptability. 
Conclusion: Too lengthy and unreliable as QoL measure and unreliable in its short-
form.  
 
8.3.2.4 “Diabetes Health Profile” (DHF)  
Background: Developed in the UK by K. Meadows. First published in 1996. 
Conceptual-Measurement model 
Aim: To identify psychosocial dysfunctioning of adult Type 1 diabetes patients. 
Item generation: Literature review, interviews with patients, existing instruments, 
health experts. 
Items: 32 in 3 subscales: psychological distress, barriers to activity, disinhibited 
eating. 
Response format: 4-point scale. 
Scoring method: Summated scores for each scale. 
Reliability: Cronbach’s α: Moderate to good (0.70 – 0.88).  
Validity and Responsiveness:  
Validity: Evidence for face and content validity. Good convergent and discriminant 
validity. 
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Responsiveness: Not formally assessed. 2 subscales tested in a subsequent study 
failed to detect differences.  
Burden &Acceptability 
Completion time: Not reported. 
Acceptability: Very good (79-86%). 
Alternative forms: Instrument adapted for use with Type 2 patients containing 18 
items with good reliability and validity. 
Cultural and Language Adaptations: 14 languages (second most translated 
measure). 
Comments: 
Strengths: 
 The only Type-specific diabetes instrument, thus reliable for clinical studies; 
 Item generation process satisfies all relevant criteria; 
 Good reliability (internal consistency), good validity in almost all its forms.  
Weaknesses: 
 As a Type-specific instrument is not suitable for general surveys; 
 Relatively lengthy thus unsuitable if used in combination with a generic 
measure. 
Conclusion:  
Although a measure with good properties, its weaknesses make the DHP unsuitable 
for this research purpose. 
 
8.3.2.5 “Diabetes Impact Measurement Scale” (DIMS)  
Background: Developed in the USA by Hammond and Aoki. First published in 
1992. 
Conceptual-Measurement model 
Aim: To measure longitudinal change in patients, in order to quantify treatment 
benefits in clinical trials.  
Item generation: Literature review, health-status instruments, health experts, no 
patient involvement. 
Items: 44 items in 4 domains (symptoms, well-being, morale, and social role). 
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Response format: 4-point scale and two visual analogue scales. 
Scoring method: subscale and total score by adding individual item scores. 
Reliability: Cronbach’s α: Low, moderate and good (0.60 – 0.85) for the various 
subscales. Test-retest reliability was assessed but with undefined and different time-
intervals, thus not conclusive.  
Validity and Responsiveness:  
Validity: Tested against global rating scales and clinical variables showing good 
correlations with symptoms of the disease, but insignificant ones with medical 
variables such as complications. 
Responsiveness: Not assessed. 
Burden &Acceptability 
Completion time: 15-20΄. 
Acceptability: Not reported. 
Alternative forms: None. 
Cultural and Language Adaptations: 3  
Comments: 
Strengths: 
 Evidence for reliability, but not for all subscales;  
 Contradictory results for validity.  
Weaknesses: 
 No patient involvement in development; 
 Poor interpretation of validity results;  
 Some items provide little or no information, but nothing has been done to 
remove them. 
Conclusion:  
The measure needs further attention to overcome its shortcomings, but it seems 
abandoned by its developers. 
 
8.3.2.6. “Diabetes Quality of Life” (DQoL) 
Background: Developed in the USA by Jacobson in 1988. The first diabetes-
specific measure. 
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Conceptual-Measurement model 
Aim: To evaluate the burden of an intensive diabetes treatment regimen. 
Item generation: Literature review, mental health & diabetes clinicians, nurses, and 
patients.  
Items: 46 core items in 4 dimensions: treatment satisfaction, treat. Impact, D worry, 
social/ vocational worry.  
Response format: 5-point scale. 
Scoring method: Subscale and total scores computed by adding individual item 
scores. 
Reliability: Cronbach’s α: Contradictory results between tests and subscales 
ranging between unacceptable and high (0.47-0.92) with most subscales at a very 
low level. Good test-retest reliability. 
Validity and Responsiveness:  
Validity: Content & face validity supported for type 1 patients only.  Good 
convergent validity, low discriminative validity. Doubts about the value of the 
DQoL as a diabetes-specific measure compared with generic ones.   
Responsiveness: Not formally assessed. An indirect assessment showed 
unsatisfactory levels of responsiveness.  
Burden &Acceptability 
Completion time: Not reported. 
Acceptability: Ranges between 77-91%. 
Alternative forms: Short-form of 15 items: the DQOL Short-Form Clinical 
Inventory. 
Cultural and Language Adaptations: French, Spanish, Chinese, and Turkish. 
Comments: 
Strengths: 
 The most widely used diabetes-specific instrument, good for comparisons – 
first instrument in the field. 
Weaknesses: 
 Instrument designed for type-1. Its adaptation for type-2 not very successful;  
 Low to unacceptable internal consistency; 
 Item generation not adequately described and only with type-1 patients;      
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 Low levels of internal consistency; 
 Lower performance compared with generic measures. 
Conclusion: 
A highly overvalued measure with serious structural deficiencies.    
 
8.3.2.7. “Diabetes QoL Clinical Trial Questionnaire” (DQLCTQ) 
Background: Developed in the USA, France, Germany, and Canada. First 
published in 1999. 
Conceptual-Measurement model 
Aim: a questionnaire for use in multinational clinical trials of patients with type 1 
and 2 diabetes containing all diabetes-related QoL domains. 
Item generation: Literature review, patients, items from other instruments (SF-36, 
the DQoL, and the HFS), and patients.28 items drawn directly from SF-36, 59 from 
the DQoL, and 17 from HFS. 
Items: 142 in 20 domains. The revised version contains 57 items across 8 domains.  
Response format: 5-point scale. 
Scoring method: Domain scores converted to 0-100. 
Reliability: Cronbach’s α: moderate, good, and high for most domains (6 out of 8). 
Test-retest was assessed but results are unreliable due to sample and mode of 
administration deficiencies.  
Validity and Responsiveness:  
Validity: Face and content validity assessed by experts and patients. Good 
discriminant validity for various groups of patients assessed against demographic 
and clinical variables. 
Responsiveness: Assessed six months from baseline showed significant changes in 
4 domains related to health and treatment, indicating good responsiveness of the 
measure. 
Burden &Acceptability 
Completion time: Not reported. Time of 10΄ reported for the revised version seems 
unrealistic. 
Acceptability: Not reported. 
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Alternative forms: The revised version of 57 items containing only the domains 
of the original with high reliability and validity make it one of the most reliable and 
valid instruments in the field. 
Cultural and Language Adaptations: German and French. 
Comments: 
Strengths:  
 The original version captures all QoL domains related to diabetes; 
 Containing entire diabetes-specific and generic measures is useful for assessing 
health status, QoL, and treatment satisfaction simultaneously;  
 Revised version reliable and valid, but further evidence is required.  
Weaknesses: 
 Item generation-reduction based on trial-and-error rather than theory and 
empirical evidence;   
 Original instrument too lengthy and unreliable; revised version still lengthy; 
 Inclusion of other instruments does not improve any properties but inherits their 
handicaps.  
Conclusion:  
It cannot be considered as a diabetes-specific instrument per se, but as a compilation 
of other instruments. 
 
 
8.3.2.8 “Diabetes-Specific Quality-of-Life Scale” (DSQoLS) 
Background: Developed in Germany by U. Bott. First published in 1998. 
Conceptual-Measurement model 
Aim: to assess four components of quality of life (physical, emotional, social 
burdens, and daily functioning) of people with type 1diabetes. 
Item generation: Based on two existing measures, patients, health experts, and 
pedagogues. 
Items: 39, in 6 domains: social relations, leisure time, physical complaints, worries 
about future, diet restrictions, and daily hassles. 
Response format: 6-point scale. 
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Reliability: Cronbach’s α: satisfactory to high (0.70-0.88). 
Validity and Responsiveness:  
Validity: Evidence for face, content, construct, discriminant, and convergent 
validity. 
Responsiveness: Not assessed. 
Burden &Acceptability 
Completion time: 10-20΄. 
Acceptability: 96% 
Alternative forms: Similar to the original, but with 5 domains (2003). 
Cultural and Language Adaptations: English, but not validated. 
Comments: 
Strengths:  
 Reliable and valid in almost all types of validity instrument. 
Weaknesses: 
 It concerns only type 1 diabetes patients;  
 Relatively lengthy for QoL;  
 Validated only in its original version (German). 
Conclusion:  
The English version is based on the assumption that the instrument keeps its original 
psychometric properties. However, these properties are not ‘built-in’ characteristics 
of an instrument, thus they “cannot be assumed to travel well” (Bradley, 1996). 
Thus, the instrument is unreliable for use in this study. 
 
8.3.2.9. “Diabetes-39” (D-39) 
Background: Developed in the USA by Boyer and Earp. First published in 1997. 
Conceptual-Measurement model 
Aim: to assess diabetes quality of life.  
Item generation: literature review, and unstructured interviews with diabetes 
physicians, educators, pharmacists and patients. 
Items: 39 in 5 domains: energy-mobility, diabetes control, anxiety-worry, social 
burden, sexual functioning.  
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Response format: 7-point Linear Analogue Scale (VAS). 
Scoring method:  transformation of item scores to 0-100 scale. 
Reliability: Cronbach’s α: High (0.81-0.93). 
Validity and Responsiveness:  
Validity: Good convergent (high correlations with SF-36) and discriminant validity 
(patients with known differences).   
Responsiveness: Not assessed. 
Burden &Acceptability: 
Completion time: Not reported. Easy to complete by old and low literacy people 
due to the use of VAS, but high burden to administrators. 
Acceptability: Low to moderate (46-73%).   
Alternative forms: None. 
Cultural and Language Adaptations: Danish, Finnish, Norwegian and Swedish. 
Also, translated, but not validated, in French, German and Italian.  
Comments: 
Strengths:  
 High reliability in the form of internal consistency. Test-retest reliability was 
not assessed; 
 Good validity as assessed against the SF-36 and known groups; 
 Good for the patient response format (VAS). 
Weaknesses: 
 The item generation process and patient participation is vague; 
 Low acceptability of the instrument; 
 Scoring difficult for the administrator. 
Conclusion:  
It is not a highly used instrument, probably because of its low acceptability and high 
administrative burden. 
 
8.3.2.10. “Problem Areas in Diabetes” (PAID) 
Background: Developed by W. Polonsky in the USA. First published in 1995. 
Conceptual-Measurement model 
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Aim:  to tap the breadth of diabetes-related emotional distress. 
Item generation: diabetes experts, and type 1 patients. No literature review, theory, 
or previous experience reported. 
Items: single index, 20 items. 
Response format: 6-point scale. 
Scoring method: result converted to 1-100 scale. 
Reliability: Cronbach’s α: 0.95 – very high internal consistency. Good item-total 
correlation: 0.68. High test-retest reliability assessed 66 days from baseline (0.83).  
Validity and Responsiveness:  
Validity: Good concurrent and predictive validity, moderate to good discriminative 
validity. 
Responsiveness: Low to moderate responsiveness assessed in 3 years period (1999-
2001). 
Burden &Acceptability: 
Completion time: reported as 3-5΄. 
Acceptability: Moderate to good (70-85%). 
Alternative forms: A 28-item version was announced and published, but it was 
never validated or used.  
Cultural and Language Adaptations: translated into 12 languages, but some of 
them with considerable equivalence problems. 
Comments: 
Strengths:  
 Good reliability; 
 Good concurrent, predictive, and discriminative validity. 
Weaknesses: 
 According to its developer bad face and content validity; 
 It does not cover critical areas of diabetes0QoL.  
Conclusion:  
The instrument seems to be abandoned by its main developer, who introduced the 
Diabetes Distress Scale. 
 
 
148 
 
8.3.2.11. “Diabetes Distress Scale” (DDS) 
Background: Developed in the USA by W. Polonsky. First published in 2005. 
Conceptual-Measurement model 
Aim: to assess the diabetes-related emotional distress for use in research and clinical 
practice. 
Item generation: Revision of previous questionnaires, performed by health experts 
and patients.   
Items: 17 in 4 domains (emotional burden, regimen-related distress, physician-
related distress, and diabetes-related interpersonal distress. 
Response format: 6-point scale. 
Scoring method: summated index. 
Reliability: Cronbach’s α: High (0.93). 
Validity and Responsiveness:  
Validity: Limited assessment of validity against medical variables and one 
depression scale with inconclusive results. 
Responsiveness: Not assessed. 
Burden &Acceptability: 
Completion time: Not reported. 
Acceptability: 72% 
Alternative forms: None 
Cultural and Language Adaptations: None  
Comments: 
Strengths:  
 Short instrument, addressing 4 different domains; 
 Clear to respondents. 
Weaknesses: 
 Not properly assessed for reliability and validity; 
 Addressing mainly diabetes-related distress and no other domains of diabetes-
QoL. 
Conclusion:  
A diabetes-distress measure with inadequately proved reliability and validity. 
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8.4 Discussion 
There are several criteria that could be taken into consideration when choosing an 
instrument for a particular study.  A decisive factor should be the psychometric 
properties of the instrument. Validity, reliability and responsiveness can determine 
how useful an instrument is in measuring quality of life. Nevertheless Hyland 
argues that:  
“The best way to select a QoL questionnaire is to examine the items of the scale 
carefully, and judge to what extent the set of items –i.e. the shopping bag of 
experiences- matches the requirements of the research that is to be carried out. The 
selection does not require a QoL expert: it can be done by anyone with a good 
understanding of the disease and the research requirements.” (Hyland, 2003) 
 
The content of an instrument, or ‘the shopping bag of experiences’, according to 
Hyland, should be the first criterion for its use in a study. This content should 
correspond to what is considered to be the accepted definition of QoL. For this study 
Bowling’s (2005c) definition has been chosen and quality of life is defined:  
 
 “in terms of having a positive psychological outlook and emotional well-being, 
having good physical and mental health and the physical ability to do the things 
they want to do, having good relationships with friends and family, participating in 
social activities and recreation, living in a safe neighbourhood with good facilities 
and services, having enough money and being independent.”  
 
However, the definition of quality of life is only one of the criteria that should be 
used in selecting an instrument. Bowling proposes a comprehensive list of another 
23 criteria that should be considered before a decision is made (Bowling, 1995a). 
17 of these criteria are considered as applicable for this research and should be taken 
into consideration before a decision is made. These criteria include:  
 The specification of key variables; 
 Decision about the use of generic and/or disease specific measures; 
 Decision about the dimensions that should be included in the measurement; 
 Multidimensionality of the scale to be used; 
 Patient’s treatment satisfaction; 
 Corroboration that the measure purports QoL; 
 Patient’s participation in instruments’ development; 
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 Published evidence of psychometric properties; 
 Scale and subscale scoring; 
 Burden  to administrators; 
 Suitability of the measure relatively to the statistical method; 
 Ethics; 
 Acceptability by different strata; 
 Ease of completion; 
 Appropriateness of the instrument relatively to the target group; 
 Patient’s self reporting;  
 Administration of the instrument in places the patients feel comfortable; 
Furthermore, Gill and Feinstein (1994) argue that an improved quality of life 
instrument should include: 
 The use of global ratings; 
 The rate of severity and importance and 
 The inclusion of supplemental items. 
 
There are some very good instruments for measuring patients’ quality of life. 
Garratt et al. (2002) undertook a systematic review to identify disease-specific 
measures of health related quality of life for diabetes and to examine the evidence 
for the reliability, validity and responsiveness of instruments. The review included 
instruments that were patient-assessed, disease-specific, with HRQOL as the main 
focus, and evaluated with adult patient populations. Out of the nine instruments 
they reviewed, the authors concluded that five of the diabetes-specific instruments 
had good evidence for reliability and internal and external construct validity: Audit 
of Diabetes Dependent Quality of Life (ADDQOL), Diabetes Health Profile (DHP-
1/18), Diabetes Quality of Life Measure, Diabetes-39 (D-39), Diabetes Specific 
Quality of Life Scale (DSQOLS) and Questionnaire on Stress in Patients with 
Diabetes-Revised (QSD-R).  
Watkins & Connell (2004) emphasised in their review of QOL measures the 
importance of careful consideration of the conceptual underpinnings of the 
available instruments, as there is little uniformity in the definition and 
151 
 
conceptualisation of HRQOL. However, they endorsed the use of the ADS, 
ADDQOL, PAID, DQOL and DSQOLS.  
Fitzpatrick et al. (2006), although accepting that there was insufficient evidence to 
single out any particular instrument, recommend that the ADDQoL, the DHP and 
DQOL should attract more attention among the diabetes-specific instruments.   
El Achhab et al. (2008) conclude in their review that the ADDQoL, DDS, DHP, 
DSQOLS, and D-39 are recommended for use, because they have good 
psychometric properties as well as because patients were involved in the 
development of these instruments. However, the assessment of validity of the DDS 
was not considered by its developers as sufficient. 
 
8.4.1 The advantages of the ADDQoL 
The ADDQoL incorporates some characteristics that makes it unique compared 
with all other instruments reviewed in this study, and in many respects a complete 
measure for diabetes-related QoL.  
 
Starting from its development procedure it could be argued that it satisfies all the 
relevant criteria. Theory, experts and the participation of patients in the item 
generation phase give the instrument high content and face validity. The ADDQoL 
has shown evidence of good internal consistency reliability and construct validity.  
 
Its authors claim that this measure may be more sensitive to change and more 
responsive to difference than earlier diabetes-specific or generic QOL measures. It 
is also sensitive to effects of diabetes (including treatment and complications), that 
cannot be captured by the measurement of treatment satisfaction alone (Bradley and 
Speight, 2002).    
 
A shortcoming of the ADDQoL could be considered that its validity was measured 
only against the two global items of the questionnaire. No other measure was used 
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for testing its (criterion) validity. Thus, there is no evidence about the instruments’ 
relationships with other quality of life measures. Nevertheless, the ADDQoL is 
characterised by some features that are not found in any other instrument. 
 
First, all other instruments examine how the patient perceives the burden that 
diabetes has on certain aspects of life (burden-type instruments). The ADDQoL is 
the only instrument that examines how diabetes interferes with the patient’s 
perception of quality of life, that is how the patient imagines his/her life without 
diabetes. However, seen from another perspective, the advantage of not being a 
burden-type instrument could also be a disadvantage. One could argue that the 
questionnaire demands that the patient makes value-judgements about an imagined 
life. This could be considered as a complex cognitive function, different from direct 
questions about diabetes-specific QoL.  
 
According to some critics this complexity could be a disadvantage with this 
measure, as it does not allow researchers to determine accurately the impact of 
diabetes in the QoL domains. Polonsky (2000) pointed this out one year after the 
publication of the ADDQoL. In 2006 the American Food and Drug Administration 
(FDA) in its guidelines for patient-reported outcome measures clearly stated that it 
did not recommend asking patients to respond hypothetically or on the basis of a 
desired situation, but it would be preferable to answer on their actual condition 
(FDA, 2006). 
 
The FDA recommendation was raised as a criticism of the ADDQoL by Speight et 
al. (2009), an ex-associate of the developer Bradley (Speight and Bradley 2000; 
Bradley and Speight 2002). The response to the FDA recommendation as well as 
to Speight’s criticism was that although this advice is sound in some instances there 
are major benefits from this because a “direct question about the impact of diabetes 
often elicits optimistic coping responses suggesting little or no impact” (Bradley, 
2006a; Brose et al. 2009). The issue was of great importance for the validity of the 
instrument, and received particular attention during the various applications of 
ADDQoL. The issue is discussed in the ADDQoL-Gr validation section of this 
thesis (Chapter 8). 
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Another characteristic of the ADDQoL is that is that it allows answers that indicate 
positive effects on certain domains. The usefulness of this characteristic was 
doubted during the translation process, as it was difficult to accept that a disease 
like diabetes might have positive effects on QoL. In a private communication 
Professor Bradley was asked about the value of the positive effect answers and 
whether this intriguing characteristic should be omitted. Professor Bradley 
answered that the positive effects of diabetes should not be expected to be of the 
same importance as the negative ones, but in some cases such as family 
relationships or dependence on others a positive response could not be a priori 
rejected. The developers of the ADDQoL recognising the fact that there are only a 
few positive responses to diabetes had already reduced the positive responses from 
three, in the initial instrument, to one in the 19 item version. With the benefit of 
hindsight the view of Professor Bradley was proved correct. Four patients 
participating in this study reported a positive impact on their lives from diabetes.  
 
A third interesting feature of the ADDQoL is that it contains two overview-global 
items: one of a generic nature concerning quality of life in general, and a disease-
specific one, relating QoL with diabetes. The advantages of using global questions 
alongside with a multi-item questionnaire have been discussed in Chapter 4. 
 
A fourth unique aspect of ADDQoL was that it asks the respondents not only to 
state how different each domain of life would be without diabetes, but also to rate 
the importance of this particular domain for their QoL. In this respect the ADDQoL 
satisfies the other recommendation made by Gill and Feinstein (1994), who suggest 
that:  
“… patients should be invited to rate not only the severity or magnitude of problems 
in those domains, but also the importance of the problems”.  
 
This was a breakthrough for QoL questionnaires and the ADDQoL is reported as 
the only instrument at the time that used an importance weighting for each item. As 
Fitzpatrick (1999) commented by the time the ADDQoL was published:  
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“The vast majority of instruments fail to address the diversity of priorities and 
concerns of respondents and the varying weights and values which they attach to 
their concerns”.                                                                                        
 
This characteristic of the ADDQoL might be the answer to a basic problem of this 
research, namely the differences in emphasis and priorities that exist among people 
with different socioeconomic, cultural and demographic backgrounds. The 
ADDQoL, by allowing the respondents to grade the importance of each aspect of 
life, provides the capability to detect value differences among different strata of 
society, a feature considered by Bowling as necessary for QoL measures (Bowling, 
2005a). 
 
Another unique feature of the ADDQoL is the fact that allows the respondents to 
answer only the questions that are relevant to them. At first glance one could say 
that this degree of freedom could probably add to the content validity or even the 
acceptability of the instrument. However, this is something a lot more than an 
attempt to improve the acceptability of the questionnaire. By answering questions 
relevant to only him/her, the patient gives his/her own quality of life domains. 
Standardised measures have the same predetermined questions and answers for all 
respondents. Thus, they try to measure a QoL concept that might be irrelevant to 
the individual patient.  
 
However, by asking the patient to rate the importance that certain domains have for 
his/her life, results in a personalised definition of QoL. This could probably be part 
of the answer to the fundamental problem of QoL measures (i.e. the definition of 
QoL). In this respect, the ADDQoL comes close to the view, expressed by Calman, 
that quality of life:  
“can only be described and measured in individual terms, and depends on present 
lifestyle, past experience, hopes for the future, dreams and ambitions” (Calman, 
1984). 
 
Later, Gill and Feinstein (1994) on the same line argued that: 
“… QoL is something perceived by each patient individually. The need to 
incorporate patients’ values and preferences is what distinguishes quality of life 
from all other measures of health”.  
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And they continued concluding that:  
“…because QoL is a uniquely personal conception, denoting the way that 
individual patients feel about their health status and/or nonmedical aspects of their 
lives, most measurements of QoL in the medical literature seem to aim at the wrong 
target. QoL can be suitably measured only by determining the preferences of 
patients and supplementing (or replacing) the authoritative opinions contained in 
statistically ‘approved’ instruments” (ibid). 
 
The ADDQoL seems to espouse better than any other instrument the view 
expressed above. 
The open question is another unique aspect of the ADDQoL. Once again the authors 
seem to follow the Gill and Feinstein recommendations, who argue that:  
“An instrument that contains standard items should be augmented with 
supplemental items that patients can add to denote important factors that may not 
have been included in the instrument” (ibid). 
 
Nevertheless, the authors do not seem to have made their minds up about how they 
should exploit the data that might be collected by this question. 
 
Finally, another advantage of the ADDQoL is that its relatively short length makes 
it easy to be used either on its own or simultaneously with a health status instrument, 
such as the SF-36. 
 
8.5 Conclusion 
Taking into consideration all the above criteria I decided that the ADDQoL should 
be the instrument of choice as the diabetes-specific measure of this study.  
In brief, the advantages of the ADDQoL compared with the other existing 
instruments are: 
 It comes close to the accepted definition of QoL (Bowling 2005c). It 
contains items covering psychological and emotional issues, physical 
ability, relationships with family and friends, independence, financial status, 
activities and recreation; 
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 It comes closer than any other instrument to the view that QoL can be 
described and measured in individual terms. It allows the respondent to 
answer only the questions that are applicable to him, and constitute his/her 
definition of QoL. The definition of QoL used for the measure’s 
development was, according to its developer (Bradley, 2006), the definition 
proposed by Joyce ‘QoL is what the individual says it is’; 
 Its items cover the three areas that the WHO QoL Group considers as 
dimensions of quality of life, that is physical, psychological and social 
functioning; 
 It rates not only the severity but also the importance of the items concerning 
the QoL; 
 It contains two global items that can be used as dependent variables for 
overall QoL; 
 It allows the respondent to add any complementary item;  
 It is shorter than most other instruments (with the exception of the ADS and 
DDS); 
 It satisfies all criteria for the item generation process; 
 There is enough evidence on its psychometric properties; 
 It is the most widely translated instrument, allowing international 
comparisons.  
All the above advantages, combined with the understanding of the disease gained 
after years of experience with diabetes patients, and knowing the research 
requirements make the choice of the ADDQoL the best solution for this project. 
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PART III: Producing the ADDQoL-Gr 
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Chapter 9: Translation and cultural 
adaptation of the ADDQoL  
9.1 Introduction 
“Language is the software of a civilisation” 
           Helen Glycatzi-Arveler- Greek historian 
 
Language, according to the Oxford English Dictionary, is the whole body of words 
and of methods of combination of words used by a nation, people, or race. Language 
is an acquired feature and not an instinctive or inborn characteristic. It is a major 
component of culture that defines and at the same time is defined by the society that 
uses it. As such language is a ‘carrier’ of culture and not a culturally ‘immunised’ 
concept. Consequently, the translation of a measure is not an “etic account” that is, 
it is not a culturally neutral issue. The whole process should be considered as an 
“emic” issue, an issue affected by culture. Translation and equivalence are therefore 
inextricable concepts and the second should be considered as a prerequisite for 
establishing that a translated measure is reliable and valid.      
 
Cultural adaptation of an instrument, according to the MAPI Institute (an 
international non-profit organisation specialising in Health Related Quality of Life 
research), is the passage from one language to another with cross-cultural 
equivalence in appropriate, acceptable and natural language. The problems that 
cultural equivalence present to a translation process are many and of various 
magnitude and importance.  
 
9.2 Cultural equivalence 
“Culture is what is left after everything we have learned has been forgotten” 
                                                     Garfield Bromley Oxnam (1892-1963) 
 
The problem of cultural equivalence can be present in a variety of forms and may 
concern different aspects of life or dimensions of quality of life. In some cases 
people are unwilling to answer questions which are considered embarrassing and 
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cause distress (Fayers et al., 1998). Sex life for example is a very difficult question 
in many Asian societies and for women in the Muslim populations worldwide.  In 
a study which took place in Singapore almost half of the respondents refused to 
answer the question about sexual satisfaction (Cheung and Thumboo, 2006).  
Hiding of disease because of the ‘stigma’ attached to it is another possibility among 
people with chronic disease in many cultures. Differences also exist in the semantic 
equivalence of some items with idiomatic expressions which usually refer to 
situations. The meaning of colours, for example, is different among cultures 
(Streiner and Norman, 2008; Breugelmans, 2009). 
Writers have not reached consensus on terms and methods of translating QoL 
measures but the equivalence aspect is central to all translation methodologies. As 
a concept however it has not been described adequately enough. Herdman et al. 
(1997), reviewing the literature concerning generic HRQoL instruments, found 
references to 19 different types of equivalence with substantial variation of 
definitions and varying degrees of precision. They argued that seven types of 
equivalence were the most frequently used: conceptual equivalence, semantic 
equivalence, functional equivalence, scalar/metric equivalence, scale equivalence, 
technical equivalence, and operational equivalence. They also found that four types 
of equivalence (criterion, content, item, experiential) were less frequently used. 
 
In a subsequent article Herdman et al. (1998) argued that six types of equivalence  
Conceptual, item,  semantic, operational, measurement, and functional equivalence 
are sufficient for examining not only how to achieve equivalence but also whether 
adaptation should take place.  
 
Stewart and Napoles-Springer (2000) in a literature review of translation methods   
provided taxonomy for assessing equivalence with six different types. Five of them 
were the same as Herdman’s et al. (1997) taxonomy, with criterion equivalence 
having replaced the functional one.  
 
Five types of equivalence (conceptual, item, semantic, psychometric, and 
operational) were examined for the development of the ADDQoL-Gr. 
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Conceptual equivalence is the first and most important type of equivalence because 
it refers to the need of determining: “what it is that is to be measured” (Bowling 
1995b). It is a hard to define type, as there is considerable lack of consensus among 
writers. Herdman et al. 1998 provide a list of 20 definitions with substantial 
differences among them. In general terms conceptual equivalence exists when: the 
concept per se exists in the target culture; it is relevant and acceptable in both 
cultures; items have similar meaning; and the value or emphasis placed on different 
domains is similar (Stewart and Napoles-Springer, 2000).  
 
A typical example representing the problem of conceptual equivalence is the health-
related quality of life concept in countries like Japan or Korea, where there is no 
equivalent of the term. Health related quality of life in Japan is discussed in terms 
of “patients’ harmony”. However, there is no western measure capturing the 
concept of harmony (Choe et al. 2001). Thus, conceptual equivalence in these 
countries might be achieved only by what Choe describes, citing Higuchi, as “the 
patient’s harmony with the world, with others, with himself and with death” (ibid), 
rather than HRQoL as conceptualised by western writers.  
 
Conceptual equivalence can be investigated by reviewing literature concerning 
health and health-related quality of life, examining questionnaires dealing with 
similar topics in the target language, and conducting health experts in the target 
culture. These should however be considered preliminary work for examining 
conceptual equivalence. The main body of work and the only way of establishing 
that conceptual equivalence between the two versions exists is the empirical 
exploration of the concept in the target language and its comparison with the source.   
 
Item equivalence exists when the items composing the questionnaire are identical, 
equally relevant, important, and acceptable in both cultures (Herdman et al.1998; 
Stewart and Napoles-Springer, 2000). Item importance concerns both the question 
of values as well as of priorities of the respondent (see Chapter 4). These values and 
priorities have to be reflected in the target version, thus item equivalence is 
prerequisite for a culturally adapted questionnaire. Bowden and Fox-Rushby (2003) 
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however, in reviewing the process of translation and adaptation of generic HRQoL 
measures, stated that the majority of writers fail to report partially or extensively on 
item equivalence.   
 
Item equivalence may be investigated first by a qualitative examination of the 
relevance of items followed by an assessment of the psychometric properties. 
Herdman et al. (1998) propose that qualitative examination should be approached 
by methods using expert judgement, such as the Delphi technique, or more 
appropriately by consulting members of the target group. For quantitative 
assessment they propose that Rasch item analysis may be useful and internal 
consistency should be examined by using Cronbach’s α in order to estimate the 
extent to which items are measuring the same underlying construct.     
 
Semantic equivalence refers to the transfer of meaning across different languages. 
It is obtained when questions mean the same thing and create similar effects to 
respondents in different languages (Herdman et al. 1998; Stewart and Napoles-
Springer, 2000). Forward – back translation, expert reviews, as well as cognitive 
debriefing interviews are some of the methods widely used to achieve and assess 
this type of equivalence   
 
Psychometric equivalence aims to ensure that comparable psychometric properties, 
mainly in terms of reliability and validity, are observed between the two languages 
versions. The methods for assessing measurement equivalence are the same as the 
ones used for measuring the psychometric properties of HRQoL measures in 
general (see Chapter 5). However, these assessment methods cause some confusion 
between item and measurement equivalence. Bowden and Fox-Rushby pointed out 
(2003) that the same methods (e.g. Cronbach’s α and Rasch analysis) are proposed 
for measuring both types of equivalence. Thus, the information gathered during the 
assessments is used to interpret item as well as measurement equivalence, making 
the distinction between those two types difficult.  
 
Operational equivalence exists when the method of administration, questionnaire 
format, item format, instructions, and measurement methods between the two 
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versions are similar. It has been proved that the administration mode of a 
questionnaire, the coding, or even the question order and the response-choice 
available to respondents are parameters that can influence the responses and thus 
the results. (Bowling, 1995b; Bowling, 2001; Bowling and Windsor, 2008). This is 
equally true for instruments that have been translated into another language. 
Methods for investigating operational equivalence include literature reviews of 
similar instrument use in the target culture, sociological data on cultural norms, 
expert panels, pre-testing, cognitive debriefing and comparison of results with the 
source version. 
 
9.3 Method 
Another area where there is little consensus is the methodology and/or terminology 
for translating an existing QoL measure into another language and culture. 
Guillemin et al. (1993) call the process ‘cross-cultural adaptation’ of the HRQoL 
measure, which has two components, the translation of individual words and 
sentences from one language into another and secondly the adaptation of idioms, 
cultural context, and lifestyle.  
 
The MAPI Research Institute uses the term ‘cultural adaptation’ which consists of 
two phases, linguistic validation and psychometric validation. The methodology is 
similar to the one proposed by Beaton et al. (2000) with one more phase - that of 
international harmonisation. The process of cultural adaptation, according to MAPI, 
aims to ensure that the new version is: 
 Conceptually equivalent to the original instrument; 
 Culturally relevant and acceptable to the target population;  
 Psychometrically comparable. 
 
Acquadro et al. (2008) published a literature review, in which they investigated the 
existing methodologies for HRQoL questionnaire translations. They concluded that 
each method proposes a different sequence of translation events and weights each 
of those steps differently.  They then proposed a multistep methodology which 
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contains 11 steps for translating an instrument into another language. The first step 
concerns the information needed for potential contacts with the developers of the 
HRQoL questionnaire, as well as their awareness about the intended translation 
and/or their participation to the project. The next 4 items (2-6) concern the forward 
translation process; items 6-8 deal with back-translation; item 9 deals with the 
approval of the forward translation in case there is no back-translation; item 10 
concerns the pilot testing of the target version with people from the target 
population. Finally they propose International Harmonization (item 11) as used by 
the MAPI Research Institute. 
 
The initial step prior to translation was to communicate with Professor Bradley, the 
developer of the ADDQoL and ask for permission to translate the measure into 
Greek. The terms and conditions of translation are outlined in the agreement 
between the Royal Holloway and Bedford New College, the developer of the 
ADDQoL Prof. C. Bradley, Prof. A. Bowling and the author of this study T. 
Pisimisis (Appendix D).    
The translation and cultural adaptation of the ADDQoL into Greek was performed 
according to the MAPI Research Institute’s methodology and the process 
prescribed by the developer of the ADDQoL (Bradley, 1994; 2007).  Guidance was 
also provided by Prof. Bradley’s team throughout the translation. Each of the nine 
phases of the procedure, as it is described in the agreement, was reported in detail 
to the developer through ten reports. The nine phases are: 
 Forward translation;  
 Back Translation; 
 Revisions to Forward Translation; 
 Review by psychologist and clinician; 
 Interviews with patients (called cognitive debriefing in the agreement); 
 Review by author;  
 Production of final version of the questionnaire; 
 Proofreading; 
 International Harmonization. 
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The submission of the ten reports requested by the developer has been a contractual 
obligation for me and included the following: 
 Linguistic Validation Plan, which included names and details of the persons 
that would be involved in the process. This report was submitted during the 
preliminary phase before the contract was signed. 
 Copies of the working translations, which included three forward 
translations and two back translations. They consist of a series of interim 
communications between the author of this thesis and the linguistic expert 
of Prof. Bradley’s team Mrs R. Plowright. 
 Forward Translation report with all discussions that took place between the 
author of this work and the developer’s team. This report was my final 
proposal to the developer for the Greek version of the ADDQoL. 
 Back Translation report including the discussions.  
 Clinician review report. 
 Psychologist review report. 
 Interviews with patients report (called by its author: Cognitive Debriefing 
Report). 
 Proof Reading Report. 
 Electronic copy of the final version of the questionnaire. 
 International Harmonisation report. 
Details about the aim of each phase are given below (sections 9.3.1 -9.3.7), where 
each phase is discussed. The aim of each stage, the methods used, as well as the 
reports required by the developer are given in Appendix D, where the Linguistic 
Validation Process is fully described. Communication with the developer’s team 
was continuous and when the solutions proposed by me were accepted a report was 
prepared and sent to Prof. Bradley containing my final proposal. Details about the 
content of the reports are given in the following sections.  The problems faced 
during the entire Linguistic Validation Process, the solutions given, and the final 
outcome of the translation and cultural adaptation are described in the results 
section of this chapter (9.4.1), where the equivalence of the two instruments is 
discussed in detail.  
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Details about the aim of each phase are given below (sections 9.3.1 -9.3.7), where 
each phase is discussed. The aim of each stage, the methods used, as well as the 
reports required by the developer are given in Appendix L, where the Linguistic 
Validation Process is fully described. Communication with the developer’s team 
was continuous and when the solutions proposed by me were accepted a report was 
prepared and sent to Prof. Bradley containing my final proposal. Details about the 
content of the reports are given in the following sections.  The problems faced 
during the entire Linguistic Validation Process, the solutions given, and the final 
outcome of the translation and cultural adaptation are described in the results 
section of this chapter (9.4.1), where the equivalence of the two instruments is 
discussed in detail.  
 
9.3.1 Forward Translation 
The main aim of the forward translation was to establish that there is equivalence 
of the concepts that the ADDQoL purports to measure (i.e. general health and 
quality of life). Also the original questionnaire was examined to establish that there 
were no items with idiomatic expressions similar to the ones described in the 
literature (Guillemin et al. 1993; Choe et al. 2001; Breugelmans, 2009). 
The first task of the translation process was to clarify the content of the 
questionnaire, by clarifying and defining the concept that each item investigates. 
This was necessary in order to ensure that each item is correctly reflected in Greek. 
Three parallel forward translations were carried out by three translators, native 
speakers of Greek, fluent in English and permanent residents of Greece (Guillemin 
et al. 1993).  One of the translators was the author of this study. All three translators 
worked independently from each other. 
A review of discrepancies among the three translations and reconciliation was 
carried out by a fourth person, who is again a native speaker of Greek and fluent in 
English. In the reconciliation meetings the three translators and the reconciliator 
produced an intermediate forward translation. A report was prepared by the author 
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of this study which was forwarded to Professor Bradley’s team. This report included 
the forward translation as well as all difficulties and problems encountered, the 
decisions made and the reasons behind them. It also included some suggestions for 
changes in the format of the questionnaire which have been rejected for reasons of 
harmonisation with other versions of the ADDQoL. Consecutive discussions 
followed, a 29 pages report was produced and agreed by both parts, and a final 
forward translation was submitted for back translation. 
 
9.3.2 Back Translation 
Back translation is a process in which the target-language translation of a measure 
is translated back by other translators into the original language. It aims to ensure 
the equivalent meaning of items in both languages. Back translation is the most 
commonly used procedure to verify, assess, and control the quality of a translation. 
Thus, the forward translation was sent for back translation to two bilingual 
translators whose native language is English. Both backward translators worked 
independently and were completely “blind” to the original ADDQoL.  The first 
translator was employed by Professor Bradley, the second one by the author of this 
study. The first back translator remains unknown to the translating team. The 
second back translator Shona Carter is a qualified psychologist and experienced 
with psychological questionnaires.     
 
The result of both back translations revealed no substantial differences with the 
original. The subtle differences that occurred had been predicted prior to back 
translation. Minor modifications of the forward translation draft were made to 
eliminate discrepancies between the original and the two back translation versions. 
The ‘revision to forward translation’ phase was completed without having to return 
to the back translators as the two translations were almost identical. A back 
translation report was prepared by the author of this study and submitted for review 
to the owner of the measure. Further discussions and modifications were carried out 
before the final version was sent to be reviewed by health professionals, according 
to the guidelines provided by Professor Bradley and the signed agreement for the 
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translation of the ADDQoL. Retranslation of any item was deemed unnecessary as 
the submitted version was accepted by the developer’s team. 
 
9.3.3 Review by health professionals and patients 
This phase of cultural adaptation examines the degree of agreement between the 
phrases used in the translated questionnaire and those used by health experts and 
patients, relating to the nature of the disease, its treatment, or associated symptoms. 
The translated questionnaire was sent to a diabetologist and a health psychologist 
working for a diabetes centre in Athens. M. Benroubi is a diabetologist, fluent in 
English, with a doctoral degree in medicine from King’s College London. She is 
director of the Polycliniki Diabetes Centre in Athens and ex-president of the 
Hellenic Diabetes Association. K. Vareli, also bilingual, is a health psychologist 
who has been working with diabetes patients for the last 25 years. The two health 
professionals worked independently, and upon completion of the review a meeting 
took place to discuss any suggestions.  
With this review the first five stages of the contractual obligations of the translator 
to the owner of the ADDQoL had been fulfilled. However, various writers have 
pointed out that usually translators, back translators, and reviewers have a much 
higher level of education and reading comprehension than the average respondent. 
Also, their living experience in the country of the original language of the 
instrument provides advantages in understanding the intentions of the original 
meanings (Mallinckrodt and Wang, 2004). To ensure that no such problem is 
hidden in the translation five patients were asked to answer the questionnaire and 
give their opinion about the wording of the questionnaire. This step was not part of 
the agreed process and it was taken as an additional precaution. The results were 
satisfactory and then the “health professional’s review report” was sent to Professor 
Bradley’s team.  The report was reviewed by the author of the questionnaire and 
their consent to continue with the Cognitive Debriefing was given.  
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9.3.4. Cognitive Debriefing  
This phase of development of a questionnaire is used to establish that whether 
concepts and items are understood by respondents in the same way that the 
instrument developer intends. It involves follow-up questions in order to gain a 
better understanding of patients’ interpretation of the items (FDA 2006). 
According to the MAPI Institute cognitive debriefing in cultural adaptation aims to 
assess the clarity, intelligibility, appropriateness, and cultural relevance of the 
translated version to the target population. It is a means to ensure that conceptual 
equivalence between the two versions is retained and might be considered as a way 
of ‘bridging’ between languages and cultures (Acquadro et al. 2008: 518). 
Five interviews were conducted during the first week of April 2009 by the author 
of this study. Table 2.1 shows the characteristics of the people recruited for the 
interviews.  
Table 5: Characteristics of the people recruited for the cognitive debriefing 
Patient Compl 
time 
Age Sex Type 
of  D 
Marital 
status 
Age 
leaving  
educat 
Job / profession Treatment  Durat
ion 
 
Treatm 
Duration 
R 1 56’ 52 M 2 M 23 businessman insulin 17 4 
R 2 44’ 49 F 1 M 20 private 
employee 
insulin 32 32 
R 3 52’ 51 F 2 M 18 Post-Office 
employee 
insulin 27 10 
R 4 41’ 65 M 2 M 12 retired 
builder 
tablets 15 14 
R 5 45’ 45 F 1 M 15 school-bus 
driver 
insulin 33 33 
Mean 47.6 52.4  
Median 45 51 
 
The interviews were taped and a report including interview transcriptions was sent 
to the developer of the ADDQoL. The first observation was that all respondents, 
with different background, education, age, and duration of diabetes faced largely 
the same difficulties in interpreting the questions, and  had similar views on 
alternatives presented to them. Another result was that the respondents faced more 
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problems related to the operational equivalence than to the semantic one, which was 
the main problem for the author of this study and the translating team in general.   
 
9.3.5 Review by author and production of final version  
This was the stage where the developer examines the proposed final version of the 
translated questionnaire. A report was sent together with the completed template of 
the ADDQoL-Gr to Professor Bradley and her team.  The original format was 
largely kept, as well as font, font size, page structure etc. The original template was 
used without adding any extra header. A slight problem emerged with respect to the 
copyright statement of the final version of the ADDQoL-Gr, but it was soon 
resolved and the final version was agreed.  
 
9.3.6 Proofreading 
The aim of proofreading is to establish that the final version is fully understood by 
people who did not participate in the translation process. The ADDQoL-Gr. was 
proofread by two individuals, native Greek speakers and a member of Professor 
Bradley’s team. This person should be familiar with the questionnaire but not 
engaged in the translation process, whose task was to examine formatting issues, 
using the original English format as a template. Two suggestions concerning the 
vertical spacing of a line and the omission of two full stops at the end of sentences 
were made at this stage.   The final version of the ADDQoL-Greek for Greece 
19.2.09 (from Standard UK English rev. 1.4.06) may be found in Appendix B of 
this thesis. 
 
9.3.7 International Harmonisation  
International Harmonisation (IH) is a stage performed mainly by the MAPI 
Institute. It aims to ensure comparability between the original and target versions 
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as well as to perform a further quality control (Acquadro et al. 2008). IH is the only 
phase of the cultural adaptation that takes place in one country, where the 
coordinating centre (i.e. MAPI Research Institute) and the developers and 
translators of the various languages meet. The purpose of the meeting is to achieve 
‘harmonisation’, not in the sense of compromising differences, but to establish that 
the major types of equivalence exist among the versions (ibid). IH does not have 
the same importance for all languages. Greek for example is used by a 
homogeneous population and so does not have to be harmonised to the same extent 
as Spanish which has 14 different versions of the same questionnaire (Juniper, 
2009).  A meeting that took place in Lyon – France in October 2009 accepted the 
ADDQoL-Gr as equivalent to the other versions of the instrument.         
 
9.4 Results 
9.4.1 Equivalence of the ADDQoL-Gr. 
Cultural problems (e.g. concerning conceptual equivalence) did not emerge during 
this work.  All respondents freely discussed their quality of life, as well as problems 
with their diabetes, sex life, worries etc. The absence of cultural problems also 
indicates that the author of the ADDQoL has avoided any idiomatic expression that 
might create semantic differences between the two versions.  
The paragraphs below might be considered as a summary of a series of 
communication between me and the developer’s linguistic expert concerning 
semantic, conceptual or operational problems discussed during the entire process. 
It is also a summary of the reports that have been sent to Prof. Bradley’s team as an 
end-result of this communication.   
9.4.1.1 Conceptual equivalence  
No problem was identified with conceptual equivalence of the two versions. The 
concept of Quality of Life was well perceived by patients and initial doubts that it 
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could be confused with ‘standard of living’ or ‘lifestyle’ were not confirmed.  The 
respondent’s perceptions of the QoL concept were nearer to the widely accepted 
views, compared with those of the physicians approached throughout the translation 
process. Before the patients were asked to answer the global question about their 
QoL they were asked to describe how they perceived the concept per se. The 
answers were taped for further qualitative assessment. The answers given during 
the interviews were issues like ‘health’, ‘family life’ ‘peaceful family life’, ‘social 
relationships with people next to us’, ‘good time’ ‘entertainment’, ‘journeys’, 
‘peace of mind’.  
On the other hand, physicians both in private conversations and in public speech 
equate quality of life with ‘perfect’ glycaemic control and intensive treatment. They 
consider control as the only way to avoid complications, and so achieving a good 
QoL.  This iatrocentric approach may be observed in various parts of the world, but 
it not as evident in literature as it was in discussions with diabetologists in Greece. 
They were not only unaware of the developments in the QoL field during the last 
two decades, but also of the very existence of the concept per se.   The enormous 
discrepancy between the two groups (patients – physicians) might be an issue for 
further research in Greece. 
 
9.4.1.2 Semantic equivalence  
There were some considerable problems in this field. The problems described in 
this section appeared during various phases of the procedure and the solutions 
emerged after discussions between me and the developer’s team, health experts and 
patients. In the end, and after trying different words or expressions the decisions 
taken were tested and proved correct in the patient interviews process (Cognitive 
Debriefing phase). The problems may be summarised as follows:  
 Instructions between overview item I and II: “Now we would like to know 
how your quality of life is affected by your diabetes, its management 
(including medication, visits to the doctor, and food) and any complications 
you may have”. There were doubts about the translation of the words 
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‘management’, ‘medication’ and ‘food’. There were fears that the word 
management in Greek might refer to administration, which has no relevance 
to diabetes-management. The equivalent word for medication was feared 
that might be too scientific for low literacy level respondents. After 
discussion with the psychologist, physicians, and patients the Greek 
equivalent of ‘management’ was used without any problem.   
 The word ‘statements’ on page 2 of the instructions was translated to 
‘questions’. The reason for this change was that ‘statement’ in Greek implies 
something very official and solemn. Thus, the word ‘questions’ was used, 
which is easily understood because it is contained in the word 
‘questionnaire’. 
 Item 3: ‘local or long distance journeys’. In Greek different words are used 
for local and long journeys. A “journey” always implies long distance. The 
solution given was to add a word similar to the English word ‘movement’ 
next to the word ‘local’. Thus the item was translated to ‘local movements 
and long journeys’. Professor Bradley’s team informed the translator that 
this problem was faced in other languages (e.g. French) and after consulting 
the back translator they accepted the addition of the word ‘movement’. 
 Item 10: The word ‘physical’ from the phrase ‘physical appearance’ was 
removed because ‘appearance’ in Greek implies the word ‘physical’, and so 
without removal would be a pleonasm. 
 Item 12: The phrase ‘my motivation would be’ was the most difficult 
problem as far as semantic equivalence was concerned. According to Guyatt 
(1993: 461) there are words that do not translate well and faithfulness to the 
original represents a procrustean approach in the sense that translators find 
the closest meaning, which is not well-suited. The only word in the 
ADDQoL that falls into this category is the word ‘motivation’. This word 
in Greek is related and would be perceived by lay people as ‘incentive’ for 
something specific (e.g. productivity or earning money). Initially, the word 
‘diathesi’ was added to the word ‘for life’. Translated into English this 
would mean ‘mood for life’ or ‘a positive frame of mind for life’. The word 
‘life’ in Greek, further to its biological dimension, covers the notions of 
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‘determination/energy/willingness to do things’. After discussion with both 
lay people and diabetes patients, it was decided to add the word ‘life’ and 
keep the word ‘motivation’, which implies a dynamic condition, while the 
word ‘diathesi’ (mood) relates to a more static situation. The developers of 
the ADDQoL found item 12 “an interesting conundrum” and they kept it as 
an option for future translations.    
 Item 13: The problem with the statement “...the way people in general react 
to me would be” was with the word ‘react’. The verb was considered 
‘strong’ as it implies some sort of ‘counter-action’ or ‘confrontation’ and 
not just ‘behaviour’. The developers were asked if the use of the word was 
intentional and questioned why verbs like ‘behave’ or respond’ were not 
used instead. The word react was however intentional; it encompasses the 
reaction of people to the ‘difference’ of people with diabetes (blood-glucose 
measuring and/or insulin injections in public, fear of hypoglycaemia). 
However, they  stated that this item might be considered for removal in a 
future shorter version of the ADDQoL, but for current purposes has to be 
kept as close as possible to ‘react’ and the Greek equivalent of the verb react 
was used.  
 Item 17: “... I would have to depend on others when I do not want to”. Two 
problems occurred with the translation of this item, one concerning semantic 
the other operational equivalence. The first one was the verb ‘depend’ 
followed by the phrase ‘when I do not want to’. It was thought that the 
phrase carries a negative emotional connotation and that no one wants to 
depend on others at any time. However, the statement implies that there are 
cases that dependence might be wanted by patients, something that created 
some doubts to the author of this study about the value of such a perception. 
The doubts were based initially on personal value judgements and later, 
substantiated by literature,  that considers autonomy to be one of the three 
innate, essential and universal psychological needs (the other two being 
competence and relatedness) (Ryan and Deci, 2000). Furthermore 
autonomy is considered as a: “basic human need and a universal 
precondition for any individual action in any culture” (Devine et al. 2008). 
As such there should not be any question that might elicit answers implying 
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that autonomy is a matter of controversy. Professor Bradley was asked 
whether the phrase “when.....” could be removed, considering that the 
statement refers to an unrealistic and hypothetical situation and moreover 
could create some degree of confusion. The answer was that the verb 
‘depend’ was used intentionally and in practice it has been established that 
sometimes people with diabetes choose to depend on others and enjoy this 
kind of dependence, although objectively they can have a high degree of 
self-efficacy in managing diabetes. They also noted that initially 
dependence is considered as an unwanted situation “till you start asking 
people and then it turns out to be less absolute”.  With the benefit of 
hindsight and after listening to many people with diabetes, it was realised 
that there are people who enjoy depending on others. In a three-day 
conference of the Greek Federation of People with Diabetes that took place 
in Salonica (October 2009) one of the speakers characterised diabetes as her 
“best friend” because it was: “the cause for all the love, care, and protection 
she received in her life”. Finding this statement provocative the author of 
this study asked the patient to explain her statement and she replied that she 
was happy to be dependent for “quite a few things”, while she wanted to do 
other things on her own. The things she enjoyed to be ‘dependent’ 
concerned mainly diet, treatment, family relations, and social relations. She 
considered that dependence-due-to-diabetes was the cause for better 
treatment and warmer relations. An answer to this problem could probably 
be found by taking into consideration that there is a difference between the 
concepts of independence and autonomy. Independence means not relying 
on others while autonomy means acting with the experience of choice. Thus, 
one could be autonomous and at the same time rely on others rather than act 
independently (Deci and Ryan, 2008). The final answer to this problem will 
be given by the results of this research, which will show whether the 
independence question is bipolar.  
 Item 19: “...my freedom to drink as I wish (e.g. fruit juice, alcohol, 
sweetened hot and cold drinks) would be”. The translation of the word 
‘sweetened’ in Greek refers to the word ‘sweetener’, which again refers to 
chemical substances like ‘aspartame’. It was considered that there is a 
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semantic difference between the two words and it was decided to use the 
equivalent of the English word ‘sugared’, which translates best the 
statement.   
 
9.4.1.3 Operational equivalence  
Four problems occurred during the translation process concerning operational 
equivalence and some changes to the original formatting and wording of the 
statements was necessary before the questionnaire was tested. The first two changes 
attracted considerable attention because they were affecting the structure of the 
questionnaire, something that could create problems with International 
Harmonisation. The changes were considered necessary by the researcher however 
to achieve operational equivalence and reliability required for the questionnaire. 
The first problem that arose during the preliminary discussions with patients was 
confirmed during the interviews with the patients. It related to the instructions of 
the introductory question of items 2, 4, 6, 8, and 9. The responses to these questions 
are: 
Yes  If yes, complete (a) and (b). 
No  If no, go straight to 3a. 
For reasons that have not been fully understood almost all the respondents were 
confused with the repetition of the words Yes and No on the same line.  When the 
instructions were explained to them they seemed to be unhappy with the 
explanation and in some way embarrassed. The issue was discussed with Professor 
Bradley and her team and after proposing to them various alternatives it was 
decided that the responses should be changed to:  
 Yes            No          
If yes, complete (a) and (b). If no, go straight to 3a. 
The change was proved to be successful during the interviews when both versions 
were tried. The issue was discussed with the developers for further examination of 
the original version.  
176 
 
The second major problem that arose during the preliminary discussions was that 
when the patients answered the (b) section of the item (i.e. the importance of the 
item in their life), they did not answer regarding the importance but in relation to 
the concept itself. For example the answer to the statement ‘my financial situation 
is: very important, important etc.’ the answers received referred to a bad or good 
financial situation. Similar answers were elicited with living conditions and sex life. 
This could be proved a serious problem for the administration of the questionnaire 
and the author of this study proposed that the structure of the whole statement 
should change by adding the words ‘for me’ at the beginning and the word 
‘something’   at the end. Thus, the statement would be ‘for me, my financial 
situation is something: ....’. The issue was discussed with the psychologist and the 
diabetologist and after their agreement it was proposed to the developer of the 
questionnaire. Although it was a major change to the questionnaire’s structure it 
was considered reasonable and the final decision was taken after the patient 
interviews where both versions were tested and the second version was adopted.  
The third operational problem that had to be resolved concerned the translation of 
p.1 instruction 4. The instruction states: “Now we would like to know how your 
quality of life is affected by your diabetes, its management (including medication, 
visits to the doctor, and food) and any complications you may have”. The words in 
brackets had to be translated and included as an alternative in the CDs, but their 
inclusion in the final version was not necessary. This was an option given by the 
developer in order to facilitate the perception of the word ‘management’ in case the 
Greek equivalent did not have a sufficiently broad meaning to cover all three 
aspects of management. The health experts used for the translation as well as the 
patients consulted confirmed that the equivalent of ‘management’ was used in 
diabetes jargon and therefore use of the word should not be problematic. The patient 
interviews proved that ‘management’ was well perceived by the respondents and it 
was decided not to include the phrase in brackets in the Greek questionnaire. 
Item 17 presented another operational difficulty. The statement is “If I did not have 
diabetes, I would have to depend on others when I do not want to”. The phrase was 
considered as complicated and to some extent confusing because it contains two 
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negations at the same sentence (‘did not’ and ‘do not’). Although it is not a syntax 
error, this kind of expression is not very acceptable in written Greek and can only 
be found in an extempore speech. The problem was presented to the developers and 
with their agreement the second ‘not’ was replaced by a phrase similar to ‘despite 
my will’ or ‘unwillingly’, which was considered as operationally more correct. The 
phrase worked well during the interviews. 
 
9.4.1.4 Item and psychometric equivalence  
The qualitative aspect of each item was examined during discussions with health 
experts and patients. The final estimation for these two types of equivalence cannot 
be assessed unless the new instrument is field-tested for its psychometric properties. 
Thus, a cross-sectional survey was conducted and the results for the psychometric 
properties of the ADDQoL-Gr and its equivalence with the original are discussed 
in chapter 10.  
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PART IV: Survey of the Greek Population 
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Chapter 10: A Cross Sectional Survey of the 
Diabetes Population in Greece  
 
10.1 Introduction  
Initially the survey will enable investigation of the reliability and validity of the 
ADDQoL-Gr and when its psychometric properties are established it will examine 
the association that medical and demographic variables have on quality of life 
(QoL) and health status (HS) of Greek people with diabetes.  
Due to their association with QoL these variables are usually called by investigators 
predictors or determinants (Rubin and Peyrot, 1999). The terms will be used in this 
research only to describe the relationship between each of the two outcomes that is 
QoL and HS with the demographic and diabetes-related variables. As mentioned in 
chapter 5 the direction of causality between all those variables is complex and 
sometimes reciprocal. However, this problem will not affect the results of the study, 
as QoL and HS are considered a priori as outcomes. 
A generic measure, the SF-36, will be used as criterion for the ADDQoL-Gr 
validation as well as for the HS assessment. The reasons for choosing the SF-36 are 
given in section 10.2.2.3.  
 
10.2 Method 
10.2.1 The sample 
A principal concern was to recruit a sample as representative as possible. Ideally, 
the analytical sample would be as representative as possible of the entire Greek 
diabetes population. To this end, a probability sampling technique either in the form 
of simple or systematic random sampling would be the best way of conducting the 
survey.  
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Nevertheless, certain problems emerged concerning the availability of diabetes 
patients for conducting this research. The number of people with diabetes in Greece 
is not known, because there is no diabetes registry in the country. Patients visit any 
clinic at they own free will, without any referral system. The choice is made by 
them and depends mainly on the reputation of the hospital or their loyalty to the 
diabetes-professionals of the clinic.  Even in the case that some clinics would keep 
some kind of records, the directors of the diabetes centre, who kindly have given 
me permission to conduct the survey in their establishments, would never give lists 
with patients, especially without their prior consent, because this is prohibited by 
law. Therefore, the sample is not   representative of the entire diabetes-population 
of Greece.  
However, bearing in mind the limitations of the sampling technique, this was the 
first attempt of collecting date at a large scale in eight different sites for validation 
of the Greek the diabetes-related quality of life instrument. Also, pragmatically this 
was the only way to get access to patients and conduct the survey. 
There are 131 secondary care or teaching hospitals, 12 social security and 
independent hospitals and around 50 hospitals in the private sector (Figure 1). Most 
of them do not deal with diabetes on an outpatient basis. Approximately 65 of them 
have a diabetes clinic that usually works on a part time basis. Even this number is 
not certain because the function of the diabetes clinic depends mainly on the 
presence of a diabetologist, which is not on a permanent basis (mobility etc.). 
Having discussed the limitations occurring from the type the sample this should 
include patients from medical centres in various parts of the country, from a range 
of settings, with various socioeconomic backgrounds.  
Special care was taken for the testing site selection process. The first concern was 
to select the most representative diabetes centres using hospital size, type of hospital 
(secondary or tertiary), as well as their reputation as selection criteria. The second 
concern was to avoid duplication of the types of institutions. Recruiting a sample 
from two or three teaching hospitals would have been a relatively easy task. 
However, although teaching hospitals accept patients from different parts of the 
country, their results would not be generalisable because patients from different 
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types and level of care settings usually score differently (McDowell, 2006). In order 
to reduce bias and/or weighting errors, I recruited patients from county hospital 
outpatient clinics, university hospital outpatient clinics, as well as primary care 
services of social security institutions (Aday and Cornelius, 2006). 
Athens and Salonica were chosen because they are the two biggest cities of Greece 
accounting for 35.4% (3.827.000) and 10.3% (1.110.312) of the total population 
respectively. Kavala is an average size provincial county with a total of around 
145.000 people (1.34%). These three areas together account for the 47.04% of the 
so called “de facto population” of 10.815.197 (Elstat, Census 2011). However, it 
should be taken into consideration that the real percentage is even higher than 
47.04% because the number given by the Elstat census includes not only the Greek 
population that satisfy the inclusion criteria of this project, but also immigrants with 
legal or semi-legal status.  
Most of the participating establishments accepted patients from the local 
population. However, the addresses given by respondents in the consent form show 
that university hospitals as well as diabetes centres in large hospitals in Athens or 
Salonica attract patients from all over Greece. The total number of the sites 
participating in the project was eight. Four of them were in Athens, three in 
Salonica, and one in Kavala.  
 “Evagelismos” of Athens was chosen as a testing site because is the biggest 
hospital in Greece both in terms of beds as well as number of admissions. 
Hippocration of Salonica is the biggest hospital of Northern Greece. “Laiko” 
(Athens) is a university hospital, higly representative of the Greek diabetes 
population, because it is considered to be an excellent diabetes centre offering a full 
range of diabetes services, including a diabetic-foot clinic, serving patients from 
various parts of Greece and not only Athens. Also, “Alexandra” and “Polycliniki” 
(Athens) have been considered representative because they are very well known 
diabetes centres, mainly attributed to their highly respected medical personnel, 
serving patients outside Athens. “Kavala” is a peripheral hospital based in the city 
of Kavala, serving the population of the city and the prefecture of Kavala. . During 
the research “Kavala” hospital moved to its new buildings, where the clinic did not 
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have any waiting room for diabetes patients, where the administration of the 
questionnaire would take place. Thus, it was decided to stop the research, in order 
to avoid violating the rules of the questionnaire’s administration. 
Another four hospitals were approached:  Xanthi in the Macedonia region, a 
hospital with characteristics and size similar to Kavala; Alexandroupolis hospital 
of Thrace (North-East part of Greece); Papageorgiou diabetes centre in Salonica, as 
well as the diabetes centre of Patras hospital (Northern Peloponnese). These 
hospitals were initially approached, but for a variety of reasons they did not 
participate in the end.  Papageorgiou had the same problem with Kavala’s new 
hospital. Patients for all clinics were waiting in the same corridor and no space was 
available to isolate respondents from other patients, in order to give instructions and 
receive reliable answers. The reason for the non-participation of Patras, Xanthi and 
Alexandroupolis hospitals was mainly lack of motivation of their directors.  
None of the directors of the above diabetes centres were in any way acquainted to 
the author before the research started. After the selection of the sites was decided 
the contact with the directors has been succeded with the cooperation of the 
Panhellenic Federation of People with Diabetes. Several personal visits to the 
hospitals have taken place in order to explain the aims and methods of the project 
and arrange the details of the procedure.   
An effort was made to include branches of IKA (Social Insurance Institute) in the 
participating institutions. IKA is the largest social security organisation in Greece 
covering almost half of the Greek population. Contrary to the OΓΑ, the agricultural 
workers social insurance organisation, IKA insures mostly urban population, 
usually manual workers from various industries. 
The participants were patients with diagnosed Type 1 or Type 2 diabetes for at least 
one year, male and female with all possible treatment types (Insulin users, non-
insulin users, on oral medication, and/or on diet only). Two exclusion criteria were 
used: patients aged < 18 year and patients who could not read Greek.  
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10.2.2 The Questionnaire 
The combined questionnaire booklet consisted of four sections and 16 pages 
containing the three questionnaires: a two page questionnaire containing questions 
of demographic nature and medical parameters; the ADDQoL-Gr; a Greek version 
of the SF-36 and a patient consent form. The questionnaires can be found in 
appendices C, E, and G.    The three questionnaires were bound together to be 
handed to respondents as one entity.  
 
10.2.2.1 The demographic-medical questionnaire design 
The first questionnaire concerned the medical and demographic characteristics of 
the patients. There was not any previous experience for such a questionnaire (people 
with diabetes) in Greece. The items have been derived from international literature, 
from discussions with diabetes experts and diabetes patients.  
Rubin and Peyrot (1999) describe a range of factors considered by various 
researchers to be elements of quality of life of people with diabetes. These are: 
Duration and type of diabetes, any existing complications, treatment regimen, and 
glycaemic control. Particular attention to the role of complications was paid, 
because it was hypothesised to be one of the most significant medical predictor of 
quality of life in people with diabetes (Parkerson et al. 1993; Trief et al. 1998). 
Rubin and Peyrot also propose that demographic variables such as age, gender, 
socioeconomic status, and marital status are factors influencing QoL, thus the 
relevant questions were included in the questionnaire.   
The layout of this questionnaire and the format of the questions was influenced by 
various health or diabetes-specific questionnaires (NHS 2006) and the guidelines 
provided by the Question Bank of the University of Essex. Also, due to its relevant 
simplicity it was introduced before the other two questionnaires, in order to build 
the necessary self-confidence in the respondent.  
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Special care was taken to keep questionnaire as short as possible, in order to reduce 
the overall length of the combined questionnaire. It contained 18 questions in four 
groups: 6 demographic, 3 socioeconomic, 8 medical and 1 of attitudinal nature. The 
demographic group asked questions about the age, gender, marital status, place of 
residence, time spent to reach the diabetes clinic, and educational level. The 
socioeconomic questions concerned the profession, monthly income, type of social 
security, as well as out of pocket payments of the respondent for diabetes care. In 
the question about profession there was a sub-question concerning the place of the 
respondent in the work hierarchy. Residence area and income are expected, 
according to the hypotheses, to play a significant role in determining quality of life. 
In this questionnaire there were two questions that might have irritated the 
respondent, one about income (especially taking into consideration the suspicion of 
the average Greek about tax issues and authorities), and the other one about age. It 
was decided that age should not be asked directly, but as the literature suggests it 
should be estimated according to the year of birth (Aday and Cornelius, 2006). The 
exact amount of income is not necessary, thus a question about family monthly 
income was asked, followed by a series of income groups (ibid). The usual 
estimation of annual income that is used in the Anglo-Saxon questionnaires was not 
considered appropriate for cultural reasons. The notion of income to lay Greek 
people is related to the monthly family income. All salaries, wages, and 
compensations are estimated on a monthly basis. This amount supplemented by 
three extra benefits (the so-called bonuses, which are percentages of the monthly 
income), for Christmas, Easter and summer holidays constitute the annual income.   
Medical questions concerned the type of diabetes, treatment regimen, duration, 
frequency of visiting a diabetologist and/or other relevant medical consultants, 
glycaemic control, any stays in hospital during the last 12 months, and the presence 
of any complications with the degree of severity. The medical questions have been 
discussed with a team of leading Greek diabetologists and a clinical psychologist.  
The attitudinal question concerns the membership of the respondent to any group 
of people with diabetes mellitus. This question has been included in the 
questionnaire, following the discussion with patients, in order to assess the social 
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cohesion of the diabetes community in Greece and possibly create a basis for a 
future examination of social capital in diabetes care. Diabetes groups try to fill the 
gaps that the Greek NHS has in diabetes care, particularly in education and health 
literacy. A statistically significant positive association between such a membership 
and high quality of life would suggest the need to re-examine and restructure health 
education and diabetes care in Greece.   
A final response rate of 75% would be satisfactory according to the international 
standards. However, due to the procedure followed the rate was a lot higher, 
reaching an estimated average of about 95%. A high response rate was anticipated, 
but the drop-out rate and the missing items, due to the length of the 3 questionnaires, 
were expected to mitigate the final result.  1035 patients participated in the study.  
However, 8 patients (0.77%) were excluded from the analyses because they had 
more than 6 domains missing, which according to the ADDQoL User Guidelines 
Rev.24.1.05A should not be tolerated. Thus, the number of respondents was 1027 
for the ADDQoL. There was a high drop-out rate when respondents were reaching 
the SF-36 questionnaire. Out of the 1027 respondents 213 answered only part or 
they did not answered the questionnaire at all. 
 
10.2.2.2 Diabetes-specific measure: the ADDQoL-Gr 
There is an almost unanimous agreement among writers that for policy making and 
community interventions, a multidimensional assessment of QoL is necessary and 
that the combination of a generic and a disease-specific measures would give the 
best results.  The use of the disease specific measure is required in order to assess 
the specific problems caused by the individual illness (Bowling, 1995a, 1995b; 
Fitzpatrick et al. 1998; Patrick and Deyo, 1989; Aaronson, 1988; Rubin and Peyrot, 
1999; Polonsky, 2000; Snoek, 2000).  Generic instruments address a wide range of 
issues that affect health status. They can be used for comparisons amongst various 
diseases as well as facilitate economic comparisons.  However, despite the fact that 
a well-designed generic measure can assess certain quality of life dimensions, such 
as emotional and physical condition mobility etc, they contain items that little 
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relevance have to diabetes, while they lack specific items that measure other aspects 
of decisive importance for QoL.  
A problem concerning the diabetes-specific instrument was faced from the 
beginning of this research, as there was not any diabetes-specific instrument 
translated into Greek. This problem was considered by writers as a handicap for 
diabetes research in Greece, but nothing had been done on the field. (Papathanasiou 
et al. 2005). The lack of translations into Greek could be attributed to the 
complexity of the translating process, which according to Harsimran and Bradley 
(2006): “is generally underestimated ...  a very time-consuming process and hence 
expensive”.  
Following a systematic review of the literature, the Audit of Diabetes Dependent 
Quality of Life (ADDQoL) was chosen as the most suitable diabetes-specific 
quality of life measure. The ADDQoL is the most translated diabetes-specific 
quality of life measure, (23 translations according to the MAPI Institute), 
facilitating comparisons with other countries. Thus, the Greek version of the 
ADDQoL (ADDQoL– Gr.) was used. The ADDQoL covers the aspects of finance, 
material welfare, sexual functioning and independence, mentioned above. The 
overall advantages of ADDQoL as a diabetes-specific measure per se have been 
discussed in the relevant chapter of the literature review.  
 
10.2.2.3 Generic measure: The SF-36 
The SF-36 is a generic instrument that assesses the impact diabetes has on every 
day’s life of the patient. It is a burden-type instrument.  The SF-36 is the most 
widely used generic measure in diabetes quality of life studies (Luscombe, 2000; 
Rubin and Peyrot, 1999).  Also, the SF-36 domains are mostly relevant to people 
with diabetes and the level of detail of responses is more appropriate for them than 
other generic measures such as the NHP (Bradley, 1996).  
However, the ADDQoL does not assess the burden, but how diabetes interferes with 
the perceived well-being of the patient. Research has proved that the two measures 
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can be used in a complementary manner (Woodcock et al. 2001). The idea of its 
use in relation with the SF-36 is strengthened even further by the ascertainment that 
the ADDQoL can differentiate between those with and without diabetic co 
morbidity. It has been reported that the ADDQoL scores are not significantly 
affected by non-diabetic co-morbidity (ibid). 
The SF-36 was used as the generic measure The SF-36 is a generic health survey 
comprising of 36 questions scored in eight dimensions. It is the most widely used 
instrument worldwide and according to its owners, it has been translated into 140 
languages (QualityMetric 2012). Garratt et al. (2002a) reviewed 3921 evaluation 
reports and they reported that the SF-36 is the most evaluated measure, accounting 
for the 10% of the total number of the reviewed reports. This may be attributed to 
the fact that the SF-36 is more sensitive to lesser degrees of dysfunction, as it is the 
case with diabetes, than other measures such as the NHP.  
The SF-36 has been proved to be a valid and reliable instrument, with 17,000 
published studies in the last 20 years. Although it is health status measure, 
researchers use it implicitly as a proxy measure of QoL.  
As it has already been said there is no “gold standard” in the field of QoL research, 
but the SF-36 has achieved such a high status among researchers, that it is 
sometimes referred as the “gold standard” for health status instruments. (Michalos 
et al. 2000). Nevertheless, the SF-36, as a generic measure, is not enough to tap 
very important issues of chronic illnesses, such as finances, material welfare, sexual 
functioning, communication, independence etc. (Bowling, 1995b).  
Another issue with generic measures that should not escape one’s notice is that the 
relative importance that patients ascribe to various domains of QoL shows 
considerable variation in relation to the disease. The prioritization of domains for 
people with diabetes, for example, is different to people with mental health 
problems (Bowling, 1996). Generic measures do not seem to be sensitive in 
detecting differences in lifestyle as well as in the perception of life by the patient 
(Jacobson, 1994; McColl et al. 1995).  As far as diabetes is concerned, the aspects 
of dietary restrictions, sexual functioning, independence, fear of hypoglycaemia, 
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and type of treatment regimen are of major importance, but not tapped by the SF-
36.  
The SF-36 has already been translated and validated into Greek (Pappa et al. 2005; 
Anagnostopoulos et al. 2005). Permission for the use of the SF-36v2 Health Survey 
in this study has been obtained from the owners QualityMetric. 
 
10.2.3 Ethical Approval  
There is no ethical committee at national level responsible for this kind of research. 
Ethical approval was obtained from the management of the hospitals, which in turn 
had to ask the ethical committee operating in each hospital. To this end an initial 
verbal contact was made with the selected hospital authorities in order to explain 
the intention of the study, the period involved, and what will be required from the 
patients and hospital staff. This conduct was followed by a letter confirming what 
was already discussed and this letter was followed by an official written application 
to hospitals’ governors that was made by the diabetologists of the centres. This 
bureaucratic process was considered necessary because the management can give 
permission for research only to hospital’s personnel and not outsiders.  
 
10.2.4 The survey 
The questionnaire was delivered to patients for completion during the waiting time 
of a regular clinic visit. In this respect, within each care unit it was a convenience 
sample. The administration took place on face-to-face basis. This sort of 
administration represents the “gold standard” in questionnaire surveys (Jackle et al. 
2006). The waiting time is usually long, because the system does not operates with 
appointments but on a “first-come, first- served” basis.   The patients arrive before 
the administrative staff starts its shift at 07.30 hrs, they pay their co-payment fee 
and wait in a lounge for the physicians, who start seeing patients at 09-09.30 hrs.  
During this long waiting time the questionnaire was administered, thus there was 
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substantial time to answer the questions and at the same time it was an interesting 
occupation for the patients.   
The investigator and/or the diabetes nurse, or the diabetes psychologist in the case 
of Polycliniki, provided patients with oral and written information about the title, 
the nature,  and the aim of the project, explained to them  the purpose and the 
importance of the study, as well as what their participation involves, and asked them 
to participate. The patients were also informed about the unique value of their 
views, the voluntary nature of their participation, confidentiality, and that a refusal 
to participate or withdrawal from the study would not affect in any way the quality 
of care they are going to receive. Patients were given the opportunity to ask 
questions about the research, as well as enough time to consider the answers 
provided. 
Upon their agreement, the patients were asked to confirm their voluntary 
participation by signing a consent form, which constituted the first page of the 
questionnaire (Appendices I and J). The consent form was containing the title of 
the study, the test-site number, and a patient’s identification number which was 
filled by the administrator.  
Information concerning the content of the questionnaires was provided and the 
patient was asked to respond to three statements. The first was that they had read 
and understood the information sheet and they agreed to participate. The second 
statement concerned the voluntary nature of their participation and the fact that they 
could withdraw at any time without any impact on their medical care. The third one 
was their agreement to communicate with them in the future asking them for their 
personal details. The patients could be asked to participate in the future in case the 
responsiveness of the ADDQoL-Gr would be examined.  
Participants were asked to fill the questionnaires under complete confidentiality 
within the health care establishment. Help in clarifying questions about the 
questionnaire’s completion was offered upon request. Those who finally accepted 
to participate were handed the 16 pages questionnaire booklet.   
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Any reference to the Federation of People with Diabetes Mellitus, the secondary 
organisation of diabetes-patients groups that helped throughout this project was 
systematically avoided. This was decided because responses may be distorted by 
the general tendency of the respondents to conform to “social desirability” 
(Veenhoven, 2002). Social desirability is the tendency of respondents to reply in a 
manner viewed favourably by others. The Federation is well known and highly 
esteemed among patients with diabetes and there is a possibility that answers would 
agree with the Federation on various issues. In such a case bias would be observed 
resulting to strong floor and ceiling effects. Last, special care was taken to avoid 
the physician’s presence as well as the presence of any spouses. In teaching 
hospitals it was ensured that no research involving people with diabetes was taking 
place.  
Data collection started in June 2010 and was finished by February 2011. 
 
10.3 Results 
A total of 1027 diabetes-patients participated in the survey from eight different 
sites. The demographic and socioeconomic characteristics are presented in Table 6. 
Diabetes-related characteristics of the sample are presented in Table 7. 
The demographic characteristics of the sample is similar in many respects to those 
of the total Greek population, especially when age is taken into consideration. The 
mean age of the sample was 58.2±16.1. Although the mean age of Greek nationals 
is 42.6 years (Eurostat, 2011) the higher age of the sample was expected because:  
a) it excluded people under 18, a population accounting for the 19.63% of the total, 
and b) the majority of the sample (72.3%) is made up of people with type 2 diabetes 
who in most cases are over the age of 45. Thus, the 72.3% of the sample does not 
include patients between 19 and 45, an age group that accounts for the 35.32 of the 
total Greek population. Because of these two reasons the mean age of the sample is 
higher than the total population’s mean. Also, it should be noted that the mean age 
of 58.2 is in consistent with reports of diabetes instruments from different countries. 
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(Jacobson et al, 1994: Mean age 44 for type 1 diabetes and 60 years for type 2; 
Welch et al., 1997: 41.6 years of age for type 1 and 63.2, 63.9, 66.6 years for various 
groups of type 2 patients; Anderson et al. 1997: 63.4 years ; Bradley et al., 1999: 
61.6 and 52.4 years for the two sites of research).  
Female respondents represent 58.9% of the total sample, which is higher than the 
national average of 51% (Elstat, 2013). This difference might be attributed to two 
reasons: a) the national average percentage includes immigrants, the majority of 
whom are males, lowering the national female average.  (Triantafyllidou, 2009: 
Immigration towards Greece at the Eve of the 21st Century. A Critical Assessment. 
Zoumpopoulou b) the sample has a mean age higher than the national average 
because of the preponderance of type 2 diabetes patients who are above this 
average. After the age of 45, in all 5-years bands, the majority of the population is 
female, with the difference between the genders increasing as age increases.    
Unmarried people in Greece are 24.3% of the total population, while the same 
category in the sample accounts for 19%.  The percentage of married/partner people 
of the sample is almost identical that of the general public with 61.9% and 61.6% 
respectively. Widow/ers account for 13.3% of the sample, which is considered 
satisfactory compared with a 9.44% of total population and 19.13% of the 
population over 50 years of age (type 2 diabetes margin). 
As far as level of education is concerned the sample is representative with 38.1% 
of respondents with primary education, compared with 36.8% in the Greek 
population, respondents with secondary education 14.5% of the sample compared 
with 11.3% in the national population; Lyceum Apolytirion holders made up 25.9% 
of the sample compared with 26.2%, and finally University graduates were 20.6% 
of the sample with a Greek average of 15.4% (Elstat, 2011).  
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Table 6: Demographic & Socioeconomic characteristics of the sample 
Testing site n (%) 
IKA Thessalonikis 1 213 (20.7%) 
IKA Thessalonikis 2 47 (4.6%) 
Hippokration Thessalonikis 264 (25.7%) 
Polikliniki Athens 89 (8.7%) 
Laiko Athens 60 (5.8%) 
Evagelismos Athens 194 (18.9%) 
Alexandras Athens 96 (9.3%) 
Kavala 64 (6.2%) 
Total  1027(100%) 
Gender  
Male 420 (40.9%) 
Female 605 (58.9%) 
Missing 2 (0.2%) 
Age (years) mean±SD 
 median (min-max) 
58.2±16.1 
62.0 (15.0-89.0) 
Family status  
Unmmaried 195 (19.0%) 
Married/partner 636 (61.9%) 
Divorced 57 (5.6%) 
Widow/er 137 (13.3%) 
Missing 2 (0.2%) 
Education  
Primary school 391 (38.1%) 
Secondary 149 (14.5%) 
Lyceum 266 (25.9%) 
University 212 (20.6%) 
Missing 9 (0.9%) 
Monthly salary (€)  
0-500 199 (19.4%) 
501-1000 305 (29.7%) 
1001-1500 275 (26.8%) 
1501-2000 100 (9.7%) 
2001-2500 43 (4.2%) 
2501-3000 25 (2.4%) 
>3000 34 (3.3%) 
missing 46 (4.5%) 
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Table 7: Diabetes related characteristics of the sample 
Diabetes Type n (%)  
I 281 (27.4%) 
II 743 (72.3%) 
missing 3(0.3%) 
Age when diagnosed with diabetes(years)  
 
mean±SD    43.3±18.5 
median (min-max)  48.0 (1.0-80.0) 
 HbA1c (%)  
6.5-7.0 382 (37.2%) 
7.0-7.5 251 (24.4%) 
7.5-8.0 163 (15.9%) 
8.0-8.5 84 (8.2%) 
8.5-9.0 43 (4.2%) 
>9.0 56 (5.5%) 
missing 48 (4.7%) 
Treatment  
Insulin 533 (51.9%) 
Oral medication 461 (44.9%) 
Diet 31 (3.0%) 
missing 2 (0.2%) 
Complication of Diabetes  
Yes 303 (29.5%) 
No 717 (69.8%) 
missing 7 (0.7%) 
Frequency of doctor/clinic visit  
Every month 226 (22.0%) 
Every 3 months 591 (57.5%) 
Every 6 months 147 (14.3%) 
Every year 44 (4.3%) 
Every 2 years 17 (1.7%) 
missing 2 (0.2%) 
Specialty  
Cardiologist 536 (52.2%) 
Eye doctor 348 (33.9%) 
Kidney doctor 14 (1.4%) 
Podiatrist 3 (0.3%) 
Psychiatrist/psychologist 6 (0.6%) 
missing 120 (11.7%) 
Hospital Visit the last year  
Yes 24 (2.3%) 
No 797 (77.6%) 
missing 6 (0.6%) 
Expenses for diabetes (last 2 months)  
0-50 289 (28.1%) 
50-100 389 (37.9%) 
100-150 162 (15.8%) 
150-200 46 (4.5%) 
200-250 32 (3.1%) 
250-300 27 (2.6%) 
>300 73 (7.1%) 
missing 9 (0.9%) 
Member of a diabetes association  
Yes 92 (9.0%) 
No 930 (90.6%) 
missing 5 (0.5%) 
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The sample is not homogeneous among the testing sites. Tables 8 and 9 present the 
differences according to demographic and diabetes-related characteristics 
respectively.  There are statistically significant differences showing that each 
diabetes centre, although typically open to anyone, attracts some special groups of 
patients. Polycliniki for example has the majority of patients with type 1 diabetes 
followed by Evangelismos. This was an unexpected result and had to be discussed 
with the directors of the diabetes-centres. The cause for this according to them was 
that, out of their own initiative, they have created some diabetes-education courses 
for type 1 patients, who afterwards continue visiting the centre on a permanent 
basis.  
There are also statistically significant differences among testing sites concerning 
the age and educational level of the patients. Polycliniki and Evangelismos, 
compared with other hospitals, attract younger, unmarried, most educated patients, 
as well as patients with an early diabetes onset. These differences should be 
expected because of the high percentage of type 1 patients in their samples. Laiko, 
Evangelismos, and Polycliniki attract more male patients compared with other 
hospitals. 
Significant differences are also observed between hospital samples and the monthly 
salary of the patients. Polycliniki and Laiko attract people with higher income, 
while Kavala’s patients report the lowest income.    
Polycliniki, Laiko, and Evangelismos seem to gather high percentages of people 
treated with insulin, while Laiko, Evangelismos, and Kavala hospitals have the 
highest numbers of patients with diabetes complications.  Laiko, Kavala and 
Hippokration have high percentages of people who were hospitalised for any reason 
during the period of twelve months before the survey.   
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Table 8: Sample differences among testing sites (Demographic) 
Testing 
Site * 
Gender Mean 
Age 
Income 
in € 
(Mean) 
 
Family Status  (p<0.0001) Educational Level (p<0.0001) 
Male Femal
e 
Total Single Married/
partner 
Divorced Widow
/er 
Primary 
School 
Gymna
sium 
Lyceum Higher 
1 81 
a:38 
b:19.3 
132 
a:62.0 
b:21.8 
213 
a:100 
b:20.8 
61.99 2.91 24 
a:11.3 
b:12.3 
119 
a:56.1 
b:18.7 
14 
a:6.6 
b:24.6 
55 
a:25.9 
b:40.1 
85 
a:41.1 
b:21.7 
41 
a:19.8 
b:27.5 
60 
a:29.0 
b:22.6 
21 
a:10.1 
b:9.9 
2 17 
a:36.2 
b:4.0 
30 
a:63.8 
b:5.0 
47 
a:100 
b:4.6 
67.19 2.71 2 
a:4.3 
b:1.0 
39 
a:83.0 
b:6.1 
0 6 
a:12.8 
b:4.4 
29 
a:61.7 
b:7.4 
2 
a:4.3 
b:1.3 
10 
a:21.3 
b:3.8 
6 
a:12.8 
b:2.8 
3 102 
a:38.9 
b:24.3 
160 
a:61.1 
b:26.4 
262 
a:100 
b:25.6 
61.57 2.19 34 
a:12.9 
b:17.4 
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a:71.1 
b:29.4 
11 
a:4.2 
b:19.3 
31 
a:11.8 
b:22.6 
136 
a:51.9 
b:34.8 
31 
a:11.8 
b:20.8 
54 
a:20.6 
b:20.3 
41 
a:15.6 
b:19.3 
4 42 
a:47.2 
b:10.0 
47 
a:52.8 
b:7.8 
89 
a:100 
b:8.7 
43.89 4.07 36 
a:40.4 
b:18.5 
45 
a:50.6 
b:7.1 
6 
a:6.7 
b:10.5 
2 
a:2.2 
b:1.5 
6 
a:6.7 
b:1.5 
8 
a:9.0 
b:5.4 
30 
a:33.7 
b:11.3 
45 
a:50.6 
b:21.2 
5 34 
a:56.7 
b:8.1 
26 
a:43.3 
b:4.3 
60 
a:100 
b:5.9 
55.50 3.33 14 
a:23.3 
b:7.2 
39 
a:65.0 
b:6.1 
2 
a:3.3 
b:3.5 
5 
a:8.3 
b:3.6 
7 
a:11.7 
b:1.8 
10 
a:16.7 
b:6.7 
18 
a:30.0 
b:6.8 
25 
a:41.7 
b:11.8 
6 94 
a:48.5 
b:22.4 
100 
a:51.5 
b:16.5 
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a:100 
b:18.9 
52.88 2.58 68 
a:35.1 
b:34.9 
90 
a:46.4 
b:14.2 
15 
a:7.7 
b:26.3 
21 
a:10.8 
b:15.3 
52 
a:26.8 
b:13.3 
27 
a:13.9 
b:18.1 
64 
a:33.0 
b:24.1 
51 
a:26.3 
b:24.1 
7 32 
a:33.3 
b:7.6 
64 
a:66.7 
b:10.6 
96 
a:100 
b:9.4 
56.41 2.57 13 
a:13.5 
b:6.7 
67 
a:69.8 
b:10.5 
6 
a:6.3 
b:10.5 
10 
a:10.4 
b:7.3 
28 
a:29.5 
b:7.2 
21 
a:22.1 
b:14.1 
24 
a:25.3 
b:9.0 
22 
a:23.2 
b:10.4 
8 18 
a:28.1 
b:4.3 
46 
a:71.9 
b:7.6 
64 
a:100 
b:6.2 
66.90 1.89 4 
a:6.3 
b:2.1 
50 
a:78.1 
b:7.9 
3 
a:4.7 
b:5.3 
7 
a:10.9 
b:5.1 
48 
a:75.0 
b:12.3 
9 
a:14.1 
b:6.0 
6 
a:9.4 
b:2.3 
1 
a:1.6 
b:0.5 
* Testing Sites 1: IKA Salonica 1; 2: IKA Salonica 2; 3: Hippokration Salonica; 4: Polycliniki Athens; 5; Laiko Athens; 6: Evangelismos Athens; 7: Alexandra Athens;  
8: Kavala 
a: % within testing site sample; b: % within total sample 
196 
 
Table 9: Sample differences among testing sites (Diabetes-related) 
 
Testing 
Site * 
Diabetes 
Type (p<0.0001) 
Diabetes 
onset age 
(p<0.0001) 
Treatment 
p<0.0001 
Complications 
p<0.0001 
Hospitalisation 
p=0.003 
1 2 Insulin Oral med Diet No Yes No Yes 
1 43 
a: 20.2 
b:15.3 
170 
a:79.8 
b:22.9 
47.77 93 
a:43.7 
b:17.4 
110 
a:51.6 
b:23.9 
10 
a:4.7 
b:32.3 
165 
a:77.5 
b:23.0 
48 
a:22.5 
b:15.8 
169 
a:79.3 
b:21.2 
44 
a:20.7 
b:19.6 
2 2 
a:4.3 
b:0.7 
45 
a:95.7 
b:6.1 
54.48 11 
a:23.4 
b:2.1 
36 
a:76.6 
b:7.8 
0 
a:0 
b:0 
35 
a:74.5 
b:4.9 
12 
a:25.5 
b:4.0 
38 
a:80.9 
b:4.8 
9 
a:19.1 
b:4.0 
3 37 
a:14.1 
b:13.2 
225 
a:85.9 
b:30.3 
47.63 130 
a:49.2 
b:24.4 
129 
a:48.9 
b:28.0 
5 
a:1.9 
b:16.1 
180 
a:69.5 
b:25.1 
79 
a:30.5 
b:26.1 
186 
a:71.5 
b:23.3 
74 
a:28.5 
b:33.0 
4 62 
a:69.7 
b:22.1 
27 
a:30.3 
b:3.6 
27.14 71 
a:79.8 
b:13.3 
16 
a:18.0 
b:3.5 
2 
a:2.2 
b:6.5 
70 
a:78.7 
b:9.8 
19 
a:21.3 
b:6.3 
76 
a:85.4 
b:9.5 
13 
a:14.6 
b:5.8 
5 19 
a:31.7 
b:6.8 
41 
a:68.3 
b:5.5 
38.43 44 
a:74.6 
b:8.3 
14 
a:23.7 
b:3.0 
1 
a:1.7 
b:3.2 
24 
a:40.0 
b:3.3 
36 
a:60.0 
b:11.9 
42 
a:70.0 
b:5.3 
18 
a:30.0 
b:8.0 
6 89 
a:45.9 
b:31.7 
105 
a:54.1 
b:14.1 
36.18 123 
a:63.4 
b:23.1 
65 
a:33.5 
b:14.1 
6 
a:3.1 
b:19.4 
135 
a:69.6 
b:18.8 
59 
a:30.4 
b:19.5 
162 
a:83.5 
b:20.3 
32 
a:16.5 
b:14.3 
7 23 
a:24.2 
b:8.2 
72 
a:75.8 
b:9.7 
44.19 31 
a:32.6 
b:5.8 
60 
a:63.2 
b:13.0 
4 
a:4.2 
b:12.9 
75 
a:79.8 
b:10.5 
19 
a:20.2 
b:6.3 
80 
a:85.1 
b:10.0 
14 
a:14.9 
b:6.3 
8 6 
a:9.4 
b:2.1 
58 
a:90.6 
b:7.8 
50.21 30 
a:46.9 
b:5.6 
31 
a:48.4 
b:6.7 
3 
a:4.7 
b:9.7 
33 
a:51.6 
b:4.6 
31 
a:48.4 
b:10.2 
44 
a:68.8 
b:5.5 
20 
a:31.3 
b:8.9 
* Testing Sites 1: IKA 1 Salonica ; 2: IKA 2 Salonica; 3: Hippocration Salonica; 4: Polycliniki Athens; 5; Laiko Athens; 
 6: Evangelismos Athens; 7: Alexandras Athens; 8: Kavala 
a: % within testing site sample; b: % within total sample 
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Chapter 11: Validation of the ADDQoL-Gr 
 
11.1 Introduction  
The principal aim of these analyses is to assess the QoL of people with diabetes in 
Greece as well as to identify the factors that determine the QoL concept. To this end 
the ADDQoL was selected as the main research instrument. However, it is well 
established that the validity of a measure is “not an once and for all” attained 
property, neither is it an “all-or-none” property (Streiner-Norman, 2008; Nunnaly-
Bernstein, 1994). Moreover, validity issues become more complicated when the 
instrument has to be translated into another language in order to be used with people 
of another culture.  Bradley (1996) epitomised the problem with the phrase: “the 
psychometric properties cannot be assumed to travel well”.  
Thus, in order to examine whether the translated and culturally adapted instrument 
has kept all its original properties, as well as the applicability of the ADDQoL-Gr to 
the Greek diabetes population, the first statistical procedure should address the 
psychometric properties of the measure.  
 
11.2 Methods  
The data collected were subjected to factor analysis. An Explanatory Factor Analysis 
was performed for the 19 items ADDQoL-Gr using a two-step approach of Principal 
Components Analysis (PCA) with varimax rotation. The two overview items were 
not included in the analysis, as these items receive a different treatment and are 
examined as separate items. “Not Applicable” responses were recoded as zero 
(Bradley, 2007). 
Reliability (internal consistency) of the ADDQoL-Gr. was assessed by Cronbach’s 
alpha. The results were compared with the original study’s results (Bradley et al. 
1999). Item-total correlation was also assessed. 
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Various types of Validity were examined. Criterion Validity, in its Concurrent form, 
was assessed against SF-36. There are no comparable results with this validation 
process, but respondents with moderate or severe problems on SF-36 are expected 
to have worse scores on the ADDQoL. Construct Validity was evaluated against the 
two global questions of the ADDQoL-Gr. It was also evaluated in the form of the 
Discriminative (or known groups) validity, using the different types of treatment as 
criterion. Face and Content Validities were examined throughout this research 
starting from the translation and continuing with interviews with patients and 
experts.  
 
11.3 Results 
11.3.1 Factor Analysis 
Factor analysis performed for ADDQoL-Gr, using listwise deletion of missed data. 
Unforced factor analysis with varimax rotation on the weighted ADDQoL scores 
generated three factors with eigenvalues greater than 1. The Kaiser-Guttman rule, 
which mostly used in analyses, factors with eigenvalues greater than 1 should be 
retained (Nunnally-Bernstein, 1994). 
The factor loadings were generally high. The magnitude of the loading that is 
acceptable for items to define a factor is heuristically accepted as ≥ 0.40 (Ferguson 
and Cox, 1993). Others believe that the lower limit is 0.30. According to Streiner 
and Norman (2008) loadings between 0.30 and 0.60 are considered to be moderately 
high and loadings greater than 0.60 are considered as high. Factor loadings <0.4 have 
not been displayed in Table 10.  
Fourteen of the 19 domains loaded greater than 0.4 on factor 1. 13 of them loaded 
on factor 1 with no cross-loading on any other of the other two factors. Cross-loading 
is defined as having factor loading of at least 0.40 on more than one factor with a 
difference between the two loadings of 0.20. The “Close personal relationship” item 
loaded on two factors with a loadings difference marginally above 0.20. Four items 
199 
 
(work, holidays, personal relationship and sexual life) loaded highly on factor 2. The 
items freedom to eat and freedom to drink loaded highly onto Factor 3.  
A three-factor solution explained 54.0% of variance. The results suggest that a 
substantial proportion of items load together on the first factor, though additional 
clusters are apparent. 
 
 
 
Table 10: Factor Loadings from unforced factor analysis with varimax rotation on the 
weighted ADDQoL-Gr scores. 
Domains Factor Loadings 
Factor 1 Factor 2 Factor 3 
Motivation 0.769   
Physical health 0.731   
Local or long journeys 0.707   
Self-confidence 0.705   
Leisure activities 0.693   
Living condition 0.680   
Physical appearance 0.670   
Friendship and social life 0.650   
Feelings about the future 0.635   
Family 0.620   
Financial situation 0.600   
People’s reaction 0.563   
Dependence on others 0.519   
Sexual life  0.742  
Work  0.685  
Close personal relationship 0.426 0.662  
Holiday  0.498  
Freedom to drink   0.852 
Freedom to eat   0.803 
 
When other factors were disallowed with a forced one-factor solution, 17 out of the 
19 domains loaded greater than 0.5 on the factor. “Freedom to eat” was less than 0.5 
and ‘’freedom to drink’’ and ‘’work’’ had the lowest loadings of less than 0.4. It 
should be noted that more than half of the patients (61.5%) responded as Non 
Applicable regarding the domain ‘work’, therefore this loading should be expected. 
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By removing the item ‘work’ and rerunning the analysis it was observed that the 
amount of variance explained was increased to 42.7%. Despite its low loading, 
freedom to drink was still within the acceptable lower limit of >0.30 (Kline, 1994; 
Streiner and Norman, 2008). Also, the item should be retained as a domain, as 51.3% 
of the patients indicated that their “freedom to drink” was “important” to “very 
important” to them. The forced one-factor solution explained 41.1% of the variance 
(Table 11). The above results support the fact that the computation of the Average 
Weighted Impact (AWI) represents the mean of the ADDQoL-Gr applicable 
domains and could be treated as a QoL outcome measure. 
 
Table 11: Factor Loadings from one forced factor analysis   
                 on the weighted ADDQoL. 
Domains Loadings 
Motivation 0.788 
Living condition 0.776 
Self-confidence 0.754 
Friendship and social life 0.744 
Physical health 0.737 
Feelings about the future 0.724 
Family 0.719 
Financial situation 0.681 
Local or long-distance journeys 0.670 
Close personal relationship 0.667 
Leisure activities 0.663 
People’s reaction 0.638 
Physical appearance 0.624 
Holidays 0.574 
Dependence on others 0.513 
Sexual life 0.511 
Freedom to eat 0.415 
Work 0.364 
Freedom to drink 0.361 
 
In conclusion, factor analysis findings support the one-factor scale structure of the 
ADDQoL. However, “strict unidimensionality” of the instrument, in the sense of one 
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dominant latent variable with no secondary minor dimensions, does not exist.  It is 
apparent that the instrument, with 14 items loading on one factor, demonstrates 
“essential dimensionality”, that is the instrument has one dominant factor with the 
inclusion of underlying secondary minor factors (Slocum-Gori et al. 2009; Slocum-
Gori and Zumbo, 2011).  
 
11.3.2 Reliability Analysis of the ADDQoL-Gr 
11.3.2.1 Internal Consistency 
11.3.2.1.1 Cronbach’s α 
Crombach’s α and item-total correlation were used to assess internal consistency of 
the ADDQoL-Gr.  
Cronbach’s α for the ADDQoL-Gr was estimated at 0.915. The original 12 items 
measure showed α= 0.846 (Bradley et al. 1999), the 18 item instrument showed α = 
0.92 (Bradley and Speight, 2002). Other translations showed alphas of 0.89 (Costa 
et al. 2006), 0.94 (Wee et al. 2006, Kamarun Imran et al. 2007). At first site an α 
over 0.90 suggests that the instrument could be shortened without losing its 
reliability. On the other hand, according to Streiner and Norman (2008) a scale of 
more than 11 items and a sample of over 300 should have an α of 0.90 in order to be 
called “good”, thus the ADDQoL-Gr with 0.915 appears to have an excellent α.   
11.3.2.1.2 Item-total correlation 
The values in the column Corrected Item-Total Correlation are the correlations 
between each item and the total score from the questionnaire. All items show an 
item-total reliability well above the limit of 0.20, which Streiner and Norman (2008) 
cite as “the usual rule of the thumb” according to which all items below that limit 
should be discarded.   
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Items for work, freedom to eat and freedom to drink had the lowest correlation with 
the overall score from the scale, but not so low that will need to be dropped in order 
to increase the degree of reliability or to necessitate a second factor. The values in 
the column “Cronbach’s Alpha if Item Deleted” are around 0.915 (the overall α). 
Only freedom to drink and freedom to eat had greater value of α than the overall α, 
showing once more the distinctiveness of these two items, but this difference is only 
marginal.  
 
Table 12: Item-Total Statistics 
Domain Scale Mean if 
Item Deleted 
Scale 
Variance if 
Item 
Deleted 
Corrected 
Item-Total 
Correlation 
Cronbach's 
Alpha if Item 
Deleted 
Leisure Activities -43.53 960.704 0.603 0.910 
Work -44.64 1000.242 0.326 0.916 
Local or long journeys -43.31 952.147 0.610 0.909 
Holiday -43.58 959.704 0.526 0.911 
Physical health -42.93 934.731 0.677 0.908 
Family life -42.93 929.721 0.663 0.908 
Friendship and social life -43.79 931.237 0.693 0.907 
Personal relationship -43.75 939.014 0.614 0.909 
Sex life -43.99 966.984 0.461 0.913 
Physical appearance -44.07 962.841 0.562 0.911 
Self-confidence -43.18 926.937 0.702 0.907 
Motivation -43.30 920.021 0.729 0.906 
People's reaction -44.50 966.716 0.583 0.910 
Feelings about the future -42.58 923.567 0.670 0.908 
Financial situation -43.56 938.658 0.627 0.909 
Living condition -43.25 918.304 0.726 0.906 
Dependence on others -43.15 963.008 0.454 0.913 
Freedom to eat -41.40 969.892 0.380 0.916 
Freedom to drink -43.41 985.691 0.335 0.916 
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11.3.3 Validity 
11.3.3.1 Construct Validity  
Construct validation of an instrument seeks agreement between a theoretical concept 
and a specific measurement.  It addresses two properties of the measure: first, its 
ability to measure what it purports to measure, and second its suitability for its pre-
defined purpose (Williams and Naylor, 1992).  Construct validity of the ADDQoL-
Gr was examined by correlating the average weighted average of the ADDQoL-Gr 
with the two global single-item questions. 
Before the various forms of validity were assessed some hypotheses should be 
generated:   
 The scores of the AWI and the global (diabetes-related) question 2 of the 
ADDQoL should correlate strongly, because they address the same attribute;  
 The correlations scores of the AWI and the global question 1 about “present 
general QoL” of the ADDQoL should be weak to moderate, because the AWI 
is disease-specific and global question 1 is of a generic nature; 
 The correlations of the AWI and the component summary scores of the SF-
36 should be weak to moderate for the same reason as above; 
 The correlations of the global question 1 about “present general QoL” should 
correlate strongly with the Component Summary Scores of the SF-36, 
because they are both generic measures; 
 The correlations of the weighted impact scores of the ADDQoL 19 items with 
the 8 health dimensions of the SF-36 should be moderate for the domains that 
could be considered relevant, and weak for the QoL domains of the ADDQoL 
that the SF-36 does not tap; 
 Respondents with complications and insulin users should report lower levels 
of QoL.  
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Corroboration of these hypotheses would be a strong indication of the ADDQoL-Gr 
validity. 
11.3.3.1.1 Discriminant - Convergent Validity  
These two types of validity, convergent and discriminant validity are grouped 
together because, although different in terminology, because they represent the two 
extremes in a continuum of associations between the dimensions of QoL. (Fayers 
and Machin, 2007). 
First, the mean weighted ADDQoL score were correlated with the two single-item 
measures of the questionnaire.  Spearman's rank correlation coefficient (rho) was 
used to test this association. Spearman’s correlation, instead of Pearson’s, was used 
because the Kolmogorov-Smirnov test showed that the distribution was not normal. 
Cohen's conventions were used to interpret the results: any correlation greater that 
0.5 is large, 0.3-0.5 is moderate, 0.1-0.3 is small, and anything smaller than 0.1 is 
insubstantial (Cohen, 1992). It was hypothesised that ADDQoL should correlate 
better with global question 2. 
As hypothesised, average weighted ADDQoL score was better correlated with the 
rating of quality of life without diabetes (r = 0.57, p<0.0001) than to the present 
quality of life (r = 0.37, p<0.0001). The relative values of the original instrument 
were r=0.31 for the first question concerning the present QoL, and r = 0.47for the 
second question i.e. for life without diabetes (Bradley et al. 1999).  
The fact that the mean weighted ADDQoL-Gr score is stronger related to the single-
item question 2 of the questionnaire, which refers to the diabetes dependent QoL, 
than to the question 1 about general QoL, might be considered as a strong indication 
for the existence of discriminant validity.    
Last, it should be noted that although both these correlations are highly significant, 
they are well below 1 indicating that the total ADDQoL-Gr scale provides 
information additional to that elicited from the two global questions.  
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11.3.3.2 Criterion Validity  
Criterion validity is the correlation of a scale whose interpretation is under question 
(target instrument) with some other measure used as criterion (anchor) (Guyatt at al., 
2002). It is used to demonstrate the accuracy of a measure by comparing it with 
another, which has been used and accepted as being valid. This criterion measure   
ideally acts as a “gold standard” (Streiner and Norman, 2008). At this point it should 
be noted that criterion validity is conceptually the same with construct validity and 
the two differ only in methodological terms (Ibid). Criterion validity should be 
considered as a “subcategory” of the construct validity (McDowell, 2006).  
Criterion validity was examined in its concurrent form. Concurrent validity is the 
corroboration that an instrument is measuring what it purports to measure against a 
criterion measure, which acts as a “gold standard”. The two measures should be 
administered at the same time. In this study criterion validity was examined against 
the SF-36, which was administered simultaneously with the ADDQoL-Gr. The 
correlations between the Summary Components of the SF-36 and the ADDQoL-Gr 
Aggregate Scores are shown in table 13. 
Table 13: Spearman’s correlations between ADDQoL and SF-36 Summary Components 
ADDQoL Aggregate Scores SF 36 Component Summaries 
 Physical Component 
Summary 
Mental Component 
Summary 
Average Weighted Impact 0.349 0.345 
 Present QoL in general 0.540 0.488 
Diabetes Related QoL 0.163 0.171 
The validity of the ADDQoL is supported by the fact that although the single-item 
global question about general QoL correlates strongly with both Physical and Mental 
components of the SF-36 (0.540 and 0.488), the AWI of the ADDQoL-Gr has a 
medium correlation with the summary components of the SF-36 (0.349 and 0.345), 
indicating that the two instruments measure similar but not identical concepts (Table 
13). There is some degree of overlapping between the two constructs, but they are 
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not redundant in any sense. The result proves that the ADDQoL-Gr provides a more 
targeted measure for diabetes than the SF-36.  
This was expected because although health status and HRQoL are similar concepts 
they are not identical. Thus, these results have a twofold use: they support the 
criterion validity of the ADDQoL-Gr, and at the same time they might be a 
contribution to the continuing discussion about the suitability of health status 
measures for measuring QoL.   
Another point worth mentioning emerges by observing the low correlations between 
the single-item question of the ADDQoL-Gr (Diabetes-Related-QoL), and the SF-
36 Summary Components. These correlations compared with the medium 
correlations of the Average Weighted Impact show the gain in sensitivity of the 19 
item weighted instrument compared with the unweighted single item question. This 
finding might be useful in the single versus multi-item instruments discussion 
mentioned in Chapter 4.  
Some of the ADDQoL-Gr domains are relevant to the SF-36 dimensions, while some 
others are not relevant at all. The dimension of pain for example is not a domain in 
diabetes patients, while “sex life”, “freedom to eat” or “drink” are not assessed by 
SF-36.  In Table 14 the domain Bodily Pain (BP) has, as expected, the lowest 
correlation coefficients with the ADDQoL items. Also, the items “close personal 
relations” and “sex life” “freedom to eat” and “freedom to drink” have very low 
correlation coefficients with SF-36 domains.  
On the other hand the domains of the ADDQoL that could, with some heuristic 
degree of freedom, be considered relevant to SF-36 dimensions should have medium 
correlations coefficients. Thus, as expected “journeys”, “physical health”, “physical 
appearance” of the ADDQoL, appear to correlate well with the “general health”, 
“physical functioning”, “role physical” and “vitality” of the SF-36. 
However, some expected correlations do not appear in the table. For example, it 
could be considered that “social life” domain of the ADDQoL, should be reflected 
in the “social functioning” dimension of the SF-36. Also, “feelings about the future”, 
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“self-confidence”, and “motivation”, should be correlated with “mental health 
(MH)” of the SF-36. For reasons that probably need further investigation this is not 
the case.  The MH domain has low correlations with all of the ADDQoL dimensions. 
The same happens with the role emotional (RE) domain of the SF-36.  
Table 14: Spearman’s correlations between ADDQoL-Gr item and SF-36 domain scores 
(N=814) 
ADDQoL 
Items 
SF-36  
domains 
 GH PF RP BP VT SF RE MH 
Leisure 0.240 0.225 0.286 0.149 0.258 0.287 0.246 0.233 
Work -0.016 -0.206 -0.058 -0.095 -0.100 -0.017 -0.035 .026 
Journeys 0.342* 0.328* 0.338* 0.253 0.318* 0.358* 0.232 0.216 
Holiday 0.100 0.019 0.103 0.063 0.068 0.082 0.080 0.081 
Physical health 0.346* 0.359* 0.364* 0.261 0.364* 0.385* 0.266 0.267 
Family life 0.222 0.227 0.263 0.168 0.243 0.292 0.264 0.236 
Social life 0.266 0.269 0.255 0.119 0.219 0.279 0.225 0.207 
Personal relations 0.089 0.077 0.092 0.011 0.068 0.139 0.154 0.143 
Sex life -0.028 -0.086 0.003 -0.054 -0.032 0.035 0.038 0.047 
Phys. appearance 0.281 0.342* 0.323* 0.216 0.278 0.330* 0.286 0.221 
Self confidence 0.291 0.219 0.256 0.183 0.233 0.262 0.258 0.232 
Motivation 0.260 0.232 0.223 0.184 0.209 0.267 0.217 0.208 
People’s reaction 0.173 0.175 0.191 0.147 0.175 0.191 0.156 0.162 
Future worries 0.230 0.181 0.222 0.144 0.154 0.232 0.214 0.172 
Financial situation  0.192 0.211 0.214 0.193 0.182 0.211 0.209 0.190 
Living condition 0.206 0.218 0.196 0.112 0.194 0.247 0.293 0.224 
Dependence 0.220 0.165 0.191 0.169 0.155 0.193 0.179 0.191 
Freedom to eat 0.200 0.208 0.164 0.122 0.158 0.207 0.112 0.096 
Freedom to drink 0.079 0.059 0.086 0.007 0.059 0.112 0.050 0.083 
*indicates moderate correlation 
 
11.3.3.3    Discriminative (or known groups) validity 
Discriminative validity refers to whether a scale is able to differentiate between two 
groups with different traits (Streiner and Norman 2008). It is based on the hypothesis 
that certain groups of patients are supposed to score differently than other groups 
(Fayers and Hand, 2002).  
Discriminative validity of the ADDQoL-Gr is supported by comparing the scores 
reported by insulin-treated patients with the oral medication-treated ones. The 
Kruskal Wallis test revealed that there was a statistically significant difference in the 
means of weighted ADDQoL scores between the type of therapy (p<0.05). Patients 
treated with insulin had significantly lower ADDQoL Average Weighted Impact 
(AWI)    score (-2.78), compared with those treated with tablets (-2.44).  
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Known groups validity was further supported by comparing the AWI scores of 
people who reported at least one complication with those without any complication 
caused by diabetes. As hypothesised the first group reported statistically significant 
lower levels of QoL (-3.36 and -2.30 respectively). 
11.3.3.4 Content and face validity 
Content and face validity, are to a great extent informal types of validity which 
depend mainly on value judgements. The assessment of both of these types was an 
ongoing procedure throughout this research. It started during the forward translation 
phase of the ADDQoL, continued with the discussions with experts, during the 
debriefing interviews, and with patients during the main course of the research.   
Special attention was paid to the issue raised by Speight (2009), which was discussed 
in Chapter 8, about any difficulty involved in answering to the hypothetical situation 
of diabetes absence.   The answers were unanimous that this did not present any 
problem, because they all had life without diabetes in the past that they could 
compare with their present condition. They could also compare their lives with 
people without diabetes in their immediate environment.  The results are considered 
satisfactory and no problem arose during the interviews during the main course of 
this research.  
 
11.4 Conclusion 
This study is the first to translate and validate a diabetes-specific QoL measure in 
Greek. The results of the internal consistency assessment indicate a very good 
reliability of the ADDQoL-Gr. for the Greek population.  
The results concerning the validity of the ADDQoL-Gr indicate that the instrument 
is valid in measuring what it purports to measure, that is the QoL of people with 
diabetes in Greece.  The validity analysis showed that the ADDQoL-Gr compared 
with the generic SF-36 provides a more targeted measure of QoL.  
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The type of the statistical analysis did not permit the assessment of the ADDQoL-Gr 
responsiveness as it requires a longitudinal study. This property has never been 
assessed in any of the ADDQoL versions. However, this is a topic of great interest 
for future research that is planned to take place after the completion of the present 
thesis. The economic-financial-social crisis that emerged in Greece during the last 
two years is a strong motive for re-examination of the QoL among people with 
diabetes in Greece, as well as a good opportunity to assess the responsiveness of the 
new instrument. 
Internal consistency and validity of the ADDQoL-Gr were demonstrated with 
satisfactory results leading to the conclusion that overall this measure should be 
considered as a very good instrument. The very good psychometric properties make 
ADDQoL-Gr suitable for use by health professionals, planners, and interest groups.  
The instrument is now accepted by the original developer and the MAPI institute as 
the Greek version of the ADDQoL and it is available for use by anyone interested in 
the field. According to the 3rd March 2008 Agreement (Appendix D) copyright in 
this questionnaire is owned by Prof Clare Bradley of Royal Holloway University of 
London, Egham, Surrey TW20 0EX, England. 
210 
 
PART V: Diabetes and Quality of Life in 
Greece 
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Chapter 12: The impact of Diabetes on QoL 
 
12.1 Introduction 
It is well established in international literature (chapter 5) that Quality of Life is 
impaired by diabetes. This chapter examines the impact diabetes has on diabetes 
patients in Greece using the ADDQoL-Gr.  
To this end the chapter has been subdivided into three headings:  
 the general impact that the disease has on Greek diabetes population; 
 the impact that diabetes has on various life domains, and;  
 the relationship of QoL with various demographic, socioeconomic, and 
medical characteristics of the patients.  
 
12.2 Method 
The available data contain the variables included in the medical-demographic, the 
SF-36 and ADDQoL-Gr questionnaires. Quality of life (ADDQoL-Gr), health status 
(SF-36) indices and the two global questions of ADDQoL-Gr are viewed as response 
(dependent) variables, whereas the remaining variables containing medical, 
demographic, and socioeconomic status are regarded as predictors (independent 
variables).   
Descriptive statistics for central tendency (mean, median) and variability (standard 
deviation, minimum and maximum) were used to present continuous variables while 
categorical variables were expressed as frequencies and percentages. Each variable 
was first examined at a univariate level (mean, standard deviation, median, minimum 
and maximum values). Normality of the distribution was checked with Kolmogorov-
Smirnov test. Theory suggests that when distribution is not normal non-parametric 
tests are used. It also suggests that when samples are large parametric methods can 
also be used to analyse these data. However, when outcomes are ordinal, ranked, or 
subject to outliers analyses with parametric methods are difficult, because major 
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assumptions are needed about their distributions and the tests involve estimation of 
the key parameters of that distribution. If the test deviate strongly from these 
assumptions nonparametric tests are preferred because they do not rely on 
assumptions about distribution. Therefore there is a trade-off between the power of 
the test, that the parametric methods provide, and the possibility of obtaining invalid 
results and reach incorrect conclusions, if the distribution assumption is strongly 
violated. In that case nonparametric tests are preferred.     Normality was checked 
and the result of the Kolmogorov-Smirnov test showed a non-normal distribution. 
To avoid the danger of reaching incorrect conclusions it was decided that non 
parametric methods should be used, such as Spearman’s correlation and Kruskal 
Wallis test. 
Some variables, like monthly salary, educational level, the HbA1c levels and the 
annually expenses, were treated as ordered categories variables rather than 
categorical variables in order to assist a meaningful interpretation of results. Mann-
Whitney U tests were used to identify any significant differences in ADDQoL scores 
between patients dichotomized on the basis of diabetes type, gender, presence of 
complications, hospitalization, and participation in any diabetes club or association.   
The association between the average weighted ADDQoL scores and the 
demographic characteristics with more than two categories was assessed with 
Kruskal-Wallis test. This was followed by post hoc tests in order to identify exactly 
in which categories there was the difference. For this purpose Mann-Whitney U test 
was used for all possible group comparisons with Bonferroni adjustment. Kruskal-
Wallis test was also used to explore differences in the average weighted ADDQoL 
scores among the various testing sites (hospitals), the type of therapy, the frequency 
of visits to the doctor and the consultants of various specialties. 
Spearman's rank correlation coefficient (rho) tested the association between 
ADDQoL scores and the Global Questions of ADDQoL, the monthly salary, the 
HbA1c levels and the expenses about diabetes. Cohen's conventions were used to 
interpret the results: any correlation greater that 0.5 is large, 0.3-0.5 is moderate, 0.1-
0.29 is small, and anything smaller than 0.1 is insubstantial. 
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Missing data were handled by pairwise deletion that is only the specific missing 
values were removed from the analysis and not the entire questionnaire that 
contained missing values. All tests were two tailed and statistical significance was 
considered for P values of less than 0.05. Statistical analyses were performed using 
the Statistical Package for the Social Sciences 19 (SPSS-19). 
 
12.2.1 Scoring 
In order to score and calculate the mean weighted score of the ADDQoL-Gr, User 
Guidelines in combination with the Supplement ADDQoL 19. (rev. 20.6.06) were 
used. (Unpublished-Personal communication with the developer Professor Bradley). 
There are 2 global questions and 19 questions on specific life domains, scored on a 
5 point scale followed by a 4 point importance rating scale. 
12.2.1.1 Overview Items of the ADDQoL-Gr 
For the first overview item the possible answers extended from “excellent” to 
“extremely bad”. The scores assigned to each one of the possible answers were from 
3 (“excellent”) to -3 (“extremely bad”). Similarly for the second overview item the 
possible answers extended from “very much better” to “very much worse”.  The 
scores assigned to each one of the possible answers were from -3 (“very much 
better”) to +3 (“very much worse”). 
12.2.1.2 The 19 specific items 
The impact of diabetes on applicable domains (part ‘a’ of an item) were rated on a 
scale of -3 (maximum negative impact) to +1 (maximum positive impact). The rate 
of the importance of those domains for patient’s QoL (part ‘b’ of an item) was scored 
on a scale from 3 (very important) to 0 (not at all important).  
Weighted-impact score for each domain is obtained by multiplying the impact 
ratings by the corresponding importance rating to provide a score ranging from -9 
(maximum negative impact) to +3 (maximum positive impact). 
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An average weighted impact score was derived by summing the applicable item 
weighted impact scores and divided by the number of applicable domains. This is 
the overall Average Weighted Impact (AWI) score. 
Selected domains have a “not applicable (N/A) option. N/A responses were excluded 
from the scoring for that individual as these items are not applicable to the individual.   
 
 
12.3 Results 
12.3.1 Impact of Diabetes on Quality of Life  
12.3.1.1 General Impact Score 
The mean AWI score was -2.62±1.81 (range: -8.83 to 0.26), indicating a negative 
impact of diabetes on quality of life in the patients participating in the study (Table 
15). This result was expected and it is in complete agreement with all previous 
studies concerning diabetes and QoL. Also, it should be noted that the vast majority 
of respondents scored their diabetes-dependent QoL negatively, despite the fact that 
they considered their present QoL in general in positive terms as “good”.  
Only 4 out of the 1028 participants reported a positive effect of diabetes on their 
quality of life. Although the number is not significant it was an unexpected finding, 
corroborating Professor Bradley’s views on the possibility of a positive diabetes 
effect. The probability of such a positive effect was doubted during the initial stages 
of the research (see 8.5.1: the advantages of ADDQoL).   
 
12.3.1.2 Overview items and mean weighted ADDQoL-Gr scores 
Overview item 1 found that the patients considered their present quality of life was 
“good” with a positive mean values of 0.60. When the patients were asked whether 
their QoL would improve without diabetes they felt that diabetes had a negative 
215 
 
impact on their QoL with a mean score of -1.51±0.96 and believed that their QoL 
would be much better without diabetes (Table 15, Figure 4).  
Table 15: Descriptive statistics for ADDQoL total and overview items 
 Mean SD n 
Average Weighted Impact  -2.62 1.81 1027 
Present QoL  0.60 1.02 1027 
Diabetes Dependent QoL -1.51 0.96 1027 
 
Figure 4:  Overview items in comparison to the average weighted impact score. 
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12.3.1.3 Impact of diabetes on life domains  
12.3.1.3.1 Distribution of Responses 
Distribution of responses to ADDQoL items is shown in table 16. Thus, items have 
been classified according to: a) their impact on QoL, b) to their importance and c) 
their weighted impact scores.  Weighting impact scores by importance ratings 
changes the ranking of domain mean scores for the impact of diabetes apparent with 
unweighted scores. In specific, although people’s freedom to eat receives the highest 
means for both unweighted and weighted impact, rankings of other items are 
particularly altered by weighting.  
Diabetes has the greatest impact on “freedom to eat” (mean±SD: -1.75±1.04) and 
least impact on “people’s reaction” to diabetes (mean±SD: -0.56±0.89). “Family 
life” was rated as the most important (mean±SD: 2.66±0.51) and “freedom to drink” 
was rated as the least important (mean±SD: 1.46±1.05) ADDQoL domain. After 
weighting was considered the most negative impact of diabetes was still freedom to 
eat (mean±SD: -4.38±3.17). The frequency of utilization of NA options ranged from 
4.2% (family life) to 61.5% (work). 
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Table 16: Distribution of responses * 
Domain Not 
Applicable 
responses 
Impact rating Importance 
rating 
AWI scores 
(% of 
responses) 
mean SD mean SD mean SD 
Leisure Act.   -1.09 0.96 2.08 0.61 -2.35 2.41 
Work 632 (61.5) -1.19 1.02 2.58 0.58 -3.09 2.86 
Journeys   -1.16 1.00 2.07 0.76 -2.52 2.55 
Holiday 243 (23.7) -1.24 0.98 2.35 0.65 -2.98 2.69 
Phys. health   -1.25 1.01 2.27 0.59 -2.96 2.73 
Family life 43 (4.2) -1.13 1.01 2.66 0.51 -3.06 2.89 
Social life   -0.82 1.02 2.42 0.61 -2.04 2.73 
Close personal 
relationship 
200 (19.5) -0.99 1.06 2.52 0.57 -2.53 2.96 
Sex life 375 (36.5) -1.10 1.06 2.49 0.60 -2.82 2.96 
Physical 
appearance 
  -0.78 1.00 2.10 0.69 -1.77 2.47 
Self-confidence   -1.08 0.99 2.30 0.58 -2.62 2.75 
Motivation   -1.04 1.05 2.32 0.58 -2.52 2.86 
People's reaction   -0.56 0.89 2.09 0.69 -1.28 2.22 
Feelings about the 
future 
  -1.30 1.04 2.32 0.63 -3.25 2.96 
Financial 
situation 
  -0.89 1.00 2.38 0.62 -2.30 2.80 
Living condition   -1.03 1.05 2.37 0.57 -2.60 2.89 
Dependence on 
others 
  -1.05 1.05 2.43 0.65 -2.66 2.94 
Freedom to eat   -1.75 1.04 2.24 0.82 -4.38 3.17 
Freedom to drink   -1.06 1.05 1.46 1.05 -2.29 2.81 
*n=1027 
 
Table 17 shows the effect of weighting on impact ratings. Weighting impact scores 
by importance changes the ranking of most domains. However, freedom to eat and 
feelings about the future remain first and second respectively for both unweighted 
and weighted impact. Also, impact on friendship and social life, physical appearance, 
and people’s reaction does not change with weighting.   Other domains are highly 
influenced by weighting. Journeys, work, drinking, dependence on others, and 
personal relationship are some of the altered domains. It is worth noting that the 
ranking of the two with the highest impact and the last three with the lowest one is 
not altered by weighting. This could imply that these domains are important to almost 
all of respondents. On the other hand, the change in ranking observed with weighting 
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shows that although respondents believe that these five domains have an impact on 
their lives, these domains have importance only to some of them.  
Table 17: Differences in ranking between unweighted – weighted means  
Domain Ranks of unweighted 
means 
Ranks of weighted 
means 
Freedom to eat 1 1 
Feelings about the future 2 2 
Physical health 3 6 
Holiday 4 5 
Work 5 3 
Local or long-distance journeys 6 13 
Family life 7 4 
Sex life 8 7 
Leisure Activities 9 14 
Self-confidence 10 9 
Freedom to drink 11 16 
Dependence on others 12 8 
Motivation 13 12 
Living condition 14 10 
Close personal relationship 15 11 
Financial situation 16 15 
Friendship and social life 17 17 
Physical appearance 18 18 
People's reaction 19 19 
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Figure 5 shows the impact of diabetes on individual life domain, indicating that the 
most negative impact of diabetes occurs to “freedom to eat” and the least negative 
impact on “people’s reaction”. 
Figure 5: Impact of diabetes on individual life domains (mean weighted ADDQoL 
score) 
 
220 
 
12.3.1.3.2 Impact of diabetes on individual life domains (by gender) 
Diabetes affects both male and female patients in all domains of life (Table 18). 
However, the impact differs between genders and among the 19 life domains and in 
some cases the difference is significant.   
Table 18: Impact of diabetes on individual life domains (by gender) 
Domain Male 
AWI scores 
Females 
AWI scores 
P value 
mean SD mean SD 
Leisure Activities -2.40 2.50 -2.32 2.35 0.8638 
Work -2.98 2.82 -3.24 2.90 0.4596 
Local or long journeys -2.50 2.689 -2.53 2.46 0.4119 
Holiday -2.85 2.60 -3.07 2.76 0.3740 
Physical health -2.95 2.81 -2.97 2.68 0.6572 
Family life -3.11 2.88 -3.02 2.89 0.5481 
Friendship and social life -2.35 2.89 -1.83 2.59 0.0040* 
Close personal relationship -2.90 3.11 -2.22 2.79 0.0007* 
Sex life -3.57 3.08 -2.00 2.61 <0.0001* 
Physical appearance -1.52 2.34 -1.95 2.53 0.0054* 
Self-confidence -2.78 2.94 -2.51 2.60 0.2762 
Motivation -2.65 3.01 -2.43 2.74 0.5318 
People's reaction -1.40 2.31 -1.20 2.15 0.1008 
Feelings about the future -3.21 3.04 -3.28 2.90 0.4875 
Financial situation -2.35 2.90 -2.26 2.72 0.9104 
Living condition -2.68 2.94 -2.55 2.86 0.4342 
Dependence on others -2.76 3.00 -2.60 2.88 0.4583 
Freedom to eat -4.39 3.25 -4.38 3.11 0.8710 
Freedom to drink -2.80 3.06 -1.94 2.56 <0.0001* 
*indicates statistical significance 
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12.3.1.3.3 Impact of diabetes on individual life domains (by type of diabetes) 
There are some statistically important differences of the weighted impact of diabetes 
on individual life domains between the type I and type II diabetes patients (Table 
19). 
Table 19: Impact of diabetes on individual life domains (by diabetes type) 
Domain Diabetes Type I 
AWI scores 
Diabetes Type II 
AWI scores 
P value 
mean SD mean SD 
Leisure Activities -2.22 2.46 -2.40 2.38 0.1334 
Work -2.91 2.66 -3.33 3.08 0.2347 
Local or long journeys -2.36 2.54 -2.58 2.55 0.1760 
Holiday -3.15 2.88 -2.90 2.58 0.5903 
Physical health -3.05 2.99 -2.93 2.62 0.9459 
Family life -2.74 2.94 -3.19 2.86 0.0134* 
Friendship and social life -1.67 2.70 -2.18 2.72 0.0008* 
Close personal relationship -2.42 3.07 -2.59 2.91 0.2647 
Sex life -2.35 2.92 -3.15 2.96 0.0001* 
Physical appearance -1.45 2.54 -1.89 2.42 0.0002* 
Self-confidence -2.71 3.00 -2.59 2.65 0.7337 
Motivation -2.12 3.09 -2.68 2.74 0.0003* 
People's reaction -1.26 2.38 -1.29 2.16 0.4733 
Feelings about the future -3.12 3.10 -3.30 2.90 0.2409 
Financial situation -2.07 2.72 -2.37 2.82 0.1448 
Living condition -2.59 3.02 -2.61 2.84 0.6372 
Dependence on others -2.68 2.90 -2.66 2.95 0.6373 
Freedom to eat -3.32 3.20 -4.80 3.05 <0.0001* 
Freedom to drink -2.30 2.82 -2.29 2.80 0.9682 
*indicates statistical significance 
 
222 
 
12.3.1.4 Discussion 
“Freedom to eat” receives the highest means both for weighted and unweighted 
impact, indicating that the greatest negative impact of diabetes is observed for this 
domain. The impact of this item is even higher for people with Type 2 diabetes. The 
heavy impact was expected taking into consideration previous studies in Europe and 
Asia (Bradley and Speight, 2002; DAFNE study group, 2002; Wee et al. 2006; Costa 
et al. 2006). 
 “People’s reaction” has the lowest means in both rankings. This could be an 
indication that diabetes does not stigmatise people in Greece any more.  These results 
are in agreement with the original ADDQoL and could be considered as an indication 
that the psychometric properties of the instrument are retained.  
The fact that the ADDQoL measures QoL according only to domains applicable to 
the patient is probably the major advantage of the instrument. However, the non-
applicable option might lead to situations where strong biases emerge and change 
the results of the analysis. To confront this problem the missing items of the non-
applicable domains should be isolated and removed from the analysis (weighting).    
When weighting takes place the ranking of domain mean scores changes in most of 
the remaining items. This is because all non-applicable domains are not scored. Thus, 
“work” moves from rank 5 (unweighted) to rank 3 (weighted). “Local or long-
distance” journeys moves from rank 6 (unweighted) to rank 13 (weighted). “Family 
life” moves from rank 7 (unweighted) to rank 4 (weighted). Rankings of other items 
are altered to some extend by weighting.  
Some important statistically significant differences are observed between genders 
when the impact of diabetes on the ADDQoL domains is assessed. For men, the 
impact of diabetes is higher than women on friendship and social life, close personal 
relationship, sex life, and freedom to drink domains, while women report more 
impact on physical appearance. 
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Diabetes in type II patients has a greater impact, compared with type I patients, on 
“family life”, “friendship”, “social life”, “sex life”, “physical appearance”, 
“motivation”, and “freedom to eat”.  The first four and to some extent “physical 
appearance” and “motivation” could be attributed to the higher age of the type II 
patients. The lower impact on “freedom to eat” for type I patients, compared with 
type II, could be explained by the use of insulin from type I patients. 
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Chapter 13: Diabetes-related QoL 
determinants 
 
13.1 Diabetes Dependent QoL in relation to 
Demographic and Medical Characteristics 
 
13.1.1 QoL and Type of Diabetes 
Mann-Whitney U test showed that there was a statistically significant difference in 
the mean weighted ADDQoL score between the two different types of diabetes 
(Table 20). Patients with type 2 diabetes had significantly lower mean ADDQoL 
score, indicating more negative impact of diabetes (p<0.05). 
Table 20: ADDQoL scores by type of diabetes 
Diabetes Type Mean S.D n p value 
Type 1 -2.460 1.871 281 
0.019* 
Type 2 -2.686 1.789 743 
In literature, the relationship between diabetes type and QoL is inconclusive and 
sometimes contradictory (Mayou et al, 1990; Jacobson et al. 1994; Stewart et al. 
1994).  Jacobson at al. (1994) found that type 2 patients enjoyed a higher level of 
QoL than type 1, even those treated with insulin. My findings contradict Jacobson’s 
results, thus it needs further investigation.  First, the type of instruments used played 
an important role in assessing QoL.  Jacobson et al. used a generic instrument (the 
SF-36) and a near-generic instrument (the DQOL), created for Type 1 diabetes only. 
The explanation for the near-generic nature of the DQOL can be found in Appendix 
B. It is not certain that these instruments can give accurate results for such a sensitive 
issue. My findings using the SF-36 do not give a clear picture on the issue (Chapter 
14). 
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Second, type of diabetes per se should be associated with QoL as long as it is 
examined in relation to confounding factors such as age or treatment regimen.  
According to Woodcock et al. (2001) the relation of Type 2 diabetes with QoL is 
intriguing because the disease is to a large extent asymptomatic for many years, 
making people suffer more from the treatment than from the disease itself. Diet, 
which is an essential part of the Type 2 treatment, imposes more severe restrictions 
on people with Type 2 diabetes. This, combined with the ADDQoL results that show 
“freedom to eat” as having the greatest impact on QoL, might be an adequate 
explanation for this finding. 
Further analysis shows that if we take age into account, diabetes type does not 
influence the ADDQoL score (see 13.1.3). 
 
13.1.2 Diabetes Dependent QoL and Gender 
Respondents were classified according to gender: Males: n= 420 (40.9%), females: 
n=605 (58.9%). There were 2 respondents with missing data (0.2%). In this case 
there was no statistically significant difference (p>0.05) between two genders 
regarding mean weighted AQQDoL score (Table 21).  
Table 21: ADDQoL scores by gender 
Gender Mean S.D. n p value 
Male -2.745 1.968 420 
0.277 
Female -2.536 1.697 605 
Male diabetes patients in general report higher levels of QoL, as well as higher 
health, status than female ones (Glasgow et al. 1997; Verbrugge, 1982; Kind et al. 
1998; Michalos, 2000; Rubin, 2000; Eiser et al. 1992; Redekop et al., 2002; Unden 
et al., 2008). Nevertheless, in this case men appear to have a lower QoL level than 
women. The difference is not statistically significant, but still does not agree with 
the main trend. It should be noted that the SF-36 results from this study show that 
men reported a higher level of health status. 
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Although the statistical difference is not significant still there should be an 
explanation why the results deviate from the main stereotype, which clearly suggests 
that men report higher levels of patient reported outcomes. The reason why this study 
differs from others is uncertain and three different possible explanations could be 
given, each one standing in its own capacity or could be a combination of all three.  
The first one could be that men seem to be more troubled by the limitations on 
personal freedom caused by diabetes. This view first expressed by Gafvels (1993) 
might be supported by examining the different effects that could be seen on  table 18 
of diabetes impact on individual life domains, where men suffer more on domains 
such as friendship and social life, close personal relationship, sex life, and freedom 
to drink domains, while women suffer significantly more only  on physical 
appearance. 
The second answer might be that men in Greece are now emancipated from the 
stereotype of being tougher than women and it is nowadays more socially acceptable 
to report their feelings, depression or anxiety, which according to some (female) 
writers was something permissible and more acceptable in the near past, even in 
western societies, only to women (Nathanson, 1975; Bradley, 1980). Thus, the views 
expressed in the past that women are more sensitive and express their emotions more 
overtly than men may no longer be valid in contemporary Greece. 
The third answer, and possibly the most convincing one, is the presence of a 
confounding factor such as age. The relation or interaction of gender, age groups and 
type of diabetes, is examined more thoroughly at the next stage of analysis, and age 
seems to play an important role. 
 
 
227 
 
13.1.3 Diabetes Dependent QoL and Age 
According to the literature older individuals report lower QoL (Lloyd and Orchard 
1999; Rubin, 2000). Although this statement seems to be generally correct, this 
approach could be considered as an oversimplification, because age and QoL have a 
more complicated relation, especially when other factors such as type of diabetes or 
gender are concerned.  
 
13.1.3.1 QoL & Age  
To examine this relationship the Kruskal-Wallis test was used in order to compare 
the mean difference of ADDQoL score between different age groups. Also, in order 
to assess how the ADDQoL score of various age groups was affected when the 
gender and the type of diabetes were taken into consideration, a factorial ANOVA 
was performed.   
Table 22 shows the ADDQoL scores by age groups. There was a statistical 
significant difference between the mean ADDQoL score and the different age groups 
(p=0.001). In particular, younger patients (<31 years old) differed significantly from 
all other age groups, meaning that for younger patients diabetes had significantly less 
impact compared with older patients.  
Table 22: ADDQoL scores by age group 
Age Groups (in years) Mean Std n 
<31 -1.90 1.45 84 
31-40 -2.44 1.84 104 
41-50 -2.99 2.22 90 
51-60 -2.92 2.06 200 
61-70 -2.57 1.75 292 
71-80 -2.58 1.52 211 
≥81 -2.71 1.48 36 
 
228 
 
Patients <31 years of age and 31-40 assessed their QoL higher than the older ones, 
probably because have shorter duration of diabetes, fewer complications, better 
social life and physical condition.  
It seems that ADDQoL score is decreasing with age up to the age of 50-60.  There 
was a slight increase in the ADDQoL score, for the age groups of 61-70 years and 
71-80 years compared with the 41-60 age groups. This, at first sight seems to be a 
paradox. However, three factors should be taken into consideration:  
 First, it should be noted that there are theories suggesting that well-being and 
happiness may improve with age (Lawton 1996; Mroczek and Kolarz, 1998; 
Bowling, 2005e). This could be explained by the fact that the age group 61-
70 includes people who are newly retired, changing therefore their way of 
life and loosing the distress that accompanies work and family problems. 
They have time, freedom and independence to enjoy life (Bowling, 2005e).  
 Second, as the duration of the condition increases patients come to terms with 
their diabetes and the conditions imposed by it. The so-called response shift 
phenomenon has been analysed in chapter 3 and it involves changing of 
individuals’ internal standards, values and conceptualization of life 
(Sprangers and Schwartz, 1999). 
 Third, Trief et al. (2003) argued that older people (the group 71-80 years of 
age), have coping skills, social relationships or other factors may act as 
buffers and prevent high levels of distress, although they face functional 
problems. The fall in QoL apparent after the age of 80 years could be a result 
of rapid deterioration in physical health.       
 
13.1.3.2 QoL Age and Gender  
There was a significant main effect of the age category on the ADDQoL score. The 
F- ratio was highly significant F (6, 1001) =4.17, p<0.0001. Age significantly 
affected ADDQoL score, when we ignored gender. The Games-Howell post hoc test 
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revealed that the ADDQoL score was significantly high in younger patients (<31 
years old) than all the other age groups combined. There was a non-significant main 
effect of gender on the ADDQoL score F (1, 1001) =0.005, p=0.946. This means that 
if we ignore age, gender did not influence ADDQoL score. There was a significant 
interaction effect between the age and the gender on the ADDQoL score, F (6, 1001) 
=2.41, p=0.026.  
This indicates that the two genders were affected differently by age. Male patients 
less than 31 years of age and over 81 years old had significantly higher ADDQoL 
score compared with female patients, indicating a better quality of life. Regarding 
the rest of the age groups (from 31-80 years old) female patients had higher (less 
negative) ADDQoL scores compared with men. For both genders ADDQoL score 
dropped after the age of 31 years old and started to increase after the age of 61 years 
old. However, for female patients after 70 years old the ADDQoL score started to 
decrease again, while for male patients of the respective age the ADDQoL score 
continued to increase, indicating an improvement in quality of life (Table 23). 
Table 23: ADDQoL scores by age group and gender. 
Age Groups Male Female 
mean SD mean SD 
≤31 -1.50 1.23 -2.27 1.56 
31-40 -2.57 1.95 -2.36 1.78 
41-50 -3.35 2.63 -2.78 1.93 
51-60 -3.36 2.25 -2.59 1.84 
61-70 -2.73 1.88 -2.46 1.66 
71-80 -2.63 1.45 -2.55 1.57 
≥81 -2.30 1.56 -2.94 1.42 
 
13.1.3.3 QoL Age and Type of Diabetes 
There was a significant main effect of age on the ADDQoL score. The F- ratio was 
highly significant F (6, 1001) =4.16 p<0.0001. Age significantly affected ADDQoL 
score, when type of diabetes was ignored. On the contrary, there was a non-
significant main effect of diabetes type on the ADDQoL score F (1, 1001) =0.74, 
p=0786. This means that if we ignore age, type of diabetes does not influence 
ADDQoL score.  
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However, there was a significant interaction effect between age and the type of 
diabetes on the ADDQoL score, F (5, 1001) =3.11, p=0.009. This indicates the effect 
of age on ADDQoL score was different for diabetes type I patients than it was for 
type II patients. In specific patients with Type 1 diabetes less than 40 years old had 
significantly higher ADDQoL score compared with diabetes Type 2 patients. For 
patients with type I diabetes ADDQoL score decreased with age, at least up to 60 
years old, where it started to increase (Table 24). On the contrary for patients with 
Type 2 diabetes ADDQoL score increased with age and after the age of 61 it started 
to have a slight decrease. At the age group of 61-70 patients between the two types 
of diabetes differ significantly regarding ADDQoL score,  with Type 2 diabetes 
patients having higher ADDQoL score (-2.52±1.74). 
Table 24: ADDQoL scores by age group, gender, and type of diabetes. 
Age Groups 
Gender 
Type I Type II  
mean SD mean SD 
≤31 years -1.90 1.45 - - 
31-40 -2.28 1.77 -4.11 1.91 
41-50 -2.89 1.98 -3.12 2.48 
51-60 -3.26 2.39 -2.87 1.98 
61-70 -3.68 1.79 -2.52 1.74 
71-80 -2.39 2.29 -2.59 1.51 
≥81 years -2.80 . -2.70 1.50 
Male -2.51 2.03 -2.84 1.93 
Female -2.43 1.74 -2.58 1.68 
 
Regarding the effect of gender on ADDQoL score between the different types of 
diabetes, there was no significant different effect. There was a non-significant main 
effect of gender on the ADDQoL score F (1, 1018) =1.74, p=0.188 and of type of 
diabetes F (1, 1018) =3.58, p=0.059. This means that if we ignore type of diabetes, 
gender does not influence ADDQoL score and also if we ignore gender, type of 
diabetes does not influence ADDQoL score. There was no significant interaction 
effect between the type of diabetes and the gender on the ADDQoL score, F (6, 1018) 
=0.516, p=0.473. This indicates that Type 1 and Type 2 diabetes patients were not 
affected differently by gender. 
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13.1.4 QoL and Complications 
According to literature diabetes complications is a strong predictor for QoL. 
According to Rubin and Peyrot (1999) complications are the most important disease-
specific determinant of QoL.  People with complications in general report a lower 
level of QoL compared with people without complications (Lloyd et al 1992; Klein 
et al., 1998; Trief et al., 1998; de Visser et al., 2002; Maddigan et al., 2005). This is 
because complications affect many aspects of patient’s life, patient’s views of 
diabetes, social life and self-perception (Gafvels et al. 1993).  
In the questionnaire the question on complications included answers for visual 
impairment, myocardial infarction, nephropathy, amputation, erectile dysfunction, 
and “other”. 303 (29.5%) of the total sample of 1027 reported at least one diabetes 
complication; 55 of them reported two complications. 
 
As expected, patients who experienced diabetes complications had significantly 
lower ADDQoL average weighted impact scores, compared with those who didn't 
have any complication (Table 25). 
Table 25: ADDQoL scores with and without complication 
Complications n (%) Mean SD p value 
Yes 303 (29.5%) -3.364 2.023 <0.0001* 
No 717 (69.8%) -2.306 1.623 
missing 7 (0%)   
*
indicates statistically significant difference 
 
The most frequent complication was visual impairment, something that could not 
easily be verified, as it was impossible to confirm to what extent the damage to 
eyesight was caused by diabetes or any confounding factor such as age (Table 26). 
Erectile dysfunction and nephropathy seem to have the most serious impact on QoL 
(-4.71 and -4.23 respectively with a mean weighted average of -2.65 for the total 
sample). 
Some of the above results might be presumed as expected, in the sense that it is 
already well established that complications are the most decisive predictor for the 
quality of life of people with diabetes.  
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However, this table shows that microvascular complications have a greater impact 
than the macrovascular disease of myocardial infarction. This contradicts the long 
standing view in international literature that macrovascular complications, especially 
coronary heart disease (CHD), have the most negative impact on QoL, followed by 
non-vascular diseases (Lloyd et al.; Wandell et al. 1998; Hart et al. 2003; Wandell, 
2005). Hart et al (2003), using two generic measures, reported that microvascular 
complications such as neuropathy, retinopathy and/or nephropathy did not have any 
statistically significant influence on QoL.  
The most astonishing result is that among all complications, and consequently among 
all determinants of diabetes-related QoL, erectile dysfunction (ED) had the most 
negative impact on QoL. This finding is, to the best of our knowledge, unique in 
international literature. We are unaware of a study concerning the weighted impact 
of each complication, including ED, on diabetes-related QoL.  
Erectile dysfunction among all complications appears to be the most understudied 
one in relation with QoL, despite its substantial prevalence among the male diabetes 
population (De Berardis et al., 2002).  Estimations of ED prevalence among male 
diabetes patients vary from 26% to 71% with type of diabetes, age, duration and co 
morbidity (e.g. hypertension) to be the most significant confounding factors for these 
variations. The definition of ED was also responsible for the variations observed in 
prevalence (Siu et al., 2001; Bacon et al., 2002; De Berardis et al., 2002; Fedele et 
al. 2000; Giuliano et al., 2004; Grover et al., 2006). 
There are not any studies investigating the relative impact ED has on QoL.  There 
are only three studies reporting the impact of ED either on QoL in general, that is not 
in relation with other complications, or in comparison with healthy controls, or even 
with diabetes-patients without ED. De Berardis et al. (2005) in a longitudinal study, 
using a generic measure the SF-36, reported that ED caused a negative impact on 
QoL and that this impact was deteriorating during the three years of the study. Penson 
et al. (2003) exploring data bases regarding erectile dysfunction concluded that men 
with diabetes and ED respond worse quality of life than men with ED but without 
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diabetes.  Avasthi et al (2011) found that men with diabetes and ED had poorer QoL 
in all domains compared with men with diabetes but without ED. 
Therefore, the problem of ED, as a major predictor of QoL, should be investigated 
further, as it constitutes a major problem for diabetes population.  
Table 26: ADDQoL scores by complication, number and severity of complications 
Complication n =303       
(% of n) 
 
%  of total 
n=1027 
Mean 
score 
SD 
Visual Impairment 173 (57.1%) 16.84% -3.36 1.98 
Myocardial Infarction 39 (12.9%) 3.80% -3.63 2.04 
Nephropathy 35 (11.6%) 3.41% -4.23 2.07 
Amputation 9 (3.0%) 0.88% -3.94 2.26 
Erectile dysfunction 29 (9.6%) 2.82% -4.71 2.56 
Other 73 (24.1%) 7.11% 3.16 1.90 
Over 2 complications 55 (18.6%) 5.36% -4.60 2.05 
Complication severity      
Slight 120 (39.6) 11.68% -3.07 1.983 
Medium 121(39.9) 11.78% -3.28 1.950 
Severe 57 (18.81) 5.55% -4.11 2.118 
Another point of great importance on the issue of complications is the impact that 
their number has on QoL.  Patients who reported more than one complication score 
very low on QoL. The mean score -4.601 compared with the mean of -2.306 for 
patients without complications shows the gravity of the condition and the importance 
this issue has for the QoL determination.  
    
13.1.5 QoL and severity of complications 
Having examined the role of complications in general and the influence that each 
one has on the level of QoL, the role of severity was assessed. There was a 
statistically significant difference between the ADDQoL score and the severity of 
the complications (p=0.004). Patients with higher severity had statistically 
significant lower ADDQoL score. Thus, people with severe complications appear to 
have an average weighted impact score of -4.11, well below the mean score of -2.62 
of the general Greek population with diabetes (Table 26). 
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Another point worth mentioning is that the ADDQoL-Gr was proved to be sensitive 
enough and capable of detecting the changes that the degree of complications’ 
severity has on the level of QoL. 
 
13.1.6 QoL and Treatment Regimen 
Treatment of diabetes from the QoL perspective is an interesting factor because 
diabetes, in its initial stages, is completely asymptomatic and does not impose a 
burden on an individual’s QoL; the main burden is caused by the treatment 
(Woodcock et al., 2001). 
Table 27: ADDQoL scores by treatment regimen 
Therapy Mean SD n p value 
Insulin -2.78 1.90 533 
0.034* Oral medication -2.44 1.68 461 
Diet only -2.57 1.94 31 
 
Consistent with previous research (Welch et al. 2003), as well as our expectations 
people treated with insulin reported significantly greater impact of diabetes (-2.78).  
However, the interesting point here is the fact that people being on diet only have 
more negative score compared with people treated with oral agents (Table 27). An 
explanation for this finding, which at first sight seems to be a paradox, might be the 
view expressed by physicians when this issue was raised, that people on “diet only” 
struggle harder than people who think that medication will manage their diabetes for 
them. 
 
13.1.7 QoL and Glycaemic control 
A degree of confusion can be observed in the literature concerning the relationship 
between good glycaemic control and QoL. This relationship is a complicated issue 
and a topic of major dispute. Snoek (2000) argued that there is a relatively weak 
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association between patient’s objective health status and their subjective QoL. 
Describing the inconsistent association between the two he argues that there are four 
categories of patients: people who experience high QoL with good glycaemic 
control; those with good QoL with poor glycaemic control; Individuals with a low 
level of QoL despite the good glycaemic control; and people with low QoL and poor 
glycaemic control. 
Nevertheless, high levels of HbA1c lead to serious diabetes complications such as 
neuropathy, retinopathy, microvascular complications, or nephropathy (DCCT, 
1996; UKPDS, 1998a; UKPDS, 1999). The UKPDS (2009) argued that different 
treatments do not affect QoL. Other studies, although they accept the relationship 
between HbA1c and microvascular complications, dispute the relationship between 
glycaemic control and macrovascular complications (ACCORD, 2008; ADVANCE, 
2008; Duckworth et al. 2009). 
However, a number of writers suggest that there is an association between intensive 
glycaemic control and QoL. (Ishii et al. 2008; Testa and Simonson, 1998; Klein et 
al., 1998; Lloyd and Orchard 1999; Goddgin et al., 1999; Kamarul et al. 2010; 
Imayama et al. 2011). Others argue that there is little or no relationship between 
HbA1c and self-reported outcomes (Weinberger et al. 1994; Wredling et al. 1995; 
Aalto et al. 1997; Sonnaville et al 1998).  
The reason why investigators express diametrically different views might lie on the 
type of investigations and the instruments used. The last seems to play an important 
role in examining the relationship between glycaemic control and QoL. Rubin and 
Peyrot focus on the type of instrument arguing that a number of studies suggest that 
this relationship exists, especially when QoL is assessed by a diabetes-specific 
measure than a generic one. This explanation may be not enough. Even among 
disease specific instruments differences are observed. It seems that 3 factors should 
be taken into consideration on this issue: the type of instrument, the domains of QoL 
investigated, and the sensitivity of the instrument to detect changes in quality of life 
and not just health status. 
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Spearman’s correlation coefficient (r) between ADDQoL score and HbA1c was -
0.149. Thus, the use of ADDQoL-Gr in this research proved that there is a 
statistically significant negative correlation between levels of HbA1c and mean 
weighted ADDQoL score (p<0.05).  
Higher HbA1c levels were related with lower mean weighted ADDQoL score that is 
more negative impact of diabetes on quality of life (Table 28). 
Table 28: ADDQoL scores and glycaemic control by level of HbA1c    
HbA1c (%) n Mean SD p-value 
6.5-7.0 382 -2.44 1.79  
7.0-7.5 251 -2.45 1.68  
7.5-8.0 163 -2.62 1.76 <0.0001 
8.0-8.5 84 -3.16 1.77  
8.5-9.0 43 -3.23 2.28  
>9.0 56 -3.63 2.21  
 
13.1.8 QoL and disease duration  
The relationship between QoL and duration of diabetes is unclear.  There are studies 
that support the view that duration of diabetes and QoL are not significantly related 
(Jacobson et al. 1994; Hanestad, 1993; Parkerson et al., 1993; Peyrot and Rubin, 
1997; Redekop, 2002). Contrary to this view, there are studies supporting that longer 
duration is related to lower QoL levels (Glasgow et al. 1997; Klein et al. 1998).  
An early onset of diabetes may influence the course of personal development, may 
facilitate the long term adjustment to diabetes positively because the individual has 
time to increase management skills, alter personal perceptions, adapt to the demands 
of the disease, or in some cases has no memory of life without diabetes (Gafvels et 
al. 1993). In this respect it might influence QoL.  
Moreover, the relationship between duration and QoL should not be considered as 
linear. This is because in the early stages of the disease (in the first few months), 
people feel more anxiety, depression and loss of control compared with people with 
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longer duration (Cassilieth et al. 1984). The finding suggests that psychological 
adaptation among patients with diabetes is effective.   
The results of this work show a non-linear evolution of QoL. The phenomenon is 
apparent throughout the duration of the disease and not only during the first few 
months. Low levels of QoL are observed after the onset of the disease (-2.47), but 
this remains constant for the first 20 years (Table 29). From 21 to 40 years of duration 
the levels of QoL are even lower. The worst deterioration of QoL levels takes place 
between 21-40 years of duration (-3.45). What at first sight seems to be unexpected 
is that   duration group >40 years of diabetes score slightly higher levels of QoL 
compared with the group of 31-40.  
Table 29: ADDQoL scores and disease duration  
Duration (years) n Mean SD p-value 
0-10 406 -2.47 1.78  
0.0005 
11-20 311 -2.47 1.58 
21-30 175 -2.58 1.93 
31-40 59 -3.45 1.86 
>41 21 -3.30 2.38 
 
By looking more closely one might conclude that this phenomenon should be seen 
in parallel to other factors such as age, where people of 60 to 80 years of age appear 
to score higher than the 2 previous age groups.  
 
13.1.9 Diabetes Dependent QoL and Marital Status 
As far as QoL is concerned both types of diabetes patients are affected by marital 
status, with divorced people experiencing the lowest levels of QoL. The association 
between family and QoL is not attributed to differences on glycaemic control that 
one might expect among various marital categories, but is more related to 
psychological factors (Trief et al. 1998; Trief et al. 2001). 
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Respondents were classified into four categories as follows: Unmarried n= 195 
(19%), married/partner n= 636 (61.9%), divorced/separated n= 57 (5.6%), Widow/er 
n=137 (13.3%). Data on family status for 2 respondents (0.2%) were missing. 
Table 30: ADDQoL scores and marital status 
Family Status Mean S.D n p value 
Unmarried -2.23 1.80 195 
0.001* Married/Partner -2.68 1.82 636 
Divorced -3.00 2.03 57 
Widow/er -2.75 1.57 137 
Kruskal-Wallis test showed that there was a statistically significant difference on the 
mean weighted ADDQoL score regarding family status (p=0.001, see Table 30). 
Unmarried patients reported significantly higher ADDQoL score compared with the 
all other categories, revealing that the impact of diabetes on their quality of life was 
less negative compared with the others. Divorced people scored the lowest level of 
QoL (-3.00), followed by widow/ers (-2.75) and married or living with a partner (-
2.68).  The results concerning divorced and widowed people are in agreement with 
international literature, as these groups are in general more vulnerable to depression 
(Peyrot and Rubin, 1997; Jacobson et al. 1994; Connell et al. 1994; Murrell et al. 
1983).  
 
13.1.10 Diabetes Dependent QoL and Education 
Respondents were classified into four categories as follows: Primary school (6-12 
years) n= 391 (38.1%), secondary (12-15 years) n= 149 (14.5%), Lyceum (15-18 
years) n= 266 (25.9%), university (>18) n=212 (20.6%). Data on education were not 
available for 2 respondents (0.2) respondents. 
Education per se is an important determinant of health outcomes, independent of 
other determinants of health. Various writers have reported that less-educated 
patients score lower on all QoL dimensions compared with more highly educated 
ones (Glasgow et. al. 1997; Rubin, 2000). The mechanisms for this correlation have 
not been adequately explained, but people with low education levels have low health 
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service utilisation rate and worse outcome in terms of complications (Van der Meer 
and Mackenbach, 1999).  
Table 31: ADDQoL scores and Education 
Education Mean SD n p value 
Primary -2.787 1.690 391 <0.0001* 
Secondary -2.869 2.056 149 
Lyceum -2.666 1.914 266 
University -2.125 1.648 212 
These findings are consistent to our expectations and the international literature. 
There is a statistically significant difference in the means of weighted ADDQoL 
scores between the education levels (p<0.05). It can be observed that the mean 
weighted ADDQoL score for university graduates is significantly higher than the 
means of the other levels of education. 
 
13.1.11 Diabetes Dependent QoL and Income 
Income is considered by lay people in general as an important parameter in 
determining QoL (Brown et al. 2004: 17). The relationship between income, health 
status and QoL is a complicated issue. The mechanisms connecting the two are still 
under investigation. It has been suggested that low income is a decisive factor in type 
2 diabetes prevalence (Connolly et al. 2008). There is also evidence that low income 
diabetes patients receive less care than high income patients (McCall et al. 2004). 
However, low income diabetes patients, even if they have good access to health care, 
have worse health outcomes compared with groups of higher income (Jotkowitz et 
al. 2006). They also report lower quality of life. (Glasgow et al., 1997).  
Various explanations have been given for this and the factors responsible vary from 
health behaviours (e.g. diet, smoking, physical activity), community factors (e.g. 
availability of healthy food, places to exercise), access to health care, and diabetes 
management (e.g. measurement of HbA1c) (Brown et al., 2004). 
Respondents were classified into seven income clusters as follows: € 0-500 n= 199 
(19.4), € 501-1000 n=305 (29.7%), € 1001-1500 n=275 (26.8%), € 1501-2000 n=100 
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(9.7%), € 2001-2500 n=43 (4.2%), € 2501-3000 n= 25 (2.4%), € > 3000 n=34 
(3.3%). As expected, the number of missing data on this question was the highest 
among all questions reaching the number of 46 (4.5%). This is due to inefficiency of 
the tax authorities which in turn result to high numbers of tax avoiding citizens. There 
are reasons to believe that these missing data belong mainly to respondents with 
higher than average incomes, who according to publications are evading taxes more 
than any other income group   (Matsaganis and Flevotomou, 2010; Vasardani, 2011; 
Artavanis et al. 2012).  
Despite the fact that a high percentage of expenses is covered by social security, 
Spearman's correlation coefficient (r) between the mean weighted impact ADDQoL 
score and monthly salary showed a statistically significant positive correlation (r = 
0.188, p<0.05), meaning that higher salary was related with higher mean weighted 
ADDQoL score, that is less negative impact of diabetes on quality of life.  
When the mean weighted impact is assessed for the various income groups it can be 
clearly seen the increase of QoL levels as income increases (Table 32). 
Table 32: ADDQoL scores and Income   
Monthly Income € n Mean SD p-value 
0-500 199 -2.95 1.85 <0.0001 
501-1000 305 -2.81 1.78  
1001-1500 275 -2.41 1.62  
1501-2000 100 -2.18 1.97  
2001-2500 43 -2.10 1.81  
2501-3000 25 -2.49 1.81  
>3000 34 -2.03 1.91  
 
13.1.12 QoL and Co-payments 
The term co-payments in diabetes includes money spent for test-strips, needles, 
additional blood tests for HbA1c, socks, shoes, glasses, and visiting consultants in the 
private sector. Co-payments in the treatment of diabetes is a major issue in the Greek 
health service. This could be attributed to inefficiencies of the national insurance 
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coverage for the particular disease, especially when sub-specialties of diabetology are 
needed.      
It has been suggested that low income groups are sensitive to cost sharing as they 
spend a higher proportion of their income on out-of-pocket expenses than do higher-
income patients (Newhouse, 1993; Gross et al. 1999).  Also, patient co-payments are 
higher for people with type 2 diabetes, as social security does not cover most of the 
consumable goods and routine blood tests.  
Spearman's correlation coefficient r between the ADDQoL average weighted score 
and the expenses for diabetes was low (r= -0,076) but statistically significant with a 
p value 0.015 (p<0.05). The negative correlation shows that patients who spent more 
money for diabetes had poorer average weighted impact ADDQoL scores. This is 
expected taking into consideration the flat coverage of expenses from the social 
security system (i.e. a fixed allowance irrespectively of diabetes severity), which 
does not favour patients with low levels of health and QoL. 
 
13.1.13 QoL by Diabetes Centre 
There was evidence of a statistically significant difference in the means of weighted 
ADDQoL scores between hospitals. Thus, post hoc tests (Mann- Whitney U test with 
Bonferroni correction) showed that the mean weighted ADDQoL score for IKA 
Salonica 1 was significantly higher than the means of Evangelismos, Alexandra and 
Kavala hospitals. Also the mean weighted ADDQoL score for Hippocration Salonica 
was significantly higher than the mean of Laiko hospital. There was no significant 
difference among the other hospitals (Table 33).  
There is no obvious explanation for these intriguing differences, and they need to be 
investigated further. The answer to the question might lie with the characteristics of 
the respondents rather than those of the hospital, and probably includes medical as 
well as social factors.   
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Table 33:  ADDQoL scores by diabetes centre 
Hospital Centre Mean SD n p value 
IKA Salonica 1 -2.176 1.208 213  
 
<0.0001* 
IKA Salonica 2 -2.799 1.527 47 
Hippokration Sal. -2.447 1.675 264 
Polycliniki Athens -2.481 2.183 89 
Laiko Athens -3.320 2.466 60 
Evangelismos Ath. -2.809 2.043 194 
Alexandra’s Athens -3.008 1.833 96 
Kavala Gen. Hospit. -3.069 1.781 64 
 
The sample was analysed by testing site and each site was analysed by the medical 
and demographic characteristics of its sample. All the results of the analysis can be 
seen in tables 8 and 9 of this thesis. At this point a simple juxtaposition of three 
hospital results show that demographic and diabetes-related variables could be seen 
as determinants of QoL not only for the individual, but for groups of people at a 
macro level. 
Polycliniki of Athens which has the best mean weighted impact among all hospitals 
and the second best among all sites has the majority of its respondents having Type 
1 diabetes (69.7%). It also has the lowest mean age among all sites (43.89). Moreover 
it has the highest percentage of unmarried people (40.4%) and the highest percentage 
of university graduates (50.6%). Patients with diabetes-complications were lower 
than average with 21.3% among the sample (average 29.7%).  Polycliniki patients 
were less hospitalised than any other site’s (14.6%). It also attracts the highest 
income people among all sites. 
Kavala’s sample is on the other extreme of the spectrum. It has the poorest patients, 
the highest percentage of hospitalisation (31.3%), the second worst percentage of 
complications (48.4), the lowest educational level with only 1.6% university 
graduates, and low percentage of unmarried people (6.3%). The mean age of 66.9 
years was also unfavourable for Kavala’s hospital.   
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Laiko of Athens, which has the lowest scores, is a university hospital and its diabetes 
centre is highly respected among people with diabetes. The low score should be 
attributed to the high number of complications. Laiko is the only diabetes clinic 
among the eight research sites that has a special diabetes-foot section that is it accepts 
patient with developed foot problems and sometimes amputated. 60% of its patients 
appear to have at least one diabetes-complication while other neighbouring hospitals 
(e.g. Polycliniki or Alexandra’s, which is less than one mile away) complications are 
around the 21% region. 
 
13.1.14 QoL and place of residence 
Next, the hospitals were summarized in 3 categories depending on the geographical 
area they belong. Applying the Kruskal-Wallis test it resulted that there was a 
statistically significant difference in the means of weighted ADDQoL scores 
between the 3 areas. Post hoc tests concluded that the mean weighted ADDQoL score 
for Thessaloniki hospitals was significantly higher than the means of the hospitals in 
Athens and Kavala (Table 34).  There was no significant difference between Athens 
hospitals and Kavala's hospital. 
There was evidence that there is a statistically significant difference in the means of 
weighted ADDQoL scores among test sites. Thus, post hoc tests (Mann- Whitney U 
test with Bonferroni correction) comparison concluded that the mean weighted 
ADDQoL score for IKA-Salonica1 was significantly higher than the means of 
Evangelismos, Alexandra’s and Kavala hospitals. Also the mean weighted ADDQoL 
score for Hippocration-Salonica was significantly higher than the mean of Laiko 
hospital. There was no significant difference among the other hospitals. There was 
no obvious answer to these differences. Some conflicting findings among research 
sites might be due to a number of competing influences that should be investigated 
further. 
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Table 34: ADDQoL scores by geographical area 
Hospital Centre Mean SD n p value 
Salonica -2.369 1.497 524  
<0.0001* Athens -2.856 2.100 439 
Kavala -3.069 1.781 64 
People living in rural areas appear in general as having higher social integration, and 
are more satisfied with their environments,  regardless of material disadvantages 
(Brown et al. 2004). These two are major components of QoL, thus they usually 
report higher levels of QoL and well-being.  This is not the case of people with 
diabetes.     
Respondents from the Kavala site reported the lowest QoL (-3.07). Kavala, is a semi-
urban/rural area of around 60,000 inhabitants. The diabetes clinic of Kavala hospital 
attracts people from the rural area around Kavala, is not a diabetes center but part of 
the internal medicine clinic, and accepts patients only one day per week. The QoL 
score difference observed between the sites of Kavala and Thessaloniki (-3.07 and -
2.37) is substantial for two cities with a distance of two hours driving. This finding 
was expected and confirms the research hypothesis, as diabetes is a disease that needs 
high levels of medical attention, health education of the diseased, and easy access to 
diabetes centres, factors that are not easily met in rural Greece. 
What was not expected initially was the difference between Salonica and Athens (-
2.37 and -2.86 respectively), because the two cities have similar establishments as 
far health services are concerned. An initial explanation could be that almost half of 
the total Salonica sample (260 out 524) was recruited from social security primary 
clinics (IKA), which usually do not attract serious cases of diabetes. However, the 
2nd IKA has lower scores than Hippocration and substantially lower than IKA 1. 
Taking into consideration that the mode of the test administration was exactly the 
same between the two IKA sites the explanation of the differences could lie with the 
gravity of the cases that each site attracts, which in turn could be attributed to 
subjective factors, such as the reputation of the medical personnel, among diabetes 
patients. 
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Another explanation for the overall difference between Athens and Salonica that 
should be taken into consideration, although not of a scientific nature, could be one 
of a cultural nature. It is widely accepted in Greece that Salonica is a place for 
entertainment, night-life, and low levels of anxiety. The proverbial “relaxed” life-
style of its residents constitutes a joke even in comedies. This common view is 
supported by the findings of this research.  
 
13.1.15 QoL and visits to consultants 
The relationship of QoL and visits to consultants does not seem to have any great 
importance in explaining QoL, as it is related to the issue of complications and no 
significant conclusions can be drawn out of it. However, regarding the specialties 
that the patients visited the previous year due to their diabetes, there was evidence 
that there is a statistically significant relationship between them and the quality of 
life measured by ADDQoL-Gr (p<0.05)[Table 35]. Specific, post hoc tests (Mann-
Whitney U tests with Benferroni correction) showed that the mean weighted 
ADDQoL-Gr score for patients visited  the cardiologist was statistically significant 
lower than the mean of the patients visiting the eye doctor (p<0.0001). This might 
be an indication that patients visiting cardiologists due to diabetes, ceteris paribus 
score lower for their quality of life compared with the patients who visit the eye 
doctor.  
Table 35: ADDQoL scores and visits to consultants 
Specialty n Mean SD P-value 
Cardiologist 536 -2.80 1.78  
0.004* 
Ophthalmologist 348 -2.45 1.90 
Nephrologist 14 -2.69 2.23 
Podiatrist 3 -3.76 1.98 
Psychiatrist 6 -2.35 2.04 
* Indicates statistically significant difference 
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13.1.16 QoL and Hospitalisation  
The presence of co morbidity is a decisive factor for QoL. A comorbidity is a disease 
or condition that coexists with a primary disease but also stands on its own as a 
specific disease. Common co-morbidities of diabetes are hyperlipidemia, 
cardiovascular disease, peripheral vascular disease, renal failure and others. 
Mann-Whitney U test revealed that patients who, during the last year were 
hospitalized (even for one night) for any reason, had significantly lower ADDQoL 
average weighted impact scores (p<0.05), compared with those who didn't spend any 
night in the hospital (Table 36).  
Table 36: ADDQoL scores by hospitalisation 
Hospital visit during last year Mean SD n p value 
Yes -2.96 1.96 224 0.006* 
No -2.52 1.76 797 
* 
indicates statistically significant difference 
Co morbidity and the resulting hospitalisation is the cause of high medical expenses 
and low QoL. Special attention should be paid to diabetes management programs in 
order to incorporate treatment for co morbid conditions that would reduce 
hospitalisation risk.    
13.1.17 QoL and Membership in a diabetes group 
The last question of the personal data questionnaire concerned the probable 
membership of the respondent in any diabetes group. There are many local groups 
in Greece that act as pressure groups as well as diabetes education centres. However, 
the number of patients joining those groups is unexpectedly low.  
The groups function as Non-Governmental-Organisations, and strangely enough are 
divided into two secondary level Federations. One Federation is part of the National 
Confederation of People with Disabilities (tertiary federation and member of the 
European Forum for People with Disabilities). It functions as the major pressure 
group for diabetes patients’ interests. At the same time it organises diabetes-
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management programs mostly with the voluntary participation of Greek 
diabetologists. The other is of less importance, more of a governmental nature, 
smaller in size, represents mostly groups created by the Greek Centre for Diabetes, 
which as a government organisation is recognised by the International Diabetes 
Federation.   
Table 37: ADDQoL scores and membership in diabetes groups 
Member of a diabetes 
group 
n  Mean SD p-value 
Yes 92 -2.34 2.08 
0.011* 
No 930 -2.65 1.79 
 
* 
indicates statistically significant difference 
Mann-Whitney U test revealed significantly lower average weighted ADDQoL 
scores (p<0,05) in patients who were not member of a diabetes group compared with 
those who were (Table 37). The fact that people who are members of a diabetes group 
have higher levels of QoL could be attributed to better diabetes management, which 
in turn could be attributed to the diabetes education lessons, provided by the diabetes 
groups on a voluntary basis, by some distinguished diabetologists, as well as by  
diabetes patients with high level of diabetes education.  
On the other hand someone could argue that people join the groups because they are 
already interested in their diabetes and its management. The type of this survey does 
not allow the location of the causal link between the two. However, although the 
direction of causality cannot be easily determined, the relationship between the two 
cannot be disputed.  
 
13.2 Discussion 
As a general remark it should be mentioned that there is not a single factor that could 
be considered as the only determinant of diabetes-dependent QoL. In all cases other 
confounding factors have to be taken into consideration in order to assess the 
influence of a factor in determining QoL.  
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Age, plays a very important role in QoL determination with an inversely proportional 
relationship existing between the two.  However, this statement should not be 
considered as a general principle, because when other confounding factors, such as 
gender or diabetes duration, are taken into consideration the association of age with 
QoL takes a different form and it is not unidirectional any more.  
 
Gender per se does not play an important role in determining the QoL of a diabetes 
patient. This applies to both types of diabetes.  The results of this research seem to 
provide an answer to the question of the influence that diabetes type has on QoL 
(12.1.1). It was proved that this relationship is not linear and changes with age to 
different directions not only for the two types of diabetes, but between different age 
clusters of the same diabetes type.  
 
Glycaemic control is another case of a determinant that should not be examined in 
isolation from other factors. In general, high levels of HbA1c have a negative effect 
on QoL. However, this factor should not be considered as predictor of QoL. Other 
confounding factors, such as complications caused from high HbA1c, or even 
treatment regimen, which in itself plays an important role, should be examined 
before the specific weight of glycaemic control in determining QoL is decided.  
 
Complications caused by diabetes should be considered as the most influential factor 
in determining the level of QoL. This, as a general statement, is in agreement with 
international literature. The novelty of this research is the finding that microvascular 
complications have the most negative impact on QoL, contrary to the mainstream 
belief that macrovascular complications mainly coronary heart disease are 
responsible for low levels of QoL. 
 
Another unique finding is the importance of erectile dysfunction on determining 
QoL. Respondents with ED report lower QoL not only compared with patients with 
other complications, but they score even lower than people with two or more 
complications.    
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Diabetes as a chronic condition demands good knowledge of the disease as well as 
good management.  General education seems to help the patient in the disease 
understanding process because the results showed that education is directly 
proportional to QoL; as education level increases QoL level moves to the same 
direction.  
 
Good management is also related to marital status with married with divorced people 
reporting the lowest levels of QoL. Married people should be expected to enjoy 
higher levels of QoL compared with other people. However, the results show that 
unmarried people enjoy higher QoL than married or people living with a partner. 
Two factors should be taken into consideration: the first one is that unmarried people 
are usually younger than all other categories and second that Greek society is still 
family centred lacking help from any other social networks, while family is child-
centred. The meaning of child is used in an extended sense, as children in Greece 
seldom leave the family of origin prior to marriage or studies (Tsamparli, Kounenou 
2004).  This, in relation to the well established fact that children living with families 
receive care from parents mainly from mothers (Faulkner, 1996; Kiess et al., 2001), 
explains the astonishing at first sight fact that unmarried people suffering from a 
chronic disease that needs good management enjoy higher levels of QoL compared 
with other sub-categories.  
 
Some interesting issues emerged when QoL was examined by diabetes centre. There 
were significant differences among the testing sites concerning the general level of 
QoL. A first conclusion might be that the differences observed are because of 
existing differences in the composition of the samples. If this is the case, another 
question arises and that is why each clinic attracts, to a great extent, populations with 
certain demographic and/or medical characteristics, which in turn determine the 
overall outcomes. The explanation of this phenomenon should not be considered as 
a result of a central diabetes-care planning as there is no such provision in the health 
system. It should be attributed to personal scientific interests and initiatives of the 
medical staff, which “specialise” in a particular type or aspect of diabetes. 
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On the other hand, diabetes patients are informed about the “sub-specialties” of 
diabetes centres and demand care accordingly. Thus, one could claim that there is an 
interactive relationship between diabetes centres and certain clusters of diabetes 
population that balances the demand and supply of diabetes care. This balance 
resembles more the characteristics of a free market, than a rationally planned health 
system.  This finding should initiate a further investigation based on and looking for 
a qualitative distribution of diabetes services in order to rationalise diabetes care and 
achieve a balance between the distribution of services and the demand for them.  
 
The incoherent distribution of services is also proved by analysing the sample by 
complication and its impact on QoL. Erectile dysfunction (ED) has the highest 
negative effect on QoL. The prevalence of the complication among male diabetes 
patients globally varies from 26% to 63.6% (see 13.1.4). In of this survey ED was 
reported only by 6.9% of the total male sample. Even by taking into consideration 
any probable cultural barriers to report ED because of the sensitivity of the matter 
for a male respondent, the percentage is still unacceptably low compared with results 
from the international literature. The answer again should be investigated in the 
structure of diabetes-care provision. None of the hospitals used as testing sites is 
specialised in treating ED for a male diabetes patient. The result is that some patients 
who can afford the expenses are turning for treatment to the private sector, while 
others visit urologists of the NHS. However, urology is a surgical specialty and 
receiving treatment from someone not specialised in diabetes might have uncertain 
results. This finding should be used, in relation to the distributional issue discussed 
in the previous paragraph, to the direction of restructuring diabetes care in Greece 
and create specialised centres of clinical excellence for diabetes patients. 
Income level as a determinant of diabetes-depended QoL is well documented in 
international literature. The results of this survey were no exception to the rule. 
However, an interesting point arises when co-payments for diabetes are taken into 
consideration. There is a reciprocal relation between money spent from family 
income and level of QoL. The problem becomes severe for low income patients, who 
cannot afford the co-payments, as they represent a substantial proportion of their 
incomes. It has been reported that co-payments reduce service utilisation among low 
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income patients with high medical risks having adverse effects on their health status 
(Manning et al., 1987; Robinson, 2002; Gruber, 2006; Lostao et al. 2007). This is 
well established and many countries have introduced exemption schemes for low 
income patients (Rosen et al., 2011; Carelli 2012). There is evidence that diabetes 
patients, especially those without complications, following the general rule, reduce 
care when co-payments increase (Babazono et al., 2005). In Greece during the last 
four years co-payments for consumables (test strips, lancet devices for finger-
pricking etc.) and medication aiming to avoid complications (e.g. for hypertension 
or cholesterol)   have risen for type 2 diabetes patients from 10% to 25%, which 
could be considered unbearable for low income patients.  The levels of co-payments, 
as well as the flat rates of reimbursement, when patients have to pay the provider 
first and then apply to the health authorities for reimbursement, have to be 
reconsidered.       
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PART VI: Diabetes and Health Status 
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Chapter 14: Diabetes and the SF-36  
 
14.1 Introduction 
An assessment of the impact of diabetes on health status is examined in this chapter, 
using the latest version of a generic measure, the SF-36. Three points should be made 
before the assessment begins: First, it should be noted that the conceptualisation of 
HRQoL of the SF-36 is a “disease burden” one that includes distress due to 
symptoms, treatment, or complications, contrary to the ADDQoL which approaches 
the concept from a different angle that of the patient’s perception of QoL i.e. how 
diabetes interferes with the life of the individual and how he/she imagines life 
without diabetes. Second, there are doubts about the sensitivity of the SF-36 in 
detecting changes in QoL of people with diabetes (Hill-Briggs et al. 2005). Third, it 
should be noted that the SF-36 is a standardised measure and therefore does not take 
into consideration the applicability or the relative weight that each domain has for 
the individual patient. The underlying assumption for the lack of weighting is that 
patients find it impossible to put comparative values on important life domains ((Carr 
and Higginson, 2001). 
The SF-36 was not used as an alternative QoL measure, as many researchers do in 
international literature using the terms “Quality of Life” and “health status” 
interchangeably, but as an auxiliary one. Health status in this project was considered 
only in the capacity of being a major component of the broader term “Quality of 
Life” and as such should be examined. In this sense result analyses were not as 
detailed as with the ADDQoL-Gr, but more of a restricted nature.  
However, there are four reasons for using the SF-36:  
 First and foremost, the assessment of health status was an aim of this project 
after that of QoL. The use of a generic measure, it gives the opportunity to 
compare health status of people with diabetes in Greece with other groups 
and controls. 
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 Second, a widely accepted criterion should be used in order to assess the 
validity of the ADDQoL-Gr. The criterion of the two global questions, used 
by the developers of the original ADDQoL, although used in this research, 
was not considered sufficient for the establishment of the Criterion Validity.  
 Third, the prevailed view among researchers is that a generic as well as a 
disease-specific instrument should be used in order to obtain reliable results.  
 Fourth, the SF36 is considered by many writers as a “compatible” to 
ADDQoL instrument.   
 
14.2 The domains of SF-36v2 
The SF-36v2 represents an improvement of the original, benefited from the hindsight 
of the SF-36 numerous applications. It differs from the original in question wording 
and layout, respond choices, scoring, and comparability with translations and 
cultural adaptations.  
The SF-36v2 contains 36 questions in eight health domains (Ware et al., 2007). 
These domains are:  
 Physical Functioning (PF): It contains 10 items (3a to 3j), which refer to the 
performance of physical activity such as self-care, walking, climbing stairs, 
etc.  
 Role Physical (RP): It is a 4 item dimension (4a to 4d), referring to the degree 
to which a person performs or has the capacity to perform activities 
corresponding to age, gender, job, housework etc. It examines possible 
limitations imposed on the kind of work or other activities, the time that 
might be spent on them, as well as the difficulty to perform them. 
 Bodily Pain (BP): It is a 2 item scale (7 and 8). One item refers to the 
intensity, frequency, duration and the second one to the limitations that pain 
imposes on the activities of an individual.  
 General Health (GH): It consists of 5 items (1 and 11a to 11d) and it refers to 
the perception of an individual’s overall prior and current health, and 
resistance to illness.   
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 Vitality (VT): 4 items (9a, 9e, 9g, and 9i) constitute this scale which 
investigates energy, fatigue and tiredness. 
 Social Functioning (SF): It consists of 2 items (6 and 10). Social functioning 
is the degree to which an individual can develop, maintain and nurture social 
relationships (family, friends, marital and sexual functioning, and 
neighbours).  
 Role Emotional (RE): 3 items (5a to 5c) refer to the functional impact that 
emotional problems have on the individual, further to the ones imposed by 
physical health, measured by the RP scale.  
 Mental Health (MH): The scale consists of 5 items (9b, 9c, 9d, 9f, and 9h). 
Each item refers at least to one of the four mental health dimensions i.e. 
anxiety, depression, loss of behavioural-emotional control, and 
psychological well-being.  
The summary of the eight domain scores are referred as Physical Component 
Summary (PCS) and the Mental Component Summary (MCS). They are derived and 
calculated with Factor Analysis, the Principal Component Analysis.  
 
14.3 Method 
The administration method of the questionnaire has been described in chapter 9. The 
collected data were introduced for statistical analysis and results for aggregate scores 
of the eight domain, as well as summary scores for the two components (PCS and 
MCS) were calculated. The QualityMetric Health Outcomes Scoring Software 2.0 
(Saris-Baglama et al., 2007) was used, complimentary provided by QualityMetric 
Incorporated.   
 
14.3.1 Scoring 
All domain scales contribute to the scores of both the Summaries. However, the PF, 
RP, BP, and GH scales have greater physical factor content, compared with the other 
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four domains and constitute the PCS measure of the instrument. The remaining four, 
i.e. VT, SF, RE, and MH might be considered as having greater mental factor content 
and constitute the MCS measure. Some scales correlate more than others with both 
components: VT correlates almost equally with them, followed by GH, and SF which 
correlate with both, although the first correlates more with the physical component 
and the second with the mental one (ibid). 
The original SF-36 used for all eight health domains scores ranging from 0 to 100. 
However, the two summary components i.e. the Physical Component Summary 
(PCS) and the (MCS) have always used norm based scores. The difficulties emerging 
in comparing the health domains with the summary components forced the 
developers to establish in the SF-36v2 a norm based scoring (NBS) system (Ware et 
al., 2007).    
Norm-based scoring (NBS) transformed the initial 0-100 scores to a standardised 
metric system with a mean of 50 and a standard deviation of 10, allowing 
comparisons between health domains and summary component scores. The mean 
was initially based on the 1998 US general population (ibid). However, the software 
received from QualityMetric has revised the general population means with the 2009 
data, thus comparisons have been made with the latest available data. The term 
“general population” embraces the population at large not only the healthy ones but 
it includes diseased and invalid persons. Consequently, the samples of the general 
population are always healthier than any group of patient samples.  
The fact that the means are based on American general population raised questions 
about the value of the scores. In a personal communication with QualityMetric 
officials it was clarified that the use of the general population means was a choice 
made to facilitate international comparisons.  
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14.4 Results 
14.4.1 Health Status for total sample 
In all eight domain scales of the SF-36v2 Norm Based Scores (NBS), as well as in 
the two summary components (PCS and MCS) scores were lower than norm (50) 
that is lower compared with those without diabetes, indicating a poor health status 
for people with diabetes in Greece. This is consistent with all previous research on 
this field in various countries (Jacobson et al., 1994; Alonso et al., 2004; Wee et al., 
2005; Chittleborough, 2006).   
 
However, what is worth mentioning here is that mental health score (MCS) is lower 
than the PCS score. This contradicts previous research findings where diabetes 
patients report significantly lower scores on physical rather mental health. In the 
IQOLA project (Alonso et al. 2004), across eight countries diabetes-patients in all 
countries reported greater impact on physical health rather than mental. Similarly, in 
the SF-36 user’s manual disease specific norms, mental health among diabetes 
patients scores higher than physical health (Ware et al. 2007). The causes for this 
dissimilarity probably cannot be found in the disease per se but to the unprecedented 
crisis, and the resulting anxiety or even depression that had already emerged during 
the fieldwork period, and affected Greek society as a whole.  
 
14.4.2 Gender and HS  
It was observed that male diabetes patients report a higher health status in both 
components as well as in all eight domains (Table 38). This consists with the 
prevalent view among researchers that men with diabetes enjoy a higher health status 
compared with women (Glasgow et al., 1997; Kind et al., 1998; Woodcock et al., 
2001; Taft et al., 2004; Chittleborough et al., 2006, Quah et al., 2011; Schunk et al., 
2012).  
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Table 38: SF-36 scores by gender across total sample 
 Component 
Summaries 
SF-36 Domains 
Gender PCS MCS PF RP BP GH VT SF RE MH 
Male 47.7 45.3 46.2 46.0 50.5 44.7 51.5 46.6 45.1 43.0 
Female 44.5 42.7 42.0 43.0 44.5 42.1 46.4 44.3 41.6 40.4 
Total 45.8 43.8 43.7 44.2 46.8 43.1 48.4 45.2 43.0 41.5 
 
PCS: Physical Component Summary; MCS: Mental Component Summary; PF: Physical Functioning; 
RP: Role Physical; BP: Bodily Pain; GH: General Health; VT: Vitality; SF: Social Functioning; RE: 
Role Emotional; MH: Mental Health. 
 
14.4.3 Age and HS 
As expected, age was another factor influencing the level of Health Status, with an 
inverse relationship between age groups and HS level (table 40). As age increases, 
the level of HS falls, with PF exhibiting the worst pattern of deterioration among all 
domains. This could be considered as a common sense finding. However, two 
important points emerge from this table:  
The first one is that the age groups between 18 and 50 reported physical health in a 
positive or normal manner. This indicates that a chronic disease like diabetes does 
not contradict good health perceptions. Although, at first sight, this seems unrealistic 
there are previous research findings corroborating this fact either for diabetes 
(Hanestad 1993) or other chronic disease patients (Pearlman and Uhlmann, 1988). 
Edelman et al. (2002) argued that QoL for newly diagnosed people with diabetes and 
throughout the following year was similar to people without diabetes.   
The second and possibly most intriguing point that could be observed here is the 
changes occurring between physical and mental health as age increases. Younger 
persons reported no impact of diabetes on their physical health (PCS, PF, RP, BP, 
VT), but a serious impairment on mental health (MCS, RE, MH), something not 
observed among older patients. The same observation was reported by Glasgow in 
1997, but no explanation has been given. Probably, the explanation lies with the 
“response shift” phenomenon, analysed in chapter 3, which refers to the change in 
the meaning and importance of one’s evaluation of certain domains in life, as a result 
of a recalibration of internal standards and reconceptualization of the domains’ 
meaning. 
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Repeating the age analysis controlling for gender the results were again unfavourable 
for female patients, while the phenomenon of “response shift” is still observable 
(Table 39). 
 
Table 39: SF-36 scores by age and gender across total sample 
 Component 
Summaries 
SF-36 Domains 
Age 
(years) 
PCS MCS PF RP BP GH VT SF RE MH 
Male           
<31 54.13 45.25 54.26 50.55 54.68 50.12 58.10 50.02 45.92 42.60 
31-40 52.72 43.26 52.71 49.68 54.33 46.21 53.50 47.03 44.15 42.43 
41-50 50.75 44.26 50.74 49.51 51.90 44.52 52.27 47.56 46.31 41.59 
51-60 48.24 45.92 46.52 46.94 50.60 45.66 51.90 48.15 45.18 43.34 
61-70 46.19 46.34 44.84 45.17 48.96 43.77 50.95 46.66 45.59 43.62 
71-80 44.10 45.49 40.57 42.70 48.65 42.99 48.68 43.96 44.60 42.81 
>80 42.19 45.95 37.03 39.88 48.71 44.68 46.04 42.36 45.38 42.99 
Female           
<31 51.44 44.81 51.61 49.98 52.78 45.59 53.29 48.22 47.50 41.54 
31-40 50.65 42.84 50.62 48.88 50.67 45.31 49.43 46.14 45.30 41.07 
41-50 48.24 44.84 46.81 48.74 46.81 46.09 50.61 47.19 44.93 42.29 
51-60 45.07 43.50 42.37 42.78 44.83 43.69 49.34 45.90 41.60 40.47 
61-70 43.86 42.28 41.36 42.81 43.61 41.04 45.35 43.54 40.91 40.65 
71-80 40.30 41.68 36.13 38.47 40.70 39.60 42.20 42.11 39.30 39.42 
>80 38.60 41.89 33.82 35.47 40.76 38.92 41.87 40.97 37.03 40.96 
Total           
<31 52.76 45.03 52.91 50.26 53.72 47.81 55.66 49.10 46.72 42.06 
31-40 51.56 42.90 51.53 49.21 52.22 45.62 51.12 46.43 44.67 41.61 
41-50 49.15 44.63 48.23 49.02 48.65 45.52 51.21 47.32 45.43 42.04 
51-60 46.25 44.38 43.90 44.37 47.00 44.40 50.26 46.68 42.97 41.53 
61-70 44.79 43.89 42.74 43.75 45.74 42.12 47.57 44.78 42.76 41.83 
71-80 41.71 43.09 37.77 44.04 43.64 40.85 44.60 42.80 41.27 40.68 
>80 39.85 43.30 34.94 37.00 43.52 40.93 43.32 41.45 39.93 41.67 
 
PCS: Physical Component Summary; MCS: Mental Component Summary; PF: Physical Functioning; 
RP: Role Physical; BP: Bodily Pain; GH: General Health; VT: Vitality; SF: Social Functioning; RE: 
Role Emotional; MH: Mental Health. 
 
14.4.4 Type of Diabetes and HS 
There are significant differences concerning the physical domains between type 1 
and 2 diabetes. Type 2 patients report substantially lower scores both in physical 
domains and physical component summary (Table 40).  
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A noteworthy point here is that although patients with type 1 diabetes report a close 
to normal PCS and PF. their MCS and MH domains are well within the “poor health” 
region of the SF-36, equally low with Type 2 diabetes.   
 
14.4.5 Treatment of diabetes and HS 
There are not significant differences among different treatment regiments according 
to the SF-36 results (Table 40). Respondents taking insulin scored slightly higher on 
physical domains and slightly lower in mental health. People on “diet only” score 
low especially in the mental health areas of the SF-36. This proves that the burden 
of diabetes is higher to people not receiving any pharmaceutical treatment, probably 
due to higher diet restrictions. 
Table 40: SF-36 scores by Diabetes type and treatment 
Diabetes 
Type 
Component 
Summaries 
SF-36 Domains 
 PCS MCS PF RP BP GH VT SF RE MH 
Type 1 49.93 43.50 50.37 48.27 50.51 46.34 51.89 47.30 44.67 41.73 
Type 2 43.58 43.09 41.31 42.45 45.33 42.04 46.96 44.28 41.98 41.08 
Treatment            
Insulin 46.23 43.23 44.00 44.40 47.43 42.93 48.38 45.07 42.72 41.03 
Tablets 45.30 44.56 43.22 44.11 46.27 43.49 48.61 45.64 43.47 42.09 
Diet only 45.57 41.53 42.25 41.76 46.12 44.26 48.32 42.05 40.87 39.48 
 
PCS: Physical Component Summary; MCS: Mental Component Summary; PF: Physical Functioning; 
RP: Role Physical; BP: Bodily Pain; GH: General Health; VT: Vitality; SF: Social Functioning; RE: 
Role Emotional; MH: Mental Health. 
 
14.4.6 Glycaemic Control and HS 
Poor glycaemic control had a negative effect on health status. With the exception of 
BP and VT the effect was moderate to high on the other six domains of the SF-36.  
Patients belonging to the 8.5 – 9.0 group were affected most on all eight domains, 
including BP and VT (Table 41).  
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Table 41: SF-36 scores across total sample by level of Glycaemic Control 
HbA1c  Component 
Summaries 
SF-36 Domains 
  PCS MCS PF RP BP GH VT SF RE MH 
6.5-7.0  46.78 44.80 44.48 45.12 47.33 44.87 49.64 45.93 43.46 42.42 
7.0-7.5  45.15 43.66 43.23 43.11 46.63 42.73 47.69 45.84 42.72 41.14 
7.5-8.0  46.15 41.63 44.54 44.13 45.78 42.03 47.42 44.33 41.89 40.26 
8.0-8.5  46.16 43.48 42.56 44.96 48.80 43.22 48.40 43.83 44.09 40.87 
8.5-9.0  37.48 40.88 36.60 36.99 41.41 37.81 41.12 39.83 40.47 39.75 
PCS: Physical Component Summary; MCS: Mental Component Summary; PF: Physical Functioning; 
RP: Role Physical; BP: Bodily Pain; GH: General Health; VT: Vitality; SF: Social Functioning; RE: 
Role Emotional; MH: Mental Health. 
 
 
14.4.7 Disease duration and HS 
Table 42 shows that longer duration of diabetes was not associated with any 
significant changes in physical and mental health, as measured with SF-36. This 
result is in agreement with previous research (Jacobson et al., 1994; Hanestad, 1993; 
Parkerson et al., 1993; Peyrot and Rubin, 1997; Redekop, 2002). 
 
Table 42: SF-36 scores by duration of diabetes across total sample 
Years PCS MCS PF RP BP GH VT SF RE MH 
0-10 47.15 44.95 44.19 45.72 48.22 45.22 54.26 45.73 44.40 41.02 
11-20 47.60 44.63 43.94 46.37 50.95 46.01 48.83 46.03 45.28 41.91 
21-30 46.27 44.50 43.20 45.05 48.53 44.47 48.01 46.59 44.36 41.53 
31-40 49.03 43.73 47.05 47.74 50.34 44.20 52.48 45.93 43.97 41.28 
>40 46.53 46.08 45.49 46.14 47.92 43.92 50.27 47.54 46.61 42.37 
 
PCS: Physical Component Summary; MCS: Mental Component Summary; PF: Physical Functioning; 
RP: Role Physical; BP: Bodily Pain; GH: General Health; VT: Vitality; SF: Social Functioning; RE: 
Role Emotional; MH: Mental Health. 
 
14.4.8 Diabetes Complications and HS 
In accordance with literature that examined QoL of diabetes patients using the SF-
36, people with complications report serious impairments in almost all SF-36 
domains. The deviation between previous findings in literature, concerning coronary 
heart disease, that was observed in the ADDQoL-Gr results (chapter 13.1.4), is still 
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observable here (Table 43). The existence of myocardial infarction, contrary to the 
findings of other researchers using generic measures (Lloyd et al.; Wandell et al., 
1998; Hart et al., 2003; Wandell, 2005), instead of having the most serious effect on 
health status, does not seem to impair most health domains seriously.  
 
This fact was investigated further across literature and the only similar result was 
found at a publication concerning the diabetes population of a small town of the 
Greek island of Lesvos. The project, took place in Plomari, a town of less than 6000 
inhabitants and a sample of 229 diabetes patients (Papadopoulos et al., 2007). This 
is the only attempt to assess QoL, in the form of health status, of a Greek diabetes 
population using the SF-36. However, no conclusions could be drawn from this 
project because there are some considerations about the reliability of results. This is 
not only because of the restricted catchment area, but because there are not any 
diabetes services provided in Plomari health centre, the sample was recruited using 
medical records concerning prescriptions of diabetes-medication, there is no 
physician among its medical staff specialised in diabetes, and finally the SF-36 
although it is a self-reported instrument was administered by trainee physicians 
during interviews with the patients.  
Table 43: SF-36 scores by diabetes caused complications across total sample 
Complication PCS MCS PF RP BP GH VT SF RE MH 
All Complications 41.55 41.75 39.75 41.07 43.22 38.78 45.15 42.18 40.28 39.50 
Visual Impairment 41.18 41.24 39.18 40.52 42.54 38.43 44.34 42.65 39.18 38.98 
Myocardial 
Infarct. 
46.49 46.00 43.66 45.93 50.38 41.66 53.34 44.81 42.89 45.15 
Nephropathy 41.10 40.51 39.55 41.59 42.70 34.20 45.47 42.30 37.13 39.36 
Amputation 42.83 49.20 39.68 40.69 52.73 44.94 47.65 43.97 50.36 45.64 
Erectile 
dysfunction 
50.20 41.82 46.54 49.30 52.32 42.26 49.63 42.30 43.98 41.39 
Other 39.27 41.45 38.81 39.14 40.43 39.13 43.30 39.95 41.85 38.13 
 
PCS: Physical Component Summary; MCS: Mental Component Summary; PF: Physical Functioning; 
RP: Role Physical; BP: Bodily Pain; GH: General Health; VT: Vitality; SF: Social Functioning; RE: 
Role Emotional; MH: Mental Health. 
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14.4.9 Income and HS 
There were significant and relatively large differences between respondents having 
different income levels. Low income people report low levels of HS both in physical 
as well as mental health. As income increases HS increases in both summary scores 
as well as in all health domains, reaching near-normal or normal levels for physical 
health for people with an income higher than €1500. Mental health however, remains 
at low levels for all income level groups.     
 
Table 44: SF-36 scores by family income across total sample 
Income (€)  PCS MCS PF RP BP GH     VT SF RE MH  
0-500 44.93 41.33 40.76 43.62 44.73 41.91 46.83 43.79 40.21 38.87 
501-1000 44.88 42.49 42.16 42.71 45.71 42.02 47.11 44.07 41.86 39.97 
1001-1500 45.31 45.51 44.12 43.92 47.65 42.93 48.86 45.77 44.51 43.36 
1501-2000 47.28 46.99 46.58 46.43 48.09 46.97 50.90 48.20 46.44 44.24 
2001-2500 51.15 47.14 50.62 50.11 54.14 48.80 52.45 49.48 47.33 45.75 
2501-3000 49.84 46.05 49.85 48.75 52.01 45.34 52.95 47.98 45.89 44.45 
>3000 50.35 45.24 49.97 48.71 50.45 46.62 55.54 47.27 45.52 42.46 
 
PCS: Physical Component Summary; MCS: Mental Component Summary; PF: Physical Functioning; 
RP: Role Physical; BP: Bodily Pain; GH: General Health; VT: Vitality; SF: Social Functioning; RE: 
Role Emotional; MH: Mental Health. 
 
 
14.4.10 Family and HS 
As in the QoL results single and divorced people represent the two ends of the 
spectrum. Single people enjoy the highest health status, while divorced score low at 
least in mental health domains (Table 45).  
 
 
14.4.11 Education and HS 
It is a well known fact for general population since the findings of the Black Report 
in 1980 that health status increases along with educational level (Townsend and 
Davidson, 1982).  
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Table 45: SF-36 scores by marital and educational status across total sample 
Marital 
Status 
PCS MC
S 
PF RP BP GH VT SF RE MH 
Single 50.33 44.48 50.37 48.72 51.61 46.22 53.58 47.94 45.62 42.75 
Married 45.60 43.86 43.11 44.12 46.95 43.23 48.16 45.27 42.95 41.57 
Divorced 45.99 40.45 44.32 42.60 46.79 39.62 48.10 41.98 41.62 37.79 
Widowed 41.05 43.10 38.25 39.62 40.86 40.55 44.03 43.18 40.73 40.81 
Level of 
Education 
          
Primary 42.48 42.52 39.02 41.53 43.42 40.45 44.65 43.70 41.26 39.98 
Secondary 46.09 42.07 43.80 42.33 47.43 42.79 48.68 43.77 40.87 40.37 
Lyceum 47.35 45.17 46.96 45.89 47.76 44.53 51.03 46.62 44.58 42.94 
University 50.19 45.43 49.04 48.64 52.06 47.11 52.54 47.79 46.06 43.11 
 
PCS: Physical Component Summary; MCS: Mental Component Summary; PF: Physical Functioning; 
RP: Role Physical; BP: Bodily Pain; GH: General Health; VT: Vitality; SF: Social Functioning; RE: 
Role Emotional; MH: Mental Health. 
 
Table 45 shows that diabetes patients are no exception to this rule.  Health Status 
increases in all summary and domain scores as educational level increases. 
Analogous findings were reported by Glasgow (1997) and by Taft et al. (2004) for 
Swedish population using the SF-36. 
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Chapter 15:  Concluding remarks  
This study examined the Quality of Life of people with diabetes in Greece. It aimed 
to increase the knowledge of the impact of diabetes on QoL.   For decades now it has 
been accepted that QoL has to be assessed because should be at the forefront in policy 
decisions about health care (Williams, 1988).  
Chapter 15 summarises the main points of the research, recalls the aims and 
objectives of the project and relates them to the results. Conclusions emerge as end-
results of these relations and recommendations are formulated according to these 
conclusions. Strengths and weaknesses (limitations) of this project are also 
highlighted at the end of the chapter. 
Two distinct concepts, namely Quality of Life and Health Status, were assessed in 
this investigation.   This study is the first attempt to assess QoL of the Greek diabetes 
population, therefore there are not any results to be compared with my findings and 
almost all findings might be considered as a contribution to literature. 
Health status (HS) was assessed with a generic health status instrument, the SF-
36v2 that measures eight domains of life and produces two physical and mental 
health summary scores. Some of the findings for the Greek diabetes population were 
analogous to the ones previously reported by other investigators at the international 
level. However, two findings constitute important deviations from the general trend.  
The first finding, that is new in literature, is that the impact of diabetes in perceived 
health status, as expressed by the SF-36 component summaries, was greater for 
mental than physical health. This contradicts previous investigations (Chittleborough 
et al., 2006; Graham et al., 2007; Schunk et al., 2012), and most importantly it 
contradicts the diabetes-specific norms of the SF-36, which is used as a reference 
size in the instrument’s manual (Ware et al., 2007). 
Two reasons might be invoked for this disparity and justify the finding of this 
research: the first one concerns diabetes population as a whole and the second refers 
to the Greek people with diabetes. First, for a long time since onset diabetes has not 
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any severe effect on physical domains, such physical functioning, role physical or 
bodily pain and consequently does not affect the physical component summary of 
the SF-36, which deteriorates gradually. Mental health on the other hand is 
influenced immediately after diagnosis and continues throughout the course of the 
disease. In this sense the finding of this research does not seem to be irrational, and 
probably is more logical than the general view, as the impact on mental health 
concerns the whole of the sample, while the physical components are not influenced 
for all the people with diabetes, but only those with medium or high duration.    
Another explanation of this finding might be some confounding factors outside 
diabetes, such as the economic crisis, which started in 2008 and brought about some 
sort of collective depression in Greek society. Anxiety and uncertainty about the 
future is widespread among people with diabetes, more than any other period in 
recent history, mainly because incomes fall drastically, social security coverage is 
rapidly reduced, and hospitals reduce services due to budget cuts.   
The second result that is not in line with previously published results is the impact 
of myocardial infarction on health status, which is very low compared with other 
complications. This finding is not isolated but it is in conjunction with the ADDQoL-
Gr result, thus it needs some further investigation as there is no obvious explanation 
for it.  
The use of the SF-36 was in some respect an auxiliary one because as a generic 
measure does not capture diabetes-related issues as the ADDQoL-Gr did (e.g. 
freedom to eat, employment, sex life etc.).  The information elicited from the disease 
specific instrument was more focused and detailed.   
Quality of Life was examined with the use of a disease specific measure, namely 
the ADDQoL-Gr that assesses how 19 domains of life are influenced by diabetes. 
The ADDQoL-Gr was translated from the English original   and was culturally 
adopted and validated in order to be used in this project. The new instrument was 
accepted by the original developer as well as the International Harmonisation 
meeting of the MAPI Institute held in Lyon-France in 2009 as equivalent to the 
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original ADDQoL. Copyright of the ADDQoL-Gr is owned by Prof Clare Bradley 
of Royal Holloway University of London, Egham, Surrey, TW20 0EX, England. 
The ADDQoL-Gr is a reliable and easily administered instrument   that can be used 
at both individual and macro levels. Used at the individual level it can provide 
information about the impact that diabetes and its treatment has on patient’s overall 
QoL. This information covers areas beyond the usual clinical and medical practice 
and contributes to the concept of personalisation that is much needed in all health 
services, especially by the Greek one. Personalised care is necessary for all patients 
with chronic conditions, in order for them to become more involved in treatments 
and take responsibility for self-care (DH, 2008).  The individual has to be treated as 
someone with his/her own preferences, strengths, motivations and aspirations. In 
trying to change to the new approach of personalised care clinicians need the tools 
for identifying the individual perceptions about QoL. The ADDQoL-Gr allows 
clinicians to follow an individualised approach to treatment and clinical practice and 
shift from “doing to” to “doing with” the patient. It can also be a valuable tool to 
monitor changes following an intervention (e.g. change in diet or treatment regimen).  
At the macro level the ADDQoL-Gr might be of great help for decision makers in 
case they decide that they should create a diabetes-management program at a national 
level and perhaps reduce the total cost of diabetes. It is valid, reliable, and the only 
existing instrument to be used for the QoL assessment of a population that constitutes 
almost the 7.5% of the total Greek population.        
The number of respondents, the excellent response rate, although not exactly 
reported, combined with the high number of testing sites gave the opportunity to 
have a good sample of the Greek diabetes population. Different subgroups formed 
according to demographic or diabetes characteristics (e.g. income, age, disease 
duration or education) were examined and compared. 
Reliability, in the form of internal consistency, was proved by a high Cronbach’s α 
of 0.915 and almost equivalent item-total correlations. Various forms of validity 
were assessed including construct, discriminant, criterion, and discriminative 
(known groups), face, and content validity. Future research should focus on 
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responsiveness. The establishment of this property would allow clinicians and health 
planners to measure treatment effects, improving outcomes and quality of care.   
The findings of this study add to the literature on the so-called predictors of diabetes 
dependent QoL in general. At the national level it creates a basis for the almost non-
existing QoL literature of Greek diabetes population. The information elicited could 
be useful for the understanding of the QoL predictors for diabetes patients in Greece. 
In this sense, the findings of this research might fill an existing gap in the area of 
diabetes-dependent quality of life. This in turn could be proved of great help at the 
micro level for clinicians in the treatment decision process. By focusing care and 
treatment efforts on the areas that have a grave impact on QoL, health professionals 
not only affect lives of individuals, but at the macro level they provide help to health 
authorities for redesigning and restructuring the diabetes services.  
As expected, the results showed that, with the exception of 4 out of 1027, the patients 
reported a negative impact of diabetes on their QoL. The most profound effect on 
diabetes patient’s QoL have the restrictions imposed on “freedom to eat”, followed 
by “worries about the future” and “work”.  
It was also shown that “people’s reaction” to diabetes has an almost non-existent 
effect on QoL, insinuating that people with diabetes are not stigmatised anymore by 
Greek society. The stigma of diabetes is not uncommon even in contemporary 
developed societies. “People’s reaction” and the irritation caused are very significant 
for people with diabetes and it is the second, after fear, most common emotion among 
white Americans (DeCoster, 2003). Stigmatisation of diabetes is important because 
it undermines the “control”, that is the discipline needed for such a demanding 
treatment, and this in turn leads to further deterioration of QoL (Broom and 
Whittaker, 2004). It should be noted that “people’s reaction” does not refer to stigma 
only. It is also the overall irritation (annoyance, bother, displeasure) that patients 
experience from interactions with significant to him/her people (e.g. family).  
An interesting finding of this research, uncommon in international literature, where 
men appear to report higher scores both in health status and QoL, is that in this 
research males reported a slightly greater impact of diabetes on their QoL. Although 
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the difference is not statistically significant the result is against the general pattern 
seen in literature, where men report significantly better results than women. This 
unexpected result was investigated further and, after taking into consideration other 
factors such as age or type of diabetes, it was revealed that age played an important 
role in QoL perception, and it also affects the two genders in a different mode.  
This finding becomes more intriguing when the gender differences in health status 
were assessed with the SF-36, where men reported better health compared with 
female patients.  This contradiction probably justifies the view expressed by Snoek 
(2000) who argued that physical health is not a strong predictor of people’s 
subjective well-being. It also seems to justify Bradley’s (2001) belief about the 
importance of differentiating QoL from health status. In this case the different results 
showed that patients perceive QoL and HS in a different manner.  
The study showed that there are no detectable differences in QoL among patients 
with different type of diabetes. However, Type 1 diabetes is associated with younger 
age, compared with Type 2, which appears significantly later in an individual’s life. 
It has been proved that age is a significant predictor of QoL and in this respect type 
of diabetes might be a predictor of QoL, but not in its own capacity. 
Diabetes-related complications had the most negative impact on QoL. The nature of 
each complication as well as its severity affects QoL in a different manner. Contrary 
to the general belief that macrovascular complications have the greatest impact on 
QoL the results of this project showed that microvascular complications are the most 
important predictors of QoL.  Erectile dysfunction has among all complications the 
gravest impact on QoL. This finding needs more future research with male young 
samples, and probably an immediate response from the health authorities, taking into 
consideration that there is not a single public diabetes-institution specialising in this 
field.   
The results also showed that the severity of complications had a heavy impact on 
QoL. People with a severe degree of complication score a very low level of QoL 
compared with any other diabetes sub-group. The same serious effect is observed 
with people suffering from two or more complications.  
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Treatment regimen is a significant factor for diabetes patients’ QoL. Results from 
this research showed that insulin treated patients report lower QoL compared with 
the ones treated with oral agents and/or diet. This could be attributed to the severity 
of the disease, which is greater for insulin treated patients, as well as to the increased 
self-care burdens escorting the insulin treatment (Delahanty et al., 2007). 
There is an enormous amount of contradicting reports in literature concerning the 
ambiguous relationship between glycaemic control and QoL. This study showed that 
there is a significant effect of the level of Glycosylated Haemoglobin on Quality of 
Life. The higher the level of HbA1c, the lower the level of QoL. The study did not 
enter the field of intensive glycaemic control versus standard control strategies, 
because there is a growing belief that the type of control strategy (intensive or 
standard) does not affect the QoL (UKPDS, 1999; Gerstein et al., 2008; Anderson et 
al., 2011), nor it significantly affects the danger of macrovascular complications  
(Gerstein et al. 2008). 
Duration of diabetes was apparently related to QoL, with an overall deterioration 
starting after the onset of diabetes. However, the relationship is not linear. There is 
a considerable fall on QoL levels during the first 20 years of disease. The fall is 
accelerated during the next twenty years, with a slight recovery appearing after the 
40 years period.    
Both measures show that marital status affects significantly the levels of QoL and 
HS, with single people scoring higher than any other sub-group. This could be 
attributed to the age factor, as single people are usually of a young age. However, 
the other three subgroups, married, divorced and widowed, could be considered as 
belonging to the same or neighbouring age groups. Nevertheless, divorced patients 
have the lowest mean weighted QoL score and mental health scores of HS, followed 
by widowed and married people.  
Educational level was proved to be an important determinant of QoL as well as HS 
with university graduates scoring substantially higher than any other education 
group. Although the mechanisms of the relationship are not adequately understood 
in the case of diabetes, a disease with high demands on self-management, a high 
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educational level should be considered as an assist in the multi-parametrical issue of 
disease management.      
Income is another predictor of QoL for diabetes people. QoL is analogous to the level 
of income.  It was found that income has a severe effect both on QOL and HS. Higher 
incomes were related with higher mean weighted ADDQoL-Gr scores, indicating a 
better QoL for better-off diabetes patients. It is well known that income and social 
class are proved in literature as strong predictors of QoL and HS. However, very 
little is known about the mechanisms that determine this relationship. Various 
explanations have been given on the subject but none of these is universally accepted 
(Adler et al. 1994; Muhlhauser et al. 1998).  
Although the mechanisms are not known, the quantification of this relationship in 
Greece is possible. The economic crisis of the Greek economy with severe income 
reduction, and the phenomenon of neo-pauperism that society is going through, is an 
opportunity to quantify this relationship. This is going to be a topic for future 
research with this assessment used probably as the base-line.   
The relationship between income and QoL justifies the popular belief among lay 
people, which is expressed by the word they still use for diabetes: the “aristocrat-
disease”. Discussing with lay people about the meaning of the word, the answer 
received was that “only wealthy people can be seen having diabetes, as poor diabetics 
are dead”. This is to a great extent an outdated belief, because the social security 
system that has been developed in Greece during the last 30 years covers a great part 
of diabetes expenses. Patients’ participation varies between 0% (insulin for type 1, 
to 10% for oral medication and 25% for consumables.  However, the system does 
not cover all the consumables needed, especially for type 2 patients, and does not 
reimburse for any of the so-called diabetes accessories such as socks and shoes. By 
looking at the co-payments section of the analysis it can be seen that there is a 
negative correlation between co-payments and QoL, indicating that people who 
spent more out of pocket money have a lower QoL level.   
The issue of co-payments should be re-examined by health authorities, especially the 
flat coverage granted to all type 2 patients irrespectively of disease gravity. The only 
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existing coverage differentiation is between the two types of diabetes with type 1 
enjoying a wider range of benefits.  Ignoring the level of gravity of type 2 patients is 
not in favour of low income people with a severe degree of diabetes that need high 
cost of treatment and co-payments. It is well documented that passing on the cost of 
treatment to the patient finally damages both the health system as well as the patient’s 
health (Menzin et al. 2001; Caro et al. 2002; Piette et al. 2004; Mahoney, 2005; 
Colombi et al. 2008; Menzin et al.  2010).   
 There are differences among the hospitals, but this was expected as the reputation 
of each hospital attracts to a great extent a certain group of people. However, the 
results from Salonica, especially the ones from Hippokration, need more 
investigation because its reputation is similar to Evagelismos and Alexandra of 
Athens, but report different results. Cultural differences should be taken into 
consideration, as well as the role of small private diabetes clinics, which probably 
attract some cases with higher degree of severity.   
The lowest QoL was reported by patients in Kavala. This semi-urban/rural area in 
Northern Greece has one of the newest hospitals in Greece, but the level of diabetes 
care provided is not up to acceptable standards. There is not diabetes centre in the 
hospital, but the internal medicine clinic accepts patients one day/week with one 
internist and a nurse running the outpatient clinic; their dedication seems to be the 
only raison d’ etre for the existence of this clinic.  
This investigation provided evidence that QoL is influenced by many factors such as 
the level of glycaemic control, the type and severity of complications, the quality of 
diabetes-care, patient’s participation in treatment costs or even the membership of a 
diabetes-patient group. The main conclusion drawn from these findings, at a policy 
level, is that restructuring of the diabetes-care system a necessary condition in order 
to improve overall QoL of people with diabetes.  
The restructuring should aim at two major goals. First, the reorganisation of the 
diabetes-care services, both geographically and institutionally.  The problem of 
service distribution and consequently diabetes management in Greece is severe. 
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Service distribution in a country that has over 1200 inhabited islands presents a 
significant problem.  
In almost half of the Greek hospitals there is not any outpatient diabetes-clinic. There 
are almost 70 hospitals where a diabetes outpatient clinic exists, but it operates one 
or two days a week.  Patients have either to visit a private diabetes clinic or travel to 
the nearest hospital that has a diabetes clinic. These clinics cost only €5 but offer a 
limited range of services and one medical professional qualified for diagnosis and 
treatment of diabetes. There are not any consultants (podiatrists, nephrologists etc.) 
attached to them in case an individual needs special treatment or diagnosis.  Some 
consultants can only be found in diabetes-centres. There are 17 centres in Greece, 12 
in Athens, 3 in Salonica, 1 in Patras, and 1 in Heraklion-Crete.  
This pattern of geographical distribution imposes additional costs to treatment and 
creates numerous barriers to access. A visit, on the other hand, to a private diabetes 
clinic may impose a cost of €200, including the tests, an expense that is not 
reimbursed by social security.  Previous investigations have shown that cost per se 
constitutes a barrier to health care (Newhouse, 1993; Piette, 2000) and consequently 
to health (Gilmer et al., 1997; Wagner et al., 2001c).     
The second major goal of restructuring concerns the issues of diabetes management 
and diabetes-education.  According to Ellrodt et al. (1997) there are at least four 
components of disease management: an integrated health care delivery system 
capable of coordinating health care across the continuum; knowledge of the 
prevention, diagnosis, and treatment of the disease; sophisticated clinical and 
administrative information systems; and continuous quality improvement methods. 
None of the above exists in the Greek NHS. 
Greece does not have any diabetes management program, despite the fact that such 
programs have been proved effective in improving QoL and other health outcomes 
(Ose et al., 2009; Knight et al., 2005; ). Diabetes programs include patient education, 
health professional’s education, psychological intervention, dietary education, self-
monitoring and telemedicine. Follow-up, self-care, and case management are 
necessary for an effective disease-management and the confrontation of the disease-
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burden.  (Norris et al., 2002). However, prevention and management of diabetes are 
not included in the priority list of the Ministry of Health. A national diabetes 
programme does not exist, because diabetes is not recognised as health condition that 
should be separately addressed, and there are no official prevalence or other 
epidemiological data (e.g. number of amputations).  
Lack of such programs in the Greek health system results to situations where people 
at high risk of complications cannot be identified and have a routine follow-up 
program, nor people at low risk find support for increasing their self-care abilities. 
Also, case management for people with complex needs is impossible.  
 
The value of diabetes education is widely recognised. It is considered a necessary 
precondition for successful self-care and disease management (Roberts, 2006). It is 
also recognised that self-care reduces visits to health care professionals, hospital 
stays, and confinement at home decause of illness (Fries and McShane, 1998). 
Diabetes education is a major goal for the International Diabetes Federation (IDF, 
2011). The five years campaign (2009-2013) of the IDF is titled “understand 
diabetes and take control”.  Without education the IDF argues that: 
“... people with diabetes are less prepared to take informed decisions, make 
behavioural changes, address the psycho-social issues presented by diabetes and, 
ultimately, may be ill-equipped to manage their diabetes effectively” (IDF, 2009).   
 
This education is not a procedure of memorising information about blood- sugar 
levels, given at seminars or day-meetings and workshops provided occasionally by 
a diabetes group or even a health professional; it is a rather lifetime procedure that 
has to be repeated many times throughout life (Khunti et al., 2012). It helps  patients 
to interrelate diabetes-knowledge with every day’s problems enabling them to make 
multiple daily choices regarding the management of the disease without help from 
any health professional (Kirkman et al., 2002; Rutten, 2005; Tessier and Lassmann-
Vague, 2007; Jarvis et al., 2010). 
 
Diabetes education in Greece is provided by diabetes-patients groups acting on a 
local basis assisted by diabetes-professionals, mainly on a voluntary basis, and 
funded by pharmaceutical or companies specialised in medical equipment and 
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diabetes accessories. The same companies finance conferences delivering education 
modules for diabetologists. They are also responsible for screening populations for 
diabetes (Andriciuc, 2009). Both diabetes education-training sessions and screening 
are based on a rather occasional basis than on a systematic and continuous program 
and with very limited duration (2-3 days).     
 
Good continuity of care is connected with better outcomes, because diabetes is a 
chronic disease that needs attention and good management (Wagner et al., 2001a). 
The structure of the Greek health system does not include any provision for ensuring 
continuity, because first of all there is no national register for people with diabetes. 
The organisational support, that the national register would provide, and a 
computerised tracking system would help continuity and improve patient’s 
adherence to treatment (Kirkman et al., 2002). There is a variety of reasons for the 
existence of the above deficiencies in the Greek health system that cannot be 
discussed, as they overstep the jurisdiction of this project.      
 
In conclusion, Quality of Life is probably the most important health outcome because 
it represents the “ultimate goal of all health interventions” (Rubin and Peyrot, 1999). 
In this respect and in order to make QoL more comprehensible this investigation 
produced an instrument with proved validity and reliability, accepted by its original 
developer and international institutions, and tried to shed light to the complex 
relationships of quality of life domains with demographic, socioeconomic, and 
medical variables.  
Last, there is no doubt that the increase of life expectancy is a major challenge for 
all health systems. The concepts of quantity and quality should not be used in a 
disjunctive manner. However, quality and not quantity is the most important issue in 
life and should be prioritised against all other health outcomes, because according to 
the phrase attributed to Abraham Lincoln, and endorsed by writers, politicians, 
geriatric and diabetes associations:  
“And in the end, it’s not the years in your life that count. It’s the life in your years”.   
277 
 
 
Strengths and Limitations of the study 
Strengths of this study could be considered: 
 The number of testing sites and their relative importance for the total diabetes 
population. The biggest hospitals of Greece were included in the testing sites, 
as well as some of the most important teaching hospitals serving diabetes 
patients from various parts of Greece.  Because of the high cost of diabetes, 
as a chronic disease, state hospitals attract the majority of diabetes patients.  
 The sample size. The final number of 1027 respondents is the highest 
amongst diabetes-related quality of life studies.    
 Whilst no records were kept, it is estimated that less than 5% of the patients 
did not wish to participate when approached. However, the patients that did 
not respond, did not refuse participation, but they declared that they belong 
to groups that were excluded from the study.  
 The broad range of variables examined. The ADDQoL-Gr covered 19 
domains of quality of life, while the demographic-medical questionnaire 
contained 18 questions of demographic, socioeconomic, medical and 
attitudinal nature. 
 The use of two of the most highly reliable and valid questionnaires used for 
the research (ADDQoL-Gr and SF-36).  
 The mode of administration. Both the instruments are self-administered and 
there was no mitigation of this rule. The presence of the researcher did not 
interfere with the administration, but the task was the provision of 
information about the research, the encouragement for participation and 
provide answers to any queries asked.   One hospital (Papageorgiou of 
Salonica) was excluded and in another one (Kavala’s new hospital) the 
research stopped because they did not satisfy the administration criteria.  
 
Limitations of the study include: 
 The fact that all medical variables are self-reported. Although diabetes 
patients usually report their diabetes management in accordance with the real 
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levels of variables such as glycaemic control (Heisler et al., 2003), this is not 
confirmed in the study by examination of medical records. 
 Despite the fact that the catchment areas of the testing sites account for almost 
40% of the total diabetes population in Greece, the sample, because of the 
sampling method, still cannot be considered as representative.  
 The length of the combined questionnaire, 94 questions in total 
(18+2+19+19+36) and the consent form led some respondents not to answer 
the SF-36 questionnaire. 
 No record was kept of non-respondents in the validation study. 
 The cross sectional type of study was sufficient to assess associations 
between socioeconomic - diabetes variables and QoL, causation cannot be 
ascribed.  
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Appendix A: Review of diabetes-specific QoL 
instruments 
 
1 Appraisal of Diabetes Scale (ADS) 
Background 
The Appraisal of Diabetes Scale (ADS) was developed in the late 80’s to 1990 in 
the USA, by M. Carey and it was first published in 1991 (Carey et al.  1991). Its 
development was based on previous theory and research regarding appraisal 
processes. Some items were based and customised to diabetes on an existing 
instrument concerning depression, the Attribution Questionnaire. There was no 
patient involvement in the construction of the instrument.  
Conceptual and Measurement model 
The ADS aims “to assess a diabetic person’s appraisal of his or her disease” (ibid.). 
According to its developers ADS could be useful as a brief screening instrument for 
adjustment to diabetes. In this respect ADS can be used to identify patients 
experiencing, or they are at risk for, dysphoric reactions and non-compliance 
problems.   
It is a single index scale and it consists only of seven items. It is the shortest 
instrument among the diabetes-specific array of measures. These items concern 
distress, control (2 items), uncertainty, prediction about the future, and coping and 
effect on life goals.  
Patients respond on a 5-point Likert scale. Scores can range from 7 to 35, with higher 
scores meaning a greater impact of diabetes.  
 
The ADS was tested at the Syracuse Veterans Administration Medical Centre - 
Diabetes Clinic with a sample of 200 outpatients, divided into two sub groups. 102 
patients were asked to complete a battery of 6 measures, including the ADS, and 98 
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patients completed the ADS only. The patients were mainly Caucasian (91%), with 
a mean age of was 58.4 years. 81% of them were married with high school education 
(M=12.2 years). The mean duration of diabetes was 15 years with 65% of them 
insulin treatment. Examination of the responses shows the patients rate themselves 
around the midpoint of the 5-point scale on all items (2.457-3.025). 
Principal Component Analysis was performed, which produced a single factor, with 
an eigenvalue of 2.73, which accounted for 39% of the variance. All items had 
loadings on this factor between 0.424 and 0.752 (Carey et al.  1991), well above the 
minimum acceptable level of 0.40.  
Reliability 
Internal Consistency and Test-retest Reliability of the ADS were assessed. 
Cronbach’s alpha was determined to be 0.73, which suggests that ADS is reliable for 
use, although reliability according to Streiner and Norman (2008) is at the lowest 
acceptable level. Item-total correlations was found to be in the range of 0.281 – 0.589 
well above the boundary of 0.20 (ibid). 
 
Test-retest reliability was assessed by retesting the sample of the 98 patients that 
completed the ADS only, 1 hour after the test on the site (95 participants) and 1 week 
later, by mailing the questionnaire (77 respondents). Pearson product moment 
correlations were found to be 0.89 and 0.85 respectively, scores that prove ADS 
stable over repeated administrations. 
   
Validity and Responsiveness 
Convergent validity was determined by testing the hypotheses that the ADS would 
correlate positively with other situation or dimension-specific measures of negative 
effect. To this end Pearson product-moment correlations were calculated between 
the ADS and the other measures used in the study. The measures used were the 
Psychiatric Symptom Index (PSI), the Perceived Stress Scale (PSS), the Diabetic 
Daily Hassles Scale (DDHS), the Diabetes Regimen Adherence Questionnaire 
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(DRAQ-R), the Diabetes Health Belief Questionnaire –Revised (DHBQ-R) and 
Glycosylated Haemoglobin (HbA1c). 
 
The results of the correlation analyses confirmed the initial hypotheses. According 
to the authors, a strong relationship was proved between the ADS and the PSI, 
indicating scores of 0.55 for anxiety, 0.39 for anger and 0.58 for depression. The 
scores for PSS and DDHS were 0.49 and 0.59 respectively indicating again a strong 
relationship between the ADS and the two measures. The results of 0.31 and 0.42 for 
the subscales of severity and susceptibility respectively, indicated a moderate 
relationship between the ADS and the DHBQ-R. Significantly low levels of 
correlation were observed between the ADS and DRAQ-R, with a score of 0.17, as 
well as the HbA1c with a score of 0.18. It should be noted that although the initial 
hypotheses of the authors about convergent validity were confirmed, there was no 
reference about the magnitude of the expected correlations. Also, the construct 
validity of the ADS was not assessed using factor analysis. 
Responsiveness 
There is no evidence concerning the responsiveness of the scale. 
Burden and Acceptability 
Completion time is reported to be five minutes or less. According to the authors, 
most of the patients found it easy to complete and it is understood easily by low 
education or visually impaired people. It was generally well accepted by patients due 
to the fact that it inquires about diabetes-related information and it does not enter 
into psychological issues. It is also easily administered by non-professional staff. 
The response rate for the third administration (1-week retest) of the instrument was 
78.5%.  
Alternative forms 
None. 
Cultural and Language Adaptations 
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None. 
Comments 
The ADS is a short and easy to administer instrument for the assessment of a diabetes 
patient’s appraisal of the disease. It has a moderate to good internal consistency and 
good test-retest reliability. 
 
In a later study, the ADS was used to examine the family environment in relation 
with glycaemic control and psychological adaptation (Trief et al.  1998). According 
to the authors, the ADS was found to strongly predict both glycaemic control and 
diabetes-related quality of life, making it a potentially first-line screening instrument. 
 
Nevertheless the measure suffers from certain deficiencies. Also, some of the 
developers’ claims are not supported by facts. The first serious deficiency is that 
there was no patient involvement during its construction with all the consequences 
that this might cause to an instrument (discussed in the previous chapter). Thus, 
although its developers claim that the instrument has face validity they could not 
claim that content validity has been proved. Moreover, the sample used for the test 
was far from being representative. It is the only diabetes-specific instrument that 
used a 100% male sample. Therefore, there is no evidence on the ADS psychometric 
properties concerning women. Also, there was not any attempt to test the 
instrument’s ability to differentiate among any other known groups.   
 
Undoubtedly the ADS is an easy to complete instrument. The developers claim that 
the ADS is easily understood even by illiterate people. However, taking into 
consideration that all males in the sample had high school education this claim cannot 
be proved. 
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2 Audit of Diabetes Dependent Quality of Life 
 
Background 
The Audit of Diabetes-Dependent Quality of Life (ADDQoL) was developed in the 
UK by C. Bradley in the second half of the 90’s and it was first published in 1999.  
The content was based on the experience of existing diabetes-specific QoL and 
generic instruments, patient-centred principles, discussion with health professionals 
and 12 in-depth interviews with adults attending a diabetes clinic (Bradley et al.  
1999). 
The design of the ADDQoL was influenced by the Schedule for the Evaluation of 
Individual QoL (SEIQoL), a widely used interview measure for individual QoL (Mc 
Gee et al.  1991). The initial draft was reviewed by the working group that had been 
established by the British Diabetic Association and the Royal College of Physicians 
and four patients. 
 
Conceptual and Measurement model 
The general concept of ADDQoL is how people with diabetes perceive and rate the 
impact of the disease on all applicable aspects of life, together with the perceived 
importance of each domain for their QoL (Bradley and Speight, 2002). The 
ADDQoL calls people with diabetes to imagine how different life would be if 
diabetes did not exist. To this end the person with diabetes is called to answer 
questions on how his/her life would be without diabetes. This is unique compared 
with all other diabetes-specific instruments, which ask questions about the problems 
occurring from the disease i.e. it burden of it, and how these problems interfere with 
their lives.  
 
The instrument consists of 19 items plus 2 overview items and one open question. 
The open question refers to diabetes management and complications in general. The 
first of the two overview item is of a generic nature, concerning the present QoL in 
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general. The second one concerns the diabetes-dependent QoL of the respondent. 
These items are included, according to the authors, in order to provide single-item 
indicators of QoL (Bradley, 2005). 
 
Item generation 
Two initial versions of the ADDQoL were produced. One consisted of 12 items plus 
2 overview items. The second version consisted of 13 plus the 2 overview items. The 
additional item concerned food enjoyment. The 13 items include all domains (social, 
physical and emotional functioning), of life that affect QoL for the better or the 
worse.  
Each question is divided into two parts. The first one is about the patients’ perception 
of a particular aspect of life, and asks patients to rate the impact of diabetes in various 
domains of their lives. The second one is to rate the importance of each particular 
domain for their life.  This was a breakthrough for QoL questionnaires and the 
ADDQoL is the only instrument that uses an importance weighting for each item.  
The 13 items asked questions about: employment/career opportunities, social life, 
family relationships, friendships, sex life, sporting, holiday, leisure opportunities, 
ease of travel, worries about the future, worries about the future, family-close friends, 
motivation, physical ability, people’s reaction, and food enjoyment. 
 
Later, in 2002, the ADDQoL has been used by the DAFNE (Dose Adjustment For 
Normal Eating) study group in the UK to assess the effect of their structured 
education program. In this study the ADDQoL was modified including 18 + 2 items 
(Bradley and Speight, 2002). 
The new items were: physical appearance, self-confidence, financial situation, living 
conditions, freedom to drink. Also, several of the previous question had been 
modified and rephrased.  
 
The respondents were asked to rate the impact of diabetes, for the condition-specific 
item, on a 7 point scale ranging from “a great deal better” (-3), to “a great deal worse” 
(+3). A “non applicable” option was provided for 10 of the 13 items, giving the 
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freedom to the respondent to answer questions considered to be applicable for his/her 
case.   
 
The patient was asked to rate the importance of each item for his/her life in a four 
scale rating (0- not at all important to 3- very important). Impact rating of each item 
was multiplied by its importance rating providing a score between -9 to +9. Non-
applicable domains were ignored in the total score. The total score was estimated by 
the sum of weighted ratings of applicable domains divided by the number of 
applicable domains. Total scores vary from -9, which stands for the maximum 
negative impact of diabetes, to +9, the maximum positive impact of diabetes. 
 
The third version of the instrument, the ADDQoL-19, is a modification of the 
ADDQoL-18 (Bradley and Speight, 2002), which in turn was modified from the 
ADDQoL-13 (Bradley et al.  1999). The instrument, in its present form, consists of 
19 items plus the two overview items. In relation to the previous one, this edition 
contains one new item about ‘close personal relationship’ and the item about 
‘holidays or leisure activities’ has been divided into two separate items. There was 
deletion of the item about enjoyment of food, as it was covered by the item of 
‘freedom to eat’. Also some simplification of the wording of the instructions has 
been made, as well as that of some items.   
 
Thus the present form of the instrument includes the following items: leisure 
activities, working life, ease of travelling, holidays, physical ability, family 
relationships, social life, personal relationships, sex life, physical appearance, self-
confidence, motivation, peoples’ reaction, worries about the future, financial 
situation, living conditions, dependence on others, , freedom to eat, and freedom to 
drink. 
 
The “non-applicable” option was considered to be a weak point in the analysis and 
it has been abandoned. Instead there are explicit questions at the beginning of 5 
items. The respondents for whom the item is not applicable are guided to proceed 
straight to the next item, assigning a zero score to the item (Bradley, 2005). 
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The administration of the ADDQoL for the DAFNE project indicated that the 
instrument has shown a universally negative impact of diabetes on all 18 life 
domains. Only a few people used the positive side of the scale and the mean weighted 
impact scores ranged between -3.6 (freedom to eat – the greatest impact) and -0.9 
(society’s reaction). Thus, it was considered that 3 different positive response options 
were unnecessary, and there has been a reduction for the condition-specific impact 
scales from 3 to 1 (Bradley and Speight, 2002). 
 
The score is estimated for the 19 domain-specific weighted impact, by multiplying 
the impact rating (-3, -2, -1, 0, +1) with the importance rating (3, 2, 1, 0) to produce 
scores ranging from -9 to 3. 
 
Sample 
The instrument was tested in two sites. The first sample was recruited from an adult 
out-patient clinic in Cambridge and the other one in Bromley at two open educational 
meetings for adults with diabetes. 
The Cambridge sample consisted of 52 patients, 54% of which males, with mean age 
52.38 years, 37.2% of them were on diet-tablet treatment, the mean duration of 
diabetes was 12.71 years, and the mean age of leaving full-time education 16.98 
years.  
The Bromley sample consisted of 102 patients, 54% of which males, with a mean 
age of 61.60 years, 67.5% on a tablet & diet treatment regimen, the mean duration 
of diabetes was 7.27 years, and the mean age of leaving full time education 16.12 
years. This sample, according to the developing team, was a convenience sample, 
which could not be considered as representative, but the pattern of its responses 
proved to be similar to the Cambridge one.  
 
Factor generation 
Unforced factor analysis with oblique rotation (oblimin), for the 12 item version, 
produced three factors with eigenvalue greater than one. Many items though, had 
been loading on more than one with loadings of more than 0.40. Following a forced 
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one-factor solution, by disallowing the other two, all domains loaded on one factor 
with satisfactory loadings ranging from 0.45 (sex life) to 0.81(social life). When the 
13th item was included, that of food enjoyment, there had been no major changes in 
the factor structure. In the 2002 study, for the 18 item measure, a forced one-factor 
analysis of the 18 item ADDQoL was performed which proved all items loading 
greater than 0.50 (Bradley and Speight, 2002). The two overview items were not 
included in the factor analysis. 
 
Reliability 
Internal consistency of the ADDQoL was measured in the relevant studies by 
estimating the scale reliability coefficient (Cronbach’s alpha). In the original study 
Cronbach’s (α) for the 12-item instrument was a satisfactory 0.84 (Bradley et al.  
1999). In the later study for the 18-item instrument (α) was 0.92, indicating that the 
ADDQoL-18 is a highly reliable measure. For the latest 19-item version of the 
ADDQoL, administered in Singapore in 2006, Cronbach’s (α) was even higher at 
0.93 (Wee et al.  2006). 
Similar studies, using translations of the ADDQoL give results very close to the 
original version. The Malay version of the 18-item measure estimated a Cronbach’s 
(α) 0.94 (Kamarul Imran et al.  2007), while in the Portuguese translation of 
ADDQoL-18 α was 0.89 (Costa et al.  2006). 
 
Item-total correlation in the initial test ranged between 0.37 and 0.67, well above 
the 0.20 limit proposed by Streiner and Norman. In the Malaysian edition of 
ADDQoL-18, Item-total correlation ranged between 0.52 and 0.78. 
 
Test retest reliability was estimated only in the Malaysian study at a 1-week 
interval. The Intraclass Correlation Coefficient (ICC) was 0.81 (using the one way 
ANOVA model), indicating that the ADDQoL-18 is a reliable measure.  
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Validity and Responsiveness  
Validity of the ADDQoL was tested against the two overview items included in the 
measure. The hypothesis of the developers that the measure would correlate better 
with the diabetes-dependent QoL item than with the generic one was proved. The 
mean weighted scores correlation with the diabetes-specific item was 0.47, while 
that with the generic one 0.31. The correlations fall far shorter than 1.0, indicating 
that the measure provides information that cannot be elicited by the overview items. 
 
The ADDQoL mean weighted score, correlated strongly with the number of reported 
complications (r = - 21) and perception of hyperglycaemia (r = -0.32), indicating a 
more negative impact of diabetes for people of those categories. Examining the 
known groups differences (Type 1 and 2) has been proved that in 12 out of 13 items 
of the measure the impact of diabetes was greater to insulin dependent patients. 
 
Burden and Acceptability 
The ADDQoL was first tested in Cambridge and Bromley. In Cambridge 67 patients 
were approached and only 32 are referred as participants (47.76%). During the two 
sessions of the Bromley application 142 were given the questionnaire and 102 
participated (71.83%). There is no explanation given by the authors neither for the 
small size of sample in the first testing site nor for the low rate of acceptability. 
 
Alternative forms 
More recently, a 25-domain ADDQOL-Teens has been developed which showed 
high internal consistency and reliability. It is a measure of perceived impact of 
diabetes and its treatment on the QOL of teenagers. There were two subscales: a 10-
item impact-self subscale (measuring the impact of diabetes and its treatment on the 
individual) and a 15-item impact-other subscale (measuring impact on interactions 
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with others and the external world). It may be used for routine clinical monitoring in 
a context of continuing evaluation (McMillan et al.  2004). 
 
Cultural and Language Adaptations  
The ADDQoL-19 has been translated into 23 languages and validated in most of 
them. That makes it by far the most translated diabetes specific instrument followed 
by DHP and PAID.  
These languages are: French (for France and Canada), German, Italian, Polish, 
Spanish (for Spain, Mexico, and the USA), English (for USA, Australia, Canada, 
India, and Singapore), Hindi (+for UK), Portuguese for Brazil, Chinese, Cantonese 
for Hong Kong, Hungarian, Malay, Punjabi (+for UK), and Slovak. 
In addition to these languages there are translations of the ADDQOL-18 in 
Norwegian, Russian, Portuguese and Spanish for Argentina.   
Comments 
[Because the ADDQoL was chosen as the main instrument for this research and in 
order to avoid repetition the comments section of the ADDQoL has been deleted and 
can be seen in the main body of the thesis (8.4.1)]. 
 
3 Diabetes Care Profile (DCP) 
Background 
The Diabetes Care Profile (DCP) was developed in the USA during the first half of 
the 90’s by J. Fitzgerald. The development of DCP was based mainly on an existing 
instrument, the Diabetes Educational Profile (DEP), which in turn was based on 
another instrument measuring adherence to a medical treatment namely the Health 
Belief Model (HBM) (Fitzgerald et al.  1996). There was no patient involvement in 
the construction of the instrument and this could be considered as a major handicap. 
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Conceptual and Measurement model 
It was designed as an instrument aiming to measure the social and psychological 
factors important in a patient’s adjustment to diabetes and its treatment. The authors 
accept the importance of self-care in the management of diabetes and its role in 
preventing complications. However, self-care has an impact on quality of life. It has 
long been established that diabetes regimen is multidimensional and that adherence 
to one dimension does not necessarily imply adherence to others.  They accept Kurtz’ 
view that patients’ adherence to diabetes regimen is usually poor, especially when 
life-style changes are involved. (Kurtz, 1990). 
    
The developers of the DCP believe that the instrument is unique because of its 
comprehensive coverage of the social and psychological aspects of diabetes and its 
treatment. The comprehensive coverage refers to the fact that the DCP contains in 
total 234 items and it is by far the longest diabetes-specific questionnaire. Initially 
the instrument contained 14 scales (Fitzgerald et al.  1996), but later 2 scales were 
added making a total of 16 (Fitzgerald et al.  2000). 
 
The DCP now consists of 16 profile scales totalling 116 questions, as well as items 
about demographic, medical, socioeconomic information and self-care practices. 
The scale uses a 5 point Likert scale. The subscale scores are weighted averages and 
there is no total score with this instrument. The 16 scales with the number of items 
and the scoring are: 
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Diabetes Care Profile Scale No of  
Items 
Scoring 
Good   Poor 
Control problems 19   1          5 
Social & personal factors 13   1          5 
Positive attitude 5   5          1 
Negative attitude 6   1          5 
Self-care ability 4   5          1 
Importance of care 4   5          1 
Self-care adherence 4   5          1 
Diet adherence 4   5          1 
Medical barriers 8   1          5 
Exercise barriers 5   1          5 
Monitoring barriers 11   1          5 
Understanding management practice 10   5          1 
Long-term care benefits 5   5          1 
Support needs 6   5          1 
Support 6   5          1 
Support attitudes 6   5          1 
Total   116  
                                                     
 
The instrument was initially evaluated in two different studies in Michigan. One was 
in a community setting and the other one at an academic medical centre. 
 
 
Samples 
Data were collected from 440 respondents. 48 of them (11%) were patients with 
IDDM. 392 (89%) were patients with NIDDM, 150 of them (34%) using insulin and 
242 (55%) not using insulin. Mean age was 61 years and mean duration of diabetes 
10 years. 55% of the sample was women and 32% had 13 or more years of education. 
Patients were asked to fill a DCP form and have a blood test to determine GHb levels. 
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352 respondents were used for data collection from the second sample (medical 
centre). 116 of them (33%) were patients with IDDM, 120 (34%) patients with 
NIDDM using insulin and another 116 (33%) not using insulin. The mean age was 
54 years and women accounted for the 60% of the sample. Mean duration of diabetes 
was 14 years. Patients from this sample were asked to complete the DCP and three 
other previously validated scales i.e. the Social Provisions Scale, the Centre for 
Epidemiologic Studies Depression scale (CES-D), and the Happiness and 
Satisfaction Scale. 
 
The DCP was compared with the SF-36 in a sample of 255 NIDDM patients, 64% 
of whom did not use insulin. Their mean age was 63.4 years and 55% of them were 
women. The mean diabetes duration was 8.6 years (Anderson et al.  1997). 
 
Another study was conducted later, with a sample of African American and 
Caucasian people with diabetes. The sample of this study consisted of 672 type 2 
diabetes patients that were either African- Americans or Caucasians. Their mean age 
was 63.1 years, 43.8% of them male, with a mean duration of diabetes of 12.45 years. 
52% of them were treated with insulin (Fitzgerald et al.  2000). 
 
The last study found in literature was one that assessed the reliability and validity of 
the DCP among Hispanic veterans in three hospitals in the SW of the USA 
(Cunningham et al.  2005). Although the results of this study are similar to the 
previous ones, it cannot be considered as sound because of major sampling 
shortcomings. All of the participants were male, all using insulin, and there was a 
discrepancy of power between the two groups (Hispanics n=81, Non-Hispanic 
whites 238).      
Factor analysis for cluster identification was used with data obtained from the DEP, 
the instrument on which the DCP was based.  
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Reliability 
All studies suggest that the reliability of the DCP is in most part satisfactory but not 
very good in all dimensions. All analyses showed significant differences among the 
scales creating doubts about the overall reliability of the instrument. In the Fitzgerald 
et al.  study (1996) some of the subscales appear to have excellent reliability (long 
term care benefits 0.95-0.95, importance of care 0.90), others marginally acceptable 
(negative attitude 0.75-0.77 and medical barriers 0.75), and some even lower than 
the minimum acceptable level of 0.70 (exercise barriers 0.60 - 0.66, monitoring 
barriers 0.65). 
 
In the Anderson et al. (1997) study Cronbach’s (α) ranged between 0.69 and 0.95 
with the exception of exercise barriers which had an α of 0.60.  Fitzgerald et al. 
(1998) investigated the reliability of the DCP for African Americans and Caucasians. 
The reliabilities were found to be similar between the two groups ranging from 0.70 
to 0.97 for African Americans and 0.68 to 0.96 Caucasians. Thus, compared with 
other diabetes-specific instruments the DCP cannot be placed among the most 
reliable ones.  
 
Validity and Responsiveness 
The DCP scales were evaluated for construct and concurrent validity. The authors 
hypothesized that specific DCP scales would correlate with the scales that were used 
in the academic medical centre, as well as with the GHb levels measured in the 
community centre sample. 
 
As hypothesized, the Social Provisions Scale was proved to be negatively correlated 
with the social and personal factors scale (-0.33) of the DCP, and positively 
correlated with the support attitude scale (0.51) of the instrument. As far as the CES-
D was concerned, the authors hypothesized that would correlate with certain scales 
of the DCP. Positive correlations were expected for control problems, social and 
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personal factors and negative attitude scales. Negative correlations were expected 
for self-care ability, support attitudes and positive attitude. 
 
All hypotheses were proved valid and to the right direction. Correlation coefficient 
of control problems was 0.34, social and personal factors 0.48, negative attitude 0.48, 
self-care ability -0.42, support attitudes -0.35 and positive attitude -0.53. Obviously, 
the correlations of these external scales with the DCP were >0.30, the level that the 
authors considered as indicative of concurrent validity for the DCP. 
 
The Happiness and Satisfaction Scale was hypothesized to correlate positively with 
positive attitude, self-care ability and support attitudes and negatively with social 
and personal factors and negative attitudes. Although the correlations proved to be 
in the right direction only two, positive attitude (0.32) and self-care ability ((0.30), 
proved to be of some significance, with all others scoring under 0.30. 
 
Construct validity in the community sample was tested by assessing the DCP scale 
correlation with the GHb levels. Due to the fact that many different factors affect 
GHb levels, the authors hypothesized that only moderate correlation (0.20 – 0.50) 
would occur. Only three scales correlated with GHb, control problems (0.21), self-
care ability (-0.33) and self-care adherence (-0.28). These correlations mean that 
patients facing difficulties with control problems had also high levels of GHb and 
patients reporting greater self-care ability and adherence had lower levels of GHb. 
Significant differences were found between type 1 and type 2 diabetes patients for 6 
out of the 14 scales of the Fitzgerald et al. study (1996).  
 
In the Anderson et al. study (op.cit.) the DCP was compared with the Short Form 36 
(SF36) for NIDDM (type 2) insulin and not insulin user patients. Overall the DCP 
correlated well with the SF-36 subscales. A greater number of significant 
correlations were found for patients with NIDDM not using insulin. The Social and 
Personal Factors subscale of the DCP had the highest number of correlations with 
the SF-36 subscales. For insulin users this subscale correlated with six SF-36 
subscales, and for non-insulin users the subscale correlated with all nine SF-36 
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subscales. The positive and negative attitude subscales of the DCP correlated with 
the Mental Health subscales of the SF-36. 
 
The study examined the relationship of the DCP and SF-36 scores to glycaemic 
control. They found that the SF-36 scales were not predictive of GHb values, while 
the DCP scales explained 17% and 15% of the variance in GHb values for insulin 
and non-insulin users respectively. The study also examined the relationship of SF-
36 and DCP subscales to the number of complications. For insulin users only two 
DCP scales were correlated with number of complications (Social - Personal Factors 
and Positive Attitude). For non-insulin users no DCP subscales correlated with 
complications. For the same group of patients the General Health scale of the SF-36 
correlated with number of correlations.  
 
There was no evidence about responsiveness. 
 
Burden and Acceptability 
The DCP contains 234 items and it is by far the longest diabetes-specific 
questionnaire. The completion time is, according to the authors, 30 – 40 minutes. 
This time seems to be unrealistic as a speed of 8-10 seconds on average per question 
is not easily achieved for a questionnaire of 234 items length. 
Out of 1,017 patients invited to participate in the community study 517 agreed and 
only 440 responded (43.26%). A lower acceptability is observed in the medical 
centre. Out of 1500 patients invited, 576 agreed but only 428 participated (28.5%). 
The acceptability rate is low, by any standards, and this can be attributed to the length 
of the questionnaire. 
 
Alternative forms 
The use of one or more individual subscales represents alternative forms of the DCP.    
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3.7 Cultural and Language Adaptations 
None reported. 
Comments 
As mentioned above a major shortcoming of the DCP is the non-patient involvement 
in its development. The length of the DCP is also a serious disadvantage. However, 
certain subscales can be used and have been used independently. Of course some 
questions about reliability and validity could be raised by using two three or four out 
of the sixteen subscales. But even if the problem of the properties of certain subscales 
could be overcome the problem that could not be ignored is that by using these 
subscales only some dimensions are tapped and not the concept of quality of life as 
a whole.  Therefore, in its complete form the instrument is difficult to administer and 
in a short form is unreliable as a quality of life measure.    
 
4 Diabetes Health Profile 
Background 
The Diabetes Health Profile (DHP) was developed in the UK by K. Meadows and 
his team between the second half of the 80’s and the first half of the 90’s. It was first 
published in 1996 (Meadows et al.  1996). The DHP is a multidimensional patient 
self-completion diabetes-specific instrument designed to identify psychosocial 
dysfunctioning of adult insulin dependent and insulin requiring patients in an 
ambulatory care setting. The instrument was developed specifically for IDDM 
patients (Type 1) and later, in 2000, it was adopted for use with Type 2 patients 
(ibid). 
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Conceptual and Measurement model 
Item generation 
The development of the DHP was based on in-depth interviews with 25 insulin 
dependent and insulin requiring patients, examination of existing instruments, 
discussions with health care experts, and a literature review. 
In the first study, concerning the instrument’s development, five areas were 
identified and used as the underlying constructs for the instrument’s development. 
These were: psychological distress, barriers to activity, eating restraint failure, 
disease management, and anxiety related to clinic attendance. 95 items were 
developed to cover these five constructs. The questionnaire was assessed by four 
health care experts in order to refine the item content, as well as for a provisional 
estimation of its content validity. They all agreed on the scales and content of the 
instrument, rewriting a few ambiguous questions. 
 
Item reduction- scale generation 
In the second study, the factor structure of the 95 item instrument was examined and 
the content of the items was evaluated. To this end, a sample of 239 respondents 
from a hospital’s out-patient clinic was used. Their mean age was 40.85 years, and 
their mean duration of diabetes was 13.7 (ibid). 
 
Principal Axis Factoring (PAF) was chosen for the analysis. 24 items failed to satisfy 
the criteria put by the developers, (i.e. good endorsement at least by a significant 
minority of respondents, and item inter-correlations under 0.30 and over 0.70 had to 
be deleted), leaving 71 items for further analysis. To identify the factors that 
emerged, PAF analysis with orthogonal rotation was carried out with the 71 
remaining items. Five factors emerged, similar to the five initially postulated 
structures, accounting for 35.8 of the total explained variance. However, two of these 
factors, management and anxiety, accounted for less than 3% of the explained 
variance and they had to be removed. Thus the 16 items representing these factors 
had to be excluded, together with another 12 items with factor loadings of less than 
0.30. Another PAF analysis was carried out with the 43 remaining items, to 
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determine the factor structure, resulted to three factors, explaining 33.3 of the total 
variance. 
 
A third study took place in out-patient clinics of general and teaching hospitals in 
England and Wales. 84 hospitals were asked to participate in the study, 74 agreed to 
do so, but only 54 participated in the end 2,239 patients responded to the 43 item 
questionnaire with 1144 (51%) of them men, and a mean age of 39.8 years and 13.1 
mean duration of diabetes (ibid).  
 
A forced three factor PAF analysis was carried out which this time proved that the 
three factors accounted for 31.5% of the total explained variance. 4 items had factor 
loadings <0.30 and another 7 items had loadings >0.30 on more than one factors. 
Thus, all 11 items had to be removed leaving the questionnaire with 32 items. These 
items were again subjected to a forced three factor PAF analysis with orthogonal 
(varimax) rotation. All items loaded well on their factors, which were identified as 
Psychological Distress (14 items), Barriers to Activity (13 items) and Disinhibited 
Eating (5 items). The three factors accounted 33% of the total variance. 
 
The final stage of the instruments development was a fourth study aiming to assess 
further the factor structure, the reliability and validity of the instrument. 233 patients 
responded, 121 of them men (52%), with mean age of 51.46 years. The three factor 
PAF analysis with varimax rotation followed proved that the three factors accounted 
for 35% of the total explained variance. Although the strength of the factors was 
somehow different from the previous studies, with BA accounting for most of the 
explained variance (22.6%), the item composition of the factors was identical (ibid).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
 
The DHP after the four phases of development is a 32 item questionnaire addressing 
3 dimensions: psychological distress containing 14 items, barriers to activity with 13 
items and disinhibited eating with 5 items. Respondents are asked to rate their 
answers on a 4-point Likert scale. Response categories are 0-3, with 0 representing 
no dysfunction or impact.  
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Subsequent Studies 
In 1996 the DHP was translated in Dutch and the psychometric properties of the 
translated instrument were assessed (Goddijn et al. 1996). The Dutch version of the 
DHP, in contrast to the original one, addressed patients with NIDDM. 
As a result, instead of 32, the DHP-Dutch contained 31 items due to the omission of 
the insulin injections item. The Dutch instrument had the same factor structure, but 
with similar factors. 8 out of the 31 items loaded on different factors. The three 
factors explained 32% of the total variance. 
 
Reliability 
Internal consistency was assessed for the first two samples, and Cronbach’s (α) 
coefficient for the three subscales exceeded the 0.70 barrier.  For psychological 
distress (α) was 0.86, for barriers to activity it was 0.82, and for disinhibited eating 
0.77. For the third sample Cronbach’s (α) for the three factors were 0.85, 0.85 and 
0.80 respectively, values that seem consisted with the ones of the other two samples. 
In the DHP-Dutch Cronbach’s alphas were found lower than the original but still at 
a satisfactory level. For psychological distress α was 0.72, for barriers to activity it 
was 0.79, and for disinhibited eating 0.72. 
 
Validity and Responsiveness  
Face and content validity 
The methods of deriving the items and the consecutive tests for subscale 
development and factor structure provide satisfactory evidence for face and content 
validity (Meadows et al.  1996).  
 
Construct validity 
Convergent and discriminant validity were assessed during the various tests of the 
instrument. 
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Convergent validity  
It was assessed during the fourth study of the instrument’s development. The authors 
investigated predictions regarding the hypothesised association between the DHP 
and the Hospital Anxiety and Depression Scale (HAD) and a generic instrument, the 
SF-36. 
The Psychological Distress (PS) scale correlated highly with the anxiety and 
depression subscale scores of the HAD (0.62 and 0.60 respectively). The PS scale 
was also highly correlated with various subscales (vitality, social function, mental 
health and general health perceptions) of the SF-36, with scores 0.55, 0.51, 0.68 and 
0.62 respectively. The Barriers to Activity (BA) scale correlated moderately with the 
HAD anxiety and depression subscales, with correlations of 0.51 and 0.50 
respectively. A low to moderate correlation (0.28 and 0.30) was observed between 
Disinhibited Eating (DE) and the two subscales of the HAD as well as to the four 
subscales of the SF-36 with scores varying between 0.17 and 0.41. 
 
In the Dutch study, the findings of the initial test results concerning convergent 
validity were to a great extent confirmed. The PD and BA subscales correlated highly 
with the corresponding dimensions of the SF-36, showing comparable results with 
the initial UK study. These subscales correlated also with the other non-
corresponding dimensions of the SF-36, although less strongly. The DE subscale did 
not correlate with the SF-36. 
 
Discriminant validity  
During the third study the discriminant validity of the DHP was assessed, by 
comparing scores between men and women, divided in age sub-categories. The 
authors predicted that women in general would score higher in all three subscales of 
the instrument. The results confirmed the predictions for PD and DE subscales, 
especially for young women. Women younger than 40 years of age scored 
significantly higher than men in the PD subscale and women younger than 65 scored 
significantly higher in the DE subscale. As far as the BA subscale was concerned, 
although women scored higher than men, there was no significant sex difference. 
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Responsiveness 
The responsiveness of the DHP was never formally evaluated. However in a study 
that took place in the UK, the responsiveness of two scales was assessed (Whitty et 
al.  1997). The scales used were the scales that emerged during the second face of 
the item reduction process. Thus, the psychological distress scale has 16 items and 
the barriers to activity15.  
 
Patients changing from diet/tablet to insulin treatment were measured at baseline, in 
6 weeks and in three months. The Standardised Response Mean were 0.23 and 0.02 
in 6 weeks, and SRM in 3 months were 0.11and 0.08 for the two scales respectively. 
According to the authors, SRM values of 0.2 are considered to be low.  Therefore 
the changes measured for the two scales were low to insignificant, indicating a failure 
of these two scales to detect changes over time. 
Burden and Acceptability 
The first 95 item questionnaire was sent to 278 patients and 239 of them returned 
them, resulting to a response rate of 86%. As far as the second sample (third study) 
is concerned, due to anonymity and the fact that the study took place in 54 sites, it 
was not possible to determine its response rate. 83.85% of those who answered the 
43 item questionnaire answered all items. A significant association was observed 
between low item completion rate and increasing age as well as women. 295 
questionnaires were distributed for the fourth study. 233 of them were returned, 
giving a response rate of 79%.   
Alternative forms 
By the year 2000, the DHP was adapted for use with type 2 diabetes patients, with 
studies taken place in England and Denmark. Items from the original instrument 
(DHP-1) relevant to insulin treatment were excluded and a new version emerged, 
containing 18 items. The psychological distress scale consists of 6 items, barriers to 
activity 7 items and disinhibited eating 5 items (Meadows et al.  2000). 
 
344 
 
The DHP-18 was tested in two diabetes centres, one in the UK and one in Denmark. 
Cronbach’s (α) for the three scales in both sites ranged between 0.70 – 0.88. The 
discriminant validity was assessed by distinguishing between insulin and tablet/diet 
treated patients. The results confirmed the hypothesis that insulin users would have 
a greater impact compared with no insulin users. Also, the equivalence between the 
item mean scores of the UK and the Danish samples indicated a high degree of 
measurement equivalence across both languages.  Therefore, according to the 
authors, the instrument was proved to have good internal consistency, validity and 
measurement equivalence (ibid). 
Cultural and Language Adaptations 
The DHP has been translated in 14 languages. These languages are Danish, Dutch, 
English for Australia, English for South Africa, Flemish, French, German, German 
for Switzerland, Hebrew, Italian, Polish, Russian, Spanish and Urdu (PROQOLID). 
According to the Mapi Institute all these translations have undergone full linguistic 
validation. 
Comments 
The DHP is an instrument focusing on diabetes related distress, activity and eating 
behaviour for people with type 1 diabetes. Later, in a shorter version the DHP-18, 
the measure was adopted only for use with type 2 diabetes. In this respect, the DHP 
is unique because it is the only diabetes type-specific instrument. This feature could 
be of very important value for clinical studies. 
 
It is one of the most carefully designed and elaborated instrument. The item 
generation and item reduction procedures are probably the lengthiest among the 
diabetes-specific instruments. This accredits the DHP with face and content validity. 
Reliability of the instrument in terms of internal consistency is good. Test-retest 
reliability was never assessed for the whole instrument, although two of its subscales 
were tested in another study with satisfactory results (Whitty et al.  1997). In the 
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same test the responsiveness of the DHP was tested with poor results. Last, the DHP 
was tested for convergent and discriminant validity with very satisfactory results.  
  
Despite the good qualities of the DHP, that make it reliable to use it in a trial, there 
are certain shortcomings that make it difficult to use it in a survey. The initial version, 
with 32 items, is a lengthy one, especially if the measure is combined with a generic 
instrument. Additionally the type-specificity of the instrument makes its use almost 
impossible for a general surveys, as the results of the two diabetes-type groups in 
these studies should be comparable.   
 
 
5 Diabetes Impact Measurement Scales 
Background 
The Diabetes Impact Measurement Scales (DIMS) was developed by Hammond and 
Aoki in California USA and it was published in 1992 (Hammond-Aoki, 1992). 
Conceptual and Measurement model 
The aim of the authors was to develop an evaluative index designed to measure 
longitudinal change in adult patients with diabetes, in order to quantify treatment 
benefit in clinical trials. The scale was designed for application to people with type 
1 and type 2 diabetes.  
The scale consists of 44 items covering 4 domains: symptoms with 17 items 
(diabetes-specific 6 items and nonspecific symptoms 11 items), well-being with11 
items, diabetes-related morale (i.e. patients’ attitudes toward managing the disease) 
with 11items, and social role fulfilment with 5 items.   
 
Item generation 
The development of the DIMS was based on previous research and studies on health 
status measurement as well as discussions with clinicians (physicians, diabetes-nurse 
and dietician). The instruments used were the Sickness Impact Profile (SIP), the 
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Arthritis Impact Measurement Scales (AIMS) and the Rand Study Scale from which 
some well-being related articles were directly drawn. There was no patient 
involvement in the construction of the instrument. The 44 developed items were 
grouped into four subscales: symptoms specific and less specific to the disease, 
diabetes related morale pertaining to the management of the disease, social role 
fulfilment, and well-being. 
 
Item reduction - Factor generation    
Principal Component Analysis was used to determine the factor structure of the 
questionnaire. One principal component was accounting for 32% of the variance and 
another nine minor components each one accounting for ≤ 7.5% of the variance 
bringing the total variance explained to 69%. This analysis showed that there is a 
major factor being measured by all subscales and total-scale scores and several minor 
factors that for which there was no statistical evidence supporting the unique 
significance of the subscales i.e. their capability to provide information beyond the 
ones provided by the total DIMS score. 
 
An item-total correlation analysis was performed proving that four items (16, 22, 39, 
and 42) did not correlated significantly with the total scale score. Although the 
authors accept that these items should be deleted from the questionnaire, for reasons 
that are not clear in the report, they have left the item reduction task to future studies, 
which have not been found in literature.  
 
Scoring method 
Patients respond to items on a 0-4 Likert scale, referring to the frequency of 
occurrence during the last month (0: all of the time, 4: none). The overall score was 
calculated by summing-up the item scores in the same scale. High scores represent 
good values for the domains covered by each subscale (Li et al.  2006). Two global 
questions included in the questionnaire packet, concerning control of diabetes and 
general health used a 90mm VAS.  
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Sample 
130 patients were recruited from the diabetes clinic of the University of California 
Medical Centre. Their mean age was 45 years, 55 of them (42%) were men, with a 
mean duration of diabetes of 11 years. 51 patients (39%) had IDDM and 77 (59%) 
had NIDDM (2 patients unclassified). 
 
Reliability 
Internal consistency of the DIMS was low to moderate. It was estimated by 
calculating Cronbach’s alphas of the subscales. They ranged between 0.60 (specific 
symptoms) to 0.85 (social role fulfilment scale) and 0.94 for the total score. 
Correlations of subscale and total-scale scores ranged between 0.46 (social role 
fulfilment) and 0.97 (non-specific symptoms).  
Test-retest reliability was estimated with repeated administrations over a period 
around one month by 52 respondents out of the 130 of the sample. Correlations 
ranged from 0.61 for the well-being scale, to 0.78 for the diabetes-related morale.  
Validity and Responsiveness  
Construct validity of the DIMS was assessed by examining the correlations of the 
instrument’s scores with the global rating scales and the clinical variables. To this 
end each participant was handed, in addition to the questionnaire, two global rating 
scales of a 99-mm line (Visual Analogue Scale), where the patient was asked to rate 
the control of diabetes and his/her general health (physical, mental, emotional). The 
same scales were presented to clinicians to be completed on behalf of each one of 
the patients. 
 
The developers hypothesised that higher DIMS scores would be negatively 
correlated with the clinical variables that indicate the presence of the disease. Most 
of the DIMS scales showed to be highly correlated with diabetes control and health 
status in both the patients and clinicians ratings. Correlations between DIMS scales 
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and control of diabetes ranged between 0.25-0.55 for patient, and 0.24-0.38 for 
clinicians ratings. Correlations between DIMS scales and general health ranged 
between 0.27-0.47 for patient, and 0.29-0.45 for clinician rating. 
 
Correlations between 38 clinical variables (diabetes type, duration of disease), and 
DIMS scales varied, but they were generally of low magnitude, with the exception 
of HbA1c, which showed some significant correlation with the symptoms and well-
being subscales. Diabetes complications were not significantly correlated with DIMS 
scores. The presence of retinopathy, nephropathy, gastropathy and numerous other 
variables showed no significant correlations with DIMS. 
 
Demographic variables such as age and sex were found to be significantly correlated 
with DIMS scale scores. Age was positively correlated with well-being and morale 
subscales. Sex was strongly correlated to the symptoms, well-being and morale 
subscales, with females scoring lower. Social role fulfilment scale was not strongly 
correlated, although it was in the same direction. There was a strong negative 
correlation between DIMS total score and sex.      
  
The responsiveness of the DIMS was never assessed. 
Burden and Acceptability 
The authors report a 15-20 minutes completion time. The scale is designed for 
completion by people with sixth-grade reading ability. 
There are not any details about the percentage of the patients who responded to the 
test, but only the fact that 90 patients (69.2%) answered all the questions of the 
DIMS. The omissions according to the authors were due either to oversight or 
because some items were not applicable to the respondents, which seems to be nearer 
to reality.    
Alternative forms 
None. 
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Cultural and Language Adaptations 
The 44 item DIMS was translated into Chinese and its reliability and validity was 
assessed for 219 patients with type 2 diabetes at a teaching hospital in Taiwan. The 
mean age of the participants was 63.5 years, 35% of them males, with a mean 
duration of diabetes 8 years (Li et al. 2006). Internal validity of the Chinese version 
was estimated with α coefficients ranging between 0.61 (morale) to 0.78 (symptoms) 
and 0.86 (total score). The results are not satisfactory, they are below the ones of the 
original validation with three out of the four scales scoring less than 0.70. The 
translators blame the small sample size and the low level of literacy for the poor 
results.  Test-retest coefficients are given as ranging between 0.55 and 0.92, but the 
measurement concerns only 20 patients with unclear time intervals. For the construct 
validation of the instrument the team hypothesised that patients with complications, 
poor glucose control and co-morbidities would have lower DIMS scores.  All 
hypotheses were confirmed by the test results.  The DIMS has also been translated 
and validated into French by Mapi Institute and there is also a translation in Italian 
(Proqolid). 
 
Comments 
The authors conclude that the DIMS is a valid measure of health status and disease 
impact. They claim that the significant correlations are in the directions they 
expected. Out of the 266 correlations examined, (7 scales and 38 clinical variables), 
57 of them were above the expected level.  
 
However there are some structural problems with the DIMS. First, there was no 
patient involvement in the initial phase of the DIMS’s development, with all the 
deficiencies that this might cause to an instrument. Second, the developers do not 
seem to pay particular attention to the fact that clinical variables and complications, 
variables that one should expect to have an impact on health status and well-being, 
show only insignificant negative correlations with the DIMS scores. This is against 
their initial hypotheses as well as the prevalent opinion among researchers (Rubin 
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and Peyrot, 1999), but the developers do not value it in their conclusions. Third, the 
authors do not give a satisfactory explanation why although the item reduction and 
scale generation process showed some interesting results related to the poor 
performance of some items and subscales, casting doubts about the value of 
information provided as well for their existence as such, they did not proceed to solve 
the problem, leaving it for future studies. Thus, the structure of the DIMS has to be 
reconsidered before it can be seen as a reliable instrument. Finally, comparison of 
responses to the DIMS of people with and without diabetes and the changes 
occurring to the scores due to a therapeutic intervention, was also postponed for 
future studies. 
 
 
 
6 Diabetes Quality of Life Measure (DQOL) 
Background 
It is the first diabetes-specific instrument ever created and it remains one of the most 
widely used. Diabetes Quality of Life Measure was developed in the USA in the first 
half of the 1980s. It was first introduced in 1988. 
 
The new instrument was designed for adults and adolescents with type 1 diabetes, to 
be used within a controlled randomised clinical trial   (Diabetes Control and 
Complications Trial). The trial compared the efficacy of two alternative treatment 
regimens on complications of Insulin Dependent Diabetes Mellitus (IDDM) 
(Jacobson et al.  1988). The measure was later used for QoL evaluation of Non 
Insulin Dependent Diabetes Mellitus (NIDDM) (Jacobson et al.  1994).  
 
Conceptual and Measurement model 
The objective of the instrument initially was to evaluate the burden of an intensive 
diabetes treatment regimen (Jacobson, 1994). The goal of this treatment was to 
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achieve blood glucose levels near to the level of people without diabetes. The idea 
was that intensive treatment would have effects on patients’ QoL and by measuring 
the patients’ personal experience a measure of QoL would occur.  
 
The scale contains 46 core items and deals with four dimensions of QoL. The first 
one is satisfaction with treatment, containing 15 core items plus three additional 
items addressed to adolescents. The second dimension refers to the impact of 
treatment, containing 20 core items, and 7 adolescent-oriented optional items. The 
third and fourth dimensions, containing 11 core items, deal with worry about 
complications of diabetes in the long run (4 items) as well as worry with 
social/vocational concerns (7 items) and 3 adolescent-oriented optional items.  
 
Item generation 
The items were derived initially by reviewing the literature on psychosocial aspects 
of diabetes and confirmed by type 1 diabetes patient and clinicians’ consultations. 
The instrument has been reviewed and revised by its developers many times and 
substantial changes took place throughout this procedure. During these revisions the 
worry dimension was added as well as the scoring method was changed.    
No further details were reported for the item generation process, except the authors’ 
claim that the strategy for scale development followed was similar to the one 
recommended by Guyatt et al. (1986). 
 
Item reduction/Factor generation 
There is no report by the developers on any formal use of Factor Analysis either for 
item reduction or factor generation of the measure.  The only relevant reference 
found in literature was an informal assessment in a study published in 1992. In this 
study the DQOL was used as a measure to assess the QoL in young adults with type 
1 diabetes in relation to demographic and disease variables. In this study the 46 items 
of the DQOL were submitted to a Principal Component Analysis with varimax 
rotation. This PCA was followed by another two analyses of individual subscales 
(Eiser et al. 1992). The PCA combined with the FAs did not confirm the four 
subscale structure proposed by the Jacobson team. Their analyses resulted in three 
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subscales: impact/worry, social relationships and diabetes concerns. However, this 
study could not be considered reliable as the data used were from a sample of 69 
patients only, which is too small for an instrument of 46 items.   
 
Scoring method 
Patients have to respond to items on a 5-point Likert scale. Initially, as the score 
increased the situation was considered as deteriorating. Thus, satisfaction rated from 
very satisfied (1) to very dissatisfied (5), situations concerning the impact and worry 
vary from never (1) to all the time affected or worried (5). The scores were presented 
as the total of the items of each dimension divided by the number of items. A low 
score indicated good QoL and conversely high scores indicated a bad one. Later the 
method of scoring changed, because it was considered to be not user-friendly 
(Jacobson et al. 1994). The responses since, have been reverse - scored i.e. positive 
QoL is getting a higher score. The scores are then summed up into a 100 point scale, 
where 0 represents the lowest possible level of QoL and 100 the highest. The row 
scores are converted to 0-100 point scale according to the SF-36 formula (Jacobson, 
1994). 
 
Sample of DCCT study 
The sample of the initial development of the DQOL was randomly selected from the 
21 diabetes centres participating in the DCCT project. 192 responded, 136 (70.8%) 
of whom were adults and 56 (29.1%) adolescents. 190 patients completed fully the 
questionnaire, the mean age of the adults was 28 years. 114 were men (60%) and 76 
women (40%). The mean duration of diabetes was 8 years. 40% of the adults were 
married. 
 
Subsequent studies 
The Parkerson et al. study 
A study, aiming to compare a disease specific instrument, the DQoL, with two 
generic measures, namely the Duke Health Profile (DUKE) and the General Health 
Perceptions Questionnaire (GHP), was published in 1993 (Parkerson et al.  1993). 
The sample for this project consisted of 170 patients with a mean age of 33.7 years, 
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46.5% of them men, 78.6% had at least high education, 63.9% were married and the 
mean duration of diabetes was 15.6 years.  
 
The Jacobson et al. study 
As already has been mentioned, in 1994 the Jacobson’s team (op.cit) published the 
results of another study for DQOL Measure. This time the study concerned adults 
only, 18-80 years of age. According to the authors, the aim of the project was to 
examine the effects of type I and type II diabetes on patient perceptions of their QoL 
and compare the psychometric properties of a generic versus a diabetes-specific QoL 
measure. 5 out of the 6 scales of the SF-36 were used for the comparison. 
There was not any elaborated process in order to adapt the IDDM and adult-
adolescent oriented initial version of the measure to a NIDDM- adult population. 
The authors simply decided that respondents would be included only if they had 
completed 12 out of the 15 satisfaction items, 16 out of 20 impact items, 2 out of 4 
diabetes worry items, and 5 out of 7 social/vocational items. The study took place in 
the out-patient department of a diabetes centre in Boston USA. 240 patients 
participated, 111 of whom with type I diabetes (46.25%) and 129 with NIDDM 
(53.75%). The mean age of type I diabetes patients was 44 years, 52 of them (47%) 
were male, 70 were married (63%), 86 (77.5) of them had at least high school 
education and their mean duration of diabetes was18.8 years.  The 129 type II 
diabetes patients had a mean age of 60 years, 66 of them (51%) were male, 89 were 
married (69%), 75 (58%) of them had at least high school education and their mean 
duration of diabetes was12 years. Of course, all of type I diabetes patients were 
treated with insulin, while 68 (53%) of type II were on insulin treatment, 49 (38%) 
on tablet treatment and 10 (9%) on diet only (ibid).  
 
Reliability 
Cronbach’s α was estimated in the DCCT study ranged between 0.67 and 0.88 for 
the 4 subscales and 0.92 for the total DQOL. The diabetes related worry scale was 
the one that failed to reach the 0.70 limit. In the Parkerson et al. (1993) study alphas 
were lower than the DCCT’s study, ranging from 0.52 (diabetes-worry) to 0.88 for 
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the total DQOL. In the 1994 Jacobson et al. study (op.cit.), Cronbach’s α coefficients 
ranged between 0.47 and 0.87. In all three studies it is obvious that internal 
consistency of the diabetes-worry scale is not at a satisfactory level.  
 
Test-retest reliability showed that the DQOL is a fairly stable instrument. It was 
assessed in the DCCT study with a mean interval between the two administrations 
of 9 days and a median of 7 days. Pearson product-moment correlations for adults 
were estimated between 0.78 (social/vocational worry) and 0.90 (for the total 
DQOL). 
 
Validity and Responsiveness  
Content and face validity 
The procedures followed in the item generation stage of the instrument’s 
development that have been mentioned in the relevant section above, advocate for a 
good face and content validity, but for type 1 patients only, who participated in the 
development procedure. 
 
Construct validity 
In the DCCT study the relationship of the DQOL was examined against three 
measures, namely the Symptoms Checklist 90-R (SCL-90), the Bradburn Affect 
Balance Scale (ABS) and the Psychological Adjustment to Illness Scale (PAIS). The 
authors expected significant positive correlations, especially with the total DQOL. 
The anticipated correlation range was 0.30 to 0.70.  
 
Moderate to strong correlations were between the DQOL and each of the three 
measures. Correlations between the DDQOL and the SCL-90 were ranging between 
0.40 (diabetes worries) and 0.60 (DQOL total). The ABS also showed the same 
pattern of positive relationship with the ABS coefficients ranging between 0.27 
(worries) and 0.57 (DQOL total). Similar, although lower, patterns of correlation 
were found between the DQOL and PAIS. The DQOL total was almost at the same 
level with the other two measures, but the worries scales (diabetes and 
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social/vocational) showed insignificant correlations with some of the PAIS scales 
(0.6-0.12). The results show that the initial assumptions of the authors were 
confirmed and prove that the Diabetes Quality of Life is related to psychological 
well-being, affective balance and adjustment to illness, supporting the instrument’s 
convergent validity.  
 
In the 1994 study (Jacobson et al.) construct validity was examined against the 
Medical Outcome Study Health Survey 36-item Short Form (SF-36). 5 dimensions 
of the SF-36 were used namely physical, social and role functioning, pain and general 
health perception. The levels of correlations followed the patterns of the previous 
study, although at a significantly lower level. The impact and satisfaction scales of 
the DQOL measure showed the highest correlations with all dimensions of the SF-
36 (0.59-social functioning to 0.28-pain), while the worry scales reached statistically 
insignificant levels. 
 
The authors claim that demographic factors such as sex and education or even the 
duration of diabetes, are not predictors of QoL. Marital status affects the level of 
QoL with divorced or separated patients experiencing worse QoL than married ones. 
Diabetes complications was the strongest predictor of quality of life as a whole, with 
lower levels of satisfaction and greater impact among patients with more severe ones. 
Finally, treatment type influenced the diabetes related QoL. Patients on insulin 
reported the lowest levels of satisfaction and the greatest diabetes impact compared 
with those on tablet and/or diet patients. 
  
In the Parkerson study the DQOL measure was examined against three generic 
measures namely the Duke Health Profile (DUHP), the General Health Perceptions 
Questionnaire (GHP), and the Health and Daily Living Form (HDL). In a Stepwise 
multiple Regression Analysis, comparing the overall scores of three instruments, the 
DQOL, DUHP and GHP, the total DQOL had 28% of its variance explained by 1 co 
morbidity and 3 psychosocial factors, while the DUHP and GHP explained the 29% 
and 16% of the variance respectively.    
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In the same analysis, selected subscales of the same three instruments were 
compared.  In the DQOL measure, the social/vocational worry subscale explained 
41% of the variance. The variance explained for the other subscales were low to 
insignificant (21% of diabetes worry, 12% of impact and 14% of the satisfaction 
subscale). In DUHP the mental health subscale had the highest explained variance 
(30%). 
 
Last, and probably the most important part of the Parkerson study, was an unexpected 
conclusion that occurred in the end of the study. The Parkerson’s team modified the 
DQOL into sub-measures, one with the pure disease specific scales of the instrument 
and one with the pure generic scales. The investigators predicted that disease-specific 
scores would be more responsive in terms of variance explained by indicators of that 
disease than the scores of the generic subscales.   
 
Contrary to this prediction, the result of the analysis was disappointing for the 
disease-specific scales. The variance explained by the independent variables for each 
of the generic scales was greater than for its disease-specific counterpart. This result, 
combined with the poor performance of the DQOL relatively to the other two generic 
measures, led the team not only to believe to that there was not any advantage by 
using the diabetes-specific DQOL measure rather than generic measures, but also to 
cast doubts upon the value of disease-specific measures as a whole against the 
generic ones.  
 
None of the studies supports the discriminant validity of the instrument. On the 
contrary in some cases the opposite has been indicated. In 1996, a cohort study was 
published by the Diabetes Control and Complication Trial Research Group 
concerning the influence of intensive diabetes treatment on QoL outcomes (DCCT 
1996).  In this study 1,141 (711 on intensive, 730 on conventional treatment) patients 
with type 1 diabetes participated for periods ranging from 3 to 9 (mean of 6.5 years). 
The DQOL failed to discriminate between the two treatment regimens. This 
unexpected result seemed to have created some doubts to the Group about the power 
of the instrument to detect clinically meaningful changes in QoL. However, the idea 
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was rejected putting the blame for this failure on a probable inadequate power of the 
DQOL to detect a relationship between hypoglycaemia and QoL. 
 
This view has not convinced other writers. A few years later the developers of 
another scale, the Diabetes Specific Quality of life Scale, expressed serious doubts 
about the discriminant validity as well as the sensitivity of the DQOL (Bott et al.  
1998). They argued that the measure was not sufficiently sensitive to group 
differences in order to detect clinically meaningful differences in QoL of patients 
undergoing intensive diabetes treatment compared with conventionally treated 
people. Bradley (2001), on the same subject, in a letter to the Lancet argued that this 
failure of the DQOL:  
“...probably had more to do with injudicious totalling of the many varied items, 
which were all given equal weight (irrespective of relevance or importance to 
individual respondents) than to any real lack of impact of intensified treatment on 
QoL”. 
 
Responsiveness 
The responsiveness of the DQOL was never formally assessed by its developers. 
There is an indirect assessment of the four DQOL subscales, when it was used as a 
constituent of another measure, the Diabetes Quality of Life Clinical Trial 
Questionnaire (Shen et al. 1999). After 6 months of insulin treatment of 328 patients 
256 (78%) of them showed an improvement in metabolic control, while 72 (22%) of 
them deteriorated in their HbA1c measurements. The results do not show a 
satisfactory level of responsiveness. For the improved group there was a significant 
improvement relatively to the baseline scores for the satisfaction subscale only (3.8). 
For the worsened group there was not any significant difference from baseline, with 
a highest score of 2.4 for the diabetes worry domain.   
Burden -Acceptability 
Completion time of the QQOL was not reported by the developers. Vague references 
are only made on the “ease of administration” and “easy to use” items (Jacobson et 
al. 1988; 1994). However, bearing in mind that the later developed 15-item short 
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form of DQOL was reported as having 10 minutes completion time (Burroughs et 
al. 2004), it can be concluded that completion time could not be less than 25 minutes. 
 
In the initial study 192 patients out of 210 approached accepted to participate in the 
study (91.4%). The acceptability rate in the second Jacobson study was 88%. In the 
Parkerson study out of the 170 patients participating in the study, 131 responded to 
the DQOL, a rate of 77%.  
Alternative forms 
In 2004 a short form of DQOL was published. It was the Diabetes Quality of Life 
Brief Clinical Inventory. This version was a 15-item questionnaire focused on 
diabetes treatment. The aim of the DQOL-15 was:  
“To provide an instrument for use in routine office visits, with specific actionable 
items to improve provider-patient communication, treatment compliance, and health 
care satisfaction” (Burroughs et al.  2004). 
 
The team mailed an initial version of DQOL (60 items), together with an 8 item 
demographic questionnaire, to 1080 adults with type 1 and 2 diabetes. 498 of them 
responded, giving a participation rate of 48%. The mean age of the respondents was 
51 years, with a mean duration of diabetes 8 years, 47% of them were male, 32% had 
diabetes type 1, and 41% had high school education. 
 
The reliability and validity of the data were compared with the ones of the Jacobson’s 
study, finding comparable results. Then, they selected 26 items predictive of health 
care and satisfaction with diabetes control and they used Principal Component 
Analysis (PCA) to identify items with overlapping content. For type 1 diabetes, six 
items were identified as predictors of satisfaction with diabetes control and another 
nine items as predictors of self-care adherence. For type 2 diabetes, six items were 
identified as predictors of satisfaction with diabetes control and another six items as 
predictors of self-care adherence. 
 
A regression analysis followed to compare the 6 and 9-item models compared with 
the initial 60-item model. The results for the type 1 diabetes patients was that the 
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short models were as effective in predicting overall satisfaction with diabetes control 
and self-care adherence, as the initial 60-item measure. The results were similar for 
the 6-item type 2 diabetes models with the initial 60-item model performing slightly 
better only with self-care behaviours. The models were combined into a 15-item 
questionnaire, the DQOL Short-Form Clinical Inventory. 
 
The reliability of the inventory, in the form of internal consistency, was good 
(Cronbach’s α= 0.85). The short-form correlated strongly with the total DQOL, as 
well as with its subscales. It was also able to explain as mush variance for satisfaction 
and self-care as the initial version of the instrument. According to the authors, these 
results show that very little information is lost by the administration of the short-
form, compared with the one of the initial measure, with obvious advantages 
concerning its use in clinical practice.   
Cultural and Language Adaptations 
In 1996 the DQOL measure was translated into Spanish. The Spanish version 
consists of 46 items, and the authors claim that it achieved a high internal consistency 
(α: 0.90). Also, this version had some outcome similarities with the original i.e. more 
favourable scores among younger patients and adult male respondents (Reviriego et 
al.  1996). They concluded that this may be a useful tool to evaluate the quality of 
life in Spanish speaking patients with diabetes. 
 
The first Chinese version of DQOL appeared in S. Francisco USA, the largest 
Chinese community of the world outside China, in 1997. This version was used in a 
study examining the QoL and social environment of Chinese immigrants with 
NIDDM (Rankin et al.  1997). The developers reported good reliability of the 
instrument with reliability coefficients of the various subscales ranging between 0.85 
and 0.95. The sample of the study though was only 30 patients, thus no reliable 
conclusion could be reached.   
 
Another Chinese version of the DQOL measure that could be used for elderly 
Chinese immigrants with type 2 diabetes was developed in 1999 in Toronto-Canada 
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(Cheng et al. 1999). This was achieved by modifying and translating the DQOL 
measure. The forward and backward translation procedure was followed and the 
translation was reviewed independently by four individuals. The modified Chinese 
version consists of 42 items and 3 scales, which includes satisfaction, impact of 
diabetes and related worries. The scale was tested for reliability, with a sample of 70 
patients, by evaluating internal consistency (Cronbach’s α: 0.76-0.92) and test-retest 
reliability (Pearson correlation: 0.94-0.99). The authors concluded that the results of 
their study indicated that this tool was a reliable and valid tool that could be used for 
elderly Chinese people with type 2 diabetes. 
 
In 2008 a Turkish version of the HRQOL was published (Akinci et al.  2008). This 
version consists of 45 items and four dimensions of QoL. The authors examined the 
association of socio-demographic and clinical characteristics with quality of life. No 
details are given about the translation process, as well as any psychometric properties 
of the measure. 
 
Comments 
According to various sources in literature the DQOL is the most widely used 
diabetes-specific measure (Magwood et al.  2008). This could be explained by the 
fact that it was the first instrument that appeared in the field. It could also be 
explained by the fact that the DQOL is probably the measure that has been tested for 
its validity probably more than any other measure. The developers of the DQOL 
measure claim that it could be useful as part of a battery of measures selected to 
identify general and disease-specific concerns of people with diabetes. Also, it can 
be used on its own as a screening measure in clinical settings to detect patients stated 
or unstated concerns about their disease. 
 
However, the DQOL was designed initially for use with young insulin users (Type 
1). When the measure was adopted to type 2 diabetes patients its performance was 
not satisfactory and its psychometric properties significantly lower. Moreover, a 
scrupulous review of the items shows that, although the DQOL is a disease specific 
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instrument, many items do not seem to be strictly and directly connected to diabetes, 
and could be the result of a broader spectrum of diseases. Among the 15 items of the 
satisfaction dimension at least 7 can get responses that indicate a burdened condition 
which might not be the result of diabetes (items 8, 9, 10, 11, 12, 14, 15). The same 
happens with impact items (6, 8) and the first seven items of the worry dimension. 
In this respect, and to some extent, DQOL acts as a generic measure.  
 
This view could be considered simply as a value judgement, not having an immediate 
effect on the relative value of the DQOL. However, the Parkerson’s team (see earlier) 
extended the matter even further, arguing that there is no advantage in the use of 
DQOL compared with a generic measure. The authors claim that the generic 
instruments they examined provided as much or even more information about QoL 
and its relationships with diabetic and non-diabetic factors, as the DQOL measure.  
This is a very important argument because in its essence invalidates the very nature 
of the DQOL as a diabetes-specific measure.  
 
The measure has not been thoroughly examined for its factor structure. There is not 
any reliable reference about using factor analysis for assessing the dimensionality of 
the DQOL. Doubts about the structure of the DQOL measure have been casted as 
early as 1994 when Bradley, although she accommodates in her book a chapter 
written by the main author of DQOL Jacobson and his associates, she points out the 
lack of empirical evidence concerning the structure of the measure (Bradley, 1994). 
The only study that performed FA to assess the structure of the DQOL, as it has been 
accepted, was unreliable due to the small sample size. Nevertheless, the study casts 
doubts on the structure of the DQOL that the developers did not try to clarify in their 
subsequent studies.  It could be an oversimplification to put the blame for all the 
above discrepancies upon this omission, but factor analysis would probably be of 
some help to improve the measure. This view is supported by the findings of the 
Burroughs et al. study (op.cit.), where it was proved that the 15-item Brief Clinical 
Inventory had the same predictive value with the original measure.  
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Another shortcoming of the DQOL could be considered the fact that although it was 
created specifically for clinical trials of insulin treated patients its discriminant 
validity has been seriously disputed and its responsiveness has not been proved. 
Also, the DQOL is a lengthy instrument, lacking of good evidence that its length is 
necessary to serve its purpose. However, despite the fact that it is a widely used 
instrument no attempt has been made to give some convincing answer to all these 
criticisms. 
 
 
7 Diabetes Quality of Life Clinical Trial 
Questionnaire 
Background 
The development of the Diabetes Quality of Life Clinical Trial Questionnaire 
(DQLCTQ) started in 1993. The early development stages took place in the USA 
and France and later stages of the study proliferated to Canada and Germany.  In this 
respect it the only instrument developed on a multinational basis.  Another ‘novelty’ 
of the instrument was the publication of a study that used the DQLCTQ two years 
before its development and validation were published (Kotsanos et al.  1997). The 
results of the whole study were reported in 1999 by Shen et al. (1999). This 
publication contained a revised version of the instrument the DQLCTQ-R.  
 
Conceptual and Measurement model 
The aim of the authors was to develop and validate a questionnaire for use in 
multinational clinical trials of patients with type I and II diabetes, which would 
include all health related quality of life domains. 
 
Item generation 
The first stage of the study was to identify the domains of importance to patients with 
diabetes. To do this 30 patient focus groups from San Francisco - USA and Lyon – 
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France were conducted, 23 of them with type I and 7 with type II diabetes. 
Additionally, a panel of 11 expert clinicians from the same places gave its views on 
the subject.  
 
In the second stage a search in literature took place, aiming to identify existing 
generic and disease specific HRQoL instruments, which contained domains relevant 
to the ones identified by the patients and clinicians. The questionnaires reviewed 
included the Diabetes Quality of Life Measure (DQoL), the Questionnaire on Stress 
in Diabetes, The Hypoglycaemia Fear Survey (HFS), the Health Insurance 
Experiment, and the Medical Outcome Study (MOS). The developers had to create 
some new items related to stigma, treatment satisfaction and symptoms, due to lack 
of relevant domains in the existing instruments. The end-result of this synthesis was 
a 293- item draft questionnaire.   
 
Item reduction/Scale generation 
The draft questionnaire was evaluated for reliability and validity, at 5 clinics and 
diabetes centres in the USA. 123 patients participated in this pilot study, 51 (41%) 
of which had type I diabetes and 72 (59%) type II. 58 of the patients completed the 
questionnaire in a second administration which took place 7-10 days after the first 
administration. The data were used to assess the test-retest reliability of the draft. 
Due to the small size of the sample the results of the validation process were not 
worthy to be reported, but they were taken under consideration for the next stage of 
the questionnaires’ development. 
  
The results of the pilot study, the existing literature, the focus groups, and the experts 
were used for item reduction, in order to produce an acceptable and practical 
instrument for use in clinical trials. Redundant items or domains were removed and 
domains with poor scores in the reliability and validity assessment were eliminated 
or modified. Two new domains, treatment satisfaction and treatment flexibility were 
created, aiming to focus on insulin - specific comparisons. 
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This item-domain reduction process produced a questionnaire, the Diabetes Quality 
of Life Clinical Trial Questionnaire (DQLCTQ), consisting of 142 items covering 
20 domains. 28 items in total were drawn from the generic instruments, i.e. the MOS 
SF-36 and SF-20 covering General health (1), Comparative health (1), Physical 
functioning (6), Global role functioning (1), Global difficulty functioning (1), Social 
functioning (1), General social functioning (1), Energy/fatigue (5), Health distress 
(6), Mental health (5). 
 
The Diabetes Quality of Life Measure (DQOL) was used to develop 59 items out of 
the four DQOL domains i.e. Satisfaction (18), Impact (27), Social worry (7) and 
Diabetes worry (7). 17 Worry items were drawn from Hypoglycaemia Fear Survey 
(HFS). 31 new items were developed covering treatment satisfaction (3), treatment 
flexibility (10), social stigma (4), frequency of symptoms (7), and bothersomeness 
of symptoms (7). Last, 3 self-efficacy and 4 demographic questions were added 
making a final total of 142 items comprising 34 domains both of generic and 
diabetes-specific nature. 
 
The instrument was translated into German and French to be used in the 
multinational clinical trials. The translations followed the forward-backward 
translation process with in-depth interviews for cultural adaptation. The QQLCTQ 
was then used in randomised clinical trials in Canada, France, Germany and the 
USA. Data from the two largest multinational trials were used to evaluate reliability, 
validity and responsiveness of the questionnaire. 
 
Scoring method 
Respondents are asked to score on scales that vary for each domain and range from 
1-5 to 1-7 with higher scores indicating better quality of life. A summary score is 
calculated for each domain, which is the average score for the questions answered, 
to represent patient’s rating. All domains are then converted to a 100-point scale. 
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The sample 
A total of 942 patients from the four countries participated in the two studies. 72 
(7.6%) of them were from Canada, 84 (8.9) from France, 188 (20%) from Germany, 
and 598 (63.5%) from the USA.  468 (49.7) of them had type I diabetes and 474 
(50.3%) diabetes type II.  533 (56.6%) of the total sample were males. The mean age 
for type I patients was 33.8 years and for type II was 58.2. The mean duration of 
diabetes for the total sample was 12.6 years. Their mean baseline HbA1c was 8.6 (SD 
=1.6) (Kotsanos et al.  1997). 
 
Reliability 
Cronbach’s α was calculated for all domains of the DQLCTQ. The results 
demonstrated moderate to high coefficients for all but two domains. Social worry 
with α: 0.62 and diabetes worry with α: 0.53. The newly developed domains showed 
good results. Treatment satisfaction: 0.81, treatment flexibility: 0.89, social stigma: 
0.84, frequency of symptoms: 0.77 and bothersomeness of symptoms: 0.80. 
 
Test-retest reliability was assessed during the pilot study. The results should not be 
considered as reliable as the sample was small and a fraction of it, 58 patients, were 
used during the pilot study. These patients completed the draft version of the 
questionnaire 7 to 10 days after the baseline.  Results are not available for all 
domains, but for those which produced results ICC were above 0.70 with the 
exception of diabetes worry (0.56) and social stigma (0.49). 
 
Validity and Responsiveness  
Three groups of patients were used to assess the construct validity of the DQLCTQ. 
Disease-specific and demographic factors were used for the classification. The first 
group was based on diabetes type, the second one on gender and the third one 
metabolic control. The hypothesis was that male patients with type I diabetes and 
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tight metabolic control and good self-perceived control of diabetes would have better 
metabolic control than any other group. 
 
The results confirmed the initial hypotheses. Patients with good control of diabetes 
had significantly higher scores in all DQLCTQ domains compared with the ones 
with low diabetes control. Patients with tight metabolic control appeared to have 
significantly higher scores in most domains and in only three domains scores were 
higher but not at a significant level (physical function, social worry and worry HFS). 
Diabetes type I patients had significantly higher scores in most domains with the 
exception of four domains where differences were not at a significant level (social 
worry, worry HFS, treatment satisfaction, treatment flexibility). 
 
A similar mode occurred with gender. Male patients scored significantly higher than 
females in most domains, with insignificant differences in satisfaction, impact, and 
social worry. An insignificant but reversed difference occurred in the social stigma 
domain where women scored higher than men. The social worry domain was the 
only one that failed to discriminate among the different groups (diabetes type, 
metabolic control and gender). The worry HFS subscale failed to significantly 
discriminate between the type of diabetes groups and metabolic control groups. All 
other domains were able to discriminate at least 3 out of the 4 disease and 
demographic factors.  
 
Responsiveness 
The responsiveness of the DQLCTQ was assessed (Shen et al. 1999) with 328 
patients after 6 months of insulin treatment. 256 (78%) of them after the six months 
treatment showed an improvement in metabolic control while 72 (22%) of them 
deteriorated in their HbA1c measurements. For the improved group there was a 
significant improvement of the satisfaction and treatment satisfaction domains 
relatively to the baseline. For the worsened group mental health was significantly 
worse compared with the baseline. When the differences between the groups are 
compared, by comparing changes from the baseline, the four domains of health 
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distress, mental health, satisfaction and treatment satisfaction showed significant 
changes, indicating good responsiveness to changes of the DQLCTQ. 
 
Alternative forms 
The results of the validation that followed the clinical trials were used as the basis 
for a further reduction of the DQLCTQ. The psychometric properties and the 
correlation structure between the domains were examined. The result of this process 
was a short form of the original instrument, the DQLCTQ-R, with 8 domains 
containing 57 questions. These domains are: Physical function, energy/fatigue, 
health distress, mental health, satisfaction, treatment satisfaction, treatment 
flexibility and frequency of symptoms.  
 
All single item domains were excluded from the revised questionnaire. Also both the 
worry domains of the DQOL as well as the stigma domain were excluded due to low 
reliability. The HFS worry scale was also deleted because it failed to discriminate 
between the sub-groups of the sample (diabetes type and metabolic control). The 
bothersomeness and impact subscales were not included in the revised version due 
to their high correlations with the frequency of symptoms and satisfaction subscales 
respectively. 
 
The DQLCTQ-R demonstrated high internal consistency with αs, for the five 
measured domains, ranging between 0.77 and 0.91. These scores classify the 
DQLCTQ-R among the most reliable diabetes-specific instruments. Intraclass 
Correlation Coefficients (ICC) for the same domains ranged between 0.74 and 0.90.  
The five domains showed that they could discriminate between the patients 
subgroups i.e. type 1&2 diabetes, male-female, tight-poor metabolic control, and 
good-poor self perceived control of diabetes.   
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Burden and Acceptability 
The authors claim that the DQLCTQ-R is an easy administered instrument with a 
completion time of 10 minutes. This claim seems to be very disputable by comparing 
the revised questionnaire with other similar ones. The short form of DQOL for 
example, the instrument from which some items of the DQLCTQ are derived, 
contains only 15 items, and it is reported to have the same completion time of 10 
minutes with the 57 item revised version (Burroughs et al.  2004).  
Cultural and Language Adaptations 
The instrument is created for use in clinical trials on multinational settings. Thus, it 
is the only instrument where translation and adaptation was part of the development 
process. A German and a French version of the instrument were created before the 
instrument was even published. Unfortunately, the attempt stopped and since then 
no other translation has been reported. 
 
Comments 
The DQLCTQ is an instrument containing generic as well as diabetes specific items. 
It is focused on clinical trials and has the advantage of being tested for its 
psychometric properties under real circumstances i.e. during various clinical trials at 
a multinational level. According to the authors the DQLCTQ especially in its revised 
form, could be a reliable, valid and comprehensive instrument in clinical trials. To 
this end further evaluation and improvement in future studies are necessary.    
 
However, the fact that the development of the DQLCTQ was not the result of primary 
research should not be ignored. In this respect the DQLCTQ was not an original 
instrument. It was rather a compilation of already existing generic and disease-
specific measures, aiming to provide a tool in clinical trials. This peculiarity led some 
reviewers to believe that the DQLCTQ should not be considered as a distinct 
instrument, worthy to be separately reviewed (Garratt et al.  2002b).    
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Nevertheless, this very nature of the instrument has its own advantages and 
disadvantages. By including entire parts of the most widely generic and disease-
specific instruments, gives the physician the opportunity to assess simultaneously 
health status, treatment satisfaction and the diabetes-related quality of life. However, 
by including the DQOL in the questionnaire the new instrument does not improve 
any of its properties, but inherits all the handicaps that the old instruments carries.    
 
According to the authors the process of questionnaire development and validation 
followed the Streiner-Norman and the McDowell- Newell model.  This seems to be 
true as far as the validation process is concerned. However, the item generation and 
scale generation process is not in agreement with the proposed by the above writers 
methods. Contrary to what the authors of the questionnaire imply, Streiner and 
Norman (2008) clearly state that items should be generated from five different 
sources: patients, theory, research, clinical observation, and expert opinion.  
Compiling tests by collecting items or whole domains from previous inventories is 
by no means the suggested method.  Streiner and Norman strongly express their 
opposition to this phenomenon by quoting two rather sarcastic comments by 
Goldberg and Angleitner concerning items that move from one inventory to another 
(ibid).  
 
The method followed by Shen’s team was rather a trial-and-error process than the 
methods proposed by the above authors and supported by FA or PCA. Their method 
seems to be more similar to what Nunnally and Bernstein years earlier described as 
“shotgun empiricism”. This is the process of gathering large quantities of data and 
then using statistical tools to get something meaningful, or studying variables 
without a theoretical basis. The two writers express their opposition to such methods 
by concluding that:  
“Progress in theory must be guided by theories rather than by random 
efforts to relate things to one another”.  
 
These words by Nunnally and Bernstein could serve as a final comment for the 
DQLCTQ. 
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8 Diabetes-Specific Quality-of Life Scale 
Background  
The Diabetes-Specific Quality-of Life Scale (DSQOLS) was developed in Germany 
by U. Bott and his associates by mid of the 1990s. In English it was first published 
in 1998 (Bott et al. 1998). It is a 64-item scale aiming to assess diabetes-specific 
quality of life and preference-weighted treatment satisfaction. 
Conceptual and Measurement model 
The DSQOLS was designed to assess four components of quality of life, namely 
physical, emotional, social burdens, as well as daily functioning of people with type 
1 diabetes (ibid). 
 
Item generation 
Its development was based on two already existing measures, developed in Germany, 
and structured group discussions with patients. The selected items were reviewed for 
item selection and word improvement by two physicians, a diabetes educator, a diet 
specialist and two pedagogues. The emerged scale consisted of 64 items covering 
seven domains. Two of them with 20 items concern treatment (treatment goals 
with10 items, treatment satisfaction with 10 items),  and five concerning diabetes-
distress with 44 items (physical complaints 10 items, emotional burdens and worries 
8 items, social problems 9 items, daily functions 11 items, and diet restrictions 6 
items). 
 
Item reduction – scale generation  
Principal Component Analysis was performed for the 44 items concerning diabetes 
distress in order to explore the structure of the DSQOLS. 6 factors emerged 
explaining 50.1% of the total variance. Four items that showed unsatisfactory results 
on factor loading and one in item-scale correlation were removed, leaving a scale 
with 39 items. The 6 factors are: Social relations with 11 items, leisure time 
flexibility with 6 items, physical complaints with 8 items, worries about future with 
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5 items, diet restrictions with 5 items, and daily hassles with 4 items. Last, the 6 
factor structure of the measure that had been emerged was confirmed by 
Confirmatory Factor Analysis. 
Scoring method 
Each of the 39-item quality of life scale is rated on a six-point Likert scale, with 
higher scores indicating better quality of life. Preference-weighted treatment 
satisfaction is calculated by rating patients’ treatment goals on a six-point scale, 
multiplied by the corresponding degree of satisfaction with the achievement of these 
goals. 
 
Sample 
657 patients all with type 1 diabetes agreed to respond answering the DSQOLS 
questionnaire; 58% of them were male, with a mean age of 36 years, and a mean 
duration of diabetes of 18 years. The patients were selected from lists of primary care 
physicians randomly selected from the district of Northrhine – Germany.  
Reliability 
Cronbach’s α was calculated for each subscale of the DSQOLS. The results were to 
a great extend satisfactory ranging between 0.70 (daily hassles) and 0.88 (social 
relations). Cronbach’s α for the 10 items of the treatment satisfaction scale was 0.77. 
Validity and Responsiveness  
Content – face validity 
The participation of patients, health professionals, and pedagogues in the item 
development process and the review of the emerging instrument gives evidence 
about content and face validity.  
 
Construct – convergent validity 
The measure was validated for type 1diabetes only. Convergent validity was assessed 
against a generic measure, the 6-item Positive Well-being Scale.  All six subscales 
as well as the treatment satisfaction subscale were significantly correlated with the 
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Well-being scale. Social relations, physical complaints, and leisure time flexibility 
showed the highest with r = 0.53, 0.52 and 0.52 respectively. They were statistically 
weak correlations between physical complaints, treatment satisfaction and worries 
about future and glycaemic control with r ranging from -0.17 to -0.22 while all the 
other subscales’ correlation ranged from 0.00 to 0.10.    
 
Diabetes duration and age showed high correlations with physical complaints and 
leisure time flexibility, which implies that younger patients and shorter duration of 
diabetes enjoy a better quality of life. The fact that age and duration of diabetes were 
highly correlated only to physical components provides, according to the authors 
further evidence for the construct validity of the scale. 
 
Discriminant validity 
The type of insulin intake was significantly related to worries about the future, leisure 
time flexibility and diet restrictions with insulin-pump users scoring higher scores 
than patients injecting insulin. Also, patients with a flexible adaptation of insulin 
dosage (i.e. insulin intake according to food consumption), achieved better scores in 
social relations, leisure time flexibility, worries, and diet restrictions. 
 
Diabetic complications were highly related to restrictions on quality of life. The 
degree of retinopathy (i.e. loss of vision), was found to have a linear relationship 
with low quality of life scores. Thus, social relations, leisure time flexibility, physical 
complaints, and worries about the future were strongly affected by visual 
impairment. Patients with diabetes-related nephropathy had also significantly lower 
scores in leisure time flexibility, physical complaints, worries about the future, as 
well as positive well-being. Treatment satisfaction subscales were not affected as 
much as the quality of life ones.     
 
Last, patients with higher social status achieved higher scores in the worries about 
the future and physical complaints subscales. Also, patients living with a partner 
showed higher scores in the treatment satisfaction scale. 
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The results on the discriminant validity of the DSQOLS combined with relevant 
results reported for the generic Positive Well-being Scale support, according to the 
authors, the superiority of disease-specific measures relatively to the generic ones. 
This view, although it is probably correct, does not seem to be absolutely justifiable 
in this case, taking into consideration that the comparison was between the DSQOLS 
and a 6-item generic measure, which by no means could be considered as a gold-
standard criterion. Nevertheless, the DSQOLS has proved sufficient discriminant 
validity. 
 
Responsiveness 
The responsiveness of the DSQOLS has not been assessed.  
 
Subsequent studies 
In 2003 Bott et al. published the results concerning a clinical trial for the treatment 
of diabetes patients with an insulin analogue. In this trial the DSQOLS was used and 
assessed for its properties. Cronbach’s α was calculated for all subscales achieving 
very good results. The 6 quality of life scales as well as the preference-weighted 
treatment satisfaction scale showed results ranging from 0.83 to 0.89. The instrument 
was used to assess the differences between the patients receiving different 
treatments. The changes in scores from baseline to 6 months show significant 
improvements in most quality of life domains for both treatment groups. The results 
were even better for the treatment satisfaction domains of the DSQOLS. The authors 
concluded that the questionnaire comprehensively covered the crucial diabetes-
specific quality of life domains. 
 
Burden and Acceptability 
Questionnaire’s completion time, according to the authors, is 10-20 min.  657 
patients accepted to respond, out of the 684 that were initially asked (96%).     6.5% 
of them declined or failed to complete the questionnaire.  
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Alternative forms 
In the Bott et al. study (ibid.) a version of DSQOLS was used containing another 
five dimensions. These dimensions were: fear of hypoglycaemia, blood glucose 
fluctuations, burdens of hypoglycaemic events, fear of genetically engineered 
insulin, and self-efficacy.   
Cultural and Language Adaptations 
The instrument was developed in Germany and the English version is an adaptation 
that has not been tested for its properties. 
Comments 
The Diabetes Specific Quality of Life Scale was developed, validated, and assessed 
for its psychometric properties in a sample of people with type 1 diabetes. It appears 
to have high internal consistency, and good construct, convergent and discriminant 
validity. Thus, the authors are justified in supporting that this tool to be a reliable and 
valid measure of quality of life related to diabetes. They state that it is a tool that 
reaches beyond traditional treatment satisfaction scales and that it achieves sufficient 
sensitivity to distinguish between different treatment and dietary regimen. Moreover, 
the DSQOLS is a measure capable to assess treatment satisfaction together with the 
QoL. It can be used to determine patients’ QOL according to treatment and diet 
regimens and to detect social inequalities. This could be represent a considerable 
advantage, as the assessment of individual treatment goals may be helpful in 
preparing individual treatment strategies. 
 
Nevertheless, the DSQOLS has certain disadvantages that not only prohibit its use 
for a study like this, but they also reduce its value as a quality of life measure. First, 
it concerns type 1 diabetes patients only, practically narrowing its use to relevant 
clinical trials. Second, it is a relatively lengthy instrument with 39 items addressing 
quality of life. Last and probably most important for the value of the instrument, is 
that it was developed, validated, and used only in German. It was translated into 
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English, with the assumption probably that the instrument keeps its properties in the 
new version, as no validation publication or use of this translation was found in 
literature.  The decision to include the DSQOLS in this review was only marginal as 
it well accepted by writers that the properties of an instrument are not ‘built-in’ 
characteristics (Nunnally and Bernstein, 1994; Streiner and Norman, 2008), and 
when major changes take place, such as a translation, they have to be tested under 
their new form. Bott et al. seem to ignore Bradley’s suggestion that “the 
psychometric properties cannot be assumed to travel well” (Bradley, 1996). 
 
 
9 Diabetes - 39 
Background 
The development of Diabetes 39 (D-39) started in the mid 90’s in N. Carolina- USA 
and first appeared in literature in 1997. It was developed by GJ Boyer and JA Earp.   
Conceptual and Measurement model 
The D-39 is an instrument designed to assess diabetes quality of life. To do this D-
39 tries to shed light on issues of importance to patients with diabetes and to 
determine their unmet needs (Boyer and Earp, 1997).  The authors clarify from the 
beginning that throughout the instrument development no attempt was made to 
define quality of life for the respondent. On the contrary, the developers asked the 
respondents to select items that best express their own perception of quality of life, 
by asking them to indicate the impact of each item on it.  
 
Item generation 
To create an initial set of 93 quality of life items the authors reviewed the literature 
on diabetes and quality of life. This was followed by a series of unstructured 
interviews with diabetes physicians, educators, pharmacists and patients. The 93 
items were grouped into 10 categories: Medication, control, anxiety-worry, energy-
mobility, sleep, food restrictions, self-acceptance, social-peer burden, co-morbidity 
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and sexual functioning. The 93 item QoL questionnaire was followed by another 26 
item questionnaire, covering demographic, general health and diabetes specific 
terms. The set of questionnaires was sent to 1000 patients of a diabetes care centre 
in Cary-NC, 516 of which returned usable anonymous questionnaires. 
 
Item reduction - factor generation 
A series of factor analysis with orthogonal rotation was performed, which ended-up 
in a pilot instrument consisting of 42-item questionnaire in six domains: Energy-
mobility (14 items), diabetes control (12 items), anxiety-worry (6 items), social-peer 
burden (5 items), sexual functioning (3 items) and diabetes medication (2 items). In 
the next phase of development (Iowa and N. Carolina) the pilot instrument was 
subjected to confirmatory factor analysis and assessed for reliability and validity. 
Factor analysis revealed five factors with eigen values >1, which together accounted 
for about 90.4% of the total variance. Item-scale correlation ranged from 0.45 to 
0.83.  By reviewing the results, the final version of the instrument emerged, with 39 
items in five domains. These domains are: Energy-mobility (15 items), diabetes 
control (12 items) anxiety-worry (4 items) social-peer burden (5 items) and sexual 
functioning (3 items).  
 
Samples 
The sample used for the first phase of the instruments development of 516 
respondents (the Cary sample). 240 of them were males (45.5%), mean age of the 
total sample was 52.4 years and the mean duration of diabetes was 13.2 years. 159 
(32.5%) patients had IDDM and 330 (67.5%) had NIDDM. 125 (27%) of the type II 
patients were on tablet/diet treatment. 64 patients (11.8) were of Hispanic or Mexican 
origin the rest of the sample were Caucasians (ibid). 
 
The sample of the Iowa study was 165 patients, recruited from a general practice 
site. 74 (45%) of them were males, the mean age of the sample was 61.6. years and 
the mean duration of diabetes was 11.5 years. 31 (19%) patients had IDDM and 128 
(81%) had NIDDM. 73 (44%) of the type II patients were on tablet/diet treatment. 
All patients were Caucasians. 
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The N. Carolina sample consisted of 262 outpatients from a hospital diabetes clinic. 
93 of them were male (36%), mean age of the sample was 55.3 years and the mean 
duration of diabetes was 10.1 years. 25 (9.5%) patients had IDDM and 218 (90%) 
had NIDDM. 91(35%) of the type II patients were on tablet/diet treatment. 142 
patients (53.4) were Afro-Americans, 109 (41.8%) of the sample were of Caucasian 
origin and the rest were of Hispanic, Asian, or American-Indian origin. 
 
The type I and type II diabetes classification of the patients in the samples is  crude 
and scientifically marginal, as they used the age of 30 years as a cut-off point and 
those over 30 were classified as type II patients, while the under 30 ones as type I 
diabetes patients.       
 
Scoring method 
The instrument uses a modified Visual Analogue Scale (VAS). The scale ranges 
from 1(not affected at all) to 7 (extremely affected). Thus a high score indicates bad 
QoL. The actual measurement of each response requires a transparent ruler, which 
spots the location of the response, measuring it to the nearest quarter of a centimetre. 
The scores derived from the items are linearly transformed to 0-100 scales, with the 
maximum 100 indicating the highest possible negative impact of the disease on 
quality of life.   
 
Reliability 
Internal consistency of the six scales pilot instrument (Cary study) as measured by 
Cronbach’s α, ranged from 0.81 to 0.92. Cronbach’s α for the final five scales 39-
item questionnaire in the Iowa study ranged between 0.82 and 0.93 and for the 
Carolina study from 0.81 and 0.93. 
A recalculation of α for patients over 75 years of age and for patients with less than 
high school education produced values well above the minimum acceptable level of 
0.70, supporting the internal validity of the instrument. 
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Validity and Responsiveness  
The validity of the pilot questionnaire was assessed by asking the respondents to rate 
their overall quality of life. The responses to this global rating were correlated with 
the scores of the six scales of the D-39. There were statistically significant 
differences among patients with various degrees of diabetes severity in four out of 
the six domains. IDDM patients scored higher than those with NIDDM. Treatment 
and duration of diabetes did not cause any differences in scale scores. Patients with 
no complications had low mean scores on five scales. Those with many co morbid 
conditions had the highest scores i.e. poor quality of life. Patients who reported 
depression as a co morbid condition scored significantly higher on all scales 
compared with those without depression. 
 
Women scored higher than men on the energy-mobility, control and anxiety- worry 
scales, while men proved to have more troubles on sexual functioning than women. 
Single people felt a greater impact on energy-mobility and anxiety-worry scales, but 
less impact on sexual functioning than married ones. These differences, according to 
the authors, were not always significant, but they were in the anticipated directions. 
Nevertheless, neither scores assessing the magnitude of the differences were ever 
published, nor initial hypotheses had been formed to support their argument. 
 
The five scale 30-item instrument was validated in the Iowa and Carolina studies 
with the use of the SF-36. Due to the reverse scoring method of the two instruments, 
negative correlation values, indicating positive relationship, between the two 
measures were predicted. As predicted, strong negative correlations were observed 
between energy-mobility scale of the D-39 and physical functioning of the SF-36 (r= 
-0.71), anxiety-worry of the D-39 and mental health of SF-36 (r= -0.64) and social 
burden of the D-39 and social functioning of the SF-36 (r= - 0.48).  
  
Similarly to the Cary study, correlations between the five scales of the D-39 and the 
global quality of life item were strong.  High overall quality of life was reported by 
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those with low scores on the D-39 scales, with the Iowa sample scoring lower than 
the Carolina one. Also, similar findings with the Cary study were found with the 
severity of diabetes and IDDM and NIDDM patients, although for the Carolina 
sample the scores for control and anxiety-worry scales were not significantly 
different between the two groups. In the Iowa sample all scales, except the anxiety-
worry one showed significant difference among the diabetes-type groups. 
 
Patients with severe co morbidity scored high on the energy-mobility scale. Men 
reported a worse situation than women only on the sexual functioning scale. Patients 
over 75 years of age scored higher than younger ones on energy-mobility. Younger 
patients scored higher on control, anxiety-worry, and social-peer burden. Patients 
reporting that diabetes was an obstacle to their employment had consistently high 
scores compared with those reporting no employment disability. 
 
Responsiveness was not assessed. 
 
Burden and Acceptability 
Out of 1000 questionnaires sent during the first phase of the development only 542 
were returned. The resulting response rate of 53.2% seems to be low and considering 
that only 516 of them were characterised as “usable” the rate drops to 51.6%. 
However, this was the “pilot” questionnaire and no conclusion could be drawn from 
this. The 42-item instrument in the Iowa study had a better performance. Out of the 
236 mailed questionnaires 170 returned, giving a satisfactory response rate of 73.3%.  
Acceptability in the Carolina study was even lower than the initial one. Out of 644 
questionnaires sent to patients only 290 returned, yielding a response rate of 45.8%. 
 
By comparing the responses, it is obvious that no safe conclusion could be drawn 
about the acceptability of the questionnaire. The fact that the 92-item pilot instrument 
was more acceptable than the 42-item version does not seem reasonable. Also the 
two studies in Iowa and Carolina, with the same instrument, had a difference in 
response rates of 27.5%, which again lacks any reasoning. The authors do not seem 
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to have an answer to this. They only make a general comment, that by looking at 
background data there not any reasons to believe that non-respondents were in any 
way different from respondents. This is another reason to conclude that there should 
be a problem in the administration of the instrument, especially in the Carolina 
project. 
 
The VAS used is considered to be an easy for the respondent scoring method. A VAS 
is easily administered by old people as well as by people of low literacy.  However, 
this method could create problems to people with visual impairment. Also, the 
measurement of the scale with a transparent ruler and quarters of centimetres with 
rounding to the highest quarter in case a response falls in-between two quarters seems 
to be a difficult task for the test administrator.  
 
It was difficult during this review to understand the scoring of the instrument. After 
communicating with the authors, Dr Greg Boyer sent the scoring instructions as well 
as the scoring software. Only a simple glance at the process justifies the concluding 
remark, made by the authors in the original paper, suggesting that this method has to 
be reconsidered, as its precision is unnecessary for the overall scale score. 
 
Alternative forms 
None. 
Cultural and Language Adaptations 
The Diabetes-39 has been translated into several languages. Soon after the 
publication of the original, the instrument was translated and validated into Danish, 
Finnish, Norwegian and Swedish (Lloyd et al.  1997). 
The translated versions showed good internal consistency with Cronbach’s α well 
above 0.70 in all countries. Correlations between SF-36 and D-39 scales were in 
most cases above 0.40, indicating satisfactory construct validity.  
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There are translation in French, German and Italian but no validation studies were 
found. The D-39 has also been adapted to UK English. The D-39 was translated and 
validated into Spanish for Mexico, but the study is published in Spanish, with 
abstract only in English (Lopez-Carmona and Rodriguez-Moctezuma, (2006). The 
instrument was very recently translated and validated into Chinese-Taiwan. Its 
validity was tested against a generic measure, the SF-36 (Huang 2008). Cronbach’s 
α for all subscales was high, ranging between 0.82 and 0.93. Construct validity was 
assessed using factor analysis. Known-groups validity was estimated by using 
various laboratory indicators. This validation process showed that the D-39 has 
satisfactory levels of validity, although compared with SF-36 it was not proved in all 
respects superior in assessing QoL.     
Comments 
The Diabetes-39 is an instrument assessing the QoL of type 1 and 2 diabetes patients 
by examining the restrictions that diabetes poses in 5 dimensions of life (energy and 
mobility, diabetes control, anxiety and worry, social burden, and sexual function). 
                                                                                                                                                                                                                                                                       
The D-39 seems to be a reliable a valid instrument. However, in the item generation 
phase of the development though, the authors give a vague reference to patient 
participation, without explaining their contribution or give details about the number 
or characteristics of the participants. For item reduction and scale generation the 
authors used factor analysis and produced an instrument, which in its final version 
showed remarkable internal consistency with α coefficients well above the limit of 
0.70. Test-retest reliability has not been reported neither in the original study nor in 
the studies followed for translation and adaptation of the D-39 in N. Europe, which 
took place with the participation of the original senior author.  
 
The D-39 has been assessed for validity by the use of SF-36 and a self-reported 
global item. Strong correlations of its five scales have been found with the global 
QoL item, as well as with most of the nine scales, indicating good validity of the 
instrument. By using demographic variable it was proved that the D-39 can 
distinguish differences between groups of patients. Nevertheless it should be noted 
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here that these differences are not quite clear, between the two samples of the second 
phase. This could be explained by differences in either the administration of the 
instrument or its acceptability that seem to be major disadvantages for the 
instrument. The scoring method could also have played a role for these disparities. 
 
 
10. Problem Areas in Diabetes 
Background 
The Problem Areas in Diabetes (PAID) scale was developed and tested by W. 
Polonsky and his associates in the Joslin Diabetes Centre in Boston USA as a tool to 
measure psychological adjustment to diabetes. It was first published in 1995 
(Polonsky et al.  1995). Soon afterwards, in 1997, another study was published, 
concerning the validation of the instrument (Welch et al.  1997). The validation 
process continued with another two studies one in 2000 (Snoec et al.  2000) and the 
other in 2003 (Welch et al.  2003). In all studies W. Polonsky, the main author of the 
PAID scale, was a member of the evaluating teams. 
Conceptual and Measurement model 
The Problem Areas in Diabetes is a scale aiming to tap the breadth of diabetes-related 
emotional distress, by trying to trace patient’s perspectives on current emotional 
burden of diabetes. The questionnaire, according to its authors, is designed as a 
screening measure for clinical research, as well as to help clinicians to identify 
patients with high level of diabetes distress and formulate interventions on specific 
problem areas of diabetes. 
 
The PAID Scale is a 20 items single factor instrument. Each item covers a unique 
area of diabetes-related emotional problems, as they are frequently reported by type 
1 and type 2 diabetes patients. These problems, related to living of diabetes and its 
treatment, include areas such as interpersonal distress, anger, guilt worry, fear, or 
depressed mood for patients. 
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Item generation    
Items started developing by 10 diabetes experts (physicians, dieticians and nurses) 
and diabetes patient interviews carried out by the W. Polonsky, the test’s main 
author. The created items were pilot-tested with 25 insulin-requiring patients. Some 
items were eliminated and some new ones were added resulting to a 20-item test. No 
details about any theory, literature review or previous experience are given by the 
authors. 
 
Item reduction - Factor Generation 
In the initial publication, by Polonsky et al. (1995), there is no reference about 
empirical assessment of the instrument’s dimensionality. Two years later, in another 
study (Welch et al.  1997) Principal Component Analysis was performed, which 
showed item loadings of >0.30 for all 20 items on one principal component, 
accounting for 52.4% of the total variance. This pattern of loadings proved the 
existence of one factor and supported the summation of the 20 items into a total 
score.  
 
The one factor conclusion of the Welch study was confirmed by another study in 
Amsterdam-the Netherlands, by Snoek et al. (2000). In this study the Principal 
Component Analysis was followed by Exploratory Factor Analyses. A forced 4 
factor EFA with oblimin rotation found four sub-dimensions: Diabetes-related 
emotional problems (12 items), treatment problems (3 items), food-related problems 
(3 items) and social support problems (2 items). In the Dutch study, by reanalysing 
data from the Welch-USA sample, was proved that the 4-factor model was 
statistically superior to the 1-factor model, although this superiority was only 
marginal. 
 
Scoring method 
Initially, patient’s responses were rated on a 6-point Likert scale, with 1 indicating a 
“not a problem” condition and 6 a “serious problem”. The total score was a summary 
score, computed by adding the total item responses and the raw item scores 
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producing a total response ranging between 24 and143. Later, the response scale 
changed to a 5-point scaling. 1 indicates the “not a problem” condition and 4 the 
“serious problem”. The result is converted to 0-100 scale by multiplying the 
summated item score by 1.25.  
 
 
Samples 
The sample for the original study in Joslin Diabetes Centre was 451female patients 
with a mean age of 36.3 years. 82.4% had diabetes type, 17.6% of them had diabetes 
type2. Their mean duration of diabetes was 15.9 years and 39.3% of them had 
completed college. 256 patients responded for the second study in the USA. This 
time the sample was mixed with 47.7% male and 52.3% female patients. Their mean 
age for the total sample was 52.3 years and their mean duration of diabetes15.1 years.  
The onset of diabetes was used as the classification criterion for type 1 and type 2 
diabetes. Patients, who had diabetes under the age of 40, were classified as type1 and 
the remainder were classified as type 2. Thus, 135 (52.6%) patients were classified 
as IDDM and 121(47.3%) as NIDDM, 85(33.2%) of them on insulin treatment. 
 
In the Dutch study 1,472 patients participated, 750 (51%) men and 722 (49%) 
women.  The mean age of the sample was 51 years and the mean duration of diabetes 
16 years. 739 (50.2%) patients were classified as having diabetes type 1 and 701 
(47.6%) as having type 2 (32 patients were not classified due to missing data.). 199 
type 2 patients (13.5%) were treated with tablets and/or diet. This study used also 
data from the second USA sample of the 256 patients. 
 
 
Reliability 
Reliability assessment in the original study found a Cronbach’s α 0.95, indicating a 
high level of internal consistency. Item-total correlations were found in the range 
0.32 to 0.84 with a mean of 0.68 (Polonsky et al.  1995). The second study in the 
USA showed the same high level of α. 
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Findings for internal consistency in the Dutch study were similar to the USA ones 
giving Cronbach’s αs of 0.93 and 0.95 for the total PAID and the two randomly 
divided subgroups of the sample. Examining the internal consistency of the 4 sub-
dimensions of the PAID, found in the Welch study, Cronbach’s αs ranged between 
0.69 (social support) and 0.93 (emotions). 
 
Test-retest reliability was assessed with completion of the questionnaire by 202 
people with a mean period of 66 days after the first administration. Pearson’s 
correlation between the two assessments was 0.83 for the total PAID and for the sub-
dimensions ranging between 0.74 (food) and 0.80 (emotions).  
 
Validity and Responsiveness  
Both types of criterion validity i.e. concurrent and predictive, of the PAID scale were 
tested in the initial study (Polonsky et al.  1995). 
Concurrent validity was assessed by examining the correlations between PAID and 
psychosocial factors, regimen adherence, long-term glycaemic control and 
demographic factors. The Brief Symptom Inventory (BSI), the Bulimia Test-Revised 
(BULIT-R), the worry sub-scale of the Hypoglycaemia Fear Survey (HFS-W), and 
HbA1c were used as external measures. From the BSI, a nine symptom dimensions 
and three global distress indices, only the Global Severity Index (GSI) was used, 
which measures current or past level of symptomatology. 
 
The PAID was highly associated with general emotional distress of the GSI (0.63), 
with fear of hypoglycaemia of the HFS-W (0.57), and disordered eating of BULIT-
R (0.61). Correlations between the PAID and adherence to self-care behaviours of 
the SCI were negative at a moderate to statistically insignificant level (food 0.49, 
exercise 0.09). Glycaemic control and PAID were positively correlated at a moderate 
level (0.30). Age and duration of diabetes had a statistically insignificant level of 
negative correlation with PAID. 
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To determine the predictive validity of the PAID, approximately two years after the 
test’s administration, medical records of 221 patients from the initial sample was 
examined for the most recent HbA1c results. The examination was performed at least 
one year from baseline (average 533 days). Statistical analysis proved that the PAID 
has insignificant clinical importance in the determination of future glycaemic control 
at about one year’s time. The authors argue that its predictive validity could be 
important only for patients who have a clinically significant change in glycaemic 
control. 
 
Concurrent validity was again evaluated in the Welch study (1997) by examining 
the correlations between the PAID and other measures. To this end, correlations were 
calculated separately for four sub-groups divided according to the treatment (type 
1diabetes and type 2 with insulin, tablets or diet treatment) between the PAID and 
various other measures. These were the attitude scale of the Health Belief Model 
(HBM), the Diabetes Social Support scale (DSS), and four diabetes-specific coping 
subscales that emerged from a psychological adjustment to diabetes measure, the 
ATT 39 and the Diabetes Coping Measure (DCM). The results showed that the PAID 
was correlating highly, as expected, with the four coping subscales, the HBM scale, 
and moderately to strong with the DSS for most of the four sub-groups. 
 
Discriminant validity was assessed by examining the differences between IDDM 
and NIDDM treatment groups by using multiple regression analyses. The 
contributions of the four type/treatment sub-groups to the total PAID scores were 
examined, adjusting for sex, duration of diabetes and age of diabetes onset. Type 1 
diabetes patients scored significantly higher than type 2 ones, irrespectively of 
treatment, on the total PAID score. No significant differences were found between 
insulin and tablet treated type 2 patients, contrary to the initial prediction Duration 
of diabetes and gender were not significantly correlated to the PAID. Also, the 
correlations found between the PAID and HbA1c were not statistically significant. 
 
The Dutch study was a cross-sectional one. It examined the PAID for its convergent 
and discriminative validity and compared the results with the USA studies. 
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Convergent validity was assessed by examining the correlations of the PAID Scale 
with other measures and medical variables. There was a low positive association 
between the PAID and HbA1c (0.11), as well as the Self-Monitoring of Blood 
Glucose (0.13). The authors claim that this low correlation was expected.  
 
Moderately high correlations (0.30 – 0.50) were expected between the PAID scale 
and the other impact measures. All associations found confirmed their hypotheses. 
Perceived burden of diabetes correlated strongly with total PAID (0.60). A negative 
moderate correlation was found with overall satisfaction with life (-0.46). Perceived 
health status had an also negative correlation of -0.35 with the total PAID. Women 
showed higher total PAID scores than men. 
 
Discriminative validity was assessed by comparing the total PAID scores with 
various subgroups. People with a history of psychological/psychiatric treatment or 
with one or more hypoglycaemic crises in the previous six months had significantly 
higher scores on the total PAID. Also people with one or more diabetes ketoacidosis 
(DKA) episodes had higher score on total PAID.  
 
Responsiveness 
The fourth subsequent study examined the responsiveness of the PAID (Welch et al.  
2003). Welch and his team obtained longitudinal data from seven diabetes treatment 
interventions that took place between 1999 and 2001. The interventions were of 
medical, educational and psychological nature. The clinical settings were of all three 
care levels; primary, secondary and university’s tertiary institutions. All 
sociodemographic and clinical data together with the PAID scores were statistically 
analysed and responsiveness was calculated using a dependent t-test and by 
calculating the effect size using Cohen’s effect size. The results of this study showed 
that the PAID has a low to moderate responsiveness, with Cohen’s effect size ranging 
between 0.32 and 0.64, and half of the results being in the >0.50 range (moderate). 
The dependent t-test, which was probably used due to the small sample sizes of the 
studies, showed values ranging from 8.5 to 2.1. 
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Burden and Acceptability 
Completion time is reported to be 3-5 minutes. In the first test out of 531 patients 
asked to participate 451 responded, giving an acceptance rate of 84, 9%. This rate 
fell to 70% in the second USA study. In the Dutch study 3,000 questionnaires were 
mailed to members of the Dutch Diabetes Association and 1472 of them were 
returned giving a rate of 49%. When test-retest reliability was assessed in this study, 
the response rate was 81%.  
 
Alternative forms 
In a paper published by Polonsky in 2000 (op.cit), it was announced that the PAID 
had been revised and the PAID-2 was already developed and that the relevant 
publication was in preparation. The revised instrument, longer than the original, 
consisted of 28 items, with four diabetes–specific dimensions: overall emotional 
distress, interpersonal distress, regimen-related distress, and physical-related 
distress. Although the PAID-2 questionnaire can be retrieved from the internet 
(PAID-2), no trace of further discussion about the revised instrument could be found. 
 
Cultural and Language Adaptations 
The PAID has been translated into several languages. These are: Chinese, Finnish, 
Danish, Japanese, Portuguese + for Brazil, German, Spanish, Dutch, Swedish and 
Icelandic. Three years after Polonsky’s announcement about the revision of the 
PAID the instrument was translated and validated into Spanish for Mexicans. 
(Lerman-Garber et al. 2003). The psychometric properties of the translated 
instrument could not be considered reliable as the sample consisted of 20 patients 
only.    
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During the writing of this review two new validated translations appeared in 
literature. One in Icelandic (Sigurdardottir  and Benediktsson, 2008) and the other 
one in Swedish (Amsberg et al.  2008).  
The Swedish translation followed the established forward-backward translation 
process. To adapt the PAID to the Swedish health system, in which the diabetes-
nurses are an important part of care provision, one item was deleted (coping with 
complications) and another one was added (satisfaction with diabetes-specialist 
nurse).   In this study, the exploratory factor analysis performed revealed one factor 
accounting for 46% of the variance. A further Principal Component Analysis was 
carried out in order to derive independent sub-scales. The PCA, contrary to the 
Welch study revealed three sub-dimensions: diabetes-related emotional problems 
(15 items), treatment-related problems (2 items) and support-related problems (3 
items).  Cronbach’s α for the total score was 0.94 and varied between 0.61 (support 
problems) and 0.94 (emotional problems). Item total correlations ranged from 0.34 
to 0.85. Convergent validity was assessed by calculating correlations coefficients 
between the Swe-PAID and the Swedish version of the Hypoglycaemia Fear Survey 
(HFS) as well as HbA1c. The total Swe-PAID showed a moderate positive correlation 
with the total HFS (r=0.45) and a low positive correlation (r=0.25) with HbA1c.  
 
The Icelandic translation followed the forward-backward translation technique. 
Factor analysis was performed revealing two factors: Distress in relation to life with 
diabetes, and distress in relation to management of diabetes. Cronbach’s a for these 
factors were 0.88 and 0.94 respectively. The translators claim that the measure 
showed good convergent and discriminant validity.   
 
Comments 
The whole process of development, revision and adaptation of the PAID seems to be 
unusual. The author recognised some imperfections of the measure and in 2000 
announced a revision of it. Although the revised PAID questionnaire was produced 
it remained unused and untested. Meanwhile the measure was translated into other 
languages (e.g. Spanish for Mexicans). Polonsky himself, three years after his 
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announcement, was member of a team that assessed the responsiveness of the PAID 
(Welch et al. 2003). 
 
In a paper published in 2005 by Polonsky et al.  the measure was criticised as 
insufficient and they announced the creation of a new instrument: the Diabetes 
Distress Scale (DDS).  The criticism was mainly focused on three areas: First, the 
inability of the PAID to cover some critical areas of diabetes. Second, the authors 
discovered that some items created confusion to respondents over the exact meaning 
of the question. And third, the PAID-2, with its 28 items, was considered to be a 
lengthy instrument. Thus, the whole attempt seems to have been abandoned and the 
DDS is the measure that has been proposed instead.  However the PAID, as the two 
2008 translations indicate, still attracts the attention of some researchers for reasons 
that have not been understood yet and should be investigated with personal 
communication in the near future.    
 
 
11 The Diabetes Distress Scale (DDS) 
Background 
The Diabetes Distress Scale is the latest instrument that appeared in the literature of 
diabetes-specific QoL instruments. It was developed by WH Polonsky and his 
associates in the USA and it was published in 2005. The reason for its development, 
according to the authors, was to address some of the limitations that other previously 
developed instruments have, such as the PAID, the QSD-R, and the ATT-39.    
 
Conceptual and Measurement model 
The DDS is a 17 item scale aiming to assess the diabetes-related emotional distress 
for use in research and clinical practice. It contains items from four domains of 
diabetes-related distress. 5 of them addressing emotional burden (EB), 5 regimen-
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related distress (RD), 4 physician-related distress (PD) and 3 diabetes-related 
interpersonal distress (ID). 
 
Item generation 
A revision of the items of the three previous instruments was performed by patients, 
diabetes-nurse specialists, dieticians, diabetologists, and diabetes-knowledgeable 
psychologists. A pool of 50 items was initially derived from four pre-established 
domains (EB, RD, PD, and ID). These items were tested with patients and a 28 items 
scale emerged. A brief examination of these items reveals that the instrument 
proposed is the revised PAID that was announced by Polonski in 2000 but never 
appeared in literature.  
 
Item reduction – scale generation 
Exploratory Factor Analysis was performed for the 28 items scale in four different 
test-sites. Different results occurred and it was decided to retain four factors, 
addressing the four pre-established domains and retest the scale with data from all 
four sites together. From this analysis, and after retaining only the items with a high 
loading on one factor, a shorter scale emerged containing 17 items. The correlation 
between the 28-item and the 17-item scale was examined and found to be extremely 
high (r = 0.99), something that supports the reduction of items. Also, the mean 
correlation between the subscales was very good with total score r = 0.82. 
 
Scoring method 
Respondents are asked to rate the degree to which each item represented a problem 
to them in a 6-point Likert scale, ranging from 1 (no problem) to 6 (serious problem). 
 
Samples 
Four different samples were used at four different test sites. Two of them were in 
diabetes clinics in Dan Diego USA, one in Boston and one in Honolulu. The total 
number of respondents was 683. 52.3% of them were male, with a mean age of 56.3 
years and a mean duration of diabetes of 12.8 years.  83.3% had type 2 diabetes, 
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50.4% of them were insulin users and 88.7% of them had high school education. 
Acceptability rate was at 72% of the sample. 
 
Reliability 
Cronbach’s α was estimated to be at the high level of 0.93 for the combined sample 
of the four test sites.  For the four subscales alphas were: 0.88 for EB, ID, and PD, 
and 0.90 for RD. No other form of reliability has been reported.   
 
Validity and Responsiveness 
The validity assessment of the DDS, according to its authors, was relatively limited 
(Polonsky et al. 2005:630). However, it was assessed by calculating Pearson 
correlation coefficients between the total scale, its four subscales and the CESD 
(Centre for Epidemiological Studies Depression scale), disease management, and 
HbA1c. It was found that the DDS total was unrelated to glycaemic control (r = 0.01) 
as well as sex, ethnicity, educational level, or diabetes duration. DDS total scores 
were positively related with depressive symptomatology as measured by CESD (r = 
0.56), regimen type with insulin users reporting the highest DDS total scores. It was 
also positively related to total cholesterol (r = 0.20) and to poorer adherence to meal 
planning recommendations (r= 0.30). Age was negatively correlated with the total 
score, indicating that young patients report greater diabetes-distress than old ones.   
Responsiveness was not assessed. 
  
Burden and Acceptability 
There is no reference for the time necessary for completion of the DDS. The authors 
suggest that the time needed for the DDS completion as well as the other two 
instruments concerning psychological functioning, self-care behaviours and clinical 
variables is about 15-20 minutes, which seems to be a quite short period of time for 
so many different items and variables.   
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Alternative forms 
None. 
 
Cultural and Language Adaptations 
None. 
Comments 
The DDS seems to have some certain qualities. It is a relatively short instrument, 
with clear to the respondent items. It is a diabetes-burden measure addressing four 
different types of diabetes-distress. However, it has not been assessed properly for 
its validity and reliability. No study has been designed to assess these psychometric 
properties, as none of the mentioned four separate studies were designed for it. A lot 
of further work is needed before it could be considered as a useful instrument. Last, 
it should be taken into consideration that the DDS addresses the diabetes related 
distress only and no other domains of quality of life.   
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Appendix B: The ADDQoL-Gr 
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Appendix C: The GB-ADDQoL  
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Appendix D: Agreement for the translation of 
the ADDQoL 
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Appendix E: SF-36v2 Greek 
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Appendix F: SF-36v2  
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Appendix G: Demographic and clinical 
questionnaire 
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Appendix H: Demographic and clinical 
questionnaire (in English) 
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Appendix I: Consent form 
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Appendix J: Consent form (in English) 
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Appendix K: License Agreement SF-36v2 
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